0001162194-19-000020.txt : 20190318 0001162194-19-000020.hdr.sgml : 20190318 20190318161229 ACCESSION NUMBER: 0001162194-19-000020 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 99 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190318 DATE AS OF CHANGE: 20190318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FLUIDIGM CORP CENTRAL INDEX KEY: 0001162194 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770513190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 19688340 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502666000 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 10-K 1 fye2018form10-k.htm 10-K Document
false--12-31FY20182018-12-3110-K0001162194YesfalseAccelerated FilerFLUIDIGM CORPfalsetrueNoYesFLDMP1YP3YP3YP1YP60DP30D3910001260000.0010.001200000000200000000387870004933800038787000493380000.110.0010.00110000000100000000000P4YP5YP3YP2YP5Y11100000P1YP1YP1YP3YP4Y 0001162194 2018-01-01 2018-12-31 0001162194 2018-06-30 0001162194 2019-03-13 0001162194 2018-12-31 0001162194 2017-12-31 0001162194 us-gaap:ServiceMember 2017-01-01 2017-12-31 0001162194 2017-01-01 2017-12-31 0001162194 us-gaap:ProductMember 2018-01-01 2018-12-31 0001162194 us-gaap:ServiceMember 2018-01-01 2018-12-31 0001162194 2016-01-01 2016-12-31 0001162194 us-gaap:ProductMember 2017-01-01 2017-12-31 0001162194 us-gaap:ProductMember 2016-01-01 2016-12-31 0001162194 us-gaap:LicenseMember 2017-01-01 2017-12-31 0001162194 us-gaap:LicenseMember 2016-01-01 2016-12-31 0001162194 us-gaap:ServiceMember 2016-01-01 2016-12-31 0001162194 us-gaap:LicenseMember 2018-01-01 2018-12-31 0001162194 us-gaap:RetainedEarningsMember 2016-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001162194 us-gaap:RetainedEarningsMember 2018-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001162194 us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001162194 us-gaap:CommonStockMember 2016-01-01 2016-12-31 0001162194 us-gaap:RetainedEarningsMember 2017-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001162194 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001162194 us-gaap:CommonStockMember 2016-12-31 0001162194 us-gaap:CommonStockMember 2017-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0001162194 us-gaap:CommonStockMember 2015-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001162194 us-gaap:AccountingStandardsUpdate201609Member us-gaap:RetainedEarningsMember 2017-01-01 0001162194 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 0001162194 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001162194 us-gaap:RetainedEarningsMember 2015-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001162194 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2018-01-01 0001162194 2016-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-12-31 0001162194 us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001162194 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0001162194 us-gaap:AccountingStandardsUpdate201609Member 2017-01-01 0001162194 us-gaap:CommonStockMember 2018-12-31 0001162194 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001162194 2015-12-31 0001162194 us-gaap:AccountingStandardsUpdate201609Member us-gaap:AdditionalPaidInCapitalMember 2017-01-01 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndFourteenConvertibleNotesMember 2016-01-01 2016-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndFourteenConvertibleNotesMember 2018-01-01 2018-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesPotentialMakeWholeSharesMember 2017-01-01 2017-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesPotentialMakeWholeSharesMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesPotentialMakeWholeSharesMember 2016-01-01 2016-12-31 0001162194 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndFourteenConvertibleNotesMember 2017-01-01 2017-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesMember 2016-01-01 2016-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesMember 2017-01-01 2017-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 2017-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-12-31 0001162194 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2017-12-31 0001162194 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 0001162194 2018-01-01 0001162194 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-12-31 0001162194 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-12-31 0001162194 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-12-31 0001162194 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-12-31 0001162194 srt:MaximumMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:ScenarioForecastMember 2019-01-01 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2018-03-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-28 0001162194 srt:MinimumMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:ScenarioForecastMember 2019-01-01 0001162194 us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 srt:MinimumMember fldm:LaboratoryAndProductionEquipmentMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:LaboratoryAndProductionEquipmentMember 2018-01-01 2018-12-31 0001162194 srt:MinimumMember fldm:CommissionCostsMember 2018-01-01 2018-12-31 0001162194 us-gaap:ProductMember srt:MaximumMember 2018-01-01 2018-12-31 0001162194 us-gaap:FurnitureAndFixturesMember 2018-01-01 2018-12-31 0001162194 us-gaap:ProductMember srt:MinimumMember 2018-01-01 2018-12-31 0001162194 us-gaap:ServiceMember srt:MaximumMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:CommissionCostsMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:ComputerEquipmentAndSoftwareMember 2018-01-01 2018-12-31 0001162194 srt:MinimumMember fldm:ComputerEquipmentAndSoftwareMember 2018-01-01 2018-12-31 0001162194 2019-01-01 2018-12-31 0001162194 2020-01-01 2018-12-31 0001162194 2022-01-01 2018-12-31 0001162194 2021-01-01 2018-12-31 0001162194 srt:AsiaPacificMember 2017-01-01 2017-12-31 0001162194 srt:AmericasMember 2017-01-01 2017-12-31 0001162194 srt:AmericasMember 2018-01-01 2018-12-31 0001162194 us-gaap:EMEAMember 2018-01-01 2018-12-31 0001162194 srt:AsiaPacificMember 2016-01-01 2016-12-31 0001162194 srt:AsiaPacificMember 2018-01-01 2018-12-31 0001162194 us-gaap:EMEAMember 2016-01-01 2016-12-31 0001162194 us-gaap:EMEAMember 2017-01-01 2017-12-31 0001162194 srt:AmericasMember 2016-01-01 2016-12-31 0001162194 fldm:ConsumablesMember 2016-01-01 2016-12-31 0001162194 fldm:ConsumablesMember 2018-01-01 2018-12-31 0001162194 fldm:InstrumentsMember 2018-01-01 2018-12-31 0001162194 fldm:ConsumablesMember 2017-01-01 2017-12-31 0001162194 fldm:InstrumentsMember 2016-01-01 2016-12-31 0001162194 fldm:InstrumentsMember 2017-01-01 2017-12-31 0001162194 fldm:CommissionCostsMember 2018-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2018-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2018-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2016-01-01 2016-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2017-01-01 2017-12-31 0001162194 fldm:DVSSciencesInc.Member 2014-02-28 0001162194 us-gaap:DevelopedTechnologyRightsMember 2018-01-01 2018-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2018-01-01 2018-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2017-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2017-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2017-01-01 2017-12-31 0001162194 us-gaap:OfficeEquipmentMember 2017-12-31 0001162194 us-gaap:OfficeEquipmentMember 2018-12-31 0001162194 fldm:ComputerEquipmentAndSoftwareMember 2018-12-31 0001162194 fldm:LaboratoryAndProductionEquipmentMember 2017-12-31 0001162194 fldm:ComputerEquipmentAndSoftwareMember 2017-12-31 0001162194 fldm:LaboratoryAndProductionEquipmentMember 2018-12-31 0001162194 us-gaap:LeaseholdImprovementsMember 2017-12-31 0001162194 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember 2018-03-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-01 2014-02-28 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-04 0001162194 us-gaap:RevolvingCreditFacilityMember 2018-08-02 2018-08-02 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-04 2014-02-04 0001162194 us-gaap:RevolvingCreditFacilityMember 2018-08-02 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember 2018-03-01 2018-03-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:ConvertibleDebtMember 2014-02-04 2014-02-04 0001162194 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember 2018-08-02 2018-08-02 0001162194 us-gaap:RevolvingCreditFacilityMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:ConvertibleDebtMember 2014-02-04 2014-02-04 0001162194 us-gaap:RevolvingCreditFacilityMember fldm:LoanAgreementOnOrAfterAugust22019Member 2018-08-02 2018-08-02 0001162194 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember 2018-08-02 2018-08-02 0001162194 us-gaap:RevolvingCreditFacilityMember fldm:LoanAgreementPriorToAugust22019Member 2018-08-02 2018-08-02 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:ConvertibleDebtMember 2014-02-04 2014-02-04 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleNotesPayableMember 2018-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleNotesPayableMember 2017-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleNotesPayableMember 2017-12-31 0001162194 us-gaap:ConvertibleNotesPayableMember 2017-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleNotesPayableMember 2018-12-31 0001162194 us-gaap:ConvertibleNotesPayableMember 2018-12-31 0001162194 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2018-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2017-12-31 0001162194 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2017-12-31 0001162194 us-gaap:CashMember 2017-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2018-12-31 0001162194 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2017-12-31 0001162194 us-gaap:CashMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndNineEquityIncentivePlanMember 2018-12-31 0001162194 fldm:TwoThousandAndSeventeenInducementAwardPlanMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndTenEquityIncentivePlanMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndElevenEquityIncentivePlanMember 2018-12-31 0001162194 fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2018-12-31 0001162194 fldm:TwoThousandAndTenEquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndElevenEquityIncentivePlanMember 2018-12-31 0001162194 fldm:TwoThousandAndElevenEquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndTenEquityIncentivePlanMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndSeventeenInducementAwardPlanMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndNineEquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndSeventeenInducementAwardPlanMember 2018-12-31 0001162194 fldm:TwoThousandAndNineEquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:CommonStockMember fldm:TwoThousandAndEighteenMarketOfferingMember 2018-12-14 2018-12-14 0001162194 us-gaap:CommonStockMember fldm:TwoThousandAndSeventeenAtTheMarketEquityOfferingProgramMember 2017-08-10 2017-08-10 0001162194 us-gaap:CommonStockMember fldm:TwoThousandAndEighteenMarketOfferingMember 2018-12-14 0001162194 us-gaap:CommonStockMember fldm:TwoThousandAndSeventeenAtTheMarketEquityOfferingProgramMember 2017-08-10 0001162194 2015-01-01 2015-12-31 0001162194 fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockMember 2016-01-01 2016-12-31 0001162194 us-gaap:EmployeeStockMember 2018-01-01 2018-12-31 0001162194 fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2017-01-01 2017-12-31 0001162194 fldm:OptionsAndRestrictedStockUnitsMember 2017-01-01 2017-12-31 0001162194 fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2016-01-01 2016-12-31 0001162194 fldm:OptionsAndRestrictedStockUnitsMember 2018-01-01 2018-12-31 0001162194 fldm:OptionsAndRestrictedStockUnitsMember 2016-01-01 2016-12-31 0001162194 us-gaap:EmployeeStockMember 2017-01-01 2017-12-31 0001162194 us-gaap:PerformanceSharesMember 2018-01-01 2018-03-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TheProgramMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:VestingScenarioTwoMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2017-08-01 2017-08-01 0001162194 fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 fldm:VestingScenarioTwoMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0001162194 fldm:EquityIncentivePlanMember 2018-01-01 2018-12-31 0001162194 us-gaap:PerformanceSharesMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-01-01 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-12-31 0001162194 fldm:StockOptionsVestingTwoMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 fldm:TheProgramMember 2017-08-23 2017-08-23 0001162194 fldm:StockOptionsVestingOneMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 srt:MinimumMember us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0001162194 us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2018-12-31 0001162194 fldm:A2017InducementAwardPlanMember 2017-01-05 0001162194 fldm:VestingScenarioOneMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 fldm:PerformanceBasedRestrictedStockOptionsMember 2016-01-01 2016-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember fldm:SharebasedCompensationAwardTrancheFourMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:VestingScenarioOneMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001162194 fldm:EquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2018-01-01 2018-12-31 0001162194 fldm:PerformanceBasedStockOptionsMember 2016-01-01 2016-12-31 0001162194 fldm:TheProgramMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2018-01-01 2018-12-31 0001162194 fldm:VestingScenarioTwoMember fldm:EquityIncentivePlanTwentyElevenMember 2018-12-31 0001162194 us-gaap:EmployeeStockMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TheProgramMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-12-31 0001162194 fldm:TheProgramMember 2017-09-20 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TheProgramMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2015-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2017-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2016-12-31 0001162194 us-gaap:PerformanceSharesMember 2017-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-01-01 2018-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-01-01 2017-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-01-01 2016-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2015-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001162194 us-gaap:DomesticCountryMember fldm:ExpiringIn2021Member 2018-12-31 0001162194 stpr:CA us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2018-12-31 0001162194 us-gaap:StateAndLocalJurisdictionMember fldm:ExpiringIn2028Through2039Member 2018-12-31 0001162194 us-gaap:DomesticCountryMember 2018-12-31 0001162194 us-gaap:DomesticCountryMember us-gaap:ResearchMember fldm:ExpiringIn2021Through2039Member 2018-12-31 0001162194 us-gaap:ForeignCountryMember fldm:ExpiringIn2019Through2027Member 2018-12-31 0001162194 srt:MaximumMember 2018-01-01 2018-12-31 0001162194 srt:AsiaPacificMember 2017-12-31 0001162194 us-gaap:EMEAMember 2018-12-31 0001162194 country:CA 2017-12-31 0001162194 country:SG 2017-12-31 0001162194 country:US 2017-12-31 0001162194 country:CA 2018-12-31 0001162194 srt:AsiaPacificMember 2018-12-31 0001162194 us-gaap:EMEAMember 2017-12-31 0001162194 country:US 2018-12-31 0001162194 country:SG 2018-12-31 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember 2017-01-01 2017-12-31 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember 2016-01-01 2016-12-31 0001162194 country:CN us-gaap:RevenueFromContractWithCustomerMember 2017-01-01 2017-12-31 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember 2018-01-01 2018-12-31 0001162194 country:CN us-gaap:RevenueFromContractWithCustomerMember 2018-01-01 2018-12-31 0001162194 country:CN us-gaap:RevenueFromContractWithCustomerMember 2016-01-01 2016-12-31 0001162194 fldm:ThermoMember 2017-08-01 2017-08-30 0001162194 fldm:ThermoMember 2017-07-01 2017-07-31 0001162194 fldm:RansomwareAttackMember us-gaap:SubsequentEventMember 2019-03-12 0001162194 2018-01-01 2018-03-31 0001162194 2018-04-01 2018-06-30 0001162194 2017-01-01 2017-03-31 0001162194 2017-07-01 2017-09-30 0001162194 2018-07-01 2018-09-30 0001162194 2018-10-01 2018-12-31 0001162194 2017-04-01 2017-06-30 0001162194 2017-10-01 2017-12-31 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2019-01-09 2019-02-27 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2019-02-27 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2019-03-01 2019-03-18 0001162194 us-gaap:WarrantyReservesMember 2017-01-01 2017-12-31 0001162194 us-gaap:WarrantyReservesMember 2018-12-31 0001162194 us-gaap:WarrantyReservesMember 2016-12-31 0001162194 us-gaap:WarrantyReservesMember 2015-12-31 0001162194 us-gaap:WarrantyReservesMember 2018-01-01 2018-12-31 0001162194 us-gaap:WarrantyReservesMember 2016-01-01 2016-12-31 0001162194 us-gaap:WarrantyReservesMember 2017-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2016-01-01 2016-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2017-01-01 2017-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2018-01-01 2018-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2017-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2018-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2016-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2015-12-31 xbrli:shares iso4217:USD xbrli:shares iso4217:USD fldm:investment xbrli:pure fldm:segment


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________
FORM 10-K
(Mark One)
x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2018
or
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
_____________________________________________
Commission file number: 001-34180
FLUIDIGM CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
 
77-0513190
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification Number)
7000 Shoreline Court, Suite 100, South San Francisco, California
 
94080

(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (650) 266-6000
_____________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Name of each exchange on which registered
Common Stock, $0.001 Par Value per Share
 
The Nasdaq Global Select Market
Securities registered pursuant to Section 12(g) of the Act:
None
_____________________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act of 1933, as amended.    Yes  x No  ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended.    Yes  ¨    No  x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.    x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer ¨
Accelerated filer x Non-accelerated filer ¨ Smaller reporting company x Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided, pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x
As of June 30, 2018, the aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant was approximately $151,752,358, based on the closing sale price on that date. Shares of common stock held by each executive officer and director and by each other person who may be deemed to be an affiliate of the Registrant have been excluded from this computation. The determination of affiliate status for this purpose is not necessarily a conclusive determination for other purposes.
As of March 13, 2019, there were 68,989,239 shares of the registrant’s common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s Proxy Statement in connection with the registrant’s annual meeting of stockholders, scheduled to be held in June 2019, are incorporated by reference in Part III of this report. Except as expressly incorporated by reference, the registrant’s Proxy Statement shall not be deemed to be part of this report.



Fluidigm Corporation
Fiscal Year 2018
Form 10-K
Annual Report
______________________________________
TABLE OF CONTENTS
 
 
 
 
 
Page
PART I
 
 
 
 
ITEM 1.
 
 
ITEM 1A.
 
 
ITEM 1B.
 
 
ITEM 2.
 
 
ITEM 3.
 
 
ITEM 4.
 
 
 
 
 
PART II
 
 
 
 
 
 
 
ITEM 5.
 
 
ITEM 6.
 
 
ITEM 7.
 
 
ITEM 7A.
 
 
ITEM 8.
 
 
ITEM 9.
 
 
ITEM 9A.
 
 
ITEM 9B.
 
 
 
 
 
PART III
 
 
 
 
 
 
 
ITEM 10.
 
 
ITEM 11.
 
 
ITEM 12.
 
 
ITEM 13.
 
 
ITEM 14.
 
 
 
 
 
PART IV
 
 
 
 
 
 
 
ITEM 15.
 
 
ITEM 16.
 
 
 
 
 
 
 
 
 
 
 

i


Special Note Regarding Forward-looking Statements and Industry Data
This Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or Exchange Act, that are based on our management’s beliefs and assumptions and on information currently available to our management. The forward-looking statements are contained principally in the sections entitled “Business,” “Risk factors,” and “Management’s discussion and analysis of financial condition and results of operations.” Forward-looking statements include information concerning our possible or assumed future cash flow, revenue, sources of revenue and results of operations, cost of product revenue and product margin, operating and other expenses, unit sales and the selling prices of our products, business strategies, financing plans, expansion of our business, competitive position, industry environment, potential growth opportunities, market growth expectations, and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipates,” “believes,” “could,” “seeks,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts, “projects,” “should,” “will,” “would,” or similar expressions and the negatives of those terms.
Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in the section entitled “Risk factors” and elsewhere in this Form 10-K. Given these uncertainties, you should not place undue reliance on these forward-looking statements.
Forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Form 10-K. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. You should read this Form 10-K completely and with the understanding that our actual future results may be materially different from what we expect.
____________________________

“Fluidigm,” the Fluidigm logo, “Access Array,” “Advanta,” “Biomark,” “C1,” “Callisto,” “CyTOF,” “Delta Gene,” “Digital Array,” “Dynamic Array,” “EP1,” “Flex Six,” “Helios,” “Hyperion,” “Imaging Mass Cytometry,” “IMC,” “Juno,” “Maxpar,” “MSL,” “Polaris,” “Script Builder,” “Singular,” and “SNP Type” are trademarks or registered trademarks of Fluidigm Corporation. Other service marks, trademarks and trade names referred to in this Form 10-K are the property of their respective owners.
____________________________

Unless the context requires otherwise, references in this Annual Report on Form 10-K to “Fluidigm,” the “Company,” “we,” “us,” and “our” refer to Fluidigm Corporation and its subsidiaries.






PART I
ITEM 1. BUSINESS
Overview
Fluidigm is a global company that improves life through comprehensive health insight. Our innovative technologies and multi-omic tools are used by researchers to reveal meaningful insights into health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. We create, manufacture, and market a range of products and services, including instruments, reagents and software that are used by researchers worldwide.
Our focus is on the most pressing needs in translational and clinical research, including cancer, immunology and immunotherapy. We use proprietary CyTOF® and microfluidics technologies to develop innovative end-to-end solutions that have the flexibility required to meet the needs of translational research and the robustness to support high-impact clinical research studies.
Our mass cytometry Helios™ system deeply profiles cell phenotype and function. Referenced by hundreds of peer-reviewed publications around the world, mass cytometry is setting a new standard in human immune profiling. Transforming biological imaging, our Hyperion™ Imaging System enables highly multiplexed protein biomarker detection in tissues and tumors while still preserving tissue architecture and cellular morphology information using Imaging Mass Cytometry™ (IMC™). Our microfluidic systems complement our mass cytometry offerings by providing highly scalable and automated workflows for quantitative polymerase chain reaction, or PCR, gene expression, copy number variation analysis, and next-generation sequencing library preparation. Used to detect somatic and genomic variations from a range of different sample types, these automated systems provide the cost efficiencies, flexibility and proven analytical performance that customers need to meet the increasing demands of molecular biomarker analysis.
We are a trusted partner of leading academic, government, pharmaceutical, biotechnology, and plant and animal research laboratories worldwide and we strive to increase the quality of life for all.
Market Opportunity
The current markets for our products address a broad range of biological analysis approaches, including the genome, proteome, transcriptome, epigenomics and microbiome used by academic life science research customers, as well as applied markets customers, including clinical research laboratories, biopharmaceutical companies, biorepositories and agricultural biotechnology entities. Our markets are increasingly looking to study data sets across these approaches in a concerted manner to answer pressing questions about immune function across cancer, immunology and immunotherapy.
Strategy
Key elements of our strategy include:
Offering innovative, differentiated products to researchers based on our mass cytometry and microfluidic technologies.
•
Mass cytometry is a leading solution to analyze many cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Our products enable innovative methods to characterize cells and other sample types not commonly achieved with other conventional technologies.
•
Imaging Mass Cytometry is a pioneering technology allowing for high multiplexed imaging to understand the composition of tissue microenvironments at a subcellular resolution.
•
Our microfluidic technologies enable a scalable and sensitive solution in fields requiring high-throughput molecular biomarker analysis, whether it be for the analysis of gene expression profiles, genotyping or library preparation in advance of gene sequencing. Microfluidic solutions also enable single-cell genomic analysis across a broad menu of applications.

1

Expanding addressable markets through attention to assay content, workflow efficiency, software improvements, desirable strategic partnerships and inorganic growth opportunities.
Our strategy addresses expanded and enhanced applications, workflows and analytics to allow our customers better productivity, increasing the value of our toolsets across our mass cytometry and microfluidics products.
•
We have developed a new workflow for comprehensive human immune monitoring for use with our Helios system, as well as application, sample protocol, antibodies and reagents that researchers use to design their own experiments. We have collaborated with industry partners to enable workflows and software for both the Helios and Hyperion systems.
•
We have developed and collaborated with industry partners to build our applications, software and assays on our microfluidic platforms for gene expression, genotyping and sequencing library preparations as well as single-cell applications for our C1 system. Our future development will leverage both in-house informatics as well as externally-partnered solutions to drive towards sample-to-answer functionality across all our platforms.
Products
We market innovative technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits (IFCs), assays, and reagents. Our primary product offerings are summarized in the table below:
Product
 
Product Description
 
Applications
Mass Cytometry
 
 
 
 
 
 
 
 
 
Analytical Systems:
 
 
 
 
 
 
 
 
 
   Helios™, a CyTOF system
 
The Helios mass cytometry system performs high-parameter single-cell analysis using antibodies conjugated to metal isotopes.
 
Mass Cytometry
 
 
 
 
 
   Hyperion™ Imaging System
 
The Hyperion Imaging System brings together imaging capability with proven high-parameter CyTOF technology to enable the simultaneous detection of up to 37 protein markers in the spatial context of the tissue microenvironment.
 
Imaging Mass Cytometry
 
 
 
 
 
   Hyperion™ Tissue Imager
 
The Hyperion Tissue Imager scans tissues at 1 micron resolution. It can be purchased as an upgrade for the Helios system to enable imaging capability, then referred to as Hyperion Imaging System.
 
Imaging Mass Cytometry
 
 
 
 
 
Assays and Reagents:
 
 
 
 
 
 
 
 
 
   Maxpar® Reagents
 
Maxpar® reagents are included in multiple product lines addressing needs in functional and phenotypic profiling of single cells, as well as nucleic acid detection. The product lines include pre-conjugated antibodies, application specific kits, and custom antibody labeling services.
 
Mass Cytometry and Imaging Mass Cytometry.
 
 
 
 
 
  Maxpar Human Immune
  Monitoring Panel Kit and Workflow
 
The kit contains 29 pre-titrated antibodies designed and optimized for deep immune profiling of human peripheral blood mononuclear cells. Enables comprehensive identification and characterization of key immune cell populations. The workflow includes protocol and data analysis.
 
Mass Cytometry
 
 
 
 
 

2

Product
 
Product Description
 
Applications
Microfluidics
 
 
 
 
 
 
 
 
 
Preparatory Instruments:
 
 
 
 
 
 
 
 
 
   Access Array System
 
A modular, flexible system that automates amplicon-based library preparation of up to 480 amplicons across 48 unique samples per processing run. The resulting barcoded libraries are ready for targeted DNA sequencing on next-generation sequencing (NGS) platforms from Illumina® and Ion Torrent®.
 
Library preparation for targeted DNA sequencing on NGS systems
 
 
 
 
 
   Juno System
 
An integrated system that automates the preparation of amplicon-based libraries for targeted next-generation DNA sequencing. Additionally, Juno automates microfluidic workflows for PCR-based gene expression, genotyping, digital PCR, and copy number variant analysis by processing IFCs prior to analysis on Biomark HD or EP1 platforms.
 
Library preparation for targeted DNA sequencing on NGS systems. End-Point PCR, SNP Genotyping, sample identification, Gene Expression, and digital PCR
 
 
 
 
 
Analytical Instruments:
 
 
 
 
 
 
 
   Biomark HD System
 
Real-time PCR analytical instrument for microfluidics-based analysis of gene expression, single-cell targeted gene expression, microRNA expression, sample identification, SNP genotyping, and real-time digital PCR.
 
SNP Genotyping, sample identification, Digital PCR, and Gene Expression, including Single-Cell Targeted Gene Expression
 
 
 
 
 
   EP1 System
 
End-point PCR analytical instrument for microfluidics-based analysis of SNP genotyping and end-point digital PCR.
 
SNP Genotyping, sample identification, and Digital PCR
 
 
 
 
 
Integrated Fluidic Circuits (IFCs):
 
 
 
 
 
 
 
 
 
   LP IFCs
 
Library Preparation IFCs to support targeted DNA sequencing of 48 or 192 samples on next generation sequencing instruments.
 
Library preparation for targeted next-generation DNA sequencing
 
 
 
 
 
   Juno Genotyping IFC
 
IFC that incorporates preamplification for genotyping of 96 samples and 96 markers on a single run.
 
Genotyping, sample identification
 
 
 
 
 
   Dynamic Array IFCs
 
IFCs based on matrix architecture, allowing users to (i) individually assay up to 24 samples against up to 192 assays, (ii) individually assay up to 48 samples against up to 48 assays, (iii) individually assay up to 96 samples against up to 96 assays, or (iv) individually assay up to 192 samples against up to 24 assays.
 
Real-time qPCR, End-Point PCR, SNP Genotyping and Gene Expression, including Single-Cell Targeted Gene Expression, sample identification, copy number variant analysis
 
 
 
 
 
   Digital Array IFCs
 
IFCs based on partitioning architecture allowing users to (i) individually assay up to 12 samples or panels across 765 chambers, or to (ii) individually assay up to 48 samples across 770 chambers per IFC.
 
Digital PCR, Copy Number Variation and
Variant Detection
 
 
 
 
 
   Flex Six IFC
 
IFC that incorporates six 12 X 12 partitions that can be organized in any configuration, in up to six separate experimental runs.
 
Gene Expression and SNP Genotyping
 
 
 
 
 

3

Product
 
Product Description
 
Applications
Assays and Reagents:
 
 
 
 
 
 
 
 
 
   Delta Gene and SNP Type Assays
 
Custom designed assays targeted to genomic regions of interest for genotyping and gene expression.
 
Gene Expression, Single-Cell Targeted Gene Expression, SNP Genotyping
 
 
 
 
 
   Access Array Target-Specific Primers and Targeted Sequencing Prep Primers
 
Custom designed assays for NGS library preparation using Access Array chemistry on the Access Array or Juno systems.
 
Library preparation for targeted next-generation DNA sequencing
 
 
 
 
 
   Targeted DNA Seq Library Assays
 
Custom designed assays for NGS library preparation using Targeted DNA Sequencing Library Preparation chemistry on the Access Array or Juno systems.
 
Library preparation for targeted next-generation DNA sequencing
 
 
 
 
 
Single Cell Microfluidics
 
 
 
 
 
 
 
 
 
Preparatory Instrument:
 
 
 
 
 
 
 
 
 
   C1 System
 
Sample preparation system that rapidly and reliably isolates and processes individual cells for genomic analysis.
 
Single-Cell Targeted Gene Expression, Single-Cell microRNA Analysis, Single-Cell mRNA Sequencing (Full Length and End-Counting), Single-Cell Targeted DNA Sequencing, Single-Cell Whole Exome Sequencing, and Single-Cell Whole Genome DNA Sequencing, Single-Cell Epigenetics, Total RNA sequencing, T-ATAC-seq, REAP-Seq (RNA and Protein)
 
 
 
 
 
Preparatory Analytical Instruments:
 
 
 
 
 
 
   Polaris System
 
System and IFC that enables single cell contextual studies by facilitating active/live cell selection, isolation, imaging, dosing, and cell culturing workflows.
 
Functional Genomics Using Single-Cell mRNA Sequencing
 
 
 
 
 
   C1 IFCs
 
IFCs that capture up to 800 cells between 5-25 microns in diameter and then automatically process the cells for a variety of genomic analysis using thermal and pneumatic controls at nanoliter scale.
 
Single-Cell Targeted Gene Expression, Single-Cell microRNA Analysis, Single-Cell mRNA Sequencing (Full Length and End-Counting), Single-Cell Targeted DNA Sequencing, Single-Cell Whole Exome DNA Sequencing, and Single-Cell Whole Genome DNA Sequencing, Total RNA sequencing, T-ATAC-seq, REAP-Seq (RNA and Protein). Additional customer and 3rd-party developed applications available through Fluidigm Script Hub
 
 
 
 
 
   Polaris IFC
 
IFC that actively selects, captures and cultures up to 48 single-cells for up to 24 hours. It integrates media exchange, dosing and time course studies followed by cell lysis, reverse transcriptions and library preparation for single cell mRNA sequencing.
 
Functional Genomics of Single Cells
 
 
 
 
 
 
 
 
 
 

4

Technology
Multi-Layer Soft Lithography
Our IFCs are manufactured using multi-layer soft lithography technology, or MSL technology, to create valves, chambers, channels and other fluidic components on our IFCs that allow nanoliter quantities of fluids to be precisely manipulated within the IFC. We have developed commercial manufacturing processes to fabricate valves, channels, vias, and chambers with dimensions in the ten to 100 micron range, at high density and with high yields.
Integrated Fluidic Circuits
Our IFCs incorporate several different types of technology that together enable us to use MSL technology to rapidly design and deploy new microfluidic applications. The first level of our IFC technology is a library of components that perform basic microfluidic functions, such as pumps, mixers, single-cell capture chambers, separation columns, control logic, and reaction chambers. The second level of our IFC technology comprises the architectures we have designed to exploit our ability to conduct thousands of reactions on a single IFC. The third level of our IFC technology involves the interaction of our IFCs with the actual laboratory environment. Our IFCs are built on specially designed input frames that are compatible with most commonly used laboratory systems.
Instrumentation and Software
Our mass cytometry instrumentation technology includes a custom-designed inductively coupled plasma ion source, ion-optical and vacuum systems, and instrument control electronics. With our Helios system, which is an enhanced version of our CyTOF 2 system, individual cells are atomized, ionized, and extracted. A time-of-flight mass analyzer separates atomic ions of different mass-to-charge ratios, providing information on temporal distribution of ions. The Hyperion Imaging System combines mass cytometry technology with imaging capability to enable simultaneous interrogation of up to 37 protein markers in the spatial context of the tissue microenvironment. Our systems have the ability to utilize up to 135 channels to detect additional parameters to meet future market needs.
Our Biomark HD system includes our custom thermal cycler, the FC1 cycler, and a sophisticated fluorescence imaging system. Our EP1 instrument is a fluorescence reader designed for end-point imaging, suitable for genotyping and digital PCR applications. Our C1 system combines the hardware elements of our IFC controllers and FC1 cycler with sophisticated scripting and protocol control software to enable automation of single-cell capture and preparation for subsequent analysis. Certain capabilities of the C1 system have been used to create our Juno system, which serves as a universal controller and cycler for our Dynamic Array IFCs. Our Polaris system combines the capabilities of all these instruments by incorporating thermal cycling, IFC control, environmental regulation, and imaging.
We have developed instrumentation technology to load samples and reagents onto our IFCs and to control and monitor reactions within our IFCs. Our line of IFC controllers consists of commercial pneumatic components and both custom and commercial electronics. They apply precise control of multiple pressures to move fluid and control valve states in a microfluidic IFC.
We have also developed specialized software to manage and analyze the unusually large amounts of data produced by our systems. We offer Fluidigm Cytobank, our cloud-based platform of analytical tools, for use with the Helios system. Our bioinformatic toolset, the Singular software, facilitates the analysis and visualization of single-cell gene expression data. More recently, we extended the scope of the toolset to include DNA analysis tools. We also developed the C1 Script Builder software to enable customers to take full advantage of the flexibility of C1 IFC architecture by allowing them to program their own control scripts for the C1 system.
Assays and Reagents
We manufacture metal-conjugated antibodies for use with our mass cytometry instruments to allow detection of up to approximately 37 protein targets simultaneously in a single cell. Our metal-conjugated antibodies are manufactured using metal-chelating polymers, which are produced using proprietary polymerization processes and subsequent post-polymerization modifications.
Our Delta Gene and single-nucleotide polymorphism type, or SNP Type, assay products consist of assay design and custom content delivery systems for gene expression and genotyping, respectively. These offerings provide low-cost alternatives to other available chemistries, and allow customers to use IFCs in more flexible ways. PCR assay reagents need to be specific to the gene targets of interest but the process of designing a set of assays may delay the implementation experiments or require the use of expensive pre-designed assays. We have developed a process to provide customers with validated assays for their targets of interest.

5

Life Science Research
Our products enable comprehensive interrogation of biological samples across a range of genomic and protein molecular biomarkers.
Genomics
One primary area of focus within life science research is genetic analysis, the study of genes and their functions. The hereditary material or nucleic acid of an organism is often referred to as its genome, the protein-encoding regions of which are commonly known as genes. Analysis of variations in genomes, genes and gene activity in and between organisms can provide valuable insight into their health and functioning. Single-cell genomics is the study of the sequence and expression of genes and their ultimate functions at the individual cell level.
There are several forms of genetic analysis in use today, including genotyping, gene expression analysis and DNA sequencing:
•
Genotyping involves the analysis of DNA variations across individual genomes. There are multiple forms of variants, including single nucleotide polymorphism, or SNPs, insertion-deletions and copy number variation. A common application of genotyping focuses on analyzing SNPs to determine whether a SNP or group of SNPs are associated with a particular genetic trait, such as propensity for a disease.
•
Gene expression analysis involves measuring the levels of particular ribonucleic acid sequences known as messenger RNAs, or mRNAs, which have been transcribed from genes. Determining these levels is important because mRNAs are often translated by the cell into proteins, and may affect the activity of the cell or the larger organism.
•
DNA sequencing is a process by which researchers are able to determine the particular order of nucleotide bases that comprise all or a portion of a particular gene or genome, and typically improves with target enrichment, such as complex sample preparation and tagging processes. Researchers are increasingly using next-generation DNA sequencers to rapidly and cost-effectively sequence portions of genomes, which is important for the identification of genetic variations that correlate with particular phenotypes.
Gene expression and genotyping are studied through a combination of various technology platforms that characterize gene function and genetic variation. These platforms often rely on PCR amplification to generate exponential copies of a DNA sample to provide sufficient signal to facilitate detection. Real-time quantitative PCR, or real-time qPCR, is a more advanced form of PCR that makes it possible to quantify the number of copies of DNA present in a sample.
Proteomics
Another focus within life science research is protein analysis, the study of proteins and their structures and functions. Proteins perform a vast array of functions within living organisms, including catalyzing metabolic reactions, replicating DNA, signaling response to stimuli and transporting molecules from one location to another. The proteome varies and is dynamic. Every cell in an individual organism has the same set of genes, but the set of proteins produced in different tissues differ from one another and are dependent on gene expression. Protein analysis is required to profile and understand cellular function as well as the interaction in tissues and other complex microenvironments.
There are several forms of high-throughput protein analysis in use today, including mass spectrometry, traditional flow cytometry, immunohistochemistry and both suspension and imaging mass cytometry.
•
Mass spectrometry is an analytical chemistry technique that measures the mass-to-charge ratio in molecules using external electric and magnetic fields. Mass spectrometry techniques are limited to bulk samples and provide an understanding of global protein dynamics on a tissue or organism level, but do not, by themselves, enable researchers to analyze data at a single cell level.
•
Traditional flow cytometry utilizes a suspension of cells in a stream of fluid and passes them through an electronic detection apparatus to allow simultaneous multi-parameter analysis of the physical and chemical characteristics of up to thousands of cells per second. Although traditional flow cytometry technologies are high-throughput with single-cell analysis capabilities, a key limitation is the use of fluorescent dyes to label antibodies for detection. These fluorescent labels have emission spectra that typically overlap, making it challenging to optimize reagents to analyze many protein markers at once. In general, the number of protein targets for conventional flow cytometry is less than about 10 with significant reagent optimization often involved.

6

•
Immunohistochemistry is a method by which cells in a tissue section are stained with antibodies and then imaged with a conventional or fluorescent microscope. Antibodies selected to bind to proteins of interest can be conjugated with either chromogenic or fluorescent labels, allowing cellular proteins to be visualized in spatial context. Immunohistochemistry is used broadly throughout the life sciences industry, and in clinical research to better understand the characteristics and relationship of cancerous versus normal cells in biopsy tissue. In general, the number of simultaneously imageable proteins is less than five, with researchers only able to achieve a higher-parameter resolution using serial sections (several adjacent sections of the same tissue) or other highly laborious, more serial staining methods.
•
Suspension mass cytometry is similar to traditional flow cytometry but is based primarily on antibodies using heavy metal isotope labels rather than fluorescent labels for detection of proteins, enabling the significant expansion of the number of parameters analyzed per individual cell versus conventional flow cytometry technologies. With high-throughput, single-cell analysis capabilities and the ability to analyze more protein markers per individual cell, researchers have more granular information, which allows them to identify and characterize even finer subpopulations of cells.
•
Imaging mass cytometry is similar to immunohistochemistry, but is also based primarily on antibodies using heavy metal isotope labels rather than fluorescent or chromogenic labels for detection of proteins. This method enables a significant expansion of the number of parameters simultaneously analyzed per tissue section rather than in adjacent sections or via serial staining protocols.
Customers
We sell our instruments to leading academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, and biopharmaceutical, biotechnology, and plant and animal research companies. No single customer represented more than 10% of our total revenue for 2018, 2017, or 2016.
Marketing, Sales, Service and Support
We distribute our systems through our direct sales force and support organizations located in North America, Europe, and Asia-Pacific, and through distributors or sales agents in several European, Latin American, Middle Eastern, and Asia-Pacific countries. Our sales and marketing efforts are targeted at laboratory directors and principal investigators at leading academic, translational research, healthcare consortiums, and biopharmaceutical companies who need reliable life science automation solutions to power their disease research with the goal of providing actionable insights.
Our sales process often involves numerous interactions and demonstrations with multiple people within an organization. Some potential customers conduct in-depth evaluations of the system, including running experiments on our system and competing systems. In addition, in most countries, sales to academic or governmental institutions require participation in a tender process involving preparation of extensive documentation and a lengthy review process. As a result of these factors and the budget cycles of our customers, our sales cycle, the time from initial contact with a customer to our receipt of a purchase order, can often be 12 months or longer.
As of December 31, 2018, we had 190 people employed in sales, technical support, and marketing, including 82 sales representatives and applications specialists located in the field.
Manufacturing
Our manufacturing operations are primarily located in Singapore and Canada. Our facility in Singapore manufactures our IFCs and manages production of our genomics instruments, which are assembled by our contract manufacturer located within our Singapore facility. All of our IFCs for commercial sale and some IFCs for our research and development purposes are also fabricated at our Singapore facility. Our mass cytometry instruments for commercial sale, as well as for internal research and development purposes, are manufactured at our facility in Canada. We also manufacture assays and reagents at our facilities in the United States.  As part of our on-going efforts related to operational excellence and improving efficiencies, we are consolidating our North American production activities into our Canadian facility.     
We rely on a limited number of suppliers for certain components and materials used in our products. Key components in our products that are supplied by sole or limited source suppliers include a specialized polymer and other specialized materials from which our IFC cores are fabricated, specialized custom camera lenses, fiber light guides, and other components required for the reader of our Biomark system; specialized pneumatic and electronic components for our C1, Juno, Callisto, and Polaris systems; the electron multiplier detector included in, and certain metal isotopes used with, our

7

Helios system; specially developed lasers used in our Hyperion Imaging System; and certain raw materials for our Delta Gene and SNP Type assays and Access Array Target-Specific primers. The loss of a single or sole source supplier would require significant time and effort to locate and qualify an alternative source of supply, if at all, and could adversely impact our business. For additional information, please see the section entitled “Risk factors” in Part I, Item 1A of this Form 10-K.
Research and Development
We have assembled experienced research and development teams at our South San Francisco, California, Markham, Ontario, Canada, and Singapore locations with the scientific, engineering, software, bioinformatic, and process talent that we believe is required to grow our business.
The largest component of our current research and development effort is in the areas of new products, new applications and new content. We developed a high-throughput C1 IFC (HT IFC) for handling up to 800 medium sized cell types applied to the work-flows of the Fluidigm-installed base instruments. In the area of mass cytometry, we developed an initial prototype imaging mass cytometer instrument in 2016, and successfully launched the commercial Hyperion Imaging System in October 2017. The imaging mass cytometer system provides spatial resolution of protein expression in complex tissue samples at the single-cell level, quantitative measurement using metal isotope tags, and analysis of up to 37 proteins. We also developed metal-labeled antibodies compatible with formalin fixed paraffin embedded tissue samples, to be used with the Hyperion. We also invest significantly in research and development efforts to expand our single-cell and production genomics applications. For example, we continue to develop and commercialize various panel sets for cancer research for use with our systems. In 2017, we successfully launched the Advanta™ Immuno-Oncology Gene Expression Assay, which is a 170-gene expression qPCR assay that enables profiling of tumor immunobiology and new biomarker identification.
The second component of our research and development effort is to continuously develop new manufacturing processes and test methods to drive down manufacturing costs, increase manufacturing throughput, widen fabrication process capability, and support new microfluidic devices and designs.
Our research and development expenses were $30.0 million, $30.8 million and $38.4 million in 2018, 2017, and 2016 respectively. As of December 31, 2018, 103 of our employees were engaged in research and development activities.
Competition
The life science markets are highly competitive and expected to grow more competitive with the increasing knowledge gained from ongoing research and development. We believe that the principal competitive factors in our target markets include competition for human resources; cost of capital equipment and supplies; reputation among customers; innovation in product offerings; flexibility and ease of use; accuracy and reproducibility of results; and compatibility with existing laboratory processes, tools, and methods.
We compete with both established and development stage life science companies that design, manufacture, and market instruments for gene expression analysis, genotyping, other nucleic acid detection, protein expression analysis, imaging, and additional applications. In addition, a number of other companies and academic groups are in the process of developing novel technologies for life science markets. Many of our competitors enjoy several competitive advantages over us, including significantly greater name recognition; greater financial and human resources; broader product lines and product packages; larger sales forces and eCommerce channels; larger and more geographically dispersed customer support organization; substantial intellectual property portfolios; larger and more established customer bases and relationships; greater resources dedicated to marketing efforts; better established and larger scale manufacturing capability; and greater resources and longer experience in research and development. For additional information, please see the section entitled “Risk factors” in Part I, Item 1A of this Form 10-K.
To successfully compete with existing products and future technologies, we need to demonstrate to potential customers that the performance of our technologies and products, the solutions we provide our customers, as well as our customer support capabilities, are superior to those of our competitors. To differentiate our company from other, larger enterprises, we need to introduce new and innovative offerings regularly and maintain a well-staffed commercial team “in the field” to successfully communicate the advantages of our products and overcome potential obstacles to acceptance of our products. In addition, ongoing collaborations and partnerships with key opinion leaders are desirable to demonstrate both biological innovation and applications that solve customer problems.

8

Intellectual Property
Patents
We have developed a portfolio of issued patents and patent applications directed to commercial products and technologies in development. As of December 31, 2018, we owned or licensed over 550 patents and we had approximately 155 pending patent applications worldwide. Our patents have expiration dates ranging up to 2036.
License Agreements
We have entered into licenses for technologies from various companies and academic institutions.
Microfluidic Technologies. Our core microfluidics technology originated at the California Institute of Technology, or Caltech, in the laboratory of Professor Stephen Quake, who is a co-founder of Fluidigm. We license microfluidics technology from Caltech, Harvard University, and Caliper Life Sciences, Inc. (Caliper), which subsequently became a PerkinElmer company:
•
We exclusively license from Caltech relevant patent filings relating to developed technologies that enable the production of specialized valves and pumps capable of controlling fluid flow at nanoliter volumes. The license agreement will terminate as to each country and licensed product upon expiration of the last-to-expire patent covering licensed products in each country. The U.S. issued patents we have licensed from Caltech expire between 2017 and 2030.
•
We have entered into a co-exclusive license agreement with Harvard University for the license of relevant patent filings relating to microfluidic technology. The license agreement will terminate with the last-to-expire of the licensed patents. The U.S. issued patents we have licensed from Harvard University expire between 2019 and 2027.
•
In May 2011, we entered into a license agreement with Caliper to license Caliper’s existing patent portfolio in certain fields. The license agreement will terminate with the last-to-expire of the licensed patents. As later amended, the license agreement provides for certain royalty payments until mid-2018 for our existing products at the time of amendment and their future equivalents.
Instrumentation and Digital PCR. On June 30, 2011, we settled litigation and entered into a series of patent cross-license and sub-license agreements with Life Technologies Corporation (now part of Thermo Fisher Scientific) and its subsidiary Applied Biosystems, LLC, referred to as Life. The agreements involve a cross-license concerning our imaging readers and other patent filings and certain of Life’s patent families relating to methods and instruments for conducting nucleic acid amplification, such as with PCR; a sub-license that provides us access to certain of Life’s digital PCR patents; and a sublicense that provides Life access to certain of our non-core technology patents licensed from Caltech. In July 2011, pursuant to the terms of the agreements, we paid Life $2.0 million in connection with our exercise of an option to preclude Life from initiating litigation under its patents existing as of June 30, 2011 against our customers for two years and against our company, with respect to our current products and equivalent future products, for four years, subject to certain exceptions. In November 2017, we settled pending litigation with Life and, pursuant to the terms of the settlement, one of the patent license agreements was amended to provide Life with a fully paid-up license under the patents covered by the agreement, subject to certain field of use restrictions. The license agreement will terminate with the last-to-expire of the licensed patents, which is expected to be in 2028.
Mass Cytometry. Some of the intellectual property rights covering our mass cytometry products were subject to a license agreement, referred to as the Original License Agreement, between Fluidigm Canada Inc., referred to as Fluidigm Canada, and PerkinElmer Health Sciences, Inc., referred to as PerkinElmer. Under the Original License Agreement, Fluidigm Canada received an exclusive, royalty bearing, worldwide license to certain patents owned by PerkinElmer in the field of inductively coupled plasma, or ICP-based mass cytometry, including the analysis of elemental tagged materials in connection therewith, referred to as the Patents, and a non-exclusive license for reagents outside the field of ICP-based mass cytometry.  On November 4, 2015, we entered into a patent purchase agreement with PerkinElmer pursuant to which we purchased the Patents for a purchase price of $6.5 million and a patent assignment agreement pursuant to which PerkinElmer transferred and assigned to us all rights, title, privileges, and interest in and to the Patents and the Original License Agreement.  Accordingly, we have no further financial obligations to PerkinElmer under the Original License Agreement.  Contemporaneously with the purchase of the Patents, we entered into a license agreement with PerkinElmer pursuant to which we granted PerkinElmer a worldwide, non-exclusive, fully paid-up license to the Patents in fields other than (i) ICP-based mass analysis of atomic elements associated with a biological material, including any elements that are unnaturally bound, directly or indirectly, to such biological material (Mass Analysis) and (ii) the development, design,

9

manufacture, and use of equipment or associated reagents for such Mass Analysis.  The license will terminate on the last expiration date of the Patents, currently expected to be in December 2025, unless earlier terminated pursuant to the terms of the license agreement.
Any loss, termination, or adverse modification of our licensed intellectual property rights could have a material adverse effect on our business, operating results, and financial condition. For additional information, please see the section entitled “Risk factors” in Part I, Item 1A of this Form 10-K.
Other
In addition to pursuing patents and licenses on key technologies, we have taken steps to protect our intellectual property and proprietary technology by entering into confidentiality agreements and intellectual property assignment agreements with our employees, consultants, corporate partners, and, when needed, our advisors.
Government Regulation
Our products are currently labeled and sold for research purposes only, and we sell them to academic institutions, life sciences and clinical research laboratories that conduct research, and biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Our products are not intended or promoted for use in clinical practice in the diagnosis of disease or other conditions, and they are labeled for research use only, not for use in diagnostic procedures. Accordingly, they are not subject to regulation by the U.S. Food and Drug Administration (FDA). Rather, while FDA regulations require that research use only products be labeled, “For Research Use Only. Not for use in diagnostic procedures,” or RUO products, the regulations do not subject such products to the FDA’s jurisdiction or the broader pre- and post-market controls for medical devices.
In November 2013, the FDA issued a final guidance document stating that merely including a labeling statement that the product is for research purposes only will not necessarily render the device exempt from the FDA’s clearance, approval, or other regulatory requirements if the totality of circumstances surrounding the distribution of the product indicate that the manufacturer knows its product is being used by customers for diagnostic uses or the manufacturer intends such a use. These circumstances may include, among other things, written or verbal marketing claims regarding a product’s performance in clinical diagnostic applications and a manufacturer’s provision of technical support for such activities. In the future, certain of our products or related applications could become subject to regulation as medical devices by the FDA. If we wish to label and market our products for use in performing clinical diagnostics, thus subjecting them to regulation by the FDA under premarket and postmarket control as medical devices, unless an exemption applies, we would be required to obtain either prior 510(k) clearance or prior pre-market approval from the FDA before commercializing the product. The FDA classifies medical devices into one of three classes. Devices deemed to pose lower risk to the patient are placed in either class I or II, which, unless an exemption applies, requires the manufacturer to submit a pre-market notification requesting FDA clearance for commercial distribution pursuant to Section 510(k) of the FFDCA. This process, known as 510(k) clearance, requires that the manufacturer demonstrate that the device is substantially equivalent to a previously cleared and legally marketed 510(k) device or a “pre-amendment” class III device for which pre-market approval applications, or PMAs, have not been required by the FDA. This FDA review process typically takes from four to twelve months, although it can take longer. Most class I devices are exempted from this 510(k) premarket submission requirement. Devices deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting, or implantable devices, or those deemed not substantially equivalent to a legally marketed predicate device, are placed in class III. Class III devices typically require PMA approval. To obtain PMA approval, an applicant must demonstrate the reasonable safety and effectiveness of the device based, in part, on data obtained in clinical studies. PMA reviews generally last between one and two years, although they can take longer. Both the 510(k) and the PMA processes can be expensive and lengthy and may not result in clearance or approval. If we are required to submit our products for pre-market review by the FDA, we may be required to delay marketing and commercialization while we obtain premarket clearance or approval from the FDA. There would be no assurance that we could ever obtain such clearance or approval.
In some cases, our customers may use our RUO products in their own laboratory-developed tests, or LDTs, or in other FDA-regulated products for clinical diagnostic use. The FDA has historically exercised enforcement discretion in not enforcing the medical device regulations against LDTs and LDT manufacturers. However, on October 3, 2014, the FDA issued two draft guidance documents that set forth the FDA’s proposed risk-based framework for regulating LDTs, which are designed, manufactured, and used within a single laboratory. In January 2017, the FDA announced that it would not issue final guidance on the oversight of LDTs and LDT manufacturers, but would seek further public discussion on an appropriate oversight approach and give Congress an opportunity to develop a legislative solution. Any future legislative or administrative rule making or oversight of LDTs and LDT manufacturers if and when finalized, may impact the sales of our

10

products and how customers use our products, and may require us to change our business model in order to maintain compliance with these laws.
We would become subject to additional FDA requirements if our products are determined to be medical devices or if we elect to seek 510(k) clearance or pre-market approval. We would need to continue to invest significant time and other resources to ensure ongoing compliance with FDA quality system regulations and other post-market regulatory requirements. For additional information, please see the section entitled “Risk factors” in Part I, Item 1A of this Form 10-K.
International sales of medical devices are subject to foreign government regulations, which vary substantially from country to country. Outside of the EU, regulatory approval needs to be sought on a country-by-country basis in order to market medical devices. Although there is a trend towards harmonization of quality system, standards and regulations in each country may vary substantially which can affect timelines of introduction.
Environmental Matters
We are subject to many federal, state, local, and foreign environmental regulations. To comply with applicable regulations, we have and will continue to incur significant expense and allocate valuable internal resources to manage compliance-related issues. In addition, such regulations could restrict our ability to expand or equip our facilities, or could require us to acquire costly equipment or to incur other significant expenses to comply with the regulations. For example, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive (RoHS) and the Waste Electrical and Electronic Equipment Directive (WEEE), both enacted in the European Union, regulate the use of certain hazardous substances in, and require the collection, reuse, and recycling of waste from, products we manufacture. Certain of our products sold in these countries are subject to RoHS and WEEE requirements. If we fail to comply with any present and future regulations, we could be subject to future fines, penalties, and restrictions, such as the suspension of manufacturing of our products or a prohibition on the sale of products we manufacture. For additional information, please see the section entitled “Risk factors” in Part I, Item 1A of this Form 10-K.
Additionally, our research and development and manufacturing processes involve the controlled use of hazardous materials, including flammables, toxics, corrosives, and biologics. Our research and manufacturing operations produce hazardous biological and chemical waste products. We seek to comply with applicable laws regarding the handling and disposal of such materials. The volume of such materials used or generated at our facilities is small. However, we cannot eliminate the risk of accidental contamination or discharge and any resultant injury from these materials. We do not currently maintain separate environmental liability coverage and any such contamination or discharge could result in significant cost to us in penalties, damages, and suspension of our operations.
Geographic Area Information
During the last three years, a significant portion of our revenue was generated outside of the United States. Total revenue received from customers outside the United States totaled $64.8 million, or 57% of our total revenue, in 2018, compared to $56.1 million, or 55% of our total revenue, in 2017, and $51.8 million, or 50% of our total revenue, in 2016. The majority of our long-lived assets are located within the United States, in Singapore and in Canada. Please see Note 3 and Note 12 to our audited consolidated financial statements for additional information regarding geographic areas.
Seasonality
Our business is not subject to significant seasonality. However, the timing of customer orders and shipments, customer budget and spending cycles, and new product releases can result in variability in our quarterly revenues.
Raw Materials
Certain raw materials used in our Delta Gene and SNP Type assays and Access Array target-specific primers are available from a limited number of sources. Additionally, certain metals used in our Maxpar reagents are available from a sole source. Currently, we do not have supply agreements with these suppliers. While we generally attempt to keep our inventory at minimal levels, we purchase incremental inventory as circumstances warrant to protect our supply chain.
Backlog
We manufacture products based on forecasts of our customers’ demand and advance non-binding commitments from customers as to future purchases. Our customers generally do not place purchase orders far in advance. A substantial portion

11

of our products are sold on the basis of standard purchase orders that are cancellable prior to shipment without penalty. Accordingly, backlog at any given time is not a meaningful indicator of future sales.
Employees
As of December 31, 2018, we had 535 employees, of which 103 work in research and development, 107 work in general and administrative, 135 work in manufacturing, and 190 work in sales, technical support, and marketing. None of our employees are represented by a labor union nor are they subject to a collective bargaining agreement.
Corporate and Available Information
We were incorporated in California in May 1999 as Mycometrix Corporation, changed our name to Fluidigm Corporation in April 2001, and reincorporated in Delaware in July 2007. Our principal executive offices are located at 7000 Shoreline Court, Suite 100, South San Francisco, California 94080. Our telephone number is (650) 266-6000. Our website address is www.fluidigm.com. We make available on our website, free of charge, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any amendments to those reports, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission, or SEC. Our SEC reports can be accessed through the investor relations page of our website located at http://investors.fluidigm.com. The SEC also maintains an Internet site at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that electronically file with the SEC.
The contents of our website are not a part of, and are not incorporated by reference into, this Annual Report on Form 10-K or any other report or document we file with the SEC. Any reference to our website is intended to be an inactive textual reference only.


12

ITEM 1A. RISK FACTORS
We operate in a rapidly changing environment that involves numerous uncertainties and risks. The following risks and uncertainties may have a material and adverse effect on our business, financial condition, or results of operations. You should consider these risks and uncertainties carefully, together with all of the other information included or incorporated by reference in this Form 10-K. The risks described below are not the only ones we face. Our business is also subject to the risks that affect many other companies, such as employment relations, general economic conditions, geopolitical events and international operations. Further, additional risks not currently known to us or that we currently believe are immaterial may in the future materially and adversely affect our business, operations, liquidity and stock price. If any of the risks or uncertainties we face were to occur, the trading price of our securities could decline, and you may lose all or part of your investment.
Risks Related to Fluidigm’s Business and Strategy
Our financial results and revenue growth rates have varied significantly from quarter-to-quarter and year-to-year due to a number of factors, and a significant variance in our operating results or rates of growth, if any, could lead to substantial volatility in our stock price.
Our revenue, results of operations, and revenue growth rates have varied in the past and may continue to vary significantly from quarter-to-quarter or year-to-year. We may experience substantial variability in our product mix from period-to-period as revenue from sales of our instruments relative to sales of our consumables may fluctuate or deviate significantly from expectations. For example, our revenue declined year-over-year in 2016 compared to 2015, and in 2017 compared to 2016. In 2018, we returned to revenue growth, but we may not be able to achieve similar revenue growth in future periods. We are also increasingly dependent on our mass cytometry business, which is very capital intensive. Variability in our quarterly or annual results of operations, mix of product revenue, including any decline in our mass cytometry revenue, or variability in rates of revenue growth, if any, may lead to volatility in our stock price as research analysts and investors respond to these fluctuations. These fluctuations are due to numerous factors that are difficult to forecast, including: fluctuations in demand for our products; changes in customer budget cycles and capital spending; seasonal variations in customer operations; tendencies among some customers to defer purchase decisions to the end of the quarter; the large unit value of our systems, particularly our proteomics systems; changes in our pricing and sales policies or the pricing and sales policies of our competitors; our ability to design, manufacture, market, sell, and deliver products to our customers in a timely and cost-effective manner; fluctuations or reductions in revenue from sales of legacy instruments that may have contributed significant revenue in prior periods; quality control or yield problems in our manufacturing operations; our ability to timely obtain adequate quantities of the materials or components used in our products, which in certain cases are purchased through sole and single source suppliers; new product introductions and enhancements by us and our competitors; unanticipated increases in costs or expenses; our complex, variable and, at times, lengthy sales cycle; global economic conditions; and fluctuations in foreign currency exchange rates. Additionally, we have certain customers who have historically placed large orders in multiple quarters during a calendar year. A significant reduction in orders from one or more of these customers could adversely affect our revenue and operating results, and if these customers defer or cancel purchases or otherwise alter their purchasing patterns, our financial results and actual results of operations could be significantly impacted. Other unknown or unpredictable factors also could harm our results.
The foregoing factors, as well as other factors, could materially and adversely affect our quarterly and annual results of operations and rates of revenue growth, if any. We have experienced significant revenue growth in the past but we may not achieve similar growth rates in future periods. You should not rely on our operating results for any prior quarterly or annual period as an indication of our future operating performance. If we are unable to achieve adequate revenue growth, our operating results could suffer and our stock price could decline. In addition, a significant amount of our operating expenses are relatively fixed due to our manufacturing, research and development, and sales and general administrative efforts. Any failure to adjust spending quickly enough to compensate for a shortfall relative to our anticipated revenue could magnify the adverse impact of such shortfalls on our results of operations. We expect that our sales will continue to fluctuate on an annual and quarterly basis and that our financial results for some periods may be below those projected by securities analysts, which could significantly decrease the price of our common stock.
We have incurred losses since inception, and we may continue to incur substantial losses for the foreseeable future.
We have incurred significant losses in each fiscal year since our inception, including net losses of $59.0 million, $60.5 million, and $76.0 million during the years 2018, 2017, and 2016, respectively. As of December 31, 2018, we had an accumulated deficit of $558.9 million. These losses have resulted principally from costs incurred in our research and development programs, and from our manufacturing costs and selling, general, and administrative expenses. To date, we have funded our operations primarily through equity offerings, the issuance of debt instruments, and from sales of our products.

13

Until we are able to generate additional revenue to support our level of operating expenses, we will continue to incur operating and net losses and negative cash flow from operations. We believe that our continued investment in research and development, sales, and marketing is essential to our long-term competitive position and future revenue growth and, as a result, we may incur operating losses for the foreseeable future and may never achieve profitability.
The life science markets are highly competitive and subject to rapid technological change, and we may not be able to successfully compete.
The markets for our products are characterized by rapidly changing technology, evolving industry standards, changes in customer needs, emerging competition, new product introductions, and strong price competition. We compete with both established and development stage life science research companies that design, manufacture, and market instruments and consumables for gene expression analysis, single-cell targeted gene expression or protein expression analysis, single nucleotide polymorphism genotyping, or SNP genotyping, polymerase chain reaction, or PCR, digital PCR, other nucleic acid detection, flow cytometry, cell imaging, and additional applications using well established laboratory techniques, as well as newer technologies such as bead encoded arrays, microfluidics, nanotechnology, high-throughput DNA sequencing, microdroplets, and photolithographic arrays. Most of our current competitors have significantly greater name recognition, greater financial and human resources, broader product lines and product packages, larger sales forces, larger existing installed bases, larger intellectual property portfolios, and greater experience and scale in research and development, manufacturing, and marketing than we do. For example, companies such as 10X Genomics, Inc., Affymetrix, Inc. (now part of Thermo Fisher Scientific Inc.), Agena Bioscience, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cellular Research, Inc. (now a part of Becton, Dickinson and Company), Danaher Corporation, Illumina, Inc., Life Technologies Corporation (now part of Thermo Fisher Scientific Inc.), LGC Limited, Luminex Corporation, Millipore Corporation, NanoString Technologies, Inc., PerkinElmer, Inc. (through its acquisition of Caliper Life Sciences, Inc.), RainDance Technologies, Inc. (acquisition by Bio-Rad Laboratories, Inc. pending), Roche Diagnostics Corporation, Sony Corporation, Thermo Fisher Scientific Inc., WaferGen Bio-systems, Inc., Cytek Biosciences, Inc., Akoya Biosciences, Inc., Innova Biosciences Ltd., QIAGEN N.V., 1CellBio, Inc., Berkeley Lights, Inc., and Mission Bio, Inc. have products that compete in certain segments of the market in which we sell our products. In addition, we have experienced increased competition in the single-cell genomics market, including new product releases from 10X Genomics, Inc. and WaferGen Bio-systems, Inc., as well as the acquisition of Cellular Research by Becton Dickinson and Company and an announced exclusive partnership between Illumina, Inc. and Bio-Rad Laboratories, Inc. In addition, due to the release of our Hyperion imaging mass cytometry system, we now are exposed to competition from companies offering imaging-based systems, specialized reagents and/or services including Carl Zeiss Inc., Leica Biosystems, Nikon Corporation, Olympus America Inc., Roche Diagnostics Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., IonPath Inc., Zellwerk GmbH, Bruker Corporation, Shimadzu Corporation, NanoString Technologies, Inc., and Neogenomics (Multiomyx).
Competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards, or customer requirements. In light of these advantages, even if our technology is more effective than the product or service offerings of our competitors, current or potential customers might accept competitive products and services in lieu of purchasing our technology. We anticipate that we will continue to face increased competition in the future as existing companies and competitors develop new or improved products and as new companies enter the market with new technologies. Increased competition is likely to result in pricing pressures, which could reduce our profit margins and increase our sales and marketing expenses. In addition, mergers, consolidations, or other strategic transactions between two or more of our competitors, or between our competitor and one of our key customers, could change the competitive landscape and weaken our competitive position, adversely affecting our business.
Market opportunities may not develop as quickly as we expect, limiting our ability to successfully sell our products, or our product development and strategic plans may change and our entry into certain markets may be delayed, if it occurs at all.
The application of our technologies to high-throughput genomics, single-cell genomics and, particularly, mass cytometry applications are in many cases emerging market opportunities. We believe these opportunities will take several years to develop or mature and we cannot be certain that these market opportunities will develop as we expect. The future growth of our markets and the success of our products depend on many factors beyond our control, including recognition and acceptance by the scientific community, and the growth, prevalence, and costs of competing methods of genetic and protein analysis. Additionally, our success depends on the ability of our sales organization to successfully sell our products into these new markets. If we are not able to successfully market and sell our products, or to achieve the revenue or margins we expect, our operating results may be harmed and we may not recover our product development and marketing expenditures. In addition, our product development and strategic plans may change, which could delay or impede our entry into these markets.

14

If our products fail to achieve and sustain sufficient market acceptance, our revenue will be adversely affected.
Our success depends on our ability to develop and market products that are recognized and accepted as reliable, enabling and cost-effective. Most of our potential customers already use expensive research systems in their laboratories and may be reluctant to replace those systems. Market acceptance of our systems will depend on many factors, including our ability to convince potential customers that our systems are an attractive alternative to existing technologies. Compared to some competing technologies, our technology is relatively new, and most potential customers have limited knowledge of, or experience with, our products. Prior to adopting our systems, some potential customers may need to devote time and effort to testing and validating our systems. Any failure of our systems to meet these customer benchmarks could result in customers choosing to retain their existing systems or to purchase systems other than ours, and revenue from the sale of legacy instruments that may have contributed significant revenue in prior periods may decrease.
In addition, it is important that our systems be perceived as accurate and reliable by the scientific and medical research community as a whole. Historically, a significant part of our sales and marketing efforts has been directed at convincing industry leaders of the advantages of our systems and encouraging such leaders to publish or present the results of their evaluation of our system. If we are unable to continue to induce leading researchers to use our systems, or if such researchers are unable to achieve and publish or present significant experimental results using our systems, acceptance and adoption of our systems will be slowed and our ability to increase our revenue would be adversely affected.
We may experience development or manufacturing problems or delays that could limit the potential growth of our revenue or increase our losses.
We may encounter unforeseen situations in the manufacturing and assembly of our products that would result in delays or shortfalls in our production. For example, our production processes and assembly methods may have to change to accommodate any significant future expansion of our manufacturing capacity, which may increase our manufacturing costs, delay production of our products, reduce our product margin, and adversely impact our business. Conversely, if demand for our products shifts such that a manufacturing facility is operated below its capacity for an extended period, we may adjust our manufacturing operations to reduce fixed costs, which could lead to uncertainty and delays in manufacturing times and quality during any transition period.
Additionally, all of our integrated fluidic circuits (IFCs) for commercial sale are manufactured at our facility in Singapore. Production of the elastomeric block that is at the core of our IFCs is a complex process requiring advanced clean rooms, sophisticated equipment, and strict adherence to procedures. Any contamination of the clean room, equipment malfunction, or failure to strictly follow procedures can significantly reduce our yield in one or more batches. We have in the past experienced variations in yields due to such factors. A drop in yield can increase our cost to manufacture our IFCs or, in more severe cases, require us to halt the manufacture of our IFCs until the problem is resolved. Identifying and resolving the cause of a drop in yield can require substantial time and resources.
Furthermore, developing an IFC for a new application may require developing a specific production process for that type of IFC. While all of our IFCs are produced using the same basic processes, significant variations may be required to ensure adequate yield of any particular type of IFC. Developing such a process can be very time consuming, and any unexpected difficulty in doing so can delay the introduction of a product.
If our manufacturing activities are adversely impacted, or if we are otherwise unable to keep up with demand for our products by successfully manufacturing, assembling, testing, and shipping our products in a timely manner, our revenue could be impaired, market acceptance for our products could be adversely affected and our customers might instead purchase our competitors’ products.
If our research and product development efforts do not result in commercially viable products within anticipated timelines, if at all, our business and results of operations will be adversely affected.
Our business is dependent on the improvement of our existing products, our development of new products to serve existing markets, and our development of new products to create new markets and applications that were previously not practical with existing systems. We intend to devote significant personnel and financial resources to research and development activities designed to advance the capabilities of our technology. We have developed design rules for the implementation of our technology that are frequently revised to reflect new insights we have gained about the technology. In addition, we have discovered that biological or chemical reactions sometimes behave differently when implemented on our systems rather than in a standard laboratory environment. Furthermore, many such reactions take place within the confines of single cells, which have also demonstrated unexpected behavior when grown and manipulated within microfluidic environments. As a result, research and development efforts may be required to transfer certain reactions and cell handling techniques to our systems. In the past,

15

product development projects have been significantly delayed when we encountered unanticipated difficulties in implementing a process on our systems. We may have similar delays in the future, and we may not obtain any benefits from our research and development activities. Any delay or failure by us to develop and release new products or product enhancements would have a substantial adverse effect on our business and results of operations.
Our products could have defects or errors, which may give rise to claims against us, adversely affect market adoption of our systems, and adversely affect our business, financial condition, and results of operations.
Our systems utilize novel and complex technology and such systems may develop or contain undetected defects or errors. We cannot assure you that material performance problems, defects, or errors will not arise, and as we increase the density and integration of our systems, these risks may increase. We generally provide warranties that our systems will meet performance expectations and will be free from defects. The costs incurred in correcting any defects or errors may be substantial and could adversely affect our operating margins. For example, we have experienced a performance issue with respect to certain IFCs used in our C1 systems due to the presence of more than one cell in an IFC chamber. Although we have redesigned such C1 IFCs, we may experience additional unexpected product defects or errors that could affect our ability to adequately address these performance issues.
In manufacturing our products, including our systems, IFCs, and assays, we depend upon third parties for the supply of various components, many of which require a significant degree of technical expertise to produce. In addition, we purchase certain products from third-party suppliers for resale. If our suppliers fail to produce components to specification or provide defective products to us for resale and our quality control tests and procedures fail to detect such errors or defects, or if we or our suppliers use defective materials or workmanship in the manufacturing process, the reliability and performance of our products will be compromised.
If our products contain defects, we may experience:
•
a failure to achieve market acceptance or expansion of our product sales;
•
loss of customer orders and delay in order fulfillment;
•
damage to our brand reputation;
•
increased cost of our warranty program due to product repair or replacement;
•
product recalls or replacements;
•
inability to attract new customers;
•
diversion of resources from our manufacturing and research and development departments into our service department; and
•
legal claims against us, including product liability claims, which could be costly and time consuming to defend and result in substantial damages.
In addition, certain of our products are marketed for use with products sold by third parties. For example, certain of our systems are marketed as compatible with major next-generation DNA sequencing instruments. If such third-party products are not produced to specification, are produced in accordance with modified specifications, or are defective, they may not be compatible with our products. In such case, the reliability and performance of our products may be compromised.
The occurrence of any one or more of the foregoing could negatively affect our business, financial condition, and results of operations.
Our business depends on research and development spending levels of our customers, a reduction in which could limit our ability to sell our products and adversely affect our business.
We expect that our revenue in the foreseeable future will continue to be derived primarily from sales of our systems, IFCs, assays, and reagents to academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories biopharmaceutical, biotechnology, and agricultural biotechnology (Ag-Bio) companies, and contract research organizations worldwide. Our success will depend upon their demand for and use of our products. Accordingly, the spending policies of these customers could have a significant effect on the demand for our technology. These policies may be based on a wide variety of factors, including concerns regarding any future federal government budget sequestrations, the availability of resources to make purchases, the spending priorities among various types of equipment, policies regarding

16

spending during recessionary periods, and changes in the political climate. In addition, academic, governmental, and other research institutions that fund research and development activities may be subject to stringent budgetary constraints that could result in spending reductions, reduced allocations, or budget cutbacks, which could jeopardize the ability of these customers to purchase our products. Our operating results may fluctuate substantially due to reductions and delays in research and development expenditures by these customers. For example, reductions in capital and operating expenditures by these customers may result in lower than expected sales of our systems, IFCs, assays, and reagents. These reductions and delays may result from factors that are not within our control, such as:
•
changes in economic conditions;
•
natural disasters;
•
changes in government programs that provide funding to research institutions and companies;
•
changes in the regulatory environment affecting life science and Ag-Bio companies engaged in research and commercial activities;
•
differences in budget cycles across various geographies and industries;
•
market-driven pressures on companies to consolidate operations and reduce costs;
•
mergers and acquisitions in the life science and Ag-Bio industries; and
•
other factors affecting research and development spending.
Any decrease in our customers’ budgets or expenditures, or in the size, scope, or frequency of capital or operating expenditures, could materially and adversely affect our operations or financial condition.
If one or more of our manufacturing facilities become unavailable or inoperable, we will be unable to continue manufacturing our instruments, IFCs, assays and/or reagents and, as a result, our business will be harmed until we are able to secure a new facility.
We manufacture our genomics analytical and preparatory instruments and IFCs for commercial sale at our facility in Singapore and our mass cytometry instruments for commercial sale at our facility in Canada. Our assays and reagents for commercial sale have been manufactured at our headquarters in the United States, however, we are consolidating our North American production activities into our Canada facility as part of our on-going efforts related to operational excellence and improving efficiencies. No other manufacturing facilities are currently available to us, particularly facilities of the size and scope of our Singapore and Canada operations. Our facilities and the equipment we use to manufacture our instruments, IFCs, assays, and reagents would be costly to replace and could require substantial lead times to repair or replace. Our facilities may be harmed or rendered inoperable by natural or man-made disasters, which may render it difficult or impossible for us to manufacture our products for some period of time. If any of our facilities become unavailable to us, we cannot provide assurances that we will be able to secure a new manufacturing facility on acceptable terms, if at all. The inability to manufacture our products, combined with our limited inventory of manufactured supplies, may result in the loss of customers or harm our reputation, and we may be unable to reestablish relationships with those customers in the future. Although we possess insurance for damage to our property and the disruption of our business, this insurance may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all. If our manufacturing capabilities are impaired, we may not be able to manufacture and ship our products in a timely manner, which would adversely impact our business.
We generate a substantial portion of our revenue internationally and our international business exposes us to business, regulatory, political, operational, financial, and economic risks associated with doing business outside of the United States.
During the years 2018, 2017, and 2016, approximately 57%, 55%, and 49% respectively, of our product and service revenue was generated from sales to customers located outside of the United States. We believe that a significant percentage of our future revenue will continue to come from international sources as we expand our international operations and develop opportunities in other countries. Engaging in international business inherently involves a number of difficulties and risks, including:
•
required compliance with existing and changing foreign regulatory requirements and laws that are or may be applicable to our business in the future, such as the European Union’s General Data Protection Regulation and other

17

data privacy requirements, labor and employment regulations, anticompetition regulations, the U.K. Bribery Act of 2010 and other anticorruption laws, and the RoHS and WEEE directives, which regulate the use of certain hazardous substances in, and require the collection, reuse, and recycling of waste from, products we manufacture;
•
required compliance with U.S. laws such as the Foreign Corrupt Practices Act, and other U.S. federal laws and regulations established by the office of Foreign Asset Control;
•
export requirements and import or trade restrictions;
•
laws and business practices favoring local companies;
•
longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain foreign legal systems
•
changes in social, economic, and political conditions or in laws, regulations and policies governing foreign trade, manufacturing, development, and investment both domestically as well as in the other countries and jurisdictions in which we operate and into which we sell our products, including as a result of the 2016 advisory referendum approving the separation of the United Kingdom from the European Union (Brexit);
•
potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements, and other trade barriers;
•
difficulties and costs of staffing and managing foreign operations; and
•
difficulties protecting or procuring intellectual property rights.
If one or more of these risks occurs, it could require us to dedicate significant resources to remedy, and if we are unsuccessful in finding a solution, our financial results will suffer.
We are subject to fluctuations in the exchange rate of the U.S. Dollar and foreign currencies.
A majority of our product sales are currently denominated in U.S. dollars and fluctuations in the value of the U.S. dollar relative to foreign currencies could decrease demand for our products and adversely impact our financial performance. For example, if the value of the U.S. dollar increases relative to foreign currencies, our products could become more costly to the international consumer and therefore less competitive in international markets, or if the value of the U.S. dollar decreases relative to the Singapore dollar or the Canadian dollar, it would become more costly in U.S. dollars for us to manufacture our products in Singapore and/or in Canada. Additionally, our expenses are generally denominated in the currencies of the countries in which our operations are located, which is primarily in the United States, with a portion of expenses incurred in Singapore and Canada where a significant portion of our manufacturing operations are located. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income or loss as a result of transaction gains or losses related to revaluing certain current asset and current liability balances that are denominated in currencies other than the functional currency of the entities in which they are recorded. Fluctuations in currency exchange rates could have an adverse impact on our financial results in the future.
Any disruption or delay in the shipping or off-loading of our products, whether domestically or internationally, may have an adverse effect on our financial condition and results of operations.
We rely on shipping providers to deliver products to our customers globally. Labor, tariff, or World Trade Organization-related disputes, piracy, physical damage to shipping facilities or equipment caused by severe weather or terrorist incidents, congestion at shipping facilities, inadequate equipment to load, dock, and offload our products, energy-related tie-ups, or other factors could disrupt or delay shipping or off-loading of our products domestically and internationally. Such disruptions or delays may have an adverse effect on our financial condition and results of operations.

18

We are dependent on single and sole source suppliers for some of the components and materials used in our products, and the loss of any of these suppliers could harm our business.
We rely on single and sole source suppliers for certain components and materials used in our products. Additionally, several of our instruments are assembled at the facilities of contract manufacturers in Singapore. We do not have long term contracts with our suppliers of these components and materials or our assembly service providers. The loss of a single or sole source supplier of any of the following components and/or materials would require significant time and effort to locate and qualify an alternative source of supply, if at all:
•
The IFCs used in our microfluidic systems are fabricated using a specialized polymer, and other specialized materials, that are available from a limited number of sources. In the past, we have encountered quality issues that have reduced our manufacturing yield or required the use of additional manufacturing processes.
•
The electron multiplier detector included in the Hyperion/Helios systems and certain metal isotopes used with the Hyperion/Helios systems are purchased from sole source suppliers.
•
The raw materials for our Delta Gene and SNP Type assays and Access Array target-specific primers are available from a limited number of sources.
Our reliance on single and sole source suppliers and assembly service providers also subjects us to other risks that could harm our business, including the following:
•
we may be subject to increased component or assembly costs and
•
we may not be able to obtain adequate supply or services in a timely manner or on commercially reasonable terms.
We have in the past experienced quality control and supply problems with some of our suppliers, such as manufacturing errors, and may again experience problems in the future. We may not be able to quickly establish additional or replacement suppliers, particularly for our single source components, or assembly service providers. Any interruption or delay in the supply of components or materials or assembly of our instruments, or our inability to obtain components, materials, or assembly services from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products.
Our future success is dependent upon our ability to expand our customer base and introduce new applications.
Our customer base is primarily composed of academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, biopharmaceutical, biotechnology, and Ag-Bio companies, and contract research organizations that perform analyses for research and commercial purposes. Our success will depend, in part, upon our ability to increase our market share among these customers, attract additional customers outside of these markets, and market new applications to existing and new customers as we develop such applications. Attracting new customers and introducing new applications require substantial time and expense. For example, it may be difficult to identify, engage, and market to customers who are unfamiliar with the current applications of our systems. Any failure to expand our existing customer base or launch new applications would adversely affect our ability to increase our revenue.
We may not be able to develop new products or enhance the capabilities of our existing systems to keep pace with rapidly changing technology and customer requirements, which could have a material adverse effect on our business, revenue, financial condition, and operating results.
Our success depends on our ability to develop new products and applications for our technology in existing and new markets, while improving the performance and cost-effectiveness of our systems. New technologies, techniques, or products could emerge that might offer better combinations of price and performance than our current or future product lines and systems. Existing markets for our products, including high-throughput genomics, single-cell genomics and mass cytometry, as well as potential markets for our products such as high-throughput DNA sequencing and molecular applications, are characterized by rapid technological change and innovation. It is critical to our success for us to anticipate changes in technology and customer requirements and to successfully introduce new, enhanced, and competitive technology to meet our customers’ and prospective customers’ needs on a timely and cost-effective basis. Developing and implementing new technologies will require us to incur substantial development costs and we may not have adequate resources available to be able to successfully introduce new applications of, or enhancements to, our systems. We cannot guarantee that we will be able to maintain technological advantages over emerging technologies in the future. While we typically plan improvements to our systems, we may not be able to successfully implement these improvements. If we fail to keep pace with emerging technologies, demand for our systems will not grow and may decline, and our business, revenue, financial condition, and

19

operating results could suffer materially. In addition, if we introduce enhanced systems but fail to manage product transitions effectively, customers may delay or forgo purchases of our systems and our operating results may be adversely affected by product obsolescence and excess inventory. Even if we successfully implement some or all of these planned improvements, we cannot guarantee that our current and potential customers will find our enhanced systems to be an attractive alternative to existing technologies, including our current products.
Our business operations depend upon the continuing efforts of our management team and other skilled and experienced personnel, and if we are unable to retain them or to recruit and train new key executives, scientists, and technical support personnel, we may be unable to achieve our goals.
Our success depends largely on the skills, experience, and performance of key members of our management team and key scientific and technical support personnel. The loss of the services of any key member of our management team or our scientific or technical support staff might significantly delay or prevent the development of our products or achievement of other business objectives by diverting management’s attention to transition matters and identification of suitable replacements, if any, and could have a material adverse effect on our business. Our research and product development efforts could also be delayed or curtailed if we are unable to attract, train, and retain highly skilled employees, particularly, senior scientists and engineers. We do not maintain fixed term employment contracts or significant key man life insurance with any of our employees.
Additionally, to expand our research and product development efforts, we need to retain and recruit key scientists skilled in areas such as molecular and cellular biology, assay development, and manufacturing. We also need highly trained technical support personnel with the necessary scientific background and ability to understand our systems at a technical level to effectively support potential new customers and the expanding needs of current customers. Competition for these people is intense and we may face challenges in retaining and recruiting such individuals if, for example, our stock price declines, reducing the retention value of equity awards, or our business or technology is no longer perceived as leading in our field. Because of the complex and technical nature of our systems and the dynamic market in which we compete, any failure to attract and retain a sufficient number of qualified employees could materially harm our ability to develop and commercialize our technology.
Our business growth strategy involves the potential for significant acquisitions, and our operating results and prospects could be harmed if we are unable to integrate future acquisitions successfully.
We may acquire other businesses to improve our product offerings or expand into new markets. Our future acquisition strategy will depend on our ability to identify, negotiate, complete, and integrate acquisitions and, if necessary, to obtain satisfactory debt or equity financing to fund those acquisitions. Mergers and acquisitions are inherently risky, and any transaction we complete may not be successful. Any merger or acquisition we may pursue would involve numerous risks, including but not limited to the following:
•
difficulties in integrating and managing the operations, technologies, and products of the companies we acquire;
•
diversion of our management’s attention from normal daily operation of our business;
•
our inability to maintain the key business relationships and the reputations of the businesses we acquire;
•
our inability to retain key personnel of the acquired company;
•
uncertainty of entry into markets in which we have limited or no prior experience and in which competitors have stronger market positions;
•
our dependence on unfamiliar affiliates and customers of the companies we acquire;
•
insufficient revenue to offset our increased expenses associated with acquisitions;
•
our responsibility for the liabilities of the businesses we acquire, including those which we may not anticipate; and
•
our inability to maintain internal standards, controls, procedures, and policies.
We may be unable to secure the equity or debt funding necessary to finance future acquisitions on terms that are acceptable to us. If we finance acquisitions by issuing equity or convertible debt securities, our existing stockholders will likely experience dilution, and if we finance future acquisitions with debt funding, we will incur interest expense and may have to comply with financial covenants and secure that debt obligation with our assets.

20

Security breaches, loss of data, cyberattacks, and other information technology failures could disrupt our operations, damage our reputation, and adversely affect our business, operations, and financial results.
We are dependent upon our data and information technology systems for the effective operation of our business and for the secure maintenance and storage of confidential data relating to our business and third-party businesses. Our information technology systems may be damaged, disrupted or shut down due to attacks by experienced programmers or hackers who may be able to penetrate our security controls and deploy computer viruses, cyberattacks, phishing schemes, or other malicious software programs, or due to employee error or malfeasance, power outages, hardware failures, telecommunication or utility failures, catastrophes or other unforeseen events, and our system redundancy and other disaster recovery planning may be ineffective or inadequate in preventing or responding to any of these circumstances. Any such compromise of our information technology systems could result in the unauthorized publication of our confidential business or proprietary information and unauthorized release of customer, supplier or employee data, any of which could expose us to a risk of legal claims or proceedings, liability under privacy or other laws, disruption of our operations and damage to our reputation, which could divert our management’s attention from the operation of our business and materially and adversely affect our business, revenues and competitive position. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to security breaches, cyberattacks and other related breaches. The cost and operational consequences of implementing further data protection measures, either as a response to specific breaches or as a result of evolving risks, could be significant. In addition, our inability to use or access our information systems at critical points in time could adversely affect the timely and efficient operation of our business. Any delayed sales, significant costs or lost customers resulting from these technology failures could adversely affect our business, operations, and financial results.
We have implemented security controls to protect our information technology infrastructure but, despite our efforts, we are not fully insulated from technology disruptions that could adversely impact us. For example, in early March 2019, we experienced a ransomware attack that infiltrated and encrypted certain of our information technology systems, including systems containing critical business data. Immediately following the attack, actions were taken to recover the compromised systems and we believe we were able to restore their operation without significant loss of business data. Based on the nature of the attack and its impact on our systems, we do not believe confidential data was lost or disclosed, but we are continuing to monitor the situation. If confidential data is later determined to have been released in the course of this event, it is possible that we could be the subject of actions by governmental authorities or claims from persons alleging they suffered damages from such a release. As of the date of this filing, we estimate the costs associated with the intrusion to be approximately $1.5 million; and are seeking to recover these costs under an applicable insurance policy. Although we believe we have now contained the disruption, we anticipate additional work and expense in the future as we continue to respond to the attack and further enhance our security processes and initiatives.
In addition to risks affecting our own systems, we could also be negatively impacted by a data breach or cyber incident happening to a third party’s network and affecting us. Third parties with which we conduct business have access to certain portions of our sensitive data, including information pertaining to our customers and employees. In the event that these third parties do not adequately safeguard our data, security breaches could result and negatively impact our business, operations, and financial results.
Our efficiency and cost-savings initiatives could be disruptive to our operations and adversely affect our results of operations and financial condition, and we may not realize some or all of the anticipated benefits of these initiatives in the time frame anticipated or at all.
Since 2017, we have been implementing efficiency and cost-savings initiatives intended to stabilize our business operations and return to growth. These efficiency initiatives have included targeted workforce reductions, optimizing our facilities, and reducing excess space. Further actions such as these may be required on an ongoing basis to optimize our organization. For example, we may need to decrease or defer capital expenditures and development activities or implement further operating expense reduction measures. The implementation of these efficiency and cost-savings initiatives could impair our ability to invest in developing, marketing and selling new and existing products, be disruptive to our operations, make it difficult to attract or retain employees, result in higher than anticipated charges, divert the attention of management, result in a loss of accumulated knowledge, impact our customer and supplier relationships, and otherwise adversely affect our results of operations and financial condition. In addition, our ability to complete our efficiency and cost-savings initiatives and achieve the anticipated benefits within the expected time frame is subject to estimates and assumptions and may vary materially from our expectations, including as a result of factors that are beyond our control. Furthermore, our efforts to grow our business and become profitable may not be successful.

21

To use our products, our Biomark, EP1, and Helios/CyTOF 2 systems in particular, customers typically need to purchase specialized reagents. Any interruption in the availability of these reagents for use in our products could limit our ability to market our products.
Our products, our Biomark, EP1, and Helios systems in particular, must be used in conjunction with one or more reagents designed to produce or facilitate the particular biological or chemical reaction desired by the user. Many of these reagents are highly specialized and available to the user only from a single supplier or a limited number of suppliers. Although we sell reagents for use with certain of our products, our customers may purchase these reagents directly from third-party suppliers, and we have no control over the supply of those materials. In addition, our products are designed to work with these reagents as they are currently formulated. We have no control over the formulation of reagents sold by third-party suppliers, and the performance of our products might be adversely affected if the formulation of these reagents is changed. If one or more of these reagents were to become unavailable or were reformulated, our ability to market and sell our products could be materially and adversely affected.
In addition, the use of a reagent for a particular process may be covered by one or more patents relating to the reagent itself, the use of the reagent for the particular process, the performance of that process, or the equipment required to perform the process. Typically, reagent suppliers, who are either the patent holders or their authorized licensees, sell the reagents along with a license or covenant not to sue with respect to such patents. The license accompanying the sale of a reagent often purports to restrict the purposes for which the reagent may be used. If a patent holder or authorized licensee were to assert against us or our customers that the license or covenant relating to a reagent precluded its use with our systems, our ability to sell and market our products could be materially and adversely affected. For example, our Biomark system involves real-time quantitative polymerase chain reaction (qPCR) technology. Leading suppliers of reagents for real-time qPCR reactions include Life Technologies Corporation (now part of Thermo Fisher Scientific) and Roche Diagnostics Corporation, who are our direct competitors, and their licensees. These real-time qPCR reagents are typically sold pursuant to limited licenses or covenants not to sue with respect to patents held by these companies. We do not have any contractual supply agreements for these real-time qPCR reagents, and we cannot assure you that these reagents will continue to be available to our customers for use with our systems, or that these patent holders will not seek to enforce their patents against us, our customers, or suppliers.
If we seek to be regulated as a medical device manufacturer by the U.S. Food and Drug Administration and foreign regulatory authorities, and seek approval and/or clearance for our products, the regulatory approval process would take significant time and expense and could fail to result in FDA clearance or approval for the intended uses we believe are commercially attractive. If our products were successfully approved and/or cleared, we would be subject to ongoing and extensive regulatory requirements, which would increase our costs and divert resources away from other projects. If we obtained FDA clearance or approval and we failed to comply with these requirements, our business and financial condition could be adversely impacted.
Our products are currently labeled, promoted and sold to academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, contract research organizations, and biopharmaceutical, biotechnology, and Ag-Bio companies “for research use only” (RUO), and are not designed, or intended to be used, for clinical diagnostic tests or as medical devices as currently marketed. Before we can begin to label and market our products for use as, or in the performance of, clinical diagnostics in the United States, thereby subjecting them to FDA regulation as medical devices, we would be required to obtain premarket 510(k) clearance or premarket approval from the FDA, unless an exception applies.
We may in the future register with the FDA as a medical device manufacturer and list some of our products with the FDA pursuant to an FDA Class I listing for general purpose laboratory equipment. While this regulatory classification is exempt from certain FDA requirements, such as the need to submit a premarket notification commonly known as a 510(k), and some of the requirements of the FDA’s Quality System Regulations, or QSRs, we would be subject to ongoing FDA “general controls,” which include compliance with FDA regulations for labeling, inspections by the FDA, complaint evaluation, corrections and removals reporting, promotional restrictions, reporting adverse events or malfunctions for our products, and general prohibitions against misbranding and adulteration.
In addition, we may in the future submit 510(k) premarket notifications to the FDA to obtain FDA clearance of certain of our products on a selected basis. It is possible, in the event we elect to submit 510(k) applications for certain of our products, that the FDA would take the position that a more burdensome premarket application, such as a premarket approval application or a de novo application is required for some of our products. If such applications were required, greater time and investment would be required to obtain FDA approval. Even if the FDA agreed that a 510(k) was appropriate, FDA clearance can be expensive and time consuming. It generally takes a significant amount of time to prepare a 510(k), including conducting appropriate testing on our products, and several months to years for the FDA to review a submission. Notwithstanding the

22

effort and expense, FDA clearance or approval could be denied for some or all of our products. Even if we were to seek and obtain regulatory approval or clearance, it may not be for the intended uses we believe are important or commercially attractive.
If we sought and received regulatory clearance or approval for certain of our products, we would be subject to ongoing FDA obligations and continued regulatory oversight and review, including the general controls listed above and the FDA’s QSRs for our development and manufacturing operations. In addition, we would be required to obtain a new 510(k) clearance before we could introduce subsequent modifications or improvements to such products. We could also be subject to additional FDA post-marketing obligations for such products, any or all of which would increase our costs and divert resources away from other projects. If we sought and received regulatory clearance or approval and are not able to maintain regulatory compliance with applicable laws, we could be prohibited from marketing our products for use as, or in the performance of, clinical diagnostics and/or could be subject to enforcement actions, including warning letters and adverse publicity, fines, injunctions, and civil penalties; recall or seizure of products; operating restrictions; and criminal prosecution.
In addition, we could decide to seek similar regulatory clearance or approval for certain of our products in countries outside of the United States. Sales of such products outside the United States will likely be subject to foreign regulatory requirements, which can vary greatly from country to country. As a result, the time required to obtain clearances or approvals outside the United States may differ from that required to obtain FDA clearance or approval and we may not be able to obtain foreign regulatory approvals on a timely basis or at all. Clearance or approval by the FDA does not ensure approval by regulatory authorities in other countries, and approval by one foreign regulatory authority does not ensure approval by regulatory authorities in other countries or by the FDA. In Europe, we would need to comply with the Medical Device Directive 93/42 EEC and/or the In Vitro Diagnostics Directive 98/79/EC, which are required to market medical devices in the European Union. These directives have been replaced by Medical Device Regulation 2017/745 and In Vitro Diagnostic Regulation 2017/746, with official entry into force in May 26, 2017 and date of applications of May 26, 2020 and May 26, 2022 respectively. This will increase the difficulty of regulatory approvals in Europe in the future. In addition, the FDA regulates exports of medical devices. Failure to comply with these regulatory requirements or obtain and maintain required approvals, clearances and certifications could impair our ability to commercialize our products for diagnostic use outside of the United States.
Our products could become subject to regulation as medical devices by the FDA or other regulatory agencies before we have obtained regulatory clearance or approval to market our products for diagnostic purposes, which would adversely impact our ability to market and sell our products and harm our business.
As products that are currently labeled, promoted and intended “for research use only” (RUO), our products are not currently subject to regulation as medical devices by the FDA or comparable agencies of other countries. However, the FDA or comparable agencies of other countries could disagree with our conclusion that our products are currently intended for research use only or deem our current sales, marketing and promotional efforts as being inconsistent with research use only products. For example, our customers may independently elect to use our research use only labeled products in their own laboratory developed tests (LDTs) for clinical diagnostic use. The FDA has historically exercised enforcement discretion in not enforcing the medical device regulations against laboratories offering LDTs. However, on October 3, 2014, the FDA issued two draft guidance documents that set forth the FDA’s proposed risk-based framework for regulating LDTs, which are designed, manufactured, and used within a single laboratory. The draft guidance documents provide the anticipated details through which the FDA would propose to establish an LDT oversight framework, including premarket review for higher-risk LDTs, such as those that have the same intended use as FDA-approved or cleared companion diagnostic tests currently on the market. In January 2017, the FDA announced that it would not issue final guidance on the oversight of LDTs and LDT manufacturers, but would seek further public discussion on an appropriate oversight approach, and give Congress an opportunity to develop a legislative solution. Any future legislative or administrative rule making or oversight of LDTs and LDT manufacturers, if and when finalized, may impact the sales of our products and how customers use our products, and may require us to change our business model in order to maintain compliance with these laws. We cannot predict how these various efforts will be resolved, how Congress or the FDA will regulate LDTs in the future, or how that regulatory system will impact our business.
Additionally, on November 25, 2013, the FDA issued Final Guidance “Distribution of In Vitro Diagnostic Products Labeled for Research Use Only.” The guidance emphasizes that the FDA will review the totality of the circumstances when it comes to evaluating whether equipment and testing components are properly labeled as RUO. The final guidance states that merely including a labeling statement that the product is for research purposes only will not necessarily render the device exempt from the FDA’s clearance, approval, and other regulatory requirements if the circumstances surrounding the distribution, marketing and promotional practices indicate that the manufacturer knows its products are, or intends for its products to be, used for clinical diagnostic purposes. These circumstances may include written or verbal sales and marketing claims or links to articles regarding a product’s performance in clinical applications and a manufacturer’s provision of technical support for clinical applications.

23

If the FDA modifies its approach to our products labeled and intended as RUO, or otherwise determines our products or related applications should be subject to additional regulation as in vitro diagnostic devices based upon customers’ use of our products for clinical diagnostic or therapeutic purposes, before we have obtained regulatory clearance or approval to market our products for diagnostic purposes, our ability to market and sell our products could be impeded and our business, prospects, results of operations and financial condition may be adversely affected. In addition, if the FDA determines that our products labeled as RUO were intended, based on a review of the totality of circumstances, for use in clinical investigation or diagnosis, those products could be considered misbranded or adulterated under the Federal Food, Drug, and Cosmetic Act and subject to recall and/or other enforcement action.
Compliance or the failure to comply with current and future regulations affecting our products and business operations worldwide, such as environmental regulations enacted in the European Union, could cause us significant expense and adversely impact our business.
We are subject to many federal, state, local, and foreign regulations relating to various aspects of our business operations. Governmental entities at all levels are continuously enacting new regulations, and it is difficult to identify all applicable regulations and anticipate how such regulations will be implemented and enforced. We continue to evaluate the necessary steps for compliance with applicable regulations. To comply with applicable regulations, we have and will continue to incur significant expense and allocate valuable internal resources to manage compliance-related issues. In addition, such regulations could restrict our ability to expand or equip our facilities, or could require us to acquire costly equipment or to incur other significant expenses to comply with the regulations. For example, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, or RoHS, and the Waste Electrical and Electronic Equipment Directive, or WEEE, enacted in the European Union, regulate the use of certain hazardous substances in, and require the collection, reuse, and recycling of waste from, products we manufacture. Certain of our products sold in these countries are subject to WEEE and RoHS. These and similar regulations that have been or are in the process of being enacted in other countries may require us to redesign our products, use different types of materials in certain components, or source alternative components to ensure compliance with applicable standards, and may reduce the availability of parts and components used in our products by negatively impacting our suppliers’ ability to source parts and components in a timely and cost-effective manner.
Any such redesigns, required use of alternative materials, or limited availability of parts and components used in our products may detrimentally impact the performance of our products, add greater testing lead times for product introductions, reduce our product margins, or limit the markets for our products, and if we fail to comply with any present and future regulations, we could be subject to future fines, penalties, and restrictions, such as the suspension of manufacturing of our products or a prohibition on the sale of products we manufacture. Any of the foregoing could adversely affect our business, financial condition, or results of operations.
If we fail to maintain effective internal control over financial reporting in the future, the accuracy and timing of our financial reporting may be impaired, which could adversely affect our business and our stock price.
The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act. Our testing may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses.
Our compliance with Section 404 requires that we incur substantial accounting expense and expend significant management time on compliance-related issues. We currently do not have an internal audit group, and we continue to evaluate our need for additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. Moreover, if we do not comply with the requirements of Section 404, or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our stock could decline and we could be subject to sanctions or investigations by the Nasdaq Global Select Market (Nasdaq), the SEC, or other regulatory authorities, which would require additional financial and management resources.
Impairment of our goodwill or other intangible assets could materially and adversely affect our business, operating results, and financial condition.
As of December 31, 2018, we had approximately $165.9 million of goodwill and net intangible assets, including approximately $104.1 million of goodwill and $61.8 million of net intangible assets. These assets represent a significant portion of the assets recorded on our consolidated balance sheet and relate primarily to our acquisition of DVS Sciences, Inc., or DVS,

24

in February 2014. In addition, if in the future we acquire additional businesses, technologies, or other intangible assets, a substantial portion of the value of such assets may be recorded as goodwill or intangible assets.
The carrying amounts of goodwill and intangible assets are affected whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We review goodwill and indefinite lived intangible assets for impairment at least annually and more frequently under certain circumstances. Other intangible assets that are deemed to have finite useful lives will continue to be amortized over their useful lives but must be reviewed for impairment when events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Events or changes in circumstances that could affect the likelihood that we will be required to recognize an impairment charge include declines in our stock price or market capitalization, declines in our market share or revenues, an increase in our losses, rapid changes in technology, failure to achieve the benefits of capacity increases and utilization, significant litigation arising out of an acquisition, or other matters. In particular, these or other adverse events or changes in circumstances may affect the estimated undiscounted future operating cash flows expected to be derived from our goodwill and intangible assets. Any impairment charges could have a material adverse effect on our operating results and net asset value in the quarter in which we recognize the impairment charge. We cannot provide assurances that we will not in the future be required to recognize impairment charges.
Our future capital needs are uncertain and we may need to raise additional funds in the future, which may cause dilution to stockholders or may be upon terms that are not favorable to us.
We believe that our existing cash and cash equivalents and availability under the Revolving Credit Facility will be sufficient to meet our anticipated cash requirements for at least the next 18 months. We have continued to experience losses and, if that trend continues, we may need to seek additional sources of financing. In addition, we may need to raise substantial additional capital for various purposes, including:
•
expanding the commercialization of our products;
•
funding our operations;
•
furthering our research and development; and
•
acquiring other businesses or assets and licensing technologies.
Our future funding requirements will depend on many factors, including:
•
market acceptance of our products;
•
the cost of our research and development activities;
•
the cost of filing and prosecuting patent applications;
•
the cost of defending any litigation including intellectual property, employment, contractual or other litigation;
•
the cost and timing of regulatory clearances or approvals, if any;
•
the cost and timing of establishing additional sales, marketing, and distribution capabilities;
•
the cost and timing of establishing additional technical support capabilities;
•
fluctuations in cash demands (e.g., due to interest payments or payouts under existing cash compensation plans);
•
sales variability through the year-end timing of related cash collections:
•
the effectiveness of our recent efficiency and cost-savings initiatives;
•
the effect of competing technological and market developments; and
•
the extent to which we acquire or invest in businesses, products, and technologies, although we currently have no commitments or agreements relating to any of these types of transactions.
To the extent we draw on our $15.0 million revolving senior credit facility (the “2018 Facility”) or otherwise incur additional indebtedness, the risks described above could increase. Further, if we increase our indebtedness, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we cannot assure you that we will be able to obtain additional funds on acceptable terms, or at all. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Debt financing in addition to the 2018 Facility, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt or equity financing that we raise may contain terms that are not favorable to us or our stockholders. If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies or our products, or grant licenses on terms that are not favorable to us. If we do not have or are unable to raise adequate funds, we may have to liquidate some or all of our assets, delay development or commercialization of our products, or license to third parties the rights to commercialize products or technologies that we

25

would otherwise seek to commercialize. We also may have to reduce marketing, customer support, research and development, or other resources devoted to our products, or cease operations. Any of these factors could harm our operating results.
If we fail to comply with the covenants and other obligations under our credit facility, the lenders may be able to accelerate amounts owed under the facilities and may foreclose upon the assets securing our obligations.
In August 2018, we entered into the Revolving Credit Facility.  The Revolving Credit Facility provides for secured revolving loans in an aggregate amount of up to $15.0 million. The Revolving Credit Facility is secured by substantially all of our assets, other than intellectual property. The Revolving Credit Facility contains customary affirmative and negative covenants which, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. If we fail to comply with the covenants and our other obligations under the 2018 Facility, the lenders would be able to accelerate the required repayment of amounts due under the 2018 Credit Agreement and, if they are not repaid, could foreclose upon the assets securing our obligations under the 2018 Facility.
We are subject to risks related to taxation in multiple jurisdictions and if taxing authorities disagree with our interpretations of existing tax laws or regulations, our effective income tax rate could be adversely affected and we could have additional tax liability.
We are subject to income taxes in both the United States and certain foreign jurisdictions. Significant judgments based on interpretations of existing tax laws or regulations are required in determining the provision for income taxes. For example, we have made certain interpretations of existing tax laws or regulations based upon the operations of our business internationally and we have implemented intercompany agreements based upon these interpretations and related transfer pricing analyses. If the U.S. Internal Revenue Service or other taxing authorities disagree with the positions, our effective income tax rate could be adversely affected and we could have additional tax liability, including interest and penalties. We recently completed a review of our European corporate structure and tax positions and, based upon our existing business operations, we restructured our European intercompany transactions, which increased our income tax liability. From time to time, we may review our corporate structure and tax positions in other international jurisdictions and such review may result in additional changes to how we structure our international business operations, which may adversely impact our effective income tax rate. Our effective income tax rate could also be adversely affected by changes in the mix of earnings in tax jurisdictions with different statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in existing tax laws or tax rates, changes in the level of non-deductible expenses (including share-based compensation), changes in our future levels of research and development spending, mergers and acquisitions, or the result of examinations by various tax authorities. Legislation commonly referred to as the 2017 Tax Cuts and Jobs Act was enacted in the United States on December 22, 2017 and introduced a number of changes to U.S. federal income tax, the consequences to us of which have not yet been fully determined and which could have material impact on the value of our deferred tax assets, could result in significant one-time charges in the current or future taxable years, and could increase our future U.S. tax expense. Payment of additional amounts as a result of changes in applicable tax law or upon final adjudication of any disputes could have a material impact on our results of operations and financial position.
Our ability to use net operating loss carryforwards to offset future taxable income for U.S. federal income tax purposes and other tax benefits may be limited.
Section 382 of the Internal Revenue Code of 1986, as amended, referred to as the “Code,” imposes an annual limitation on the amount of taxable income that may be offset if a corporation experiences an “ownership change” as defined in Section 382 of the Code. An ownership change occurs when a company’s “five-percent shareholders” (as defined in Section 382 of the Code) collectively increase their ownership in the company by more than 50 percentage points (by value) over a rolling three-year period. Additionally, various states have similar limitations on the use of state net operating losses, referred to as our NOLs, following an ownership change.
If we experience an ownership change, our ability to use our NOLs, any loss or deduction attributable to a “net unrealized built-in loss” and other tax attributes, which we refer to as tax benefits, could be substantially limited, and the timing of the usage of the tax benefits could be substantially delayed, which could significantly impair the value of the tax benefits.  There is no assurance that we will be able to fully utilize the tax benefits and we could be required to record an additional valuation allowance related to the amount of the tax benefits that may not be realized, which could adversely impact our results of operations.
We believe that these tax benefits are a valuable asset for us. However, legislation commonly known as the 2017 Tax Cuts and Jobs Act includes a decrease in the U.S. federal corporate income tax rate from 35% to 21%, and our tax benefits were

26

revalued at the newly enacted rate. We do not expect this to have a material impact on our financial statements because we currently maintain a full valuation allowance on our U.S. deferred tax assets; however, this reduction in the U.S. federal corporate income tax rate results in a corresponding reduction in the value of our tax benefits. On November 21, 2016, our board of directors approved a tax benefit preservation plan, or Tax Benefit Preservation Plan, in an effort to protect our tax benefits during the effective period of the tax benefit preservation plan. Our board of directors elected to let the Tax Benefit Preservation Plan expire in August 2017 based on its determination, in consultation with our management and tax advisors, that our NOLs were not at material risk of limitation based on an ownership change pursuant to Section 382. Our board of directors will continue to monitor our NOLs, however, and could elect to adopt a similar plan if it believes a potential risk exists that our NOLs could be limited. Any future tax benefit preservation plan could make it more difficult for a third party to acquire, or could discourage a third party from acquiring, us or a large block of our common stock.
Adverse conditions in the global economy and disruption of financial markets may significantly harm our revenue, profitability, and results of operations.
The global credit and financial markets have in recent years experienced volatility and disruptions, including diminished liquidity and credit availability, increased concerns about inflation and deflation, and the downgrade of U.S. debt and exposure risks on other sovereign debts, decreased consumer confidence, lower economic growth, volatile energy costs, increased unemployment rates, and uncertainty about economic stability. In addition, certain geopolitical events, including the prolonged shutdown of the United States government and the ongoing negotiation of the United Kingdom’s withdrawal from the European Union, have caused significant economic, market, political and regulatory uncertainty in some of our markets. Volatility and disruption of financial markets could limit our customers’ ability to obtain adequate financing or credit to purchase and pay for our products in a timely manner or to maintain operations, which could result in a decrease in sales volume that could harm our results of operations. General concerns about the fundamental soundness of domestic and international economies may also cause our customers to reduce their purchases. Changes in governmental banking, monetary, and fiscal policies to address liquidity and increase credit availability may not be effective. Significant government investment and allocation of resources to assist the economic recovery of sectors which do not include our customers may reduce the resources available for government grants and related funding for life science, Ag-Bio, and clinical research and development. Continuation or further deterioration of these financial and macroeconomic conditions could significantly harm our sales, profitability, and results of operations.
If we are unable to expand our direct sales and marketing force or distribution capabilities to adequately address our customers’ needs, our business may be adversely affected.
We may not be able to market, sell, and, distribute our products effectively enough to support our planned growth. We sell our products primarily through our own sales force and through distributors in certain territories. Our future sales will depend in large part on our ability to continue to develop and substantially expand our direct sales force and to increase the scope of our marketing efforts. Our products are technically complex and used for highly specialized applications. As a result, we believe it is necessary to continue to develop a direct sales force that includes people with specific scientific backgrounds and expertise, and a marketing group with technical sophistication. Competition for such employees is intense. In addition, we have experienced significant changes in our sales organization in recent quarters due to reorganizations and changes in leadership. We may not be able to attract and retain personnel or be able to build an efficient and effective sales and marketing force, which would negatively impact sales of our products and reduce our revenue and profitability.
In addition, we may continue to enlist one or more sales representatives and distributors to assist with sales, distribution, and customer support globally or in certain regions of the world. If we do seek to enter into such arrangements, we may not be successful in attracting desirable sales representatives and distributors, or we may not be able to enter into such arrangements on favorable terms. If our sales and marketing efforts, or those of any third-party sales representatives and distributors, are not successful, our technologies and products may not gain market acceptance, which would materially and adversely impact our business operations.
If we seek to implement a company-wide implementation of an enterprise resource planning, or ERP, system, such implementation could adversely affect our business and results of operations or the effectiveness of internal control over financial reporting.
We have considered implementing a company-wide ERP system to handle the business and financial processes within our operations and corporate functions. ERP implementations are complex and time-consuming projects that involve substantial expenditures on system software and implementation activities that can continue for several years. ERP implementations also require transformation of business and financial processes in order to reap the benefits of the ERP system. If we decide to implement a company-wide ERP system, our business and results of operations could be adversely affected if we experience operating problems and/or cost overruns during the ERP implementation process, or if the ERP system and the associated

27

process changes do not give rise to the benefits that we expect. If we do not effectively implement the ERP system as planned or if the system does not operate as intended, our business, results of operations, and internal controls over financial reporting could be adversely affected.
Changes in accounting principles, or interpretations thereof, could have a significant impact on our financial position and results of operations.
We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, referred to as U.S. GAAP. These principles are subject to interpretation by the SEC and various bodies formed to interpret and create appropriate accounting principles. A change in these principles can have a significant effect on our reported results and may even retroactively affect previously reported transactions. Additionally, the adoption of new or revised accounting principles may require that we make significant changes to our systems, processes and controls.
For example, the U.S.-based Financial Accounting Standards Board, referred to as FASB, is currently working together with the International Accounting Standards Board, referred to IASB, on several projects to further align accounting principles and facilitate more comparable financial reporting between companies who are required to follow U.S. GAAP under SEC regulations and those who are required to follow International Financial Reporting Standards outside of the United States. These efforts by the FASB and IASB may result in different accounting principles under U.S. GAAP that may result in materially different financial results for us in areas including, but not limited to, principles for recognizing revenue and lease accounting. Additionally, significant changes to U.S. GAAP resulting from the FASB’s and IASB’s efforts may require that we change how we process, analyze and report financial information and that we change financial reporting controls. Additionally, the FASB issued new guidance (ASU 2014-09) Revenue from Contracts with Customers (Topic 606) which supersedes nearly all existing U.S. GAAP revenue recognition guidance. The new guidance was effective for our fiscal year 2018. We adopted ASU 2014-09 in the first quarter of 2018 using the modified retrospective method. Under the modified retrospective method, periods prior to the adoption of ASU 2014-09 are not restated and the cumulative effect of initially applying the new standard is reflected in the opening balance of retained earnings as of January 1, 2018. To date, the adoption has not had a material impact on our consolidated financial statements. Additional disclosures are required for significant differences between the reported results under the new standard and those that would have been reported under the legacy standard, which required us to make certain changes to our business processes and controls to support revenue recognition and disclosure under the new standard.
The FASB also issued Accounting Standards Update (ASU) 2016-02, Leases (Topic 842). The core principle is that lessees should recognize the assets and liabilities arising from leases on the balance sheet. Under the new standard, lessees will be required to recognize lease assets and liabilities for all leases, with certain exceptions, on their balance sheets. We will adopt ASU 2016-02 as of January 1, 2019. We continue to evaluate the initial cumulative effect of the new standard as well as on our ongoing financial reporting. We continue to identify the appropriate changes to our business processes, systems, and controls to support the new lease standards and the required disclosures under the new standard.
It is not clear if or when these potential changes in accounting principles may become effective, whether we have the proper systems and controls in place to accommodate such changes and the impact that any such changes may have on our financial position and results of operations.
We have a significant amount of outstanding indebtedness, and our financial condition and results of operations could be adversely affected if we do not efficiently manage our liabilities.
We have significant outstanding convertible debt, and may be required to repay, refinance or restructure a portion of such debt before 2021. As of December 31, 2018, we had outstanding $150.00 million aggregate principal amount of our 2018 Notes and $51.3 million aggregate principal amount of our 2014 Notes. Subsequent to December 31, 2018, all of the 2018 Notes have since been converted into shares of our common stock pursuant to conversion notices received from the holders of such 2018 Notes and in connection with the Issuer’s Conversion Option and no 2018 Notes remain outstanding. Please see the section entitled “Recent Developments” in Part II, Item 7 of this Form 10-K for more information on the conversion of the 2018 Notes.
The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. Holders of the 2014 Notes may require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2021, February 6, 2024, and February 6, 2029 at a repurchase price in cash equal to 100% of the principal amount of the Notes plus accrued and unpaid interest. If we undergo a fundamental change, as defined in the terms of each of the applicable series of Notes, holders of the 2014 Notes may require us to repurchase the 2014 Notes in whole or in part for cash at a repurchase price equal to 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest. If we refinance the debt owed under the 2014 Notes, we may issue additional convertible notes or other debt, which could include additional company obligations and represent more dilution to existing stockholders and noteholders.

28

This significant amount of debt has important risks to us and our investors, including:
•
requiring a portion of our cash flow from operations to make interest payments on this debt;
•
increasing our vulnerability to general adverse economic and industry conditions;
•
reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our business;
•
limiting our flexibility in planning for, or reacting to, changes in our business and the industry; and
•
limiting our ability to borrow additional funds as needed or take advantage of business opportunities as they arise.
In addition, to the extent we draw on our Revolving Credit Facility or otherwise incur additional indebtedness, the risks described above could increase. Further, if we increase our indebtedness, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to refinance our debt.
Risks Related to Intellectual Property
Our ability to protect our intellectual property and proprietary technology through patents and other means is uncertain.
Our commercial success depends in part on our ability to protect our intellectual property and proprietary technologies. We rely on patent protection, where appropriate and available, as well as a combination of copyright, trade secret, and trademark laws, and nondisclosure, confidentiality, and other contractual restrictions to protect our proprietary technology. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We apply for patents covering our products and technologies and uses thereof, as we deem appropriate. However, we may fail to apply for patents on important products and technologies in a timely fashion or at all. Our pending U.S. and foreign patent applications may not issue as patents or may not issue in a form that will be sufficient to protect our proprietary technology and gain or keep our competitive advantage. Any patents we have obtained or do obtain may be subject to re-examination, reissue, opposition, or other administrative proceeding, or may be challenged in litigation, and such challenges could result in a determination that the patent is invalid or unenforceable. In addition, competitors may be able to design alternative methods or devices that avoid infringement of our patents. Both the patent application process and the process of managing patent disputes can be time consuming and expensive.
Furthermore, the laws of some foreign countries may not protect our intellectual property rights to the same extent as do the laws of the United States, and many companies have encountered significant problems in protecting and defending such rights in foreign jurisdictions. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. Changes in either the patent laws or in interpretations of patent laws in the United States or other countries may diminish the value of our intellectual property. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. For example:
•
We might not have been the first to make the inventions covered by each of our pending patent applications;
•
We might not have been the first to file patent applications for these inventions;
•
The patents of others may have an adverse effect on our business; and
•
Others may independently develop similar or alternative products and technologies or duplicate any of our products and technologies.
To the extent our intellectual property, including licensed intellectual property, offers inadequate protection, or is found to be invalid or unenforceable, our competitive position and our business could be adversely affected.

29

We may be involved in lawsuits to protect or enforce our patents and proprietary rights, to determine the scope, coverage and validity of others’ proprietary rights, or to defend against third party claims of intellectual property infringement, any of which could be time-intensive and costly and may adversely impact our business or stock price.
Litigation may be necessary for us to enforce our patent and proprietary rights, determine the scope, coverage, and validity of others’ proprietary rights, and/or defend against third party claims of intellectual property infringement against us as well as against our suppliers, distributors, customers, and other entities with whom we do business. Litigation could result in substantial legal fees and could adversely affect the scope of our patent protection. The outcome of any litigation or other proceeding is inherently uncertain and might not be favorable to us, and we might not be able to obtain licenses to technology that we require. Even if such licenses are obtainable, they may not be available at a reasonable cost. We could therefore incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our product margins or financial position. Further, we could encounter delays in product introductions, or interruptions in product sales, as we develop alternative methods or products.
As we move into new markets and applications for our products, incumbent participants in such markets may assert their patents and other proprietary rights against us as a means of impeding our entry into such markets or as a means to extract substantial license and royalty payments from us. Our commercial success may depend in part on our non-infringement of the patents or proprietary rights of third parties. Numerous significant intellectual property issues have been litigated, and will likely continue to be litigated, between existing and new participants in our existing and targeted markets. For example, some of our products provide for the testing and analysis of genetic material, and patent rights relating to genetic materials remain a developing area of patent law. A recent U.S. Supreme Court decision held, among other things, that claims to isolated genomic DNA occurring in nature are not patent eligible, while claims relating to synthetic DNA may be patent eligible. We expect the ruling will result in additional litigation in our industry. In addition, third parties may assert that we are employing their proprietary technology without authorization, and if they are successful in making such claims, we may be forced to enter into license agreements, pay additional royalties or license fees, or enter into settlements that include monetary obligations or restrictions on our business.
Our customers have been sued for various claims of intellectual property infringement in the past, and we expect that our customers will be involved in additional litigation in the future. In particular, our customers may become subject to lawsuits claiming that their use of our products infringes third-party patent rights, and we could become subject to claims that we contributed to or induced our customer’s infringement. In addition, our agreements with some of our suppliers, distributors, customers, and other entities with whom we do business may require us to defend or indemnify these parties to the extent they become involved in infringement claims against us, including the claims described above. We could also voluntarily agree to defend or indemnify third parties in instances where we are not obligated to do so if we determine it would be important to our business relationships. If we are required or agree to defend or indemnify any of these third parties in connection with any infringement claims, we could incur significant costs and expenses that could adversely affect our business, operating results, or financial condition.
We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our employees’ former employers or other institutions or third parties with whom such employees may have been previously affiliated.
Many of our employees were previously employed at universities or other life science or Ag-Bio companies, including our competitors or potential competitors. In the future, we may become subject to claims that our employees, or we, have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers or other third parties or institutions with whom our employees may have been previously affiliated. Litigation may be necessary to defend against these claims. For example, we were a defendant in litigation brought against us and one of our non-executive employees by Thermo Fisher Scientific Inc. (Thermo) alleging, among other claims, misappropriation of proprietary information and breach of contractual and fiduciary obligations. While we resolved our dispute with Thermo in July 2017, if we fail in defending against similar claims brought in the future we could be subject to injunctive relief against us. A loss of key research personnel work product could hamper or prevent our ability to commercialize certain potential products or a loss of or inability to hire key marketing, sales or research and development personnel could adversely affect our future product development, sales and revenues, any of which could severely harm our business. Even if we are successful in defending against any similar claims brought in the future, litigation could result in substantial costs and be a distraction to management.

30

We depend on certain technologies that are licensed to us. We do not control these technologies and any loss of our rights to them could prevent us from selling our products, which would have an adverse effect on our business.
We rely on licenses in order to be able to use various proprietary technologies that are material to our business, including our core IFC, multi-layer soft lithography, and mass cytometry technologies. In some cases, we do not control the prosecution, maintenance, or filing of the patents to which we hold licenses, or the enforcement of these patents against third parties. Additionally, our business and product development plans anticipate and may substantially depend on future in-license agreements with additional third parties, some of which are currently in the early discussion phase. For example, Fluidigm Canada Inc., or Fluidigm Canada, an Ontario corporation and wholly-owned subsidiary of Fluidigm Sciences, was party to an interim license agreement, now expired, with Nodality, Inc., or Nodality, under which Nodality granted Fluidigm Canada a worldwide, non-exclusive, research use only, royalty bearing license to certain cytometric reagents, instruments, and other products. While we were able to secure a license under a new license agreement with Nodality, we cannot provide assurances that we will always be able to obtain suitable license rights to technologies or intellectual property of other third parties on acceptable terms, if at all.
In-licensed intellectual property rights that are fundamental to the business being operated present numerous risks and limitations. For example, all or a portion of the license rights granted may be limited for research use only, and in the event we attempt to expand into diagnostic applications, we would be required to negotiate additional rights, which may not be available to us on commercially reasonable terms, if at all.
Our rights to use the technology we license are also subject to the negotiation and continuation of those licenses. Certain of our licenses contain provisions that allow the licensor to terminate the license upon specific conditions. Our rights under the licenses are subject to our continued compliance with the terms of the license, including the payment of royalties due under the license. Because of the complexity of our products and the patents we have licensed, determining the scope of the license and related royalty obligation can be difficult and can lead to disputes between us and the licensor. An unfavorable resolution of such a dispute could lead to an increase in the royalties payable pursuant to the license. If a licensor believed we were not paying the royalties due under the license or were otherwise not in compliance with the terms of the license, the licensor might attempt to revoke the license. If such an attempt were successful and the license is terminated, we might be barred from marketing, producing, and selling some or all of our products, which would have an adverse effect on our business. Potential disputes between us and one of our existing licensors concerning the terms or conditions of the applicable license agreement could result, among other risks, in substantial management distraction; increased expenses associated with litigation or efforts to resolve disputes; substantial customer uncertainty concerning the direction of our product lines; potential infringement claims against us and/or our customers, which could include efforts by a licensor to enjoin sales of our products; customer requests for indemnification by us; and, in the event of an adverse determination, our inability to operate our business as currently operated. Termination of material license agreements could prevent us from manufacturing and selling our products unless we can negotiate new license terms or develop or acquire alternative intellectual property rights that cover or enable similar functionality. Any of these factors would be expected to have a material adverse effect on our business, operating results, and financial condition and could result in a substantial decline in our stock price.
We are subject to certain manufacturing restrictions related to licensed technologies that were developed with the financial assistance of U.S. governmental grants.
We are subject to certain U.S. government regulations because we have licensed technologies that were developed with U.S. government grants. In accordance with these regulations, these licenses provide that products embodying the technologies are subject to domestic manufacturing requirements. If this domestic manufacturing requirement is not met, the government agency that funded the relevant grant is entitled to exercise specified rights, referred to as “march-in rights,” which if exercised would allow the government agency to require the licensors or us to grant a non-exclusive, partially exclusive, or exclusive license in any field of use to a third party designated by such agency. All of our microfluidic systems revenue is dependent upon the availability of our IFCs, which incorporate technology developed with U.S. government grants. Our genomics instruments, including microfluidic systems, and IFCs are manufactured at our facility in Singapore. The federal regulations allow the funding government agency to grant, at the request of the licensors of such technology, a waiver of the domestic manufacturing requirement. Waivers may be requested prior to any government notification. We have assisted the licensors of these technologies with the analysis of the domestic manufacturing requirement, and, in December 2008, the sole licensor subject to the requirement applied for a waiver of the domestic manufacturing requirement with respect to the relevant patents licensed to us by this licensor. In July 2009, the funding government agency granted the requested waiver of the domestic manufacturing requirement for a three-year period commencing in July 2009. In June 2012, the licensor requested a continued waiver of the domestic manufacturing requirement with respect to the relevant patents, but the government agency has not yet taken any action in response to this request. If the government agency does not grant the requested waiver or the government fails to grant additional waivers of such requirement that may be sought in the future, then the U.S. government could exercise its march-in

31

rights with respect to the relevant patents licensed to us. In addition, the license agreement under which the relevant patents are licensed to us contains provisions that obligate us to comply with this domestic manufacturing requirement. We are not currently manufacturing instruments and IFCs in the United States that incorporate the relevant licensed technology. If our lack of compliance with this provision constituted a material breach of the license agreement, the license of the relevant patents could be terminated or we could be compelled to relocate our manufacturing of microfluidic systems and IFCs to the United States to avoid or cure a material breach of the license agreement. Any of the exercise of march-in rights, the termination of our license of the relevant patents or the relocation of our manufacturing of microfluidic systems and IFCs to the United States could materially adversely affect our business, operations and financial condition.
We are subject to certain obligations and restrictions relating to technologies developed in cooperation with Canadian government agencies.
Some of our Canadian research and development is funded in part through government grants and by government agencies. The intellectual property developed through these projects is subject to rights and restrictions in favor of government agencies and Canadians generally. In most cases the government agency retains the right to use intellectual property developed through the project for non-commercial purposes and to publish the results of research conducted in connection with the project. This may increase the risk of public disclosure of information relating to our intellectual property, including confidential information, and may reduce its competitive advantage in commercializing intellectual property developed through these projects. In certain projects, we have also agreed to use commercially reasonable efforts to commercialize intellectual property in Canada, or more specifically in the province of Ontario, for the economic benefit of Canada and the province of Ontario. These restrictions will limit our choice of business and manufacturing locations, business partners and corporate structure and may, in certain circumstances, restrict our ability to achieve maximum profitability and cost efficiency from the intellectual property generated by these projects. In one instance, a dispute with the applicable government funded entity may require mediation, which could lead to unanticipated delays in our commercialization efforts to that project. One of our Canadian government funded projects is also subject to certain limited “march-in” rights in favor of the government of the Province of Ontario, under which we may be required to grant a license to our intellectual property, including background intellectual property developed outside the scope of the project, to a responsible applicant on reasonable terms in circumstances where the government determines that such a license is necessary in order to alleviate emergency or extraordinary health or safety needs or for public use. In addition, we must provide reasonable assistance to the government in obtaining similar licenses from third parties required in connection with the use of its intellectual property. Instances in which the government of the Province of Ontario has exercised similar “march-in” rights are rare; however, the exercise of such rights could materially adversely affect our business, operations and financial condition.
Risks Related to Our Common Stock
Our stock price may fluctuate significantly, particularly if holders of substantial amounts of our stock attempt to sell, and holders may have difficulty selling their shares based on current trading volumes of our stock. In addition, numerous other factors could result in substantial volatility in the trading price of our stock.
Our stock is currently traded on Nasdaq, but we can provide no assurance that we will be able to maintain an active trading market on Nasdaq or any other exchange in the future. The trading volume of our stock tends to be low relative to our total outstanding shares, and we have several stockholders who hold substantial blocks of our stock. As of December 31, 2018, we had 49,338,473 shares of common stock outstanding, and stockholders holding at least 5% of our stock, individually or with affiliated persons or entities, collectively beneficially owned or controlled approximately 46.6%of such shares and one stockholder beneficially owned 25.3% of our outstanding common stock. Sales of large numbers of shares by any of our large stockholders could adversely affect our trading price, particularly given our relatively small historic trading volumes. If stockholders holding shares of our common stock sell, indicate an intention to sell, or if it is perceived that they will sell, substantial amounts of their common stock in the public market, the trading price of our common stock could decline. Moreover, if there is no active trading market or if the volume of trading is limited, holders of our common stock may have difficulty selling their shares. In addition, the concentration of ownership of our outstanding common stock (approximately 46.6% held by our top three stockholders) means that a relatively small number of stockholders have significant control over the outcomes of stockholder voting.
In addition, the trading price of our common stock may be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. These factors include:
•
actual or anticipated quarterly variation in our results of operations or the results of our competitors;

32

•
announcements or communications by us or our competitors relating to, among other things, new commercial products, technological advances, significant contracts, commercial relationships, capital commitments, acquisitions or sales of businesses, and/or misperceptions in or speculation by the market regarding such announcements or communications;
•
issuance of new or changed securities analysts’ reports or recommendations for our stock;
•
developments or disputes concerning our intellectual property or other proprietary rights;
•
commencement of, or our involvement in, litigation;
•
market conditions in the life science, Ag-Bio, and CRO sectors;
•
failure to complete significant sales;
•
manufacturing disruptions that could occur if we were unable to successfully expand our production in our current or an alternative facility;
•
any future sales of our common stock or other securities in connection with raising additional capital or otherwise;
•
any major change to the composition of our board of directors or management; and
•
general economic conditions and slow or negative growth of our markets.
The stock market in general, and market prices for the securities of technology-based companies like ours in particular, have from time to time experienced volatility that often has been unrelated to the operating performance of the underlying companies. These broad market and industry fluctuations may adversely affect the market price of our common stock regardless of our operating performance. In several recent situations where the market price of a stock has been volatile, holders of that stock have instituted securities class action litigation against the company that issued the stock. If any of our stockholders were to bring a lawsuit against us, the defense and disposition of the lawsuit could be costly and divert the time and attention of our management and harm our operating results.
If securities or industry analysts publish unfavorable research about our business or cease to cover our business, our stock price and/or trading volume could decline.
The trading market for our common stock may rely, in part, on the research and reports that equity research analysts publish about us and our business. We do not have any control of the analysts or the content and opinions included in their reports. The price of our stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which in turn could cause our stock price or trading volume to decline.
Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.
Provisions in our certificate of incorporation and bylaws may have the effect of delaying or preventing a change of control or changes in our management, including provisions that:
•
authorize our board of directors to issue, without further action by the stockholders, up to 10,000,000 shares of undesignated preferred stock;
•
require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;
•
specify that special meetings of our stockholders can be called only by our board of directors, the chairman of the board, the chief executive officer or the president;
•
establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;

33

•
establish that our board of directors is divided into three classes, Class I, Class II, and Class III, with each class serving staggered three-year terms;
•
provide that our directors may be removed only for cause;
•
provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;
•
specify that no stockholder is permitted to cumulate votes at any election of directors; and
•
require a super-majority of votes to amend certain of the above-mentioned provisions.
These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us.
We have never paid cash dividends on our capital stock, and we do not anticipate paying any cash dividends in the foreseeable future.
We have paid no cash dividends on any of our classes of capital stock to date and currently intend to retain our future earnings to fund the development and growth of our business. In addition, we cannot pay any cash dividends on any of our classes of common stock without approval from the lender under our 2018 Credit Facility, and may become subject to covenants under future debt arrangements that place restrictions on our ability to pay dividends. As a result, capital appreciation, if any, of our common stock will be stockholders’ sole source of gain for the foreseeable future.
Risks Related to Our Outstanding Convertible Notes
Our outstanding convertible notes are effectively subordinated to our secured debt and any liabilities of our subsidiaries.
Our outstanding 2014 Notes rank:
•
senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the 2014 Notes;
•
equal in right of payment to all of our liabilities that are not so subordinated;
•
effectively junior in right of payment to any of our secured indebtedness, including, but not limited to, any indebtedness under the Revolving Credit Facility, to the extent of the value of the assets securing such indebtedness; and
•
structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries.
In February 2014, we completed the offering of our 2014 Notes with an aggregate outstanding principal amount of $201.3 million. In March 2018, we completed an exchange of $150.0 million in aggregate principal amount of our 2014 Notes for $150.0 million in aggregate principal amount of our 2018 Notes, leaving approximately $51.3 million in aggregate principal amount of 2014 Notes outstanding. Subsequent to December 31, 2018, all of the 2018 Notes have since been converted into shares of our common stock pursuant to conversion notices received from the holders of such 2018 Notes and in connection with the Issuer’s Conversion Option and no 2018 Notes remain outstanding. Please see the section entitled “Recent Developments” in Part II, Item 7 of this Form 10-K for more information on the conversion of the 2018 Notes. In the event of our bankruptcy, liquidation, reorganization, or other winding up, our assets that secure debt ranks senior in right of payment to 2014 Notes will be available to pay obligations on the 2014 Notes only after the secured debt, including but not limited to, any indebtedness under the Revolving Credit Facility, has been repaid in full from these assets, and the assets of our subsidiaries will be available to pay obligations on the 2014 Notes only after all claims senior to the 2014 Notes have been repaid in full. There may not be sufficient assets remaining to pay amounts due on any or all of the 2014 Notes then outstanding. The indenture governing the 2014 Notes does not prohibit us from incurring additional senior debt or secured debt, nor does it prohibit our subsidiaries from incurring additional liabilities.

34

The 2014 Notes are our obligations only and some of our operations are conducted through, and a portion of our consolidated assets are held by, our subsidiaries.
The 2014 Notes are our obligations exclusively and are not guaranteed by any of our operating subsidiaries. A portion of our consolidated assets is held by our subsidiaries. Accordingly, our ability to service our debt, including the 2014 Notes, depends in part on the results of operations of our subsidiaries and upon the ability of such subsidiaries to provide us with cash, whether in the form of dividends, loans, or otherwise, to pay amounts due on our obligations, including the 2014 Notes. Our subsidiaries are separate and distinct legal entities and have no obligation, contingent or otherwise, to make payments on the 2014 Notes or to make any funds available for that purpose. In addition, dividends, loans, or other distributions to us from such subsidiaries may be subject to contractual and other restrictions and are subject to other business and tax considerations.
Recent and future regulatory actions and other events may adversely affect the trading price and liquidity of the 2014 Notes.
We expect that many investors in, and potential purchasers of, the 2014 Notes will employ, or seek to employ, a convertible arbitrage strategy with respect to the 2014 Notes. Investors would typically implement such a strategy by selling short the common stock underlying the 2014 Notes and dynamically adjusting their short position while continuing to hold the 2014 Notes. Investors may also implement this type of strategy by entering into swaps on our common stock in lieu of or in addition to short selling the common stock. As a result, any specific rules regulating equity swaps or short selling of securities or other governmental action that interferes with the ability of market participants to effect short sales or equity swaps with respect to our common stock could adversely affect the ability of investors in, or potential purchasers of, the 2014 Notes to conduct the convertible arbitrage strategy that we believe they will employ, or seek to employ, with respect to the 2014 Notes. This could, in turn, adversely affect the trading price and liquidity of the 2014 Notes.
The SEC and other regulatory and self-regulatory authorities have implemented various rules and taken certain actions, and may in the future adopt additional rules and take other actions, that may impact those engaging in short selling activity involving equity securities (including our common stock). Such rules and actions include Rule 201 of SEC Regulation SHO, the adoption by the Financial Industry Regulatory Authority, Inc. and the national securities exchanges of a “Limit Up-Limit Down” program, the imposition of market-wide circuit breakers that halt trading of securities for certain periods following specific market declines, and the implementation of certain regulatory reforms required by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Although the direction and magnitude of the effect that Regulation SHO, FINRA, securities exchange rule changes, and implementation of the Dodd-Frank Act may have on the trading price and the liquidity of the 2014 Notes will depend on a variety of factors, many of which cannot be determined at the date of this report, past regulatory actions (such as certain emergency orders issued by the SEC in 2008 prohibiting short sales of stock of certain financial services companies) have had a significant impact on the trading prices and liquidity of convertible debt instruments. Any governmental or regulatory action that restricts the ability of investors in, or potential purchasers of, the 2014 Notes to effect short sales of our common stock, borrow our common stock, or enter into swaps on our common stock or increases the costs of implementing an arbitrage strategy could adversely affect the trading price and the liquidity of the 2014 Notes.
Volatility in the market price and trading volume of our common stock could adversely impact the trading price of the 2014 Notes.
The stock market in recent years has experienced significant price and volume fluctuations that have often been unrelated to the operating performance of companies. The market price of our common stock could fluctuate significantly for many reasons, including in response to the risks described in this report, or for reasons unrelated to our operations, such as reports by industry analysts, investor perceptions or negative announcements by our customers, competitors or suppliers regarding their own performance, as well as industry conditions and general financial, economic and political instability. The market price of our common stock could also decline as a result of sales of a large number of shares of our common stock in the market, particularly sales by our directors, executive officers, employees, and significant stockholders, and the perception that these sales could occur may also depress the market price of our common stock. A decrease in the market price of our common stock would likely adversely impact the trading price of the 2014 Notes. The market price of our common stock could also be affected by possible sales of our common stock by investors who view the 2014 Notes as a more attractive means of equity participation in us and by hedging or arbitrage trading activity that we expect to develop involving our common stock. This trading activity could, in turn, affect the trading price of the 2014 Notes.

35

We have incurred additional debt and may still incur substantially more debt or take other actions which would intensify the risks discussed above.
We are not restricted under the terms of the indenture governing the 2014 Notes from incurring additional debt, securing existing or future debt, recapitalizing our debt, or taking a number of other actions that are not limited by the terms of the indenture governing the 2014 Notes that could have the effect of diminishing our ability to make payments on the 2014 Notes when due. Any failure by us or any of our significant subsidiaries to make any payment at maturity of indebtedness for borrowed money in excess of $15.0 million or the acceleration of any such indebtedness in excess of $15.0 million would, subject to the terms of the indenture governing the 2014 Notes, constitute a default under the indenture. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the 2014 Notes when required.
In August 2018, we entered into the Revolving Credit Facility with Silicon Valley Bank, which matures on August 2, 2020. Amounts drawn under the Revolving Credit Facility will be used for working capital and general corporate purposes. While we currently have no outstanding debt under the Revolving Credit Facility, we may incur up to $15.0 million of secured debt pursuant to the Revolving Credit Facility. See Note 6 to the Consolidated Financial Statements included in this Form 10-K for more information about the Revolving Credit Facility.
We may not have the ability to raise the funds necessary to repurchase the 2014 Notes upon specified dates or upon a fundamental change, and our future debt may contain limitations on our ability to repurchase the 2014 Notes.
Holders of the 2014 Notes have the right to require us to repurchase all or a portion of their 2014 Notes on certain dates or upon the occurrence of a fundamental change at a repurchase price equal to, for the 2014 Notes, 100% of the principal amount of the 2014 Notes to be repurchased plus accrued and unpaid interest, if any. We may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of 2014 Notes surrendered therefor.
In addition, our ability to repurchase the 2014 Notes may be limited by law, regulatory authority, or agreements governing our future indebtedness. Our failure to repurchase the 2014 Notes at a time when the repurchase is required by the indenture would constitute a default under the indenture. A default under the indenture or the fundamental change itself could also lead to a default under agreements governing our future indebtedness. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and repurchase the 2014 Notes when required.
Holders of 2014 Notes are not entitled to any rights with respect to our common stock, but they are subject to all changes made with respect to them to the extent our conversion obligation includes shares of our common stock.
Holders of 2014 Notes are not entitled to any rights with respect to our common stock (including, without limitation, voting rights and rights to receive any dividends or other distributions on our common stock) prior to the conversion date with respect to any 2014 Notes they surrender for conversion, but they are subject to all changes affecting our common stock. For example, if an amendment is proposed to our certificate of incorporation or bylaws requiring stockholder approval and the record date for determining the stockholders of record entitled to vote on the amendment occurs prior to the conversion date with respect to any 2014 Notes surrendered for conversion, then the holder surrendering such 2014 Notes will not be entitled to vote on the amendment, although such holder will nevertheless be subject to any changes affecting our common stock.
We have made only limited covenants in the indenture governing the 2014 Notes, and these limited covenants may not protect a noteholder's investment.
The indenture governing the 2014 Notes does not:
•
require us to maintain any financial ratios or specific levels of net worth, revenues, income, cash flows, or liquidity and, accordingly, does not protect holders of the 2014 Notes in the event that we experience adverse changes in our financial condition or results of operations;
•
limit our subsidiaries’ ability to guarantee or incur indebtedness that would rank structurally senior to the 2014 Notes;
•
limit our ability to incur additional indebtedness, including secured indebtedness;
•
restrict our subsidiaries’ ability to issue securities that would be senior to our equity interests in our subsidiaries and therefore would be structurally senior to the 2014 Notes;

36

•
restrict our ability to repurchase our securities;
•
restrict our ability to pledge our assets or those of our subsidiaries; or
•
restrict our ability to make investments or pay dividends or make other payments in respect of our common stock or our other indebtedness.
Furthermore, the indenture governing the 2014 Notes contains only limited protections in the event of a change of control. We could engage in many types of transactions, such as acquisitions, refinancings, or certain recapitalizations, that could substantially affect our capital structure and the value of the 2014 Notes and our common stock but may not constitute a “fundamental change” that permits holders to require us to repurchase their 2014 Notes or a “make-whole fundamental change” that permits holders to convert their 2014 Notes at an increased conversion rate. For these reasons, the limited covenants in the indenture governing the 2014 Notes may not protect a noteholder's investment in the 2014 Notes.
The increase in the conversion rate for 2014 Notes converted in connection with a make-whole fundamental change or provisional redemption may not adequately compensate noteholders for any lost value of the 2014 Notes as a result of such transaction or redemption.
If (i) a make-whole fundamental change occurs prior to February 6, 2021, or (ii) upon our issuance of a notice of provisional redemption, under certain circumstances, we will increase the conversion rate by a number of additional shares of our common stock for the 2014 Notes converted in connection with such events. The increase in the conversion rate for the 2014 Notes converted in connection with such events may not adequately compensate noteholders for any lost value of the 2014 Notes as a result of such transaction or redemption. In addition, if the price of our common stock in the transaction is greater than $180.00 per share or less than $39.96 per share (in each case, subject to adjustment), no additional shares will be added to the conversion rate for the 2014 Notes. Moreover, in no event will the conversion rate per $1,000 principal amount of 2014 Notes as a result of this adjustment exceed 25.0250 shares of common stock, subject to adjustment.
Our obligation to increase the conversion rate for 2014 Notes converted in connection with such events could be considered a penalty, in which case the enforceability thereof would be subject to general principles of reasonableness and equitable remedies.
The conversion rate of the 2014 Notes may not be adjusted for all dilutive events.
The conversion rate of the 2014 Notes is subject to adjustment for certain events, including, but not limited to, the issuance of certain stock dividends on our common stock, the issuance of certain rights or warrants, subdivisions, combinations, distributions of capital stock, indebtedness, or assets, cash dividends and certain issuer tender or exchange offers. However, the conversion rate will not be adjusted for other events, such as a third-party tender or exchange offer or an issuance of common stock for cash, that may adversely affect the trading price of the 2014 Notes or our common stock. An event that adversely affects the value of the 2014 Notes may occur, and that event may not result in an adjustment to the conversion rate.
Some significant restructuring transactions may not constitute a fundamental change, in which case we would not be obligated to offer to repurchase the 2014 Notes.
Upon the occurrence of a fundamental change, a holder of 2014 Notes has the right to require us to repurchase the 2014 Notes. However, the fundamental change provisions will not afford protection to holders of 2014 Notes in the event of other transactions that could adversely affect the 2014 Notes. For example, transactions such as leveraged recapitalizations, refinancings, restructurings, or acquisitions initiated by us may not constitute a fundamental change requiring us to repurchase the 2014 Notes. In the event of any such transaction, the holders would not have the right to require us to repurchase the 2014 Notes, even though each of these transactions could increase the amount of our indebtedness, or otherwise adversely affect our capital structure or any credit ratings, thereby adversely affecting the holders of 2014 Notes.
In addition, absent the occurrence of a fundamental change or a make-whole fundamental change as described under changes in the composition of our board of directors will not provide holders with the right to require us to repurchase the 2014 Notes or to an increase in the conversion rate upon conversion.
We cannot assure noteholders that an active trading market will develop or be maintained for the 2014 Notes.
We do not intend to apply to list our outstanding 2014 Notes on any securities exchange or to arrange for quotation on any automated dealer quotation system. In addition, the liquidity of the trading market in the 2014 Notes and the market price quoted for the 2014 Notes may be adversely affected by changes in the overall market for this type of security and by changes

37

in our financial performance or prospects or in the prospects for companies in our industry generally. As a result, we cannot assure noteholders that an active trading market will develop or be maintained for the 2014 Notes. If an active trading market does not develop or is not maintained, the market price and liquidity of the 2014 Notes may be adversely affected. In that case, noteholders may not be able to sell the 2014 Notes at a particular time or at a favorable price.
Any adverse rating of the 2014 Notes may cause their trading price to fall.
We do not intend to seek a rating on the 2014 Notes. However, if a rating service were to rate the 2014 Notes and if such rating service were to lower its rating on the 2014 Notes below the rating initially assigned to the 2014 Notes or otherwise announces its intention to put the 2014 Notes on credit watch, the trading price of the 2014 Notes could decline.
Holders of 2014 Notes may be subject to tax if we make or fail to make certain adjustments to the conversion rate of the 2014 Notes even though they do not receive a corresponding cash distribution.
The conversion rate of the 2014 Notes is subject to adjustment in certain circumstances, including the payment of cash dividends. If the conversion rate is adjusted as a result of a distribution that is taxable to our common stockholders, such as a cash dividend, a noteholder may be deemed to have received a dividend subject to U.S. federal income tax without the receipt of any cash. In addition, a failure to adjust (or to adjust adequately) the conversion rate after an event that increases a noteholder's proportionate interest in us could be treated as a deemed taxable dividend to you. If a make-whole fundamental change occurs prior to February 6, 2021 or upon our issuance of a notice of provisional redemption, under some circumstances, we will increase the conversion rate for the 2014 Notes converted in connection with the make-whole fundamental change or provisional redemption. Such increase may also be treated as a distribution subject to U.S. federal income tax as a dividend. For a non-U.S. holder, any deemed dividend would be subject to U.S. federal withholding tax at a 30% rate, or such lower rate as may be specified by an applicable treaty, which may be set off against subsequent payments on the 2014 Notes.
Any conversions of the 2014 Notes will dilute the ownership interest of our existing stockholders, including holders who had previously converted their notes.
Any conversion of some or all of the 2014 Notes will dilute the ownership interests of our existing stockholders. The initial conversion price under the 2014 Notes is approximately $55.94. As a result, each of the outstanding 2014 Notes is initially convertible into 17.8750 shares of our common stock per $1,000 principal amount. Issuances of shares of common stock upon conversion of our 2014 Notes could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. In addition, the existence of the 2014 Notes may encourage short selling by market participants because the conversion of the 2014 Notes could depress the price of our common stock.

ITEM 1B. UNRESOLVED STAFF COMMENTS
None. 

ITEM 2. PROPERTIES

We lease approximately 74,100 square feet of office and laboratory space at our headquarters in South San Francisco, California under a lease that expires in April 2020. Additionally, we lease office, laboratory and manufacturing space in Singapore of approximately 50,000 square feet and in Ontario, Canada of approximately 44,500 square feet under leases that expire in June 2022 and March 2026, respectively. As of December 31, 2018, we also leased office space in Japan, China, and France, with various expiration dates through February 2026. In addition, we believe that our properties are in good condition and are adequate and suitable for their purposes.

ITEM 3. LEGAL PROCEEDINGS

In the normal course of business, we are from time to time involved in legal proceedings or potential legal proceedings, including matters involving employment, intellectual property, or others. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending matters would not have a material adverse effect on our business, operating results, financial condition, or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.

38


PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market for Our Common Stock; Dividends
Our common stock began trading on the Nasdaq Global Select Market under the symbol “FLDM” on February 10, 2011.
We had 86 stockholders of record as of March 13, 2019; however, because many of our outstanding shares are held by brokers or other institutions on behalf of stockholders, we are unable to estimate the total number of beneficial owners represented by the holders of record.
We have never declared or paid cash dividends on our common stock and do not expect to pay dividends on our common stock for the foreseeable future. Instead, we anticipate that all of our earnings in the foreseeable future will be used for the operation and growth of our business.
Stock Performance Graph
The following performance graph shall not be deemed “soliciting material” or to be “filed” with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any filing of Fluidigm Corporation under the Securities Act or the Exchange Act.
The following graph compares, from December 31, 2013 through December 31, 2018, the cumulative total return for our common stock, the Nasdaq Composite Total Return Index, and the Nasdaq US Benchmark Medical Equipment Index, assuming in each case an initial investment of $100 and reinvestment of all dividends. Such returns are based on historical results and are not intended to suggest future performance.
chart-46e59a14696d2292a72.jpg

39


Sales of Unregistered Securities
None.
Issuer Purchases of Equity Securities
We did not repurchase any shares of our common stock during the year ended December 31, 2018.

ITEM 6. SELECTED FINANCIAL DATA
The following selected financial data should be read in conjunction with the consolidated financial statements and related notes thereto appearing elsewhere in this Form 10-K. We have derived the consolidated statement of operations data for the years ended December 31, 2018, 2017, and 2016, and consolidated balance sheet data as of December 31, 2018, and December 31, 2017 from audited consolidated financial statements included elsewhere in this Form 10-K. The consolidated statement of operations data for the years ended December 31, 2015, and 2014, and the consolidated balance sheet data as of December 31, 2016, December 31, 2015, and December 31, 2014 were derived from audited consolidated financial statements that are not included in this Form 10-K.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2018
 
2017
 
2016
 
2015
 
2014
 
 
 
(in thousands, except per share amounts)
Consolidated Statement of Operations Data:
 
 
 
 
 
 
 
 
 
 
 
Total revenue
 
$
112,964

 
$
101,937

 
$
104,446

 
$
114,712

 
$
116,456

 
Loss from operations
 
(48,164
)
 
(58,360
)
 
(73,190
)
 
(50,155
)
 
(51,836
)
 
Net loss
 
(59,013
)
 
(60,535
)
 
(75,985
)
 
(53,315
)
 
(52,830
)
 
Net loss per share, basic and diluted
 
(1.49
)
 
(1.84
)
 
(2.62
)
 
(1.86
)
 
(1.90
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2018
 
2017
 
2016
 
2015
 
2014
 
 
 
(in thousands)
Consolidated Balance Sheet Data:
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, and short and long-term investments
 
$
95,401

 
$
63,136

 
$
59,430

 
$
101,465

 
$
142,800

 
Working capital (1)
 
100,988

 
71,565

 
76,334

 
123,433

 
133,440

 
Total assets (2)
 
303,647

 
287,351

 
306,395

 
370,050

 
406,506

 
Total long-term debt (2)
 
172,058

 
195,238

 
194,951

 
194,673

 
194,402

 
Total stockholders’ equity
 
72,116

 
30,935

 
53,233

 
114,901

 
150,419

 

(1) Working capital excludes deferred revenue.
(2) $1.0 million and $1.1 million of debt issuance costs for Convertible notes were previously included in Total assets reclassified to Total long-term debt as a deduction in December 31, 2015 and December 31, 2014, respectively.

40


ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis should be read together with our consolidated financial statements and the notes to those statements included elsewhere in this Form 10-K. This discussion contains forward-looking statements based on our current expectations, assumptions, estimates and projections about Fluidigm and our industry. These forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those indicated in these forward-looking statements as a result of certain factors, as more fully described in “Risk factors” in Item 1A of this Form 10-K, in this Item 7, and elsewhere in this Form 10-K. Except as may be required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.
Overview
Fluidigm is a global company that improves life through comprehensive health insight. Our innovative technologies and multi-omic tools are used by researchers to reveal meaningful insights in health and disease, identify biomarkers to inform decisions and accelerate the development of more effective therapies. We create, manufacture, and market innovative technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including IFCs, assays, and reagents.
Our focus is on the most pressing needs in translational and clinical research, including cancer, immunology and immunotherapy. We use proprietary CyTOF® and microfluidics technologies to develop innovative end-to-end solutions that have the flexibility required to meet the needs of translational research and the robustness to support high-impact clinical research studies. We sell our products to leading academic, government, pharmaceutical, biotechnology and plant and animal research laboratories worldwide.
We distribute our systems through our direct sales force and support organizations located in North America, Europe, and Asia-Pacific, and through distributors or sales agents in several European, Latin American, Middle Eastern, and Asia-Pacific countries. Our manufacturing operations are located in Singapore and Canada. Our facility in Singapore manufactures our genomics instruments, which are assembled by our contract manufacturer located within our in Singapore facility. All of our IFCs for commercial sale and some IFCs for our research and development purposes are also fabricated at our Singapore facility. Our mass cytometry instruments for commercial sale, as well as for internal research and development purposes, are manufactured at our facility in Canada. We also manufacture assays and reagents at our facilities in the United States. We also manufacture assays and reagents at our facilities in the United States.  As part of our on-going efforts related to operational excellence and improving efficiencies, we are consolidating our North American production activities into our Canadian facility.
Our total revenue was $113.0 million in 2018, $101.9 million in 2017, and $104.4 million in 2016. We have incurred significant net losses since our inception in 1999 and, as of December 31, 2018, our accumulated deficit was $558.9 million.
At the end of 2016, we began reallocating our resources based on revenue contribution and growth expectations across our target markets, including a reorganization of our sales team and commercial leadership. We implemented certain operational efficiencies and cost-savings initiatives beginning in the first quarter of 2017 intended to align our resources with our product strategy, reduce our operating expenses, and manage our cash flows. In 2017 and 2018, we have grown our revenues, increased gross margins, reduced operating expenses, streamlined our manufacturing operations, and rationalized our headcount and facilities. These activities have resulted in lower net losses, improving from $76.0 million in 2016 to $59.0 million in 2018. We have also strengthened our balance sheet through the issuance of common stock and refinancing our convertible debt. In August 2017, we sold 9.1 million shares of common stock for aggregate net proceeds of approximately $28.8 million; in December 2018, we sold approximately 9.4 million shares of common stock for aggregate net proceeds of $59.1 million. In March 2018, we refinanced $150 million of our convertible debt which effectively extended the maturity of the debt while providing us with additional financing flexibility. These transactions are described in Note 6 and Note 8 of our audited 2018 consolidated financial statements.
Recent Developments
From January 9, 2019 through February 27, 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately $138.1 million in aggregate principal amount pursuant to the terms of the Second Supplemental Indenture dated March 6, 2018, between us and U.S. Bank National Association (Trustee) to the Indenture dated as of February 14, 2014, between us and the Trustee. As a result of such voluntary conversions, we have elected to fully satisfy our conversion obligations by delivering approximately 17.9 million shares of our common stock to such holders and have retired approximately $138.1 million of the 2018 Notes. On February 27, 2019, we notified the Trustee of our intention to

41


exercise our Issuer’s Conversion Option pursuant to the terms of the Second Supplemental Indenture with respect to the remaining approximately $11.9 million in aggregate principal amount of 2018 Notes. These bonds were converted into approximately 1.5 million shares of our common stock and the bonds retired in March 2019.
In early March 2019, we experienced a ransomware attack that infiltrated and encrypted certain of our information technology systems, including systems containing critical business data. Immediately following the attack, actions were taken to recover the compromised systems and we believe we were able to restore their operation without significant loss of business data. Based on the nature of the attack and its impact on our systems, we do not believe confidential data was lost or disclosed, but we are continuing to monitor the situation. If confidential data is later determined to have been released in the course of this event, it is possible that we could be the subject of actions by governmental authorities or claims from persons alleging they suffered damages from such a release. As of the date of this filing, we estimate the costs associated with the intrusion to be approximately $1.5 million and are seeking to recover these costs under an applicable insurance policy. Although we believe we have now contained the disruption, we anticipate additional work and expense in the future as we continue to respond to the attack and further enhance our security processes and initiatives.

Critical Accounting Policies, Significant Judgments and Estimates

Our consolidated financial statements and the related notes included elsewhere in this Form 10-K are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs, and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Changes in accounting estimates may occur from period to period. Accordingly, actual results could differ significantly from the estimates made by our management. We evaluate our estimates and assumptions on an ongoing basis. To the extent that there are material differences between these estimates and actual results, our future financial statement presentation, financial condition, results of operations, and cash flows will be affected.

We believe that the following critical accounting policies involve a greater degree of judgment and complexity than our other accounting policies. Accordingly, these are the policies we believe are the most critical to understanding and evaluating of our audited 2018 consolidated financial statements.

Revenue Recognition

We generate revenue primarily from sales of our products and services. Our product revenue consists of sales of our mass cytometry, high-throughput genomics and single-cell genomics instruments and consumables, including IFCs, assays, and other reagents. Our service revenue consists of post-warranty service contracts, preventive maintenance plans, repairs, installation, training and other specialized product support services. We also receive revenue from our license agreements with third parties. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities.

We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSPs) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.

Product Revenue

We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and become due in 30 to 60 days.

Service Revenue

We recognize revenue from repairs, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed.


42


Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally one to three years. We believe this approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our consolidated balance sheet as deferred revenue.

Contract Costs

Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally one to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred.

Product Warranties

We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the consolidated statements of operations.

Significant Judgments

Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchase consideration in multi-element arrangements and estimating the future amount of our warranty obligations. Significant judgment is also required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.

Goodwill, Intangible Assets and Other Long-Lived Assets

Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.

Goodwill and intangible assets with indefinite lives are not subject to amortization, but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. We first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we then conduct a two-step test for impairment of goodwill. In the first step, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then the second step of the impairment test must be performed in order to determine the implied fair value of the goodwill. If the carrying value of the goodwill exceeds its implied fair value, then an impairment loss equal to the difference would be recorded.

We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicators of impairment exist, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset and adjust the carrying value of the asset accordingly. We did not recognize any impairment of long-lived assets for any of the periods presented herein.

Convertible Notes

In February 2014, we closed an underwritten public offering $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our new 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). Following the exchange, approximately $51.3 million in

43


aggregate principal amount of the 2014 Notes remained outstanding in addition to $150.0 million in aggregate principal amount of the 2018 Notes.

As the 2018 Notes are convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. The embedded conversion option value was calculated as the difference between (i) the total fair value of the 2018 Notes and (ii) the fair value of a similar debt instrument excluding the embedded conversion option. We determined an embedded conversion option value of $29.3 million, which was recorded in additional paid-in-capital and reduced the carrying value of the 2018 Notes. The resulting discount on the 2018 Notes will be amortized over the expected term of the 2018 Notes, using the effective interest method through the first note holder put date of February 6, 2023.

For both the 2014 Notes and 2018 Notes, offering-related costs, including underwriting costs, were capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are amortized over the expected term of the related Notes using the effective interest method.

Stock-Based Compensation

Our board of directors sets the terms, conditions, and restrictions related to our Employee Stock Purchase Plan (ESPP) and the grant of stock options, Restricted Share Units (RSUs) and performance-based awards under our various stock-based plans. Our board of directors determines the number of awards to grant and sets the vesting criteria. For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.

We recognize compensation costs for all stock-based awards, including stock options, RSUs, and stock purchased under our ESPP, based on the grant date fair value of the award. We recognize stock-based compensation expense on a straight-line basis over the requisite service periods for non-performance-based awards. For performance-based stock awards, stock-based compensation expense is recognized over the requisite service period when the achievement of each individual performance goal becomes probable.

Stock-based compensation cost for restricted stock units granted to employees is measured based on the closing fair market value of our common stock on the date of grant. The fair value of options and stock purchases under ESPP on the grant date is estimated using the Black-Scholes option-pricing model, which requires the use of certain subjective assumptions, including expected term, volatility, risk-free interest rate and the fair value of our common stock. These assumptions generally require significant judgment. We determine the expected volatility based on our historical stock price volatility generally commensurate with the estimated expected term of the stock awards. The expected term of an award is based on historical forfeiture experience, exercise activity, and the terms and conditions of the stock awards. The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to each grant’s expected term. We account for forfeitures as they occur.

Income Taxes

We use the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Significant management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation allowance recorded against our deferred tax assets. Our provision for income taxes generally consists of tax expense/benefit related to current period earnings/losses.

As part of the process of preparing our consolidated financial statements, we continuously monitor the circumstances impacting the expected realization of our deferred tax assets for each jurisdiction. We consider all available evidence, including historical operating results in each jurisdiction, expectations and risks associated with estimates of future taxable income, and ongoing prudent and feasible tax planning strategies in assessing the need for a valuation allowance. To the extent a deferred tax asset cannot be recognized, a valuation allowance is established to reduce our deferred tax assets to the amount that is more likely than not to be realized. These deferred tax assets primarily consist of net operating loss carryforwards, research and development tax credits, and stock-based compensation. We intend to maintain such valuation allowance until sufficient evidence exists to support its reduction. Our deferred tax liabilities primarily consist of book and tax basis differences in fixed

44


assets and acquired identifiable intangible assets. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.

We recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. Any interest and penalties related to uncertain tax positions are reflected in the income tax provision.

The Tax Cuts and Jobs Act (the Tax Act) was enacted in December 2017. The Tax Act introduced a broad range of tax reform measures that significantly changed the federal income tax laws. At December 31, 2017, we recorded the provisional income tax effects of the Tax Act in accordance with ASU No. 2018-05, Income Taxes (Topic 740). Due to our having recorded a full valuation allowance against its U.S. federal and state deferred tax assets, there was no net impact on our tax provision as a result of the remeasurement of U.S. deferred taxes using the relevant tax rate at which we expect them to reverse. The one-time transition tax on post-1986 foreign unremitted earnings did not have a material impact to our effective tax rate as a result of our generating net foreign deficit earnings. In accordance with Staff Accounting Bulletin (SAB No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense were required. We continue to monitor supplemental legislation and technical interpretations of the tax law that may cause the final impact from the Tax Act to differ from the amounts previously recorded.

At December 31, 2017, we changed our permanent reinvestment assertion and will not permanently reinvest our foreign earnings outside the United States. The cash generated from some of our foreign subsidiaries may be used domestically to fund operations. Any domestic, foreign withholding tax and state taxes that may be due upon future repatriation of earnings is not expected to be significant.

Inventory Valuation

Inventories are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory costs include direct materials, direct labor, and normal manufacturing overhead. Finished goods that are used for research and development are expensed as consumed or depreciated over their period of use. We regularly review inventory for excess and obsolete products and components. Provisions for slow-moving, excess, and obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values based on product life cycle, development plans, product expiration, and quality issues.


Recent Accounting Changes and Accounting Pronouncements

Adoption of New Accounting Guidance
In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers (Topic 606). Topic 606 and its related amendments supersede Revenue Recognition (Topic 605), issued in June 2010, and provide principles for recognizing revenue for goods and services in a manner consistent with the transfer of control of those goods and services to the customer.

We adopted Topic 606 on January 1, 2018, using the modified retrospective method applied to those contracts with unrecognized revenue on the adoption date. We recognized the effect of applying the new revenue standard by recording a cumulative catch-up adjustment that reduced the accumulated deficit component of stockholders’ equity by $0.4 million and increased current assets by $0.2 million and non-current assets by $0.2 million. The adjustment capitalized certain sales commission costs that were incurred to obtain instrument service contracts. Under Topic 605, we accounted for these incremental contract acquisition costs by recognizing them as expense at the point the contract was awarded. Under Topic 606, the costs are capitalized and amortized to expense over the life of the contract, which is generally one to three years. The comparative information for periods prior to January 1, 2018, has not been restated and continues to be reported in accordance with Topic 605.

The following table summarizes the cumulative effect of adopting Topic 606 on amounts previously reported in our consolidated balance sheet at December 31, 2017 (in thousands):


45


 
 
Balance at December 31, 2017
 
Topic 606 Transition Adjustments
 
Balance at January 1, 2018
Prepaid expenses and other current assets
 
$
1,528

 
$
153

 
$
1,681

Total current assets
 
$
94,801

 
$
153

 
$
94,954

Other non-current assets
 
$
7,541

 
$
205

 
$
7,746

        Total assets
 
$
287,351

 
$
358

 
$
287,709

Accumulated deficit
 
$
(500,196
)
 
$
358

 
$
(499,838
)
Total stockholders' equity
 
$
30,935

 
$
358

 
$
31,293

        Total liabilities and stockholders' equity
 
$
287,351

 
$
358

 
$
287,709


The following table summarizes the impacts on our consolidated statement of operations of adopting Topic 606 compared to Topic 605 for the twelve months ended December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
Topic 606
 
Effect of Change
 
 
Twelve Months Ended December 31, 2018
Selling, general and administrative
 
$
79,783

 
$
79,859

 
$
(76
)
Total costs and expenses
 
$
161,128

 
$
161,204

 
$
(76
)
Loss from operations
 
$
(48,164
)
 
$
(48,240
)
 
$
76

Loss before income taxes
 
$
(61,420
)
 
$
(61,496
)
 
$
76

      Net loss
 
$
(59,013
)
 
$
(59,089
)
 
$
76

The following table summarizes the impacts on our consolidated balance sheet of adopting Topic 606 compared to Topic 605 at December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
Topic 606
 
Effect of Change
 
 
 
 
December 31, 2018
 
 
Prepaid expenses and other current assets
 
$
2,051

 
$
1,884

 
$
167

Total current assets
 
$
127,106

 
$
126,939

 
$
167

Other non-current assets
 
$
6,208

 
$
5,941

 
$
267

        Total assets
 
$
303,647

 
$
303,213

 
$
434

Stockholders' equity
 
$
72,116

 
$
71,682

 
$
434

        Total liabilities and stockholders' equity
 
$
303,647

 
$
303,213

 
$
434


In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. This ASU allows SEC reporting companies to record provisional amounts in earnings for the year ended December 31, 2017, due to the complexities involved in accounting for the enactment of the Tax Act. We recognized the estimated income tax effects of the Tax Act in its 2017 Consolidated Financial Statements in accordance with SEC Staff Accounting Bulletin No. 118. In accordance with SAB No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense were required. Refer to Note 10 of the consolidated financial statements in the Form 10-K for the fiscal year ended December 31, 2018 for further information regarding the provisional amounts recorded by the Company.

In August 2016, the FASB issued ASU 2016-15 Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The ASU addresses eight specific cash flow issues and their presentation within the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.

46



In November 2016, the FASB issued ASU 2016-18 Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB’s Emerging Issues Task Force, which amended the presentation of restricted cash within the statement of cash flows. The new guidance requires restricted cash be included within cash and cash equivalents on the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.

Recent Accounting Pronouncements

In August 2018, the FASB issued ASU 2018-15 Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact of adoption on its consolidated financial statements.

In February 2016, the FASB established Topic 842, Leases, by issuing Accounting Standards Update (ASU) No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (ROU) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating; the classification will impact the expense recognition in the income statement.

A Modified Retrospective Transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. We expect to adopt the new standard on January 1, 2019 and use the effective date as our date of initial application. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. For dates and periods prior to January 1, 2019, the original disclosures under ASC 840 will be disclosed.

The new standard provides several optional practical expedients upon transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification, and initial direct costs. We do not expect to elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us.

We expect that this standard will have a material effect on our financial statements. While we continue to assess all the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our building, vehicle and equipment leases. On adoption, we currently expect to recognize $8.0 million to $11.0 million of additional operating liabilities, based on the present value of the remaining fixed rental payments under current leasing standards for existing operating leases, with corresponding ROU assets of approximately $6.0 million to $9.0 million. The difference between the initial lease liability and right of use asset is attributable to deferred rent. We do not expect any impact on retained earnings from the adoption of ASC 842.

The new standard also provides certain accounting elections for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities. We also currently expect to elect to not separate lease and nonlease components for our building leases and to take a portfolio approach for our vehicle leases by country.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU will be effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020, with early adoption permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements.




47



Results of Operations

The following table presents our historical consolidated statements of operations data for the years ended December 31, 2018, 2017, and 2016, and as a percentage of total revenue for the respective years (in thousands):

 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Revenue:
 
 
 
 
 
 
 
 
 
 
 
 
Total revenue
 
$
112,964

 
100
 %
 
$
101,937

 
100
 %
 
$
104,446

 
100
 %
Cost of sales:
 
 
 
 
 
 
 
 
 
 
 
 
Cost of product revenue
 
44,861

 
39

 
45,039

 
44

 
41,110

 
39

Cost of service revenue
 
6,454

 
6

 
4,916

 
5

 
4,899

 
5

Total cost of sales
 
51,315

 
45

 
49,955

 
49

 
46,009

 
44

Gross profit
 
61,649

 
55
 %
 
51,982

 
51
 %
 
58,437

 
56
 %
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
Research and development
 
30,030

 
27

 
30,826

 
30

 
38,415

 
37

Selling, general and administrative
 
79,783

 
71

 
79,516

 
78

 
93,212

 
89

Total operating expenses
 
109,813

 
98

 
110,342

 
108

 
131,627

 
126

Loss from operations
 
(48,164
)
 
(43
)
 
(58,360
)
 
(57
)
 
(73,190
)
 
(70
)
Interest expense
 
(13,893
)
 
(12
)
 
(5,824
)
 
(6
)
 
(5,820
)
 
(6
)
Other income (expense), net
 
637

 
1

 
385

 
1

 
(1,167
)
 
(1
)
Loss before income taxes
 
(61,420
)
 
(54
)
 
(63,799
)
 
(62
)
 
(80,177
)
 
(77
)
Benefit from income taxes
 
2,407

 
2

 
3,264

 
3

 
4,192

 
4

Net loss
 
$
(59,013
)
 
(52
)%
 
$
(60,535
)
 
(59
)%
 
$
(75,985
)
 
(73
)%

Revenue

We generate revenue primarily from sales of our products and services, and license agreements. Our product revenue consists of sales of instruments and consumables. Consumable revenues are largely driven by the size of our installed base of instruments and the annual level of pull-through per instrument. Service revenue is linked to our sales of instruments as our service revenue consists of post-warranty service contracts, preventive maintenance plans, instrument parts, installation and training. Our license revenue is generated primarily in the United States and relates to licensing our technology to third-parties.

We sell our instruments to leading academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, and biopharmaceutical, biotechnology, contract research organizations, and Ag-Bio companies. No single customer represented more than 10% of our total revenue for 2018, 2017, or 2016. Revenue from our five largest customers was 17%, 14% and 15% of total revenue in 2018, 2017, and 2016, respectively.


48


The following table presents our revenue by source for the years ended December 31, 2018, 2017, and 2016, and as a percentage of total revenue for the respective years (in thousands):

 
 
Year Ended December 31,
 
Change
 
 
2018
 
2017
 
2016
 
2018
 
2017
Revenue:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Instruments
 
$
45,491

 
40
%
 
$
42,505

 
42
%
 
$
46,834

 
45
%
 
7
 %
 
(9
)%
Consumables
 
48,159

 
43

 
41,894

 
41

 
42,169

 
40

 
15
 %
 
(1
)%
Product revenue
 
93,650

 
83
%
 
84,399

 
83
%
 
89,003

 
85
%
 
11
 %
 
(5
)%
Service revenue
 
19,314

 
17

 
17,348

 
17

 
15,205

 
15

 
11
 %
 
14
 %
License revenue
 
—

 
—

 
190

 
—

 
238

 
—

 
(100
)%
 
(20
)%
Total revenue
 
$
112,964

 
100
%
 
$
101,937

 
100
%
 
$
104,446

 
100
%
 
11
 %
 
(2
)%
 
 
 
 


 
 
 
 
 
 
 
 
 
 
 
 

The following table presents our total revenue by geographic area of our customers and as a percentage of total revenue for each year presented (in thousands):

 
 
Year Ended December 31,
 
Change
 
 
2018
 
2017
 
2016
 
2018
 
2017
Americas
 
$
51,172

 
46
%
 
$
49,290

 
48
%
 
$
56,229

 
54
%
 
4
%
 
(12
)%
EMEA
 
36,617

 
32

 
32,642

 
32

 
29,739

 
28

 
12
%
 
10
 %
Asia-Pacific
 
25,175

 
22

 
20,005

 
20

 
18,478

 
18

 
26
%
 
8
 %
Total revenue
 

$112,964

 
100
%
 

$101,937

 
100
%
 

$104,446

 
100
%
 
11
%
 
(2
)%

The Americas revenue includes revenue generated in the United States of $48.1 million, $45.8 million, and $52.6 million for 2018, 2017 and 2016, respectively.


Total Revenue

Total revenue increased by $11.0 million or 11%, to $113.0 million for 2018 compared to $101.9 million for 2017, primarily due to increased sales of our mass cytometry instruments and related service revenues, mass cytometry consumables, and microfluidics consumables. Revenue grew in 2018 compared to the prior year across all regions for both products and services. The significant growth in the Asia-Pacific region primarily reflects mass cytometry instrument and consumables growth in Japan and China. Changes in foreign currency exchange rates had a minimal impact on revenue in 2018.

Total revenue decreased by $2.5 million, or 2%, to $101.9 million for 2017 compared to $104.4 million for 2016. The revenue decrease was predominantly in the United States, partially offset by increases in Europe and Asia-Pacific. The decrease in the United States was mainly attributable to lower instrument sales, particularly our single-cell systems, partially offset by an increase in service revenue. The increases in Europe and Asia-Pacific were primarily driven by higher mass cytometry product sales, partially offset by a decrease in sales of our single-cell products.

Product Revenue

Product revenue increased by $9.3 million, or 11%, to $93.7 million for 2018 from $84.4 million in 2017. Instrument sales increased $3.0 million, or 7% in 2018 compared to 2017, due to higher mass cytometry instrument sales in the Americas and Asia-Pacific from higher unit volumes and average selling prices, partially offset by softer microfluidic instrument sales in both regions. Instrument sales in EMEA declined in 2018 compared to 2017, with softer mass cytometry instrument sales partially offset by higher microfluidic instrument sales.

Consumables sales increased $6.3 million, or 15% in 2018 compared to 2017, due to unit volume growth in both mass cytometry and microfluidic consumables, which comprise the bulk of our microfluidics business. Asia-Pacific and EMEA experienced strong growth in both mass cytometry and microfluidics consumables year-over-year. Total consumables sales in the Americas were essentially flat in 2018 versus 2017, with growth in mass cytometry offset by declines in microfluidics.

49



Product revenue decreased by $4.6 million, or 5%, to $84.4 million for 2017 compared to $89.0 million for 2016. Instrument revenue decreased by $4.3 million, or 9%, to $42.5 million for 2017 compared to 2016, predominately due to lower unit sales of our microfluidics instruments and particularly our C1 systems, partially offset by higher unit sales of our mass cytometry instruments. Consumables revenue decreased by $0.3 million, or 1%, to $41.9 million for 2017 compared to 2016, largely attributable to decreased unit sales of single-cell consumables and lower average selling prices for most consumables, partially offset by increased unit sales of mass cytometry reagents.

We expect the average selling prices of our products to fluctuate over time based on market conditions, product mix, and currency fluctuations.

Service Revenue

Service revenue increased by $2.0 million, or 11%, to $19.3 million for 2018 compared to 2017. Service revenue increased by $2.1 million, or 14%, to $17.3 million for 2017 compared to 2016. The increases in both 2018 and 2017 were primarily due to an increase in instruments under post-warranty service contracts as a result of growth in mass cytometry instruments. Revenue from post-warranty service contracts generally lags changes our instrument revenue by one year.
 
Cost of Product and Service Revenue

Cost of product revenue includes manufacturing costs incurred in the production process, including component materials, labor and overhead, installation, packaging, and delivery costs. In addition, cost of product revenue includes amortization of developed technology and intangibles, royalty costs for licensed technologies included in our products, warranty, provisions for slow-moving and obsolete inventory, and stock-based compensation expense. Cost of service revenue includes direct labor hours, overhead and instrument parts. While margins vary between product and service offerings, in general, instruments have the lowest profit margin, while margins on consumables tend to be higher than instrument margins. Service margins tend to be between the instrument and consumable margins.

The following table presents our cost of product and service revenue, total cost of sales, product and service margin, and gross margin for each year presented (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Cost of product revenue
 
$
44,861

 
$
45,039

 
$
41,110

Cost of service revenue
 
6,454

 
4,916

 
4,899

Total cost of sales
 
$
51,315

 
$
49,955

 
$
46,009

 
 
 
 
 
 
 
Product margin
 
52.1
%
 
46.6
%
 
53.8
%
Service margin
 
66.6
%
 
71.7
%
 
67.8
%
Gross margin
 
54.6
%
 
51.0
%
 
55.9
%

Product margin increased 5.5 percentage points in 2018 compared to 2017. The year-over-year increase in product margin was due to favorable manufacturing capacity utilization and product mix, coupled with the impact of fixed amortization on a higher revenue base in 2018.

Product margin decreased 7.0 percentage points in 2017 compared to 2016, primarily driven by increased microfluidic unit product costs from lower production volumes, higher excess and obsolete inventory expense and, to a lesser extent, lower average selling prices across most of the products, and the impact of fixed amortization on a lower revenue base in 2017. Favorable product mix partially offsets these negative factors.

Service margin decreased 5.1 percentage points during 2018 compared to 2017. Service margin decreased primarily due to product mix, with a greater percentage of service revenue coming from servicing mass cytometry products than microfluidics products. Service costs tend to be higher for mass cytometry instruments compared to microfluidic instruments as the servicing is more labor-intensive.

Service margin increased 3.9 percentage points during 2017 compared to 2016, mainly due to lower labor costs driven by product mix.

50



Operating Expenses

The following table presents our operating expenses for each year presented (in thousands):

 
 
Year Ended December 31,
 
2018 vs. 2017 change
 
2017 vs. 2016 change
 
 
2018
 
2017
 
2016
 
 
Research and development
 
$
30,030

 
$
30,826

 
$
38,415

 
(3
)%
 
(20
)%
Selling, general and administrative
 
79,783

 
79,516

 
93,212

 
—
 %
 
(15
)%
Total operating expenses
 
$
109,813

 
$
110,342

 
$
131,627

 
—
 %
 
(16
)%

Research and Development

Research and development expense consists primarily of personnel and independent contractor costs, prototype and material expenses and other allocated facilities, and information technology expenses. We have made substantial investments in research and development since our inception. Our research and development efforts have focused primarily on enhancing our technologies and supporting development and commercialization of new and existing products and services.

Research and development expense decreased by $0.8 million, or 3%, to $30.0 million for 2018 compared to $30.8 million for 2017, as a result of the lower severance and employee-related expenses.

Research and development expense decreased by $7.6 million, or 20%, to $30.8 million for 2017. The decrease in research and development expense for 2017 was primarily attributable to our cost-savings initiatives, which included headcount and compensation savings of $3.6 million. In addition, product materials and supplies costs decreased by $3.1 million mainly due to fewer projects in 2017 driven by our strategic realignment and focus.

We believe that our continued investment in research and development is essential to our long-term competitive position and that these expenses may increase in future periods.

Selling, General and Administrative

Selling, general and administrative expense consists primarily of personnel costs for our sales, marketing and administrative employees, facilities, depreciation and professional services, such as legal and accounting services.

Selling, general and administrative expense increased by $0.3 million, or 0%, to $79.8 million for 2018 compared to $79.5 million for 2017. The increase in 2018 was primarily due to higher headcount-related costs.

Selling, general and administrative expense decreased by $13.7 million or 15% to $79.5 million for 2017 compared to $93.2 million for 2016. This decrease for 2017 was primarily due to our cost-savings initiatives, which included infrastructure and facilities savings of $3.4 million. In addition, we had lower net legal expenses of $6.2 million mainly attributable to settlements in 2017 of previously pending litigations, a decrease in outside services of $1.5 million, a decrease in travel expenses of $1.2 million and a decrease in recruiting costs of $1.1 million.

Interest Expense and Other Income (Expense), Net

The following table presents these items for each year presented (in thousands):
 
 
 
Year Ended December 31,
 
2018 vs. 2017 change
 
2017 vs. 2016 change
 
 
2018
 
2017
 
2016
 
 
Interest expense
 
$
(13,893
)
 
$
(5,824
)
 
$
(5,820
)
 
(139
)%
 
—
 %
Other income (expense), net
 
637

 
385

 
(1,167
)
 
(65
)%
 
133
 %
Total
 
$
(13,256
)
 
$
(5,439
)
 
$
(6,987
)
 
(144
)%
 
22
 %



51


As noted above in Critical Accounting Policies, in March 2018, we entered into privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for $150.0 million in aggregate principal amount of our new 2.75% Exchange Convertible Senior Notes due 2034. As the 2018 Notes are convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock. we accounted for the 2018 Notes under the cash conversion guidance in ASC 470. Because of this conversion option, along with a redemption premium, the net effective interest rate for the 2018 Notes is higher than the 2014 Notes. The effective interest rate on the 2014 Notes and the 2018 Notes is approximately 3.0% and 12.3%, respectively. The majority of the difference in effective interest rates is due to non-cash amortization of debt discounts. With the higher effective interest rate, interest expense increased in 2018 as compared to 2017 and 2016.

Other income, net, of $0.6 million for 2018 is primarily attributable to $0.6 million of interest income. Other income, net, of $0.4 million for 2017 includes $0.3 million of interest income. Other expense, net, of $1.2 million for 2016 was mainly associated with losses of $1.5 million from revaluation of certain foreign currency denominated assets and liabilities, partially offset by $0.3 million of interest income.

Benefit from Income Taxes

We recorded a tax benefit of $2.4 million, or an effective tax rate benefit of 3.9%, for the year ended December 31, 2018. The tax benefit was principally due to the amortization of our acquisition-related deferred tax liability, partially offset by net income tax expense from our foreign operations and unrecognized tax benefits.

We recorded a tax benefit of $3.3 million, or an effective tax rate benefit of 5.1%, for the year ended December 31, 2017. This tax benefit was primarily attributable to amortization of our acquisition-related deferred tax liability.

We recorded a tax benefit of $4.2 million, or an effective tax rate benefit of 5.2% for the year ended December 31, 2016. The tax benefit was principally due to the amortization of our acquisition-related deferred tax liability, partially offset by net income tax expense from our foreign operations and unrecognized tax benefits.


Liquidity and Capital Resources

Sources of Liquidity

As of December 31, 2018, our principal sources of liquidity consisted of $95.4 million of cash and cash equivalents.

The following table presents our cash flow summary for each year presented (in thousands):
 
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Cash flow summary:
 
 
 
 
 
 
Net cash used in operating activities
 
$
(25,201
)
 
$
(24,098
)
 
$
(39,138
)
Net cash provided by investing activities
 
4,719

 
17,658

 
45,102

Net cash provided by financing activities
 
57,660

 
28,997

 
116

Net increase in cash and cash equivalents
 
37,345

 
23,011

 
5,928


Net Cash Used in Operating Activities

We derive cash flows from operations primarily from cash collected from the sale of our products and services, and license agreements. Our cash flows from operating activities are also significantly influenced by our use of cash for operating expenses and working capital to support the business. We have historically experienced negative cash flows from operating activities as we have expanded our business and built our infrastructure domestically and internationally.

Net cash used in operating activities in 2018 was $25.2 million and consisted of net loss of $59.0 million less non-cash adjustments of $36.3 million, and a net increase in assets and liabilities of $2.5 million. Non-cash items primarily included amortization of developed technology of $11.2 million, stock-based compensation expense of $11.0 million, amortization of debt discounts and issuance costs of $8.4 million and depreciation and amortization of $5.4 million. The net increase in assets

52


and liabilities was primarily due to lower accrued liabilities for retention bonuses, which were paid in November 2018 in the form of stock.

Net cash used in operating activities in 2017 was $24.1 million and consisted of net loss of $60.5 million less non-cash adjustments of $27.2 million, and a net reduction in assets and liabilities of $9.2 million. Non-cash items primarily included amortization of developed technology of $11.2 million, stock-based compensation expense of $9.1 million, and depreciation and amortization of $7.4 million. The net change in assets and liabilities was primarily driven by a decrease in inventory, an increase in deferred revenue, an increase in other liabilities and a decrease in prepaid expenses and other current assets.

Net cash used in operating activities in 2016 was $39.1 million and consisted of net loss of $76.0 million less non-cash adjustments of $32.1 million, and a net decrease in assets and liabilities of $4.7 million. Non-cash items primarily included stock-based compensation expense of $13.9 million, amortization of developed technology of $11.2 million, and depreciation and amortization of $6.7 million. The net change in assets and liabilities was primarily driven by a decrease in accounts receivable, offset by an increase in inventory and a decrease in accounts payable.

Net Cash Provided by Investing Activities

Our primary investing activities consist of purchases, sales, and maturities of our short-term investments and to a much lesser extent, capital expenditures for manufacturing, laboratory, computer equipment and software to support our infrastructure and work force. We expect to continue to incur costs for capital expenditures for demonstration units and loaner equipment to support our sales and service efforts, and computer equipment and software to support our business operations. However, we may choose to decrease or defer certain capital expenditures and development activities, while further optimizing our organization.

Net cash provided by investing activities in 2018 was $4.7 million, which included proceeds from sales and maturities of investments of $6.5 million, offset by purchases of investments of $1.5 million and capital expenditures of $0.4 million to support our commercial and manufacturing operations.

Net cash provided by investing activities in 2017 was $17.7 million, which included proceeds from sales and maturities of investments of $25.6 million, offset by purchases of investments of $6.3 million and capital expenditures of $1.6 million to support our commercial and manufacturing operations.

Net cash provided by investing activities in 2016 was $45.1 million, which included proceeds from sales and maturities of investments of $86.4 million and proceeds from the sale of investment in Verinata of $2.3 million, offset by purchases of investments of $38.6 million and capital expenditures of $5.1 million to support our commercial and manufacturing operations.

Net Cash Provided by Financing Activities

We generated cash from financing activities of $57.7 million during 2018. Approximately $59.5 million was generated from a public offering of our common stock. The remainder reflects the proceeds from stock option exercises and ESPP purchases, offset by debt and equity issuance costs and payments of taxes for the net settlement of equity awards. We generated cash from financing activities of $29.0 million during 2017, primarily due to a public equity offering. In 2016, we generated cash of $0.1 million, primarily from proceeds received in connection with the exercise of options for our common stock.

Capital Resources

At December 31, 2018 and December 31, 2017, our working capital, excluding deferred revenues, was $101.0 million and $71.6 million, respectively, including cash and cash equivalents of $95.4 million and $58.1 million, respectively, and short-term investments of $0.0 million and $5.1 million, respectively.

In February 2014, we closed an underwritten public offering of $201.3 million in aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for $150.0 million in aggregate principal amount of our new 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). Following the exchange transactions, approximately $51.3 million in aggregate principal amount of 2014 Notes remained outstanding. Our board of directors determined that the private exchange transactions were in our best interest and in the best interest of our stockholders following substantial review with management and our financial advisors concerning the amount of our outstanding indebtedness relative to the market capitalization of our common stock and, in particular, obligations under the

53


indenture for the 2014 Notes that could require us to repurchase the 2014 Notes beginning in 2021 at a repurchase price equal to the aggregate principal amount of the 2014 Notes (approximately $201.3 million prior to the exchange). The principal differences between the 2014 Notes and the 2018 Notes are the following:

•
The date on which we may be first required to repurchase the 2018 Notes has been extended to February 2023, compared to February 2021 under the 2014 Notes. In addition, while the applicable cash repurchase price for the 2014 Notes is 100% of the outstanding principal amount, the cash repurchase price for the 2018 Notes is based on a formula that would result in the 2018 Notes being redeemed for up to an amount equal to 120% of the original principal amount, plus, in each case, accrued and unpaid interest.

•
The initial conversion price under the 2018 Notes is approximately $7.88, as compared to approximately $55.94 under the 2014 Notes. As a result, each of the outstanding 2018 Notes is initially convertible into 126.9438 shares of our common stock per $1,000 principal amount, while the 2014 Notes are initially convertible into 17.8750 shares of our common stock per $1,000 principal amount.

•
Under the supplemental indenture for the 2018 Notes, we may at any time cause the then-outstanding 2018 Notes to be converted into shares of our common stock at the then-applicable 2018 Note conversion price if the volume weighted average price of our common stock is at least 110% of the applicable 2018 Note conversion price on each applicable trading day over a period specified in the supplement indenture for the 2018 Notes.  Under the indenture for the 2014 Notes, we may only redeem the 2014 Notes for cash under certain circumstances during the period from February 6, 2018, through February 6, 2021.

•
Under certain circumstances such as a “fundamental change” (as defined in the applicable indenture) that occurs prior to (i) February 6, 2021, in the case of the 2014 Notes and (ii) February 6, 2023, in the case of the 2018 Notes, holders of the Notes are entitled to a “make-whole” premium that will result in an increase in the applicable conversion rate. Under the terms of the 2018 Notes (but not the 2014 Notes), holders will be entitled to receive additional shares reflecting the economic equivalent of approximately two years of additional coupon payments, subject to certain limitations, in connection with a voluntary conversion by the noteholder prior to our exercise of our early conversion option.

The foregoing summaries of the 2014 Notes, the 2018 Notes, and the exchange transactions completed in March 2018 are not complete and are qualified in their entirety by the applicable indentures, forms of global notes, and other agreements and documents filed with the Securities and Exchange Commission with respect to the 2018 Notes and the exchange, and investors should refer to the text of the Second Supplemental Indenture, dated March 6, 2018, between Fluidigm Corporation and U.S. Bank National Association and the Form of Global Note included in the Second Supplemental Indenture, which are incorporated by reference as Exhibits 4.6 and 4.7, respectively, in our Annual Report on Form 10-K for the year ended December 31, 2017. With respect to the 2014 Notes, of which approximately $51.3 million in aggregate principal amount remains outstanding, investors should refer to the text of the Indenture, dated as of February 4, 2014, by and between Fluidigm Corporation and U.S. Bank National Association, the First Supplemental Indenture, dated as of February 4, 2014, by and between Fluidigm Corporation and U.S. Bank National Association, and the Form of Global Note included in the First Supplemental Indenture which are incorporated by reference as Exhibits 4.2, 4.3 and 4.4, respectively, in our Annual Report on Form 10-K for the year ended December 31, 2017.

On August 2, 2018, we entered into a Revolving Credit Facility with Silicon Valley Bank, which matures on August 2, 2020. Amounts drawn under the Revolving Credit Facility will be used for working capital and general corporate purposes. As of December 31, 2018, total availability under the Revolving Credit Facility was $12.3 million. We currently have no outstanding debt under the Revolving Credit Facility, and we are in compliance with all the terms and conditions of the loan agreement governing the Revolving Credit Facility. See Note 6 to the Consolidated Financial Statements included in this Form 10-K for more information about the Revolving Credit Facility.

In early 2017, we implemented a retention incentive plan that provided for payment of cash bonuses in January 2019 to plan participants who were employees at the time the plan was implemented and who remained with Fluidigm through January 1, 2019. In September 2018, certain plan participants were permitted to elect to surrender their right to receive all or a portion of the cash bonus in exchange for fully vested restricted stock units issued under our 2011 Equity Incentive Plan. Among other reasons, our compensation committee adopted the exchange program to encourage employee stock ownership and to effectively manage cash resources. Participants opted to exchange approximately $2.4 million of cash bonus payments for approximately 380,000 fully vested RSUs issued in November 2018. The cash bonus payments payable in January 2019 for plan participants that remain employed with Fluidigm through January 1, 2019 is approximately $3.3 million.


54


We believe our existing cash, cash equivalents, and investments will be sufficient to meet our working capital and capital expenditure needs for at least the next 18 months. However, we may experience lower than expected cash generated from operating activities or greater than expected capital expenditures, cost of revenue, or operating expenses, and we may need to raise additional capital to fund our operations, further our research and development activities, or acquire or invest in a business. Our future funding requirements will depend on many factors, including market acceptance of our products, the cost of our research and development activities, the cost of filing and prosecuting patent applications, the cost associated with litigation or disputes relating to intellectual property rights or otherwise, the cost and timing of regulatory clearances or approvals, if any, the cost and timing of establishing additional sales, marketing, and distribution capabilities, the cost and timing of establishing additional technical support capabilities, and the effect of competing technological and market developments. In the future, we may acquire businesses or technologies from third parties, and we may decide to raise additional capital through debt or equity financing to the extent we believe this is necessary to successfully complete these acquisitions.

If we require additional funds in the future, we may not be able to obtain such funds on acceptable terms, or at all. If we raise additional funds by issuing equity securities, our stockholders could experience dilution. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt or equity financing that we raise may contain terms that are not favorable to us or our stockholders. If we do not have, or are not able to obtain, sufficient funds, we may have to delay development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce marketing, customer support, research and development, or other resources devoted to our products.


Off-Balance Sheet Arrangements

Since our inception, we have not had any off-balance sheet arrangements as defined in Item 303(a)(4) of the Securities and Exchange Commission’s Regulation S-K.

Contractual Obligations and Commitments

The following summarizes our contractual obligations as of December 31, 2018 (in thousands):
 
 
Payments Due by Period
 
 
Total
 
Less than 1
Year
 
1-3 Years
 
3-5 Years
 
Thereafter
Long term debt obligations
 
$
271,725

 
$
5,534

 
$
11,069

 
$
189,074

 
$
66,048

Operating lease obligations, net
 
9,578

 
3,664

 
3,294

 
1,379

 
1,241

Purchase obligations
 
1,596

 
1,596

 
—

 
—

 
—

Total
 
$
282,899

 
$
10,794

 
$
14,363

 
$
190,453

 
$
67,289

Debt obligations include the principal amount of the Notes and interest payments to be made under the Notes. Although the Notes mature in 2034, they can be converted into cash and shares of our common stock prior to maturity if certain conditions are met. See Note 6 to our consolidated financial statements for additional information regarding the terms of the Notes.
Our operating lease obligations, net of sublease income, relate to leases for our current headquarters and leases for manufacturing and office space for our foreign subsidiaries. Purchase obligations consist of contractual and legally binding commitments to purchase goods and services.
We lease facilities and equipment under non-cancelable lease agreements expiring at various times through 2026. Our lease payments are expensed on a straight-line basis over the life of the leases. Rental expense under operating leases, net of amortization of lease incentive, totaled $5.0 million, $4.7 million, $6.3 million for 2018, 2017, and 2016, respectively.
We have entered into several license and patent agreements. Under these agreements, we pay annual license maintenance fees, non-refundable license issuance fees, and royalties as a percentage of net sales for the sale or sublicense of products using the licensed technology. Future payments related to these license agreements have not been included in the contractual obligations table above as the period of time over which the future license payments will be required to be made, and the amount of such payments, are indeterminable. We do not expect the license payments to be material in any particular year.

55


ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates. We do not hold or issue financial instruments for trading purposes.
Foreign Currency Exchange Risk
As we expand internationally our results of operations and cash flows will become increasingly subject to fluctuations due to changes in foreign currency exchange rates. Our revenue is generally denominated in the local currency of the contracting party. Historically, the majority of our revenue has been denominated in U.S. dollars. Our expenses are generally denominated in the currencies in which our operations are located, which is primarily in the United States, with a portion of expenses incurred in Singapore and Canada where our manufacturing facilities are located. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income or loss as a result of transaction gains or losses related to revaluing certain current asset and current liability balances that are denominated in currencies other than the functional currency of the entities in which they are recorded. For the years ended December 31, 2018 and 2017, we experienced foreign currency losses of $0.0 million and $0.1 million, respectively. To date, we have not entered into any foreign currency hedging contracts although we may do so in the future. As our international operations grow, we will continue to reassess our approach to manage our risk relating to fluctuations in currency rates. If foreign currency exchange rates had changed by 10% during the periods presented, it would not have had a material impact on our financial position or results of operations.
Interest Rate Sensitivity
We had cash and cash equivalents of $95.4 million at December 31, 2018. These amounts were held primarily in cash on deposit with banks and money market funds which are short-term. We had no investments at December 31, 2018. Cash and cash equivalents and investments are held for working capital purposes. We believe that we do not have any material exposure to changes in the fair value of our money market portfolio as a result of changes in interest rates. Declines in interest rates, however, will reduce future investment income. If overall interest rates had decreased by 10% during the periods presented, our interest income would not have been materially affected.
Fair Value of Financial Instruments
We do not have material exposure to market risk with respect to investments. We do not use derivative financial instruments for speculative or trading purposes. We may adopt specific hedging strategies in the future.

56


ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Index to Consolidated Financial Statements

57




Report of Independent Registered Public Accounting Firm


To the Board of Directors and
Stockholders of Fluidigm Corporation


Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Fluidigm Corporation and its subsidiaries (the “Company”) as of December 31, 2018 and 2017, and the related consolidated statements of operations, of comprehensive loss, of stockholders’ equity, and of cash flows for each of the three years in the period ended December 31, 2018, including the related notes and financial statement schedule listed in the accompanying index (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2018, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2018 and 2017, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2018 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2018, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Change in Accounting Principle
 
As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for revenues from contracts with customers in 2018.

Basis for Opinions

The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.


58


Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.



/s/ PricewaterhouseCoopers LLP

San Jose, California
March 18, 2019


We have served as the Company’s auditor since 2015.







59


FLUIDIGM CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts)
 
 
 
December 31,
 
 
2018
 
2017
ASSETS
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
95,401

 
$
58,056

Short-term investments
 
—

 
5,080

Accounts receivable (net of allowances of $126 and $391, at December 31, 2018 and 2017, respectively)
 
16,651

 
15,049

Inventories
 
13,003

 
15,088

Prepaid expenses and other current assets
 
2,051

 
1,528

Total current assets
 
127,106

 
94,801

Property and equipment, net
 
8,825

 
12,301

Other non-current assets
 
6,208

 
7,541

Developed technology, net
 
57,400

 
68,600

Goodwill
 
104,108

 
104,108

Total assets
 
$
303,647

 
$
287,351

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable
 
$
4,027

 
$
4,211

Accrued compensation and related benefits
 
14,470

 
10,535

Other accrued liabilities
 
7,621

 
8,490

Deferred revenue, current
 
11,464

 
10,238

Total current liabilities
 
37,582

 
33,474

Convertible notes, net
 
172,058

 
195,238

Deferred tax liability
 
13,714

 
16,919

Deferred revenue, non-current
 
6,327

 
4,960

Other non-current liabilities
 
1,850

 
5,825

Total liabilities
 
231,531

 
256,416

Commitments and contingencies
 


 


Stockholders’ equity:
 
 
 
 
Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either December 31, 2018 or 2017
 
—

 
—

Common stock: $0.001 par value, 200,000 shares authorized at December 31, 2018 and 2017; 49,338 and 38,787 shares issued and outstanding at December 31, 2018 and 2017, respectively
 
49

 
39

Additional paid-in capital
 
631,605

 
531,666

Accumulated other comprehensive loss
 
(687
)
 
(574
)
Accumulated deficit
 
(558,851
)
 
(500,196
)
Total stockholders’ equity
 
72,116

 
30,935

Total liabilities and stockholders’ equity
 
$
303,647

 
$
287,351

See accompanying notes

60


FLUIDIGM CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
 
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Revenue:
 
 
 
 
 
 
Product revenue
 
$
93,650

 
$
84,399

 
$
89,003

Service revenue
 
19,314

 
17,348

 
15,205

License revenue
 
—

 
190

 
238

Total revenue
 
112,964

 
101,937

 
104,446

Cost of sales:
 
 
 
 
 
 
Cost of product revenue
 
44,861

 
45,039

 
41,110

Cost of service revenue
 
6,454

 
4,916

 
4,899

Total cost of sales
 
51,315

 
49,955

 
46,009

Gross profit
 
61,649

 
51,982

 
58,437

Operating expenses:
 
 
 
 
 
 
Research and development
 
30,030

 
30,826

 
38,415

Selling, general and administrative
 
79,783

 
79,516

 
93,212

Total operating expenses
 
109,813

 
110,342

 
131,627

Loss from operations
 
(48,164
)
 
(58,360
)
 
(73,190
)
Interest expense
 
(13,893
)
 
(5,824
)
 
(5,820
)
Other income (expense), net
 
637

 
385

 
(1,167
)
Loss before income taxes
 
(61,420
)
 
(63,799
)
 
(80,177
)
Benefit from income taxes
 
2,407

 
3,264

 
4,192

Net loss
 
(59,013
)
 
(60,535
)
 
(75,985
)
Net loss per share, basic and diluted
 
$
(1.49
)
 
$
(1.84
)
 
$
(2.62
)
Shares used in computing net loss per share, basic and diluted
 
39,652

 
32,980

 
29,008


See accompanying notes

61


FLUIDIGM CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In thousands)
 
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Net loss
 
$
(59,013
)
 
$
(60,535
)
 
$
(75,985
)
Other comprehensive income (loss), net of tax
 
 
 
 
 
 
Foreign currency translation adjustment
 
(112
)
 
183

 
314

Unrealized gain (loss) on available-for-sale securities, net
 
(1
)
 
3

 
70

Other comprehensive income (loss)
 
(113
)
 
186

 
384

Comprehensive loss
 
$
(59,126
)
 
$
(60,349
)
 
$
(75,601
)

See accompanying notes

62


FLUIDIGM CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)
 
 
Common Stock
 
Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
(Loss)/Income
 
Accumulated
Deficit
 
Total
Stockholders’
Equity
 
 
Shares
 
Amount
 
Balance at December 31, 2015
 
28,844

 
$
29

 
$
479,508

 
$
(1,144
)
 
$
(363,492
)
 
$
114,901

Issuance of restricted stock, net of shares withheld for taxes, and other
 
307

 
—

 
(152
)
 
—

 
—

 
(152
)
Issuance of common stock from option exercises
 
57

 
—

 
227

 
—

 
—

 
227

Stock-based compensation expense
 
—

 
—

 
13,858

 
—

 
—

 
13,858

Net loss
 
—

 
—

 
—

 
—

 
(75,985
)
 
(75,985
)
Other comprehensive income
 
—

 
—

 
—

 
384

 
—

 
384

Balance at December 31, 2016
 
29,208

 
$
29

 
$
493,441

 
$
(760
)
 
$
(439,477
)
 
$
53,233

At-the-market offering
 
9,091

 
9

 
28,793

 
—

 
—

 
28,802

Issuance of restricted stock, net of shares withheld for taxes, and other
 
413

 
1

 
(166
)
 
—

 
—

 
(165
)
Issuance of common stock from option exercises
 
25

 
—

 
100

 
—

 
—

 
100

Issuance of common stock under ESPP
 
50

 
—

 
222

 
—

 
—

 
222

Cumulative-effect of new accounting standard for Topic 718 Stock Compensation
 
—

 
—

 
184

 
—

 
(184
)
 
—

Stock-based compensation expense
 
—

 
—

 
9,092

 
—

 
—

 
9,092

Net loss
 
—

 
—

 
—

 
—

 
(60,535
)
 
(60,535
)
Other comprehensive income
 
—

 
—

 
—

 
186

 
—

 
186

Balance at December 31, 2017
 
38,787

 
$
39

 
$
531,666

 
$
(574
)
 
$
(500,196
)
 
$
30,935

Market offering
 
9,373

 
9

 
59,084

 
—

 
—

 
59,093

Issuance of restricted stock, net of shares withheld for taxes, and other
 
886

 
1

 
(379
)
 
—

 
—

 
(378
)
Issuance of common stock from option exercises
 
40

 
—

 
208

 
—

 
—

 
208

Issuance of common stock under ESPP
 
252

 
—

 
1,203

 
—

 
—

 
1,203

Conversion option on convertible debt
 
—

 
—

 
29,357

 
—

 
—

 
29,357

Closing cost related to conversion option on convertible debt
 
—

 
—

 
(557
)
 
—

 
—

 
(557
)
Cumulative-effect of new accounting standard for Topic 606 Revenue
 
—

 
—

 
—

 
—

 
358

 
358

Stock-based compensation expense
 
—

 
—

 
11,023

 
—

 
—

 
11,023

Net loss
 
—

 
—

 
—

 
—

 
(59,013
)
 
(59,013
)
Other comprehensive loss
 
—

 
—

 
—

 
(113
)
 
—

 
(113
)
Balance at December 31, 2018
 
49,338

 
$
49

 
$
631,605

 
$
(687
)
 
$
(558,851
)
 
$
72,116

 
 
 
 
 
 
 
 
 
 
 
 
 
See accompanying notes

63


FLUIDIGM CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Operating activities
 
 
 
 
 
 
Net loss
 
$
(59,013
)
 
$
(60,535
)
 
$
(75,985
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
 
Depreciation and amortization
 
5,372

 
7,409

 
6,738

Stock-based compensation expense
 
11,023

 
9,092

 
13,858

Amortization of developed technology
 
11,200

 
11,200

 
11,200

Amortization of debt discounts, premiums and issuance costs
 
8,379

 
287

 
278

Other non-cash items
 
175

 
(890
)
 
(26
)
Loss on disposal of property and equipment
 
141

 
135

 
87

Changes in assets and liabilities:
 
 
 
 
 
 
Accounts receivable
 
(1,788
)
 
(554
)
 
10,521

Inventories
 
1,488

 
4,596

 
(3,387
)
Prepaid expenses and other assets
 
178

 
1,583

 
(457
)
Accounts payable
 
(294
)
 
585

 
(2,271
)
Deferred revenue
 
2,574

 
1,636

 
(274
)
Other liabilities
 
(4,636
)
 
1,358

 
580

Net cash used in operating activities
 
(25,201
)
 
(24,098
)
 
(39,138
)
Investing activities
 
 
 
 
 
 
Purchases of investments
 
(1,450
)
 
(6,276
)
 
(38,594
)
Proceeds from sales and maturities of investments
 
6,541

 
25,550

 
86,431

Proceeds from sale of investment in Verinata
 
—

 
—

 
2,330

Purchases of intangible assets
 
—

 
(50
)
 
—

Purchases of property and equipment
 
(372
)
 
(1,566
)
 
(5,065
)
Net cash provided by investing activities
 
4,719

 
17,658

 
45,102

Financing activities
 
 
 
 
 
 
Payment of debt and equity issuance costs
 
(2,862
)
 
—

 
—

Net proceeds from issuance of common stock
 
59,469

 
28,793

 
—

Proceeds from exercise of stock options
 
208

 
100

 
227

Proceeds from stock issuance from ESPP
 
1,203

 
222

 
—

Payments for taxes related to net share settlement of equity awards
 
(358
)
 
(118
)
 
(111
)
Net cash provided by financing activities
 
57,660

 
28,997

 
116

Effect of foreign exchange rate fluctuations on cash and cash equivalents
 
167

 
454

 
(152
)
Net increase in cash and cash equivalents
 
37,345

 
23,011

 
5,928

Cash and cash equivalents at beginning of period
 
58,056

 
35,045

 
29,117

Cash and cash equivalents at end of period
 
$
95,401

 
$
58,056

 
$
35,045

Supplemental disclosures of cash flow information
 
 
 
 
 
 
Cash paid for interest
 
$
5,534

 
$
5,534

 
$
5,534

Cash paid for income taxes, net of refunds
 
$
321

 
$
245

 
$
355


See accompanying notes

64


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2018
1. Description of Business

Fluidigm Corporation (we, our, or us) was incorporated in the State of California in May 1999 to commercialize microfluidic technology initially developed at the California Institute of Technology. In July 2007, we were reincorporated in Delaware. Our headquarters are located in South San Francisco, California.

We create, manufacture, and market innovative technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including IFCs, assays, and reagents. Our focus is on the most pressing needs in translational and clinical research, including cancer, immunology and immunotherapy. We use proprietary CyTOF® and microfluidics technologies to develop innovative end-to-end solutions that have the flexibility required to meet the needs of translational research and the robustness to support high-impact clinical research studies. We sell our instruments to leading academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, and biopharmaceutical, biotechnology and Ag-Bio companies.

2. Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly-owned subsidiaries. As of December 31, 2018, we had wholly-owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, and Germany. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.

Certain prior period amounts in the consolidated statements of stockholders’ equity and consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders' equity, total revenue, total costs and expenses, loss from operations or net loss.

Use of Estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.


Foreign Currency

Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year.

Revenue Recognition

We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities.


65

We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.

Product Revenue

We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.

We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.

Service Revenue

We recognize revenue from repairs, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed.

Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally one to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our consolidated balance sheet as deferred revenue.

Contract Costs

Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally one to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred.

Product Warranties

We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the consolidated statements of operations.

Significant Judgments

Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.

66


Cash and Cash Equivalents

We consider all highly liquid financial instruments with maturities at the time of purchase of three months or less to be cash equivalents. Cash and cash equivalents may consist of cash on deposit with banks, money market funds, and notes from government-sponsored agencies.

Investments

Short-term investments are comprised of notes from government-sponsored agencies. All investments are recorded at estimated fair value. Any unrealized gains and losses from investments are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity. We evaluate our investments to assess whether investments with unrealized loss positions are other-than-temporarily impaired. An investment is considered to be other-than-temporarily impaired if the impairment is related to deterioration in credit risk or if it is likely that we will sell the securities before the recovery of their cost basis. No investment has been assessed as other than temporarily impaired, and realized gains and losses were immaterial during the years presented. The cost of securities sold, or the amount reclassified out of accumulated other comprehensive income into earnings is based on the specific-identification method.

Accounts Receivable

Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.

Concentrations of Business and Credit Risk

Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns.

We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. No single customer represented more than 10% of total revenue for 2018, 2017, or 2016, and no single customer represented more than 10% of total accounts receivable at December 31, 2018, 2017, or 2016.

Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.

Inventories

Inventories are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory costs include direct materials, direct labor, and normal manufacturing overhead. Finished goods that are used for research and development are expensed as consumed or depreciated over their period of use. Provisions for slow-moving, excess, and obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values based on product life cycle, development plans, product expiration, and quality issues.

Property and Equipment

Property and equipment, including leasehold improvements, are stated at cost less accumulated depreciation. Accumulated depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets or the remaining term of the lease, whichever is shorter. The estimated useful lives of our property and equipment are generally as follows: computer

67

equipment and software, three to four years; laboratory and manufacturing equipment, two to five years; and office furniture and fixtures, five years.

Depreciation expense for the years ended December 31, 2018, 2017, and 2016 was $4.2 million, $5.9 million, and $5.1 million, respectively.

Goodwill, Intangible Assets and Other Long-Lived Assets

Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.

Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. We first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we then conduct a two-step test for impairment of goodwill. In the first step, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceed its fair value, then the second step of the impairment test must be performed in order to determine the implied fair value of the goodwill. If the carrying value of the goodwill exceeds its implied fair value, then an impairment loss equal to the difference would be recorded.

We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset, and adjust the carrying value of the asset accordingly. We did not recognize any impairment of long-lived assets for any of the periods presented herein.

Convertible Notes

In February 2014, we closed an underwritten public offering $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our new 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). Following the exchange, approximately $51.3 million in aggregate principal amount of the 2014 Notes remained outstanding in addition to $150.0 million in aggregate principal amount of the 2018 Notes.

As the 2018 Notes are convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. The embedded conversion option value was calculated as the difference between (i) the total fair value of the 2018 Notes and (ii) the fair value of a similar debt instrument excluding the embedded conversion option. We determined an embedded conversion option value of $29.3 million, which was recorded in additional paid-in-capital and reduced the carrying value of the 2018 Notes. The resulting discount on the 2018 Notes will be amortized over the expected term of the 2018 Notes, using the effective interest method through the first note holder put date, of February 6, 2023.

For both the 2014 Notes and 2018 Notes, offering-related costs, including underwriting costs are capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are being be amortized over the expected term of the related Notes using the effective interest method.

68

Fair Value of Financial Instruments

Our financial instruments consist primarily of cash and cash equivalents, investments, accounts receivable, accounts payable, and convertible notes. Our cash equivalents, investments, accounts receivable, and accounts payable have short maturity or payment periods. Accordingly, their carrying values approximated their fair values at December 31, 2018 and 2017. The convertible notes are presented at their carrying value, with fair value disclosures made in Note 7. As a basis for considering fair value, we follow a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level I: observable inputs such as quoted prices in active markets;
Level II: inputs other than quoted prices in active markets that are observable either directly or indirectly; and
Level III: unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions.

This hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. Our cash equivalents, which include money market funds, are classified as Level I because they are valued using quoted market prices. Our investments and convertible notes are generally classified as Level II because their value is based on valuations using significant inputs derived from or corroborated by observable market data. Depending on the security, the income and market approaches are used in the model driven valuations. Inputs of these models include recently executed transaction prices in securities of the issuer or comparable issuers and yield curves.

Research and Development

We recognize research and development expenses in the period incurred. Research and development expenses consist of personnel costs, independent contractor costs, prototype and materials expenses, allocated facilities and information technology expenses, and related overhead expenses.

Advertising Costs

We expense advertising costs as incurred. We incurred advertising costs of $2.2 million, $1.8 million and $2.3 million during 2018, 2017, and 2016, respectively.

Income Taxes

We use the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a “more likely than not” criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.

We recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. Any interest and penalties related to uncertain tax positions are reflected in the income tax provision.


69

Stock-Based Compensation

We account for stock options and restricted stock units granted to employees and directors and stock purchases under ESPP based on the fair value of the awards. We recognize stock-based compensation expense on a straight-line basis over the requisite service periods for non-performance-based awards. For performance-based stock awards, stock-based compensation expense is recognized over the requisite service period when the achievement of each individual performance goal becomes probable.

 Comprehensive Loss

Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the consolidated statements of comprehensive loss.

The components of accumulated other comprehensive loss, net of tax, for the years ended December 31, 2018, 2017, and 2016 are as follows (in thousands):
 
 
Foreign Currency Translation Adjustment
 
Unrealized Gain (Loss) on Investments
 
Accumulated Other Comprehensive Income (Loss)
Ending balance at December 31, 2016
 
$
(758
)
 
$
(2
)
 
$
(760
)
Change during the year
 
183

 
3

 
186

Ending balance at December 31, 2017
 
$
(575
)
 
$
1

 
$
(574
)
Change during the year
 
(112
)
 
(1
)
 
(113
)
Ending balance at December 31, 2018
 
$
(687
)
 
$
—

 
$
(687
)


Immaterial amounts of unrealized gains and losses have been reclassified into the consolidated statement of operations for the years ended December 31, 2018, 2017 and 2016.

Net Loss per Share

Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units and options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.

The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):

 
 
December 31,
 
 
2018
 
2017
 
2016
Stock options, restricted stock units and performance awards
 
4,354

 
3,501

 
4,622

2018 Convertible Notes
 
19,035

 
—

 
—

2018 Convertible Notes potential make-whole shares
 
757

 
—

 
—

2014 Convertible Notes
 
916

 
3,598

 
3,598

Total
 
25,062

 
7,099

 
8,220




70

Recent Accounting Changes and Accounting Pronouncements

Adoption of New Accounting Guidance

In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers (Topic 606). Topic 606 and its related amendments supersede Revenue Recognition (Topic 605), issued in June 2010, and provide principles for recognizing revenue for goods and services in a manner consistent with the transfer of control of those goods and services to the customer.

We adopted Topic 606 on January 1, 2018, using the modified retrospective method applied to those contracts with unrecognized revenue on the adoption date. We recognized the effect of applying the new revenue standard by recording a cumulative catch-up adjustment that reduced the accumulated deficit component of stockholders’ equity by $0.4 million and increased current assets by $0.2 million and non-current assets by $0.2 million. The adjustment capitalized certain sales commission costs that were incurred to obtain instrument service contracts. Under Topic 605, we accounted for these incremental contract acquisition costs by recognizing them as expense at the point the contract was awarded. Under Topic 606, the costs are capitalized and amortized to expense over the life of the contract, which is generally one to three years. The comparative information for periods prior to January 1, 2018, has not been restated and continues to be reported in accordance with Topic 605.

The following table summarizes the cumulative effect of adopting Topic 606 on amounts previously reported in our consolidated balance sheet at December 31, 2017 (in thousands):
 
 
Balance at December 31, 2017
 
Topic 606 Transition Adjustments
 
Balance at January 1, 2018
Prepaid expenses and other current assets
 
$
1,528

 
$
153

 
$
1,681

Total current assets
 
$
94,801

 
$
153

 
$
94,954

Other non-current assets
 
$
7,541

 
$
205

 
$
7,746

Total assets
 
$
287,351

 
$
358

 
$
287,709

Accumulated deficit
 
$
(500,196
)
 
$
358

 
$
(499,838
)
Total stockholders' equity
 
$
30,935

 
$
358

 
$
31,293

Total liabilities and stockholders' equity
 
$
287,351

 
$
358

 
$
287,709



The following table summarizes the impacts on our consolidated statements of operations of adopting Topic 606 compared to Topic 605 for the twelve months ended December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
 Topic 606
 
Effect of Change
 
 
Twelve Months Ended December 31, 2018
Selling, general and administrative
 
$
79,783

 
$
79,859

 
$
(76
)
Total costs and expenses
 
$
161,128

 
$
161,204

 
$
(76
)
Loss from operations
 
$
(48,164
)
 
$
(48,240
)
 
$
76

Loss before income taxes
 
$
(61,420
)
 
$
(61,496
)
 
$
76

Net loss
 
$
(59,013
)
 
$
(59,089
)
 
$
76



71

The following table summarizes the impacts on our consolidated balance sheets of adopting Topic 606 compared to Topic 605 at December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
Topic 606
 
Effect of Change
 
 
 
 
December 31, 2018
 
 
Prepaid expenses and other current assets
 
$
2,051

 
$
1,884

 
$
167

Total current assets
 
$
127,106

 
$
126,939

 
$
167

Other non-current assets
 
$
6,208

 
$
5,941

 
$
267

Total assets
 
$
303,647

 
$
303,213

 
$
434

Stockholders' equity
 
$
72,116

 
$
71,682

 
$
434

Total liabilities and stockholders' equity
 
$
303,647

 
$
303,213

 
$
434



In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. This ASU allows SEC reporting companies to record provisional amounts in earnings for the year ended December 31, 2017, due to the complexities involved in accounting for the enactment of the Tax Act. We recognized the estimated income tax effects of the Tax Act in its 2017 Consolidated Financial Statements in accordance with SEC Staff Accounting Bulletin No. 118 (“SAB No. 118”). In accordance with SAB No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense was required. Refer to Note 10 for further information regarding the provisional amounts recorded by the Company.

In February 2018, the FASB issued ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This ASU amends the reporting of comprehensive income to allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act (the Tax Act). The Tax Act was enacted in December 2017 and reduced the U.S federal corporate income tax rate and made other changes to U.S. federal tax law. ASU 2018-02 is effective for our fiscal year beginning January 1, 2019, and early adoption is permitted. This standard did not have a material effect on our consolidated financial statements.

In August 2016, the FASB issued ASU 2016-15 Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The ASU addresses eight specific cash flow issues and their presentation within the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18 Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB’s Emerging Issues Task Force, amending the presentation of restricted cash within the statement of cash flows. The new guidance requires that restricted cash be included within cash and cash equivalents on the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.

Recent Accounting Pronouncements

In August 2018, the FASB issued ASU 2018-15 Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact of adoption on our consolidated financial statements.

In February 2016, the FASB established Topic 842, Leases, by issuing Accounting Standards Update (ASU) No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard

72

establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating; the classification will impact the expense recognition in the income statement.

Modified Retrospective Transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. We expect to adopt the new standard on January 1, 2019 and use the effective date as our date of initial application. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. For dates and periods prior to January 1, 2019, the original disclosures under ASC 840 will be disclosed.

The new standard provides several optional practical expedients in transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. We do not expect to elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us.

We expect that this standard will have a material effect on our financial statements. While we continue to assess all the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our building, vehicle and equipment leases.
 
On adoption, we currently expect to recognize $8.0 million to $11.0 million of additional operating liabilities, based on the present value of the remaining fixed rental payments under current leasing standards for existing operating leases, with corresponding ROU assets of approximately $6.0 million to $9.0 million. The difference between the initial lease liability and right of use asset is attributable to deferred rent. We do not expect any impact on retained earnings from the adoption of ASC 842.

The new standard also provides certain accounting elections for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities. We also currently expect to elect to not separate lease and nonlease components for our building leases and to take a portfolio approach for our vehicles leases by country.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU will be effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020, with early adoption permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements.
3. Revenue
Disaggregation of Revenue
The following table presents our revenue for the year ended December 31, 2018, 2017, and 2016, respectively, based on geographic area and by products and services (in thousands):
 
Year Ended December 31,
 
2018
 
2017
 
2016
Geographic Markets:
 
 
 
 
 
Americas
$
51,172

 
$
49,290

 
$
56,229

EMEA
36,617

 
32,642

 
29,739

Asia-Pacific
25,175

 
20,005

 
18,478

Total
$
112,964

 
$
101,937

 
$
104,446



73

 
Year Ended December 31,
 
2018
 
2017
 
2016
Products and Services:
 
 
 
 
 
Instruments
$
45,491

 
$
42,505

 
$
46,834

Consumables
48,159

 
41,894

 
42,169

Product revenue
93,650

 
84,399

 
89,003

Services
19,314

 
17,348

 
15,205

License
—

 
190

 
238

Total
$
112,964

 
$
101,937

 
$
104,446



Performance Obligations

We reported $15.2 million of deferred revenue on our December 31, 2017 consolidated balance sheet. During the twelve months ended December 31, 2018, $9.1 million of the opening balance was recognized as revenue and $11.7 million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At December 31, 2018, we reported $17.8 million of deferred revenue.

The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at December 31, 2018 (in thousands):
Fiscal Year
 
 
 
 
Expected Revenue (1)
2019
 
 
 
 
$
10,037

2020
 
 
 
 
5,149

2021
 
 
 
 
2,525

Thereafter
 
 
 
 
1,436

Total
 
 
 
 
$
19,147

_______
(1) Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.

We apply the practical expedient that permits us to not disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.

Contract Costs

We reported $0.4 million of capitalized commission costs from instrument service contracts at December 31, 2018 in the consolidated balance sheet.



74

4. Goodwill and Intangible Assets, net

In connection with our acquisition of DVS in February 2014, we recognized goodwill of $104.1 million. Intangible assets include developed technology related to the DVS acquisition and other intangible assets included in Other non-current assets.
Developed Technology, Patents and Licenses

Developed technology as a result of the DVS acquisition, and patents and licenses, were as follows (in thousands):

 
December 31, 2018
 
 
Gross Amount
 
Accumulated Amortization
 
Net
 
Weighted-Average Amortization Period
Developed technology
 
$
112,000

 
$
(54,600
)
 
$
57,400

 
10.0 years
Patents and licenses
 
$
11,274

 
$
(6,861
)
 
$
4,413

 
7.8 years

 
 
December 31, 2017
 
 
Gross Amount
 
Accumulated Amortization
 
Net
 
Weighted-Average Amortization Period
Developed technology
 
$
112,000

 
$
(43,400
)
 
$
68,600

 
10.0 years
Patents and licenses
 
$
11,274

 
$
(5,721
)
 
$
5,553

 
7.8 years

Total amortization expense for the years ended December 31, 2018, December 31, 2017, and December 31, 2016 was $12.3 million, $12.4 million and $12.4 million, respectively.

Based on the carrying value of intangible assets, net, as of December 31, 2018, the annual amortization expense is expected to be as follows (in thousands):
Fiscal Year
Developed Technology Amortization Expense
 
Patents and Licenses Amortization Expense
 
Total
2019
$
11,200

 
$
1,046

 
$
12,246

2020
11,200

 
1,046

 
12,246

2021
11,200

 
888

 
12,088

2022
11,200

 
815

 
12,015

2023
11,200

 
610

 
11,810

Thereafter
1,400

 
8

 
1,408

Total
$
57,400

 
$
4,413

 
$
61,813




75

5. Balance Sheet Details

Cash and Cash Equivalents

Cash and cash equivalents consisted of the following as of December 31, 2018 and 2017 (in thousands):
 
 
December 31,
Cash and cash equivalents:
 
2018
 
2017
Cash
 
$
17,685

 
$
20,129

Money market funds
 
77,716

 
16,142

       U.S. Government and agency securities
 
—

 
21,785

Total
 
$
95,401

 
$
58,056



Inventories

Inventories consisted of the following as of December 31, 2018 and 2017 (in thousands):
 
 
December 31,
Inventories:
 
2018
 
2017
Raw materials
 
$
5,996

 
$
7,566

Work-in-process
 
650

 
929

Finished goods
 
6,357

 
6,593

Total inventories, net
 
$
13,003

 
$
15,088



Property and Equipment, net

Property and equipment consisted of the following as of December 31, 2018 and 2017 (in thousands):
 
 
December 31,
Property and equipment:
 
2018
 
2017
Computer equipment and software
 
$
4,201

 
$
4,179

Laboratory and manufacturing equipment
 
18,780

 
20,069

Leasehold improvements
 
7,173

 
7,799

Office furniture and fixtures
 
1,506

 
1,892

Property and equipment, gross
 
31,660

 
33,939

Less accumulated depreciation and amortization
 
(22,855
)
 
(21,646
)
Construction-in-progress
 
20

 
8

Property and equipment, net
 
$
8,825

 
$
12,301


 
Product Warranties

Activity for our warranty accrual for the years ended December 31, 2018 and 2017, which are included in other accrued liabilities, is summarized below (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
Beginning balance
 
$
699

 
$
1,023

Accrual for current period warranties
 
1,573

 
695

Warranty costs incurred
 
(1,409
)
 
(1,019
)
Ending balance
 
$
863

 
$
699



76

6. Convertible Notes and Credit Facility
2014 Senior Convertible Notes (2014 Notes)
On February 4, 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes) pursuant to an underwriting agreement, dated January 29, 2014. The 2014 Notes accrue interest at a rate of 2.75% per year, payable semi-annually in arrears on February 1 and August 1 of each year. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes.

The initial conversion rate of the 2014 Notes is 17.8750 shares of our common stock, par value $0.001 per share, per $1,000 principal amount of 2014 Notes (which is equivalent to an initial conversion price of approximately $55.94 per share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events including upon conversion in connection with a fundamental change, as defined in the indenture governing the 2014 Notes or, subject to certain conditions, redemption of the 2014 Notes by us.

Holders may surrender their 2014 Notes for conversion at any time prior to the stated maturity date. On or after February 6, 2018, and prior to February 6, 2021, we may redeem any or all of the 2014 Notes in cash if the closing price of our common stock exceeds 130% of the conversion price for a specified number of days, and on or after February 6, 2021, we may redeem any or all of the 2014 Notes in cash without any such condition. The redemption price of the 2014 Notes will equal 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest. Holders may require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2021, February 6, 2024, and February 6, 2029, at a repurchase price in cash equal to 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest. If we undergo a fundamental change, as defined in the terms of the 2014 Notes, holders may require us to repurchase the 2014 Notes in whole or in part for cash at a repurchase price equal to 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest.

In February 2014, we received $195.2 million, net of underwriting discounts, from the issuance of the 2014 Notes and incurred approximately $1.1 million in offering-related expenses. The underwriting discount of $6.0 million and the debt issuance costs of $1.1 million were recorded as offsets to the proceeds. The underwriting discount and offering-related expenses are being amortized to interest expense using the effective-interest rate method.

2018 Senior Convertible Notes (2018 Notes)

In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for new convertible notes (2018 Notes). As of the closing of the 2018 Notes on March 12, 2018, the estimated fair value was $145.5 million. The difference between the $150.0 million aggregate principal amount of the 2018 Notes and its fair value will be amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023.

We accounted for the exchange transaction as an extinguishment of debt due to the significance of the change in value of the embedded conversion option, resulting in a $0.1 million gain. The gain on extinguishment of debt was calculated as the difference between the reacquisition price (i.e., the fair value of the principal amount of 2018 Notes) and the net carrying value of the 2014 Notes exchanged net of unamortized debt discount and debt issuance cost write-offs.

The 2018 Notes accrue interest at a rate of 2.75%, payable semi-annually in arrears on February 1 and August 1 of each year. The 2018 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the indenture governing the 2018 Notes. The initial conversion rate of the 2018 Notes is 126.9438 shares of our common stock, par value $0.001 per share, per $1,000 principal amount of the 2018 Notes (which is equivalent to an initial conversion price of approximately $7.88 per share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events. Those certain specified events include Holders who convert their 2018 Notes voluntarily prior to our exercise of the Issuer's Conversion Option or in connection with a make-whole fundamental change prior to February 6, 2023, are entitled, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2018 Notes. Any time prior to the maturity of the 2018 Notes, we may convert the 2018 Notes, in whole but not in part, into cash, shares of our common stock, or combination thereof, if the closing price of our common stock equals or exceeds 110% of the conversion price then in effect for a specified number of days (Issuer’s Conversion Option). On or after February 6, 2022, we may elect to redeem all or any portion of the

77

2018 Notes at a redemption price equal to 100% of the accreted principal amount of the 2018 Notes on the redemption date of the 2018 Notes, plus accrued and unpaid interest.

Holders of the 2018 Notes have the right, at their option, to require us to purchase all or a portion of the 2018 Notes (i) on February 6, 2023, February 6, 2026, and February 6, 2029, or (ii) in the event of a fundamental change, as defined in the indenture governing the 2018 Notes, in each case, at a repurchase price equal to 100% of the accreted principal amount (i.e., up to 120% of the outstanding principal amount) of the 2018 Notes on the fundamental change repurchase date, plus accrued and unpaid interest.

Offering-related costs for the 2018 Notes were approximately $2.8 million. Offering-related costs of $2.2 million were capitalized as debt issuance costs, recorded as an offset to the carrying value of the 2018 Notes, and are being be amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. Offering-related costs of $0.6 million were accounted for as equity issuance costs, recorded as an offset to additional paid-in capital, and are not subject to amortization. Offering-related costs were allocated between debt and equity in the same proportion as the allocation of the 2018 Notes between debt and equity.

The carrying values of the components of the 2014 Notes and 2018 Notes are as follows (in thousands):
 
 
December 31,
 
 
2018
 
2017
   2.75% 2014 Notes due 2034
 
 
 
 
Principal amount
 
$
51,250

 
$
201,250

Unamortized debt discount
 
(1,232
)
 
(5,087
)
Unamortized debt issuance cost
 
(224
)
 
(925
)
 
 
$
49,794

 
$
195,238

   2.75% 2018 Notes due 2034
 
 
 
 
Principal amount
 
$
149,999

 
$
—

Premium accretion
 
3,755

 
—

Unamortized debt discount
 
(29,558
)
 
—

Unamortized debt issuance cost
 
(1,932
)
 
—

 
 
$
122,264

 
$
—

 
 
$
172,058

 
$
195,238



2018 Revolving Credit Facility

On August 2, 2018, we entered into a revolving credit facility with Silicon Valley Bank (Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $15.0 million (Maximum Amount) or (ii) the sum of (a) 85% of our eligible receivables and (b) 50% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. Subject to the level of this borrowing base, we may make and repay borrowings from time to time until the maturity of the revolving credit facility. The borrowing base as of December 31, 2018 under the revolving credit facility was $12.3 million. There were no borrowings outstanding under the Revolving Credit Facility at December 31, 2018.

The Revolving Credit Facility matures on August 2, 2020, and is collateralized by substantially all our property, other than intellectual property. Outstanding loans under the Revolving Credit Facility will bear interest, at the greater of (i) prime rate plus 0.50% or (ii) 5.50%. Interest on any outstanding loans is due and payable monthly and the principal balance is due at maturity though loans can be prepaid at any time without penalty. In addition, we pay a quarterly unused revolving line facility fee of 0.75% per annum on the average unused facility.

Subject to certain exceptions, we must pay a prepayment fee equal to (i) 2.00% of the Maximum Amount if it prepays all advances and terminates the Loan Agreement prior to August 2, 2019, or (ii) 1.00% of the Maximum Amount if it prepays all advances and terminates the Loan Agreement on or after August 2, 2019, and prior to the maturity date.

78


We incurred approximately $335,000 of debt issuance costs in connection with the facility, including $225,000 in commitment fees. Half of the commitment fee was paid at the inception of the facility with the remainder due on the earliest of (i) August 2, 2019, (ii) the date on which we terminate the agreement or (iii) the occurrence and continuance of an event of default. Debt issuance costs were capitalized and are being amortized to interest expense over the life of the Revolving Credit Facility.

The Revolving Credit Facility contains customary affirmative and negative covenants which, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. The Revolving Credit Facility also contains customary events of default, subject to customary cure periods for certain defaults, that include, among other things, non-payment defaults, covenant defaults, material judgment defaults, bankruptcy and insolvency defaults, cross-defaults to certain other material indebtedness, and defaults due to inaccuracy of representation and warranties. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Revolving Credit Facility. During the existence of an event of default, interest on the obligations under the Revolving Credit Facility could be increased to 5.0% above the otherwise applicable rate of interest.

We were in compliance with all the terms and conditions of the Revolving Credit Facility at December 31, 2018.


79

7. Fair Value of Financial Instruments
The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands):
 
December 31, 2018
 
Carrying Amount
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Fair Value
 
Cash and Cash Equivalents
 
Short-Term Marketable Securities
Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash
$
17,685

 
$
—

 
$
—

 
$
17,685

 
$
17,685

 
$
—

Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
    Level I:
 
 
 
 
 
 
 
 
 
 
 
         Money market funds
77,716

 
—

 
—

 
77,716

 
77,716

 
—

         U.S. treasury securities
—

 
—

 
—

 
—

 
—

 
—

    Level II:
 
 
 
 
 
 
 
 
 
 
 
         U.S. government and agency securities
—

 
—

 
—

 
—

 
—

 
—

Total
$
95,401

 
$
—

 
$
—

 
$
95,401

 
$
95,401

 
$
—

 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2017
 
Carrying Amount
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Fair Value
 
Cash and Cash Equivalents
 
Short-Term Marketable Securities
Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash
$
20,129

 
$
—

 
$
—

 
$
20,129

 
$
20,129

 
$
—

Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
    Level I:
 
 
 
 
 
 
 
 
 
 
 
         Money market funds
16,142

 
—

 
—

 
16,142

 
16,142

 
—

         U.S. treasury securities
497

 
—

 
—

 
497

 
—

 
497

    Level II:
 
 
 
 
 
 
 
 
 
 
 
         U.S. government and agency securities
26,369

 
—

 
(1
)
 
26,368

 
21,785

 
4,583

Total
$
63,137

 
$
—

 
$
(1
)
 
$
63,136

 
$
58,056

 
$
5,080


There were no transfers between Level I and Level II measurements during the year ended December 31, 2018, and there were no changes in the valuation techniques used.
Based on an evaluation of securities that were in a loss position, we did not recognize any other-than-temporary impairment charges for the years ended December 31, 2018, 2017, and 2016. None of our investments have been in a continuous loss position for more than 12 months. We concluded that the declines in market value of our available-for-sale securities investment portfolio were temporary in nature and did not consider any of our investments to be other-than-temporarily impaired.
Convertible Notes
The estimated fair value of the 2014 and 2018 Notes is based on a market approach and represents a Level II valuation. When determining the estimated fair value of our long-term debt, we used a commonly accepted valuation methodology and market-based risk measurements that are indirectly observable, such as credit risk.

80

The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2018 Notes at December 31, 2018 and 2017, respectively (in thousands):
 
December 31, 2018
 
December 31, 2017
 
Par Value
 
Carrying Value
 
Fair Value
 
Par Value
 
Carrying Value
 
Fair Value
2014 Notes
$
51,250

 
$
49,794

 
$
43,665

 
$
201,250

 
$
195,238

 
$
166,162

2018 Notes
149,999

 
122,264

 
171,843

 
—

 
—

 
—

Total
$
201,249

 
$
172,058

 
$
215,508

 
$
201,250

 
$
195,238

 
$
166,162



8. Shareholders' Equity

Tax Benefit Preservation Plan

On August 1, 2017, the Tax Benefit Preservation Plan (Tax Plan) dated as of November 21, 2016 expired and all of the preferred share purchase rights distributed to the holders of our common stock pursuant to the Tax Plan expired.

2018 Market Offering

On December 14, 2018, we closed on our previously announced underwritten public offering of 9,372,500 shares our common stock, $0.001 par value. The common stock was sold at a price to the public of $6.75 per share, for aggregate gross proceeds of approximately $63.3 million, from our existing shelf registration statement. Net proceeds from the offering were approximately $59.1 million after deducting underwriting discounts and commissions of $3.8 million and the $0.4 million of estimated expenses of the offering. We intend to use the net proceeds of the offering for general corporate purposes, including working capital, capital expenditures and continued research and development with respect to products and technologies, and to fund possible investments in or acquisitions of complementary businesses, products, or technologies.

2017 At-the-Market Offering

On August 10, 2017, we sold 9,090,909 shares of our common stock, $0.001 par value per share, pursuant to an earlier Sales Agreement, for aggregate gross proceeds of $30.0 million. Our aggregate net proceeds were approximately $28.8 million, after deducting related expenses, including commissions of approximately $0.7 million and issuance costs of approximately $0.5 million. These sales fully exhausted the shares that were available for sale under the Sales Agreement. 

At December 31, 2018, we had reserved shares of common stock for future issuance under equity compensation plans as follows:
(in 000's)
 
Securities To Be Issued Upon Exercise Of Options
 
Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units
 
Number Of Remaining Securities Available For Future Issuance
2009 Equity Incentive Plan
 
43

 
—

 
—

2011 Equity Incentive Plan
 
2,064

 
1,631

 
2,022

DVS Sciences Inc. 2010 Equity Incentive Plan
 
38

 
—

 
—

2017 Inducement Award Plan
 
240

 
338

 
1,422

2017 Employee Stock Purchase Plan
 

 
—

 
698

 
 
2,385

 
1,969

 
4,142



9. Stock-Based Plans
Our board of directors sets the terms, conditions, and restrictions related to our ESPP and the grant of stock options, RSUs and performance-based awards under our various stock-based plans. Our board of directors determines the number of awards to grant and also sets vesting criteria.

81

In general, RSUs vest on a quarterly basis over a period of four years from the date of grant at a rate of 25% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, subject to the employees' continued employment.
Incentive stock options and non-statutory stock options granted under the 2011 Plan have a term of no more than ten years from the date of grant and an exercise price of at least 100% of the fair market value of the underlying common stock on the date of grant. If a participant owns stock representing more than 10% of the voting power of all classes of our stock on the grant date, an incentive stock option awarded to the participant will have a term of no more than five years from the date of grant and an exercise price of at least 110% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either 25% on the first anniversary of the option grant date and ratably each month over the remaining period of 36 months, or ratably each month over 48 months. We may grant options with different vesting terms from time to time.
For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.
2011 Equity Incentive Plan
On January 28, 2011, our board of directors adopted the 2011 Equity Incentive Plan (the 2011 Plan) under which incentive stock options, non-statutory stock options, restricted stock units (RSUs), stock appreciation rights, performance units, and performance shares may be granted to our employees, directors, and consultants.
2009 Equity Incentive Plan and 1999 Stock Option Plan
Our 2009 Equity Incentive Plan (the 2009 Plan) terminated on the date the 2011 Plan was adopted. Options granted, or shares issued under the 2009 Plan that were outstanding on the date the 2011 Plan became effective, remained subject to the terms of the 2009 Plan.
2017 Inducement Award Plan
On January 5, 2017, we adopted the Fluidigm Corporation 2017 Inducement Award Plan (the “Inducement Plan”) and reserved 2 million shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provides for the grant of equity-based awards and its terms are substantially similar to the 2011 Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan may only be made to individuals not previously our employees or non-employee members of our board of directors (or following such individual's bona fide period of non-employment), as an inducement material to the individual's entry into employment with us or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the Nasdaq Listing Rules.
Valuation and Expense Information
We use the Black-Scholes option-pricing model to estimate the fair value of stock options granted under our equity incentive plans. The weighted average assumptions used to estimate the fair value were as follows:
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Stock options:
 
 
 
 
 
 
Weighted average expected volatility
 
68.4
%
 
65.0
%
 
43.4
%
Weighted average expected term
 
4.7 years

 
4.2 years

 
6.0 years

Weighted average risk-free interest rate
 
2.7
%
 
1.7
%
 
1.4
%
Dividend yield
 
—

 
—

 
—

Weighted-average fair value per share
 
$
3.45

 
$
2.97

 
$
3.19

 
 
 
 
 
 
 


We determine the expected volatility based on our historical stock price volatility generally commensurate with the estimated expected term of the stock awards. The expected term of an award is based on historical forfeiture experience, exercise activity, and the terms and conditions of the stock awards. The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to each grant’s expected

82

life. Each of these inputs is subjective and generally requires significant judgment by us. The fair value of the underlying common stock is also required to compute the fair value calculation of options and ESPP. We account for forfeitures as they occur.

We grant stock options at exercise prices not less than the fair value of our common stock at the date of grant. The fair value of RSUs granted to employees was estimated on the date of grant by multiplying the number of shares granted by the fair market value of our common stock on the grant date.

Activity under the 2011 Plan, the 2009 Plan, the 1999 Plan, and the Inducement Plan is as follows:

Restricted Stock Units:
 
 
Number of Units (in 000's)
 
Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 2015
 
663

 
$
32.48

RSU granted
 
940

 
$
7.06

RSU released
 
(328
)
 
$
24.71

RSU forfeited
 
(210
)
 
$
17.82

Balance at December 31, 2016
 
1,065

 
$
15.31

RSU granted
 
916

 
$
5.73

RSU released
 
(445
)
 
$
15.57

RSU forfeited
 
(368
)
 
$
13.11

Balance at December 31, 2017
 
1,168

 
$
8.55

RSU granted
 
1,822

 
$
5.98

RSU released
 
(945
)
 
$
9.63

RSU forfeited
 
(233
)
 
$
8.50

Balance at December 31, 2018
 
1,812

 
$
7.09



The total intrinsic value of RSUs vested and released during the year ended December 31, 2018, 2017 and 2016 were approximately $6.8 million, $2.3 million and $2.4 million, respectively. The intrinsic value of vested and released RSUs is calculated by multiplying the fair market value of our common stock on the vesting date by the number of shares vested. As of December 31, 2018, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $9.7 million. We expect to recognize those costs over a weighted average period of 2.9 years.

2018 Retention Bonus Program

Included in the 2018 RSU activity are 379,593 of grants and releases related to a retention bonus program. As disclosed in our Current Report on Form 8-K filed on February 10, 2017, we previously implemented a company-wide retention bonus incentive program in which our executive officers at the time also participated. The bonus program provides for the payment of cash bonuses to program participants who were employees at the time the plan was implemented and who remain with Fluidigm through January 1, 2019. On September 18, 2018, the compensation committee of our board of directors approved an exchange program for our executive officers and for employees resident in the United States and Canada who are retention bonus program participants. In the exchange program, eligible participants could elect to surrender their right to receive a cash bonus in exchange for fully vested restricted stock units issued under our 2011 Equity Incentive Plan on the terms described below. Among other reasons, our compensation committee adopted the exchange program to encourage employee stock ownership and to effectively manage cash resources.
 
In connection with the bonus exchange program, each eligible employee could elect to exchange 25%, 50%, 75%, or 100% of the retention cash bonus otherwise payable under the terms of the program. Each employee participating in the exchange would receive a number of fully vested restricted stock units equal to the quotient, rounded up to the next whole number, determined by dividing the cash amount of the retention cash bonus that such eligible employee elects to exchange by an amount equal to 85% of the lower of the closing prices of one share of our common stock on the commencement date of the

83

exchange offer or the closing date of the exchange offer. The exchange offer closed on November 5, 2018. The total value of the 379,593 shares of common stock issued under this program was $2.8 million and is included in the total intrinsic value of RSUs released in 2018.

Stock Options:
 
 
Number of
Options (000's)
 
Weighted-Average
Exercise Price
per Option
 
Weighted-
Average Remaining Contractual Life (in Years)
 
Aggregate
Intrinsic
Value (1) in (000's)
Balance at December 31, 2015
 
3,242

 
$
20.45

 
2.2
 
 
Options granted
 
978

 
$
7.44

 
 
 
 
Options exercised
 
(57
)
 
$
4.04

 
 
 
$
310

Option forfeited
 
(603
)
 
$
23.53

 
 
 
 
Balance at December 31, 2016
 
3,560

 
$
16.62

 
6.8
 
 
Options granted
 
1,364

 
$
5.61

 
 
 
 
Options exercised
 
(25
)
 
$
4.07

 
 
 
$
42

Option forfeited
 
(2,735
)
 
$
16.33

 
 
 
 
Balance at December 31, 2017
 
2,164

 
$
10.41

 
6.6
 
 
Options granted
 
758

 
$
6.05

 
 
 
 
Options exercised
 
(40
)
 
$
5.24

 
 
 
$
81

Option forfeited
 
(497
)
 
$
16.09

 
 
 
 
Balance at December 31, 2018
 
2,385

 
$
7.56

 
7.8
 
$
5,991

Vested at December 31, 2018
 
1,026

 
$
9.92

 
6.3
 
$
2,111

Expected to vest at December 31, 2018
 
1,359

 
$
5.78

 
8.9
 
$
3,879


(1)
Aggregate intrinsic value as of December 31, 2018 was calculated as the difference between the closing price per share of our common stock on the last trading day of 2018, which was $8.62, and the exercise price of the options, multiplied by the number of in-the-money options.
As of December 31, 2018, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $4.2 million. We expect to recognize those costs over a weighted average period of 2.6 years.
2017 Stock Option Exchange
Included in the 2017 option activity above is the impact of our 2017 Stock Option Exchange Program. On August 23, 2017, we launched a one-time Stock Option Exchange Program (the Program), which eligible employees were able to exchange certain outstanding stock options (Eligible Options), whether vested or unvested, with an exercise price greater than $4.37 per share and greater than the closing price of a share of our common stock on the Nasdaq Global Select Market on the expiration date of the exchange offer (the Offer), for restricted stock units or stock options (New Awards) covering a lesser number of shares than were subject to the Eligible Options exchanged immediately before being canceled in the Offer. Non-employee members of our board of directors were not eligible to participate in the Program. The Program expired on September 20, 2017, with a closing price of $5.13 per share.
Employees elected to surrender Eligible Options to purchase a total of 1,204,198 shares of our common stock. All surrendered options were canceled effective as of the expiration date, and immediately thereafter, in exchange for such surrendered options, we issued (i) new options to purchase an aggregate of 399,117 shares of our common stock with an exercise price of $5.13; and (ii) restricted stock units representing 54,944 shares of our common stock, each, pursuant to the terms of the Offer and our 2011 Equity Incentive Plan. The new awards granted under the Program generally vest over three years.
The Program did not result in a material incremental stock-based compensation expense because the fair value of the new awards was approximately equal to the fair value of the surrendered options immediately prior to the exchange date. The

84

original fair value of the surrendered options plus the incremental stock-based compensation expense is being recognized over the vesting periods of the New Awards.
Performance-based Awards
2018 Performance Stock Units
During the three months ended March 31, 2018, we granted 167,000 performance stock units to certain executive officers and senior level employees. The number of performance stock units ultimately earned is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the performance period from January 1, 2018, to December 31, 2020. The percentage of performance stock units that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted.
Under FASB ASC Topic 718, the provisions of the performance stock unit awards related to TSR are considered a market condition, and the effects of that market condition should be reflected in the grant date fair value of the awards. We used a Monte Carlo simulation pricing model to incorporate the market condition effects at our grant date with a fair value of $10.09 per unit.
Activity under the 2018 performance stock units is as follows:
 
 
Number of Units (in 000's)
 
Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 2017
 
—

 
$
—

RSU granted
 
167

 
10.09

RSU released
 
—

 
—

RSU forfeited
 
(12
)
 
10.09

Balance at December 31, 2018
 
155

 
$
10.09


As of December 31, 2018, the unrecognized compensation costs related to these awards were $1.2 million. We expect to recognize those costs over a weighted average period of 2.2 years.
2016 Performance-based Stock Options and Restricted Stock Units
In 2016, we granted 184,050 and 87,620 performance-based stock options and performance-based restricted stock units (each, a performance award), respectively, to executive officers and employees, which were accounted for as equity awards. The number of performance awards that ultimately vested depended on the achievement of certain performance criteria set by the compensation committee of our board of directors. The performance-based stock options had an exercise price per share of $7.10. We recognize stock-based compensation expense over the vesting period of the performance awards when achievement of the performance criteria becomes probable. The performance criteria were not met, and the awards did not vest. We did not recognize any expense related to these performance awards in 2018, 2017 or 2016.
2017 Employee Stock Purchase Plan
On August 1, 2017, our stockholders approved our 2017 Employee Stock Purchase Plan (ESPP) at the annual meeting of stockholders. Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our ESPP has a six-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible to participate through payroll deductions of up to 10% of their compensation and may not purchase more than $25,000 of stock in any calendar year. The purchase price at which shares are sold under the ESPP is 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. Our first ESPP offering period began on October 1, 2017 with a shorter offering period ending on November 30, 2017.

85

Stock-Based Compensation
Total stock-based compensation expense recognized was as follows (in thousands):
 
 
For the Year Ended December 31,
 
 
2018
 
2017
 
2016
2018 Retention Bonus Program
 
$
2,809

 
$
—

 
$
—

Options and Restricted Stock Units
 
7,716

 
8,972

 
13,858

Employee Stock Purchase Plan
 
498

 
120

 
—

Total Share-Based Compensation
 
$
11,023

 
$
9,092


$
13,858



10. Income Taxes

Our loss before income taxes consists of the following (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Domestic
 
$
(47,600
)
 
$
(56,885
)
 
$
(65,211
)
International
 
(13,820
)
 
(6,914
)
 
(14,966
)
Loss before income taxes
 
$
(61,420
)
 
$
(63,799
)
 
$
(80,177
)


Significant components of our benefit for income taxes are as follows (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Current:
 
 
 
 
 
 
Federal
 
$
(27
)
 
$
—

 
$
—

State
 
(19
)
 
(17
)
 
(14
)
Foreign
 
(32
)
 
(501
)
 
286

Total current tax (expense) benefit
 
(78
)
 
(518
)
 
272

Deferred:
 
 
 
 
 
 
State
 
—

 
—

 
—

Foreign
 
2,485

 
3,782

 
3,920

Total deferred benefit
 
2,485

 
3,782

 
3,920

Total benefit for income taxes
 
$
2,407

 
$
3,264

 
$
4,192




86

Reconciliation of income taxes at the statutory rate to the benefit from (provision for) income taxes recorded in the statements of operations is as follows:
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Tax benefit at federal statutory rate
 
21.0
 %
 
34.0
 %
 
34.0
 %
State tax expense, net of federal benefit
 
2.3

 
5.5

 
2.2

Foreign tax benefit (expense)
 
(1.1
)
 
0.4

 
(0.7
)
Change in valuation allowance
 
(19.2
)
 
39.2

 
(31.2
)
Federal research and development credit
 
1.5

 
1.9

 
1.3

Unrecognized tax benefit
 
(0.2
)
 
(0.6
)
 
(1.3
)
Impact of the Tax Act
 
—

 
(74.6
)
 
—

Other, net
 
(0.4
)
 
(0.7
)
 
0.9

Effective tax rate
 
3.9
 %
 
5.1
 %
 
5.2
 %



The Tax Act was enacted in December 2017. The Tax Act introduced a broad range of tax reform measures that significantly change the federal income tax laws. At December 31, 2017, we recorded the provisional income tax effects of the Tax Act under Accounting Standards Codification Topic 740, Income Taxes. Due to our having recorded a full valuation allowance against its U.S. federal and state deferred tax assets, there was no net impact on our tax provision as a result of the remeasurement of U.S. deferred taxes using the relevant tax rate at which we expect them to reverse. The one-time transition tax on post-1986 foreign unremitted earnings did not have a material impact to our effective tax rate as a result of generating net foreign deficit earnings. In accordance with Staff Accounting Bulletin (“SAB”) No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense was required. We continue to monitor supplemental legislation and technical interpretations of the tax law that may cause the final impact from the Tax Act to differ from the amounts previously recorded.

At December 31, 2017, we changed our permanent reinvestment assertion and will not permanently reinvest our foreign earnings outside the United States. The cash generated from some of our foreign subsidiaries may be used domestically to fund operations. Any domestic, foreign withholding tax and state taxes that may be due upon future repatriation of earnings is not expected to be significant.

Significant components of our deferred tax assets and liabilities are as follows (in thousands):
 
 
December 31,
 
 
2018
 
2017
Deferred tax assets:
 
 
 
 
Net operating loss carryforwards
 
$
98,920

 
$
91,701

Reserves and accruals
 
7,167

 
3,927

Depreciation and amortization
 
4,262

 
5,591

Tax credit carryforwards
 
16,675

 
14,838

Stock-based compensation
 
1,899

 
5,994

Total gross deferred tax assets
 
128,923

 
122,051

Valuation allowance on deferred tax assets
 
(126,109
)
 
(119,228
)
Total deferred tax assets, net of valuation allowance
 
2,814

 
2,823

Deferred tax liabilities:
 
 
 
 
Fixed asset and intangibles
 
(16,528
)
 
(18,912
)
Total deferred tax liabilities
 
(16,528
)
 
(18,912
)
Net deferred tax liability
 
$
(13,714
)
 
$
(16,089
)


We evaluate a number of factors to determine the realizability of our deferred tax assets. Recognition of deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is

87

dependent upon several factors including historical financial results. The net deferred tax assets have been partially offset by a valuation allowance because we have incurred losses since our inception. The valuation allowance increased by $6.9 million during 2018, decreased by $27.1 million during 2017 and increased by $22.1 million during 2016, respectively. The change in valuation allowance during 2018 is mainly due to significant taxable losses and an increase in tax attributes. The change in valuation allowance during 2017 is mainly due to the change in Federal statutory rate from 34% to 21%, offset by a significant increase in the taxable loss in 2017.

The valuation allowances of $126.1 million and $119.2 million as of December 31, 2018 and 2017, respectively, primarily relate to temporary tax differences, net operating losses and research and development credits generated in the current and prior years. We believe it is more likely than not that U.S. federal and state of California deferred tax assets relating to temporary differences, net operating losses and research and development credits are not realizable. As such, full valuation allowances have been applied against the deferred tax assets relating to jurisdictions of the federal U.S. and the state of California.

A reconciliation of the beginning and ending amount of the valuation allowance for the years ended December 31, 2018, 2017, and 2016 is as follows (in thousands):
 
Valuation Allowance
December 31, 2015
$
124,137

Charges to earnings
—

Charges to other accounts
22,148

December 31, 2016
146,285

Charges to earnings
830

Charges to other accounts
(27,887
)
December 31, 2017
119,228

Charges to earnings
—

Charges to other accounts
6,880

December 31, 2018
$
126,108



As of December 31, 2018, we had net operating loss carryforwards for U.S. federal income tax purposes of $432.2 million, which expire beginning in 2021, and U.S. federal research and development tax credits of $8.5 million, which expire in the years 2021 through 2039. As of December 31, 2018, we had net operating loss carryforwards for state income tax purposes of $170.3 million, which expire beginning in 2028 through 2039, and California research and development tax credits of $11.0 million, which do not expire. As of December 31, 2018, we had foreign net operating loss carryforwards of $1.9 million, which expire in the years 2019 through 2027.

Utilization of the net operating loss carryforwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. In 2015, we completed a Section 382 analysis for the period from our inception in May 1999 through December 31, 2015, which excluded the net operating loss carryforwards for DVS prior to the acquisition and determined that an ownership change as defined under Section 382 occurred in November 2001, which resulted in a reduction to our U.S. federal net operating losses by $1.2 million. In 2016, 2017 and 2018, we continued the Section 382 analysis through December 31, 2018 and determined that an ownership change did not occur during the periods.

88

Uncertain Tax Positions

The aggregate changes in the balance of our gross unrecognized tax benefits during 2018, 2017, and 2016 were as follows (in thousands):
December 31, 2015
$
8,662

Increases in balances related to tax positions taken during prior period
46

       Increases in balances related to tax positions taken during current period
1,673

       Decreases in balances related to tax positions taken during prior period
(1,048
)
December 31, 2016
9,333

Increases in balances related to tax positions taken during current period
61

Decreases in balances related to tax positions taken during prior period
(2,077
)
December 31, 2017
7,317

Increases in balances related to tax positions taken during current period
255

Decreases in balances related to tax positions taken during prior period
(228
)
December 31, 2018
$
7,344



Accrued interest and penalties related to unrecognized tax benefits were included in the income tax provision and are immaterial as of December 31, 2018 and 2017.

As of December 31, 2018, there are $0.4 million unrecognized tax benefits that, if recognized, would affect our effective tax rate. We do not anticipate that our existing unrecognized tax benefits will significantly increase or decrease within the next 12 months.

We file income tax returns in the United States, various states, and certain foreign jurisdictions. As a result of net operating loss carryforwards, all of our tax years are open to federal and state examination in the United States. Tax years from 2013 are open to examination in various foreign countries.

11. Employee Benefit Plans

We sponsor a 401(k) savings plan for our employees in the United States that stipulates that eligible employees may elect to contribute to the plan, subject to certain limitations, up to the lesser of 90% of eligible compensation or the maximum amount allowed by the U.S. Internal Revenue Service. In 2015, we implemented a match formula of 100% up to $2,000 annually, following a 4-year vesting schedule. Employer matching contributions to the 401(k) plan for the years ended December 31, 2018, 2017, and 2016 were $0.4 million, $0.5 million, and $0.6 million, respectively.

12. Information About Geographic Areas

We operate in one reporting segment that develops, manufacturers and commercializes tools for life sciences research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.

A summary table of our total revenue by geographic areas of our customers and by product and services for the years ended December 31, 2018, 2017 and 2016 is included in Note 3 to the Consolidated Financial Statements of this Form 10K.

Sales to customers in the United States represented $48.1 million or 43%, of total revenues for the year ended December 31, 2018. Sales to customers in the United States represented $45.8 million or 45% of total revenues for the year ended December 31, 2017, and $52.6 million or 50% for the year ended December 31, 2016.


89

Sales to customers in China represented $14.0 million or 12%, of total revenues for the year ended December 31, 2018. Sales to customers in China represented 11% or $11.1 million, of total revenues for each of the years ended December 31, 2017, and 2016 respectively.

We had long-lived assets consisting of property, plant and equipment, net of accumulated depreciation, in the following geographic areas for each year presented (in thousands):
 
 
December 31,
 
 
2018
 
2017
United States
 
$
1,881

 
$
3,500

Singapore
 
3,748

 
5,167

Canada
 
3,104

 
3,481

EMEA
 
66

 
125

Asia-Pacific
 
26

 
28

Total
 
$
8,825

 
$
12,301



13. Commitments and Contingencies
Operating Leases
We have entered into various long-term non-cancelable operating lease agreements for equipment and facilities expiring at various times through March 2026. We lease office space under non-cancelable leases in the United States, Canada, Singapore, Japan, China, France and United Kingdom. Certain facility leases also contain rent escalation clauses. Our lease payments are expensed on a straight-line basis over the life of the leases. Rental expense under operating leases, net of amortization of lease incentives and sublease income, for the years ended December 31, 2018, 2017, and 2016 was $5.0 million, $4.7 million, and $6.3 million, respectively.
Future minimum lease payments and minimum sublease income under non-cancelable operating leases as of December 31, 2018 are as follows (in thousands):
Fiscal Year
 
Minimum Lease Payments
 
Minimum Sublease Income
 
Net Operating Leases
2019
 
$
4,184

 
$
(520
)
 
$
3,664

2020
 
2,213

 
(164
)
 
2,049

2021
 
1,245

 
—

 
1,245

2022
 
827

 
—

 
827

2023
 
552

 
—

 
552

   Thereafter
 
1,241

 
—

 
1,241

Total
 
$
10,262

 
$
(684
)
 
$
9,578

Other Commitments
In the normal course of business, we enter into various contractual and legally binding purchase commitments. As of December 31, 2018, these commitments were approximately $1.6 million.
Indemnifications
From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our

90

officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for related expenses including, among others, attorneys' fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding.
We incurred legal expenses between October 2015 and the third quarter of 2017 to defend claims by Thermo Fisher Scientific, Inc., (Thermo) against one of our employees. In December 2015, Thermo Fisher Scientific, Inc., (Thermo) filed a complaint in the Circuit Court for the County of Kalamazoo, Michigan against one of its former employees who had recently been hired by us alleging, among other claims, misappropriation of proprietary information and breach of contractual and fiduciary obligations to Thermo while such individual was still an employee of Thermo. In November 2016, Thermo amended its complaint to add us as a party to the litigation, making various commercial and employment-related claims and seeking damages and injunctive relief. In July 2017, we entered into a settlement agreement with Thermo. Pursuant to the terms of the settlement agreement, we agreed to pay Thermo a one-time payment of $3.0 million in exchange for a release and dismissal of all claims with prejudice upon payment of the settlement. In August 2017, we paid the settlement of $3.0 million and received an insurance recovery payment of $1.0 million related to this matter.
Contingencies
In early March 2019, we experienced a ransomware attack that infiltrated and encrypted certain of our information technology systems, including systems containing critical business data. Immediately following the attack, actions were taken to recover the compromised systems and we believe we were able to restore their operation without significant loss of business data. Based on the nature of the attack and its impact on our systems, we do not believe confidential data was lost or disclosed, but we are continuing to monitor the situation. As of the date of this filing, we estimate the costs associated with the intrusion to be approximately $1.5 million and are seeking to recover these costs under an applicable insurance policy.
From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.

14. Quarterly Results of Operations (Unaudited)

Selected quarterly results of operations for the years ended December 31, 2018 and 2017 are as follows (in thousands, except for per share amounts):
2018
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
25,248

 
$
26,428

 
$
28,963

 
$
32,325

Net loss
 
$
(13,247
)
 
$
(16,241
)
 
$
(14,750
)
 
$
(14,775
)
Net loss per share, basic and diluted
 
$
(0.34
)
 
$
(0.42
)
 
$
(0.38
)
 
$
(0.36
)
 
 
 
 
 
 
 
 
 
2017
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
25,533

 
$
23,912

 
$
24,747

 
$
27,745

Net loss
 
$
(17,202
)
 
$
(16,933
)
 
$
(15,944
)
 
$
(10,456
)
Net loss per share, basic and diluted
 
$
(0.59
)
 
$
(0.58
)
 
$
(0.46
)
 
$
(0.27
)

15. Subsequent Event
From January 9, 2019 through February 27, 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately $138.1 million in aggregate principal amount pursuant to the terms of the Second Supplemental Indenture dated March 6, 2018, between us and U.S. Bank National Association (Trustee) to the Indenture dated

91

as of February 14, 2014, between us and the Trustee. As a result of such voluntary conversions, we have elected to fully satisfy our conversion obligations by delivering approximately 17.9 million shares of our common stock to such holders and have retired approximately $138.1 million of the 2018 Notes. On February 27, we notified the Trustee of our intention to exercise our Issuer’s Conversion Option pursuant to the terms of the Second Supplemental Indenture with respect to the remaining approximately $11.9 million in aggregate principal amount of 2018 Notes. These bonds were converted into approximately 1.5 million shares of our common stock and the bonds retired in March 2019.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2018. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December 31, 2018, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.
Management’s Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as such term is defined in Exchange Act Rule 13a-15(f) to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Management assessed our internal control over financial reporting as of December 31, 2018. Management based its assessment on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework). Based on that evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2018.
The effectiveness of our internal control over financial reporting as of December 31, 2018 has been audited by PricewaterhouseCoopers, LLP, an independent registered public accounting firm, as stated in their report included in this Annual Report on Form 10-K.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the three months ended December 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on the Effectiveness of Controls
Control systems, no matter how well conceived and operated, are designed to provide a reasonable, but not an absolute, level of assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.
 

92


ITEM 9B. OTHER INFORMATION
Not applicable.


93


PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information called for by this item will be set forth in our Proxy Statement for the Annual Meeting of Stockholders to be filed with the SEC within 120 days of the fiscal year ended December 31, 2018 and is incorporated herein by reference.
Our board of directors has adopted a Code of Ethics and Conduct that applies to all of our employees, officers and directors, including our Chief Executive Officer, Chief Financial Officer and other executive and senior financial officers. The full text of our code of business conduct and ethics is posted on the investor relations page on our website which is located at www.fluidigm.com. We will post any amendments to our code of business conduct and ethics, or waivers of its requirements, on our website.

ITEM 11. EXECUTIVE COMPENSATION
The information called for by this item will be set forth in our Proxy Statement and is incorporated herein by reference.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information, if any, required by this item will be set forth in our Proxy Statement and is incorporated herein by reference.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information, if any, required by this item will be set forth in our Proxy Statement and is incorporated herein by reference.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
The information required by this item will be set forth in our Proxy Statement and is incorporated herein by reference.


94


PART IV
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
1. Financial Statements. See “Index to Consolidated Financial Statements” in Part II, Item 8 of this Form 10-K.
2. Financial Statement schedule. See “Index to Consolidated Financial Statements” in Part II, Item 8 of this Form 10-K.
3. Exhibits. The exhibits listed in the accompanying Index to Exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the U.S. Securities and Exchange Commission.


95


SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
 
 
 
In thousands
 
 
Balance at
Beginning of
Period
 
Additions/
Charged to
Expense
 
Deductions
 
Balance at
End of
Period
Year ended December 31, 2018
 
 
 
 
 
 
 
 
Accounts receivable allowance
 
$
391

 
$
162

 
$
(427
)
 
$
126

Year ended December 31, 2017
 
 
 
 
 
 
 
 
Accounts receivable allowance
 
$
502

 
$
24

 
$
(135
)
 
$
391

Year ended December 31, 2016
 
 
 
 
 
 
 
 
Accounts receivable allowance
 
$
103

 
$
484

 
$
(85
)
 
$
502


 
 
In thousands
 
 
Balance at
Beginning of
Period
 
Additions/
Charged to
Expense
 
Deductions
 
Balance at
End of
Period
Year ended December 31, 2018
 
 
 
 
 
 
 
 
Warranty allowance
 
$
699

 
$
1,573

 
$
(1,409
)
 
$
863

Year ended December 31, 2017
 
 
 
 
 
 
 
 
Warranty allowance
 
$
1,023

 
$
695

 
$
(1,019
)
 
$
699

Year ended December 31, 2016
 
 
 
 
 
 
 
 
Warranty allowance
 
$
1,076

 
$
885

 
$
(938
)
 
$
1,023




96



ITEM 16. FORM 10-K SUMMARY

None.

INDEX TO EXHIBITS
Exhibit
Number
 
Description
 
Incorporated
by Reference
From Form
 
Incorporated
by Reference
From Exhibit
Number
 
Date Filed
2.1
 
 
8-K
 
2.1
 
1/29/2014
3.1
 
 
10-K
 
3.1
 
3/28/2011
3.2
 
 
10-K
 
3.2
 
3/28/2011
3.3
 
 
8-K
 
3.1
 
11/22/2016
3.4
 
 
8-K
 
3.1
 
8/2/2017
4.1
 
 
S-8
 
4.1
 
8/3/2017
4.2
 
 
8-K
 
4.1
 
2/4/2014
4.3
 
 
8-K
 
4.2
 
2/4/2014
4.4
 
 
8-K
 
4.3
 
2/4/2014
4.5
 
 
8-K
 
4.1
 
11/22/2016
4.6
 
 
8-K
 
4.2
 
3/6/2018
4.7
 
 
8-K
 
4.3
 
3/6/2018
10.1
 
 
S-1/A
 
10.1
 
1/28/2011
10.2
 
Reserved.
 
 
 
 
 
 
10.3#
 
 
S-1
 
10.3
 
12/3/2010
10.3A#
 
 
S-1
 
10.3A
 
12/3/2010
10.4#
 
 
S-1/A
 
10.4
 
1/28/2011
10.4A#
 
 
S-1/A
 
10.4A
 
1/28/2011
10.4B#
 
 
8-K
 
10.2
 
8/2/2017
10.4C#
 
 
SC TO-I
 
(d)(2)
 
8/23/2017

97


Exhibit
Number
 
Description
 
Incorporated
by Reference
From Form
 
Incorporated
by Reference
From Exhibit
Number
 
Date Filed
10.4D
 
 
SC TO-I
 
(d)(3)
 
8/23/2017
10.4E
 
 
SC TO-I
 
(d)(4)
 
8/23/2017
10.4F
 
 
SC TO-I
 
(d)(5)
 
8/23/2017
10.4G#
 
 
SC TO-I
 
(d)(6)
 
8/23/2017
10.4H#
 
 
SC TO-I
 
(d)(7)
 
8/23/2017
10.5†
 
 
S-1
 
10.5
 
12/3/2010
10.5A†
 
 
S-1
 
10.5A
 
12/3/2010
10.6†
 
 
S-1
 
10.6
 
12/3/2010
10.6A†
 
 
S-1
 
10.6A
 
12/3/2010
10.7†
 
 
S-1
 
10.7
 
12/3/2010
10.8†
 
 
S-1
 
10.8
 
12/3/2010
10.9†
 
 
S-1
 
10.9
 
12/3/2010
10.10#
 
 
8-K
 
10.1
 
1/11/2017
10.11
 

 
8-K
 
10.1
 
8/2/2018
10.12
 
Reserved.
 
 
 
 
 
 
10.13#
 
 
10-K
 
10.13
 
3/3/2017
10.14#
 
 
8-K
 
10.14
 
12/11/2012
10.15#
 
 
10-Q
 
10.1
 
5/8/2018

10.16#
 
 
10-Q
 
10.2
 
11/9/2016
10.17#
 
 
S-1
 
10.17
 
12/3/2010
10.18#
 
 
Filed herewith
 
 
 
 

98


Exhibit
Number
 
Description
 
Incorporated
by Reference
From Form
 
Incorporated
by Reference
From Exhibit
Number
 
Date Filed
10.19
 
 
S-1/A
 
10.19
 
1/7/2011
10.19A
 
 
10-Q
 
10.19A
 
5/9/2013
10.19B
 
 
10-Q
 
10.3
 
8/4/2014
10.19C
 
 
10-Q
 
10.2
 
11/6/2014
10.19D
 
 
8-K
 
10.1
 
12/14/2015
10.19E
 
 
10-Q
 
10.1
 
5/9/2017
10.19F
 
 
8-K
 
10.1
 
8/3/2017
10.19G
 
 
10-Q
 
10.2
 
8/8/2018
10.20
 
 
S-1
 
10.20
 
12/3/2010
10.21
 
 
10-K
 
10.21
 
3/12/2014
10.22
 
 
10-Q
 
10.1
 
8/10/2015
10.23†
 
 
10-Q
 
10.1
 
11/9/2015
10.24#
 
 
8-K
 
10.1
 
2/10/2017
10.25#
 
 
8-K
 
10.1
 
9/20/2018
10.26#
 
 
10-K
 
10.25
 
3/28/2011
10.27†
 
 
10-Q/A
 
10.3
 
9/15/2014
10.28†
 
 
10-Q/A
 
10.4
 
9/15/2014
10.29#
 
 
8-K
 
99.1
 
10/24/2016
10.30
 
 
8-K
 
10.1
 
8/2/2017

99


Exhibit
Number
 
Description
 
Incorporated
by Reference
From Form
 
Incorporated
by Reference
From Exhibit
Number
 
Date Filed
10.31
 
 
8-K
 
1.1
 
8/3/2017
10.32#
 
 
8-K
 
10.1
 
8/23/2017
10.33#
 
 
10-Q
 
10.5
 
11/7/2017
21.1
 
 
10-K
 
21.1
 
3/3/2017
23.1
 
 
Filed herewith
 
 
 
 
24.1
 
 
Filed herewith
 
 
 
 
31.1
 
 
Filed herewith
 
 
 
 
31.2
 
 
Filed herewith
 
 
 
 
32.1~
 
 
Filed herewith
 
 
 
 
32.2~
 
 
Filed herewith
 
 
 
 
101.INS
 
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
Filed herewith
 
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
Filed herewith
 
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
Filed herewith
 
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
 
Filed herewith
 
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Document
 
Filed herewith
 
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Document
 
Filed herewith
 
 
 
 
 # Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to participate.
† Portions of the exhibit have been omitted pursuant to an order granted by the Securities and Exchange Commission for confidential treatment.
~ In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management’s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-K and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that Fluidigm Corporation specifically incorporates it by reference.


100


SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
FLUIDIGM CORPORATION
 
 
 
Dated: March 18, 2019
By:
 
/s/ Stephen Christopher Linthwaite
 
 
 
 
 
Stephen Christopher Linthwaite
 
 
 
 
 
President and Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Stephen Christopher Linthwaite and Vikram Jog, jointly and severally, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign this Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
Signature
 
Title
 
Date
 
 
 
/s/ Stephen Christopher Linthwaite
 
President and Chief Executive Officer (Principal Executive Officer); Director
 
March 18, 2019
Stephen Christopher Linthwaite
 
 
 
 
/s/ Vikram Jog
 
Chief Financial Officer (Principal Financial and Accounting Officer)
 
March 18, 2019
Vikram Jog
 
 
/s/ Samuel D. Colella
 
Chairman of the Board of Directors
 
March 18, 2019
Samuel D. Colella
 
 
/s/ Nicolas M. Barthelemy
 
Director
 
March 18, 2019
Nicolas M. Barthelemy
 
 
/s/ Gerhard F. Burbach
 
Director
 
March 18, 2019
Gerhard F. Burbach
 
 
/s/ Laura M. Clague
 
Director
 
March 18, 2019
Laura M. Clague
 
 
/s/ Patrick S. Jones
 
Director
 
March 18, 2019
Patrick S. Jones
 
 
/s/ Carlos V. Paya
 
Director
 
March 18, 2019
Carlos V. Paya
 
 
 
 

101
 EX-10.18 2 exhibit1018.htm EXHIBIT 10.18 Exhibit
exhibit1018image1.jpg

Exhibit 10.18


February 13, 2018


Bradley A. Kreger    
8106 Polo Crosse Avenue
Vineyard, California 95829

Dear Brad,

I am pleased to offer you a position with Fluidigm Corporation (the “Company”) as a Senior Vice President, Product Operations, reporting directly to me. Other terms of employment include:

Start Date: March 26, 2018

Compensation:
You will receive an initial salary of $13,541.67 per pay period. We are on a semi-monthly pay schedule, with two pay periods per calendar month which generally fall on the 15th and the last day of the month. This equates to a base compensation of $325,000.00 on an annual basis, less deductions as required by law, which will be paid in accordance with the Company’s normal payroll procedures.

Bonus Target:
You will be eligible to participate in the Company’s Employee Bonus Plan.  The bonus will be subject to achievement of performance objectives with the actual bonus amount to be determined by the Company in its discretion.  To earn a bonus, you must remain employed with the Company through the date bonuses are actually paid.  Your bonus target is 42.5%

Equity Award:
We will recommend to our Board of Directors or one of its committees after commencement of your employment with Fluidigm Corporation that you receive an on-hire grant of 100,000 Stock Options and 50,000 Restricted Stock Units. Your grant will be subject to the approval of the Board, or its committee, and is subject to the terms of our equity incentive plan, and our policies governing grants of equity incentive awards.

Benefits:
You are eligible to receive the Company’s standard benefits package which currently includes medical, dental, vision, life and disability insurance benefits. Benefits will be effective on your date of hire. Additional benefits, as the Company may make generally available to its employees from time to time, will be made available to you. You will be entitled to accrue up to 3 weeks paid vacation each year and such paid holidays as the Company gives to its employees generally, in accordance with company policies.

Workers’ Compensation Insurance:
The Company provides a comprehensive workers’ compensation insurance program at no cost to employees. This program covers any injury or illness sustained in the course of employment that requires medical, surgical or hospital treatment. Insurance carrier: Preferred Employers Group - PO BOX 85838, San Diego, CA 92186, phone number (866) 472-9602.

Confidentiality and Company Policies:
It is important to protect our confidential information and proprietary material. Therefore, as a condition of employment you will be required to sign the Company’s standard At-Will Employment, Confidential Information, Invention Assignment, And Arbitration Agreement.

Background and reference checks: This offer is contingent upon successfully passing your background and reference checks.

Employment Authorization:
For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to us within three (3) business days of your date of hire, or our employment relationship may be terminated.




Other:
This letter shall be interpreted under California law. You should be aware that your employment with the Company is for no specified period and constitutes “at will” employment. As a result, you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause. In addition, the Company may change your compensation, duties, assignments, responsibilities, location of your position, or any other terms and conditions of employment at any time, to adjust to the changing needs of our dynamic Company.

In the event of any dispute or claim relating to or arising out of our employment relationship, you and the Company agree that all such disputes shall be fully and finally resolved by binding arbitration conducted by the Judicial Arbitration & Mediation Services (“JAMS”) in Santa Clara County California. The current JAMS employment arbitration rules & procedures can be found at http://www.jamsadr.com/rules-employment-arbitration/. The JAMS employment arbitration rules & procedures may, however, be amended by JAMS.) You acknowledge that you are waiving your right to a jury trial.

This offer expires on Feb 20, 2018, unless you accept prior to this date. To indicate your acceptance of the Company's offer, please sign and date this letter in the space provided below and return it in the envelope provided to Rachael Papalia, Director of Talent Acquisition, 7000 Shoreline Court, Suite 100, South San Francisco, CA 94080. A copy is provided for your records.

This letter, along with the agreement relating to proprietary rights between you and the Company, set forth the terms of your employment with the Company and supersede any prior representations or agreements, whether written or oral. This letter may not be modified or amended except by a written agreement, signed by the Company and by you.

Our employees are committed to the success and growth of our business.  At Fluidigm, we believe that our values are not just words on paper – they are a statement of our character.  Fluidigmers should:  Win as a team; Work hard and with passion; Be strong; Be aggressive; Do what you say you will do; Sweat the details; and Keep learning.  We believe our values define who we are as a company and as employees of Fluidigm.  We aspire to live by these values each day and work hard to exhibit these traits because these are the things that are worth believing. 

Brad, we look forward to you joining and being part of Fluidigm!  I am certain we can build a great company together.
Sincerely,

/s/ Christopher Linthwaite

Christopher Linthwaite
President & Chief Executive Officer
Fluidigm Corporation

ACCEPTED AND AGREED TO:     




/s/ Bradley A. Kreger                        2/17/2018        
Bradley A. Kreger                        Date




 EX-23.1 3 exhibit23110k2018.htm EXHIBIT 23.1 Exhibit

Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 as amended (No. 333-216542), Form S-8 (Nos. 333-172206, 333-180363, 333-187204, 333-202325, 333-209904, 333-215555, 333-219667, 333-222561, 333-229214), and Form S-3/S-8 (No. 333-194084) of Fluidigm Corporation of our report dated March 18, 2019 relating to the financial statements and financial statement schedule, and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


/s/ PricewaterhouseCoopers LLP
San Jose, California
March 18, 2019



 EX-31.1 4 exhibit31110k2018.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1
CERTIFICATION OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER
PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Stephen Christopher Linthwaite, certify that:
1.
I have reviewed this annual report on Form 10-K of Fluidigm Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: March 18, 2019
 
 
By:
/s/ Stephen Christopher Linthwaite
 
 
 
 
Stephen Christopher Linthwaite
 
 
 
 
President and Chief Executive Officer


 EX-31.2 5 exhibit31210k2018.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Vikram Jog, certify that:
1.
I have reviewed this annual report on Form 10-K of Fluidigm Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: March 18, 2019
 
 
By:
/s/ Vikram Jog
 
 
 
 
Vikram Jog
 
 
 
 
Chief Financial Officer


 EX-32.1 6 exhibit32110k2018.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Stephen Christopher Linthwaite, the chief executive officer of Fluidigm Corporation (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,
1.the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 18, 2019

By:
/s/ Stephen Christopher Linthwaite
 
 
Stephen Christopher Linthwaite
 
 
President and Chief Executive Officer
 
 
 




 EX-32.2 7 exhibit32210k2018.htm EXHIBIT 32.2 Exhibit


Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Vikram Jog, the chief financial officer of Fluidigm Corporation (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,
1.the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 18, 2019

By:
/s/ Vikram Jog
 
 
Vikram Jog
 
 
Chief Financial Officer
 
 
 


 EX-101.SCH 8 fldm-20181231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2105100 - Disclosure - Balance Sheet Details link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Balance Sheet Details - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Balance Sheet Details - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Balance Sheet Details (Tables) link:presentationLink link:calculationLink link:definitionLink 2405405 - Disclosure - Balance Sheet Details - Warranty Accrual (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Convertible Notes and Credit Facility link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Convertible Notes and Credit Facility - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Convertible Notes and Credit Facility - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Convertible Notes and Credit Facility (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2411401 - Disclosure - Employee Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Fair Value of Financial Instruments - Fair Value of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Goodwill and Intangible Assets, net link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Goodwill and Intangible Assets, net (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2410408 - Disclosure - Income Taxes - Aggregate Changes in Balance of Gross Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Income Taxes - Loss Before Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2410406 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Income Taxes - Reconciliation of Income Taxes at Statutory Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2410407 - Disclosure - Income Taxes - Valuation Allowance (Details) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Information About Geographic Areas link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Information About Geographic Areas - Long-lived Assets by Geographic Areas (Details) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Information About Geographic Areas - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Information About Geographic Areas (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Quarterly Results of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Quarterly Results of Operations (Unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Quarterly Results of Operations (Unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - Revenue - Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 2416401 - Disclosure - Schedule II-Valuation And Qualifying Accounts And Reserve (Detail) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Schedule II-Valuation And Qualifying Accounts And Reserves link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Shareholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Stock-Based Plans link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Stock-Based Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2409406 - Disclosure - Stock-Based Plans - Stock-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - Stock-Based Plans - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Stock-Based Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Stock-Based Plans - Weighted-average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2415401 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2402404 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 2402406 - Disclosure - Summary of Significant Accounting Policies - Impact on Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 2402407 - Disclosure - Summary of Significant Accounting Policies - Impact On Income Statement (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2402405 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 fldm-20181231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 fldm-20181231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 fldm-20181231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Debt Disclosure [Abstract] Schedule of debt Schedule of Debt [Table Text Block] Income Tax Disclosure [Abstract] Loss before income taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Significant components of provision for income taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Reconciliation of income taxes at statutory rate to (provision for)/benefit from income taxes recorded in statements of operations Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Significant components of deferred tax assets and liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Summary of valuation allowance Summary of Valuation Allowance [Table Text Block] Aggregate changes in balance of gross unrecognized tax benefits Summary of Income Tax Contingencies [Table Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Performance Shares Performance Shares [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of Nonvested and Outstanding Units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Beginning Balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Released (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Ending Balance (shares) Weighted-Average Grant Date Fair Value per Share Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Beginning Balance (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Released (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Ending Balance (usd per share) Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets, net Intangible Assets Disclosure [Text Block] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed technology Developed Technology Rights [Member] Patents and licenses Patents and License Agreements [Member] Patents and License Agreements [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] 2019 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Net Finite-Lived Intangible Assets, Net Fair Value Disclosures [Abstract] Schedule of cash and available-for-sale securities Debt Securities, Available-for-sale [Table Text Block] Deferred tax assets: Deferred Tax Assets, Net [Abstract] Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Reserves and accruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Depreciation and amortization Deferred Tax Assets Depreciation And Amortization Deferred Tax Assets, Depreciation and Amortization Tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Stock-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Total gross deferred tax assets Deferred Tax Assets, Gross Valuation allowance on deferred tax assets Deferred Tax Assets, Valuation Allowance Total deferred tax assets, net of valuation allowance Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Liabilities, Gross [Abstract] Deferred Tax Liabilities, Gross [Abstract] Fixed asset and intangibles Deferred Tax Liabilities, Property, Plant and Equipment Total deferred tax liabilities Deferred Tax Liabilities, Gross Net deferred tax liability Deferred Tax Liabilities, Net Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Beginning Balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Options granted (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Option exercised (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Options forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Ending Balance (shares) Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Expected to vest (in shares) Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number Weighted-Average Exercise Price per Share Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Beginning Balance (usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Options granted (usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options exercised (usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options forfeited (usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Ending Balance (usd per share) Vested (usd per share) Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price Expected to vest (usd per share) Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price Weighted- Average Remaining Contractual Life (in Years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Vested Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One Expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term 1 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1 Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Balance at December 31, 2018 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Vested at December 31, 2018 Share Based Compensation Arrangement By Share Based Payment Award Options Vested Aggregate Intrinsic Value Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value Expected to vest at December 31, 2018 Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value Share price (usd per share) Share Price Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Commitments and Contingencies Disclosure [Abstract] Future minimum lease payments under non-cancelable operating leases Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Accounting Policies [Abstract] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Unrealized Gain (Loss) on Investments Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Beginning Balance Stockholders' Equity Attributable to Parent Change during the year Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Ending Balance SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Schedule II-Valuation And Qualifying Accounts And Reserves SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Income Statement [Abstract] Statement [Table] Statement [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Product revenue Product [Member] Service revenue Service [Member] License revenue License [Member] Statement [Line Items] Statement [Line Items] Revenue: Revenues [Abstract] Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Cost of sales: Costs and Expenses [Abstract] Total cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income (Loss) Interest expense Interest Expense Other income (expense), net Other Nonoperating Income (Expense) Loss before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Benefit from income taxes Income Tax Expense (Benefit) Net loss Net Income (Loss) Attributable to Parent Net loss per share, basic and diluted (usd per share) Earnings Per Share, Basic and Diluted Shares used in computing net loss per share, basic and diluted (shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Components of accumulated other comprehensive loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Summary of potential common shares excluded from computations of net loss per share attributed to common stockholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of new accounting pronouncements Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Tax Period [Axis] Tax Period [Axis] Tax Period [Domain] Tax Period [Domain] Expiring In 2021 Expiring In 2021 [Member] Expiring In 2021 [Member] Expiring In 2021 Through 2039 Expiring In 2021 Through 2039 [Member] Expiring In 2021 Through 2039 [Member] Expiring In 2028 Through 2039 Expiring In 2028 Through 2039 [Member] Expiring In 2028 Through 2039 [Member] Expiring In 2019 Through 2027 Expiring In 2019 Through 2027 [Member] Expiring In 2019 Through 2027 [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] California CALIFORNIA Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Domestic Tax Authority Domestic Tax Authority [Member] Foreign Tax Authority Foreign Tax Authority [Member] State and Local Jurisdiction State and Local Jurisdiction [Member] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Increase (decrease) in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Valuation allowance Operating loss carryforward Operating Loss Carryforwards Reduction in net operating losses Operating Loss Carryforwards, Limitations on Use, Amount Operating Loss Carryforwards, Limitations on Use, Amount Unrecognized tax benefits, that if recognized would affect effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Quarterly Financial Information Disclosure [Abstract] Quarterly results of operations Quarterly Financial Information [Table Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Ransomware Attack Ransomware Attack [Member] Ransomware Attack [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] Thermo Thermo [Member] Thermo [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Rent expense Operating Leases, Rent Expense Purchase commitment due in the next year Purchase Obligation, Due in Next Twelve Months Litigation settlement amount awarded to other party Litigation Settlement, Amount Awarded to Other Party Payments for legal settlements Payments for Legal Settlements Insurance recoveries Insurance Recoveries Estimate of possible loss Loss Contingency, Estimate of Possible Loss Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] United States UNITED STATES Singapore SINGAPORE Canada CANADA EMEA EMEA [Member] Asia-Pacific Asia Pacific [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total property and equipment, net Property, Plant and Equipment, Net Retirement Benefits [Abstract] Employee Benefit Plans Compensation and Employee Benefit Plans [Text Block] Statement of Comprehensive Income [Abstract] Net loss Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Unrealized gain (loss) on available-for-sale securities, net Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax Other comprehensive income (loss) Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Number of reporting segment Number of Reportable Segments Schedule of Product Information [Table] Schedule of Product Information [Table] China CHINA Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Revenue from Contract with Customer Revenue from Contract with Customer [Member] Product Information [Line Items] Product Information [Line Items] Sales to customers Concentration risk, percentage Concentration Risk, Percentage Document And Entity Information [Abstract] Document and Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Current Reporting Status Entity Current Reporting Status Entity Voluntary Filers Entity Voluntary Filers Entity Filer Category Entity Filer Category Entity Emerging Growth Company Entity Emerging Growth Company Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Entity Common Stock, Shares Outstanding (shares) Entity Common Stock, Shares Outstanding Entity Public Float Entity Public Float Equity [Abstract] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Stock Option Employee Stock Option [Member] Restricted Stock And Performance Share Units Restricted Stock And Performance Share Units [Member] Restricted Stock And Performance Share Units [Member] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2009 Equity Incentive Plan Two Thousand And Nine Equity Incentive Plan [Member] Two Thousand And Nine Equity Incentive Plan [Member] 2011 Equity Incentive Plan Two Thousand And Eleven Equity Incentive Plan [Member] Two Thousand And Eleven Equity Incentive Plan [Member] DVS Sciences Inc. 2010 Equity Incentive Plan Two Thousand And Ten Equity Incentive Plan [Member] Two Thousand And Ten Equity Incentive Plan [Member] 2017 Inducement Award Plan Two Thousand And Seventeen Inducement Award Plan [Member] Two Thousand And Seventeen Inducement Award Plan [Member] 2017 Employee Stock Purchase Plan Two Thousand Seventeen Employee Stock Purchase Plan [Member] Two Thousand Seventeen Employee Stock Purchase Plan [Member] Class of Stock [Line Items] Class of Stock [Line Items] Securities To Be Issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number Of Remaining Securities Available For Future Issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Information About Geographic Areas Segment Reporting Disclosure [Text Block] Statement of Financial Position [Abstract] Accounts receivable, allowances Allowance for Doubtful Accounts Receivable, Current Preferred stock, par value (usd per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (shares) Preferred Stock, Shares Outstanding Common stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (shares) Common Stock, Shares Authorized Common stock, shares issued (shares) Common Stock, Shares, Issued Common stock, shares outstanding (shares) Common Stock, Shares, Outstanding Income Taxes Income Tax Disclosure [Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Carrying Value Reported Value Measurement [Member] Fair Value Estimate of Fair Value Measurement [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Convertible Debt Convertible Debt [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Senior Convertible Notes due 2034 Senior Convertible Notes due 2034 [Member] Senior Convertible Notes due 2034 [Member] Exchange Convertible Senior Notes due 2034 Exchange Convertible Senior Notes Due 2034 [Member] Exchange Convertible Senior Notes Due 2034 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Par Value Debt Instrument, Face Amount Debt Debt Instrument, Fair Value Disclosure Compensation Plan [Table] Compensation Plan [Table] Compensation Plan [Table] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Maximum Maximum [Member] Compensation Plan [Line Items] Compensation Plan [Line Items] Compensation Plan [Line Items] Percentage of employees eligible compensation Defined Contribution Plan Eligible Compensation Contributed By Employee Percentage Defined Contribution Plan Eligible Compensation Contributed By Employee Percentage Percent of employee match Defined Contribution Plan, Employer Matching Contribution, Percent of Match Maximum annual employee contribution matched by employer Defined Contribution Plan, Employer Matching Contribution, Maximum Annual Match Per Employee, Amount Defined Contribution Plan, Employer Matching Contribution, Maximum Annual Match Per Employee, Amount Vesting period Defined Contribution Plan, Employers Matching Contribution, Vesting Period Defined Contribution Plan, Employers Matching Contribution, Vesting Period Employer matching contributions expense Defined Contribution Plan, Cost Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Minimum Minimum [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Prime Rate Prime Rate [Member] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Redemption, Period One Debt Instrument, Redemption, Period One [Member] Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Redemption, Period Three Debt Instrument, Redemption, Period Three [Member] Loan Agreement Prior To August 2, 2019 Loan Agreement Prior To August 2, 2019 [Member] Loan Agreement Prior To August 2, 2019 [Member] Loan Agreement On Or After August 2, 2019 Loan Agreement On Or After August 2, 2019 [Member] Loan Agreement On Or After August 2, 2019 [Member] 2018 Convertible Notes Two Thousand And Eighteen Convertible Notes [Member] Two Thousand And Eighteen Convertible Notes [Member] Principal amount Interest rate on notes Debt Instrument, Interest Rate, Stated Percentage Initial conversion rate of notes Initial Conversion Rate Of Notes Initial Conversion Rate Of Notes Initial conversion price of stock (usd per share) Initial Conversion Price Of Stock Initial Conversion Price Of Stock Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price Debt instrument redemption price Debt Instrument, Redemption Price, Percentage Debt instrument, redemption price when undergo fundamental change Debt Instrument, Redemption Price, Percentage, Fundamental Change Debt Instrument, Redemption Price, Percentage, Fundamental Change Net proceeds from issuance of convertible notes, net Proceeds from Convertible Debt Debt issuance costs Debt Issuance Costs, Net Underwriting discount Underwriting Discount Underwriting Discount Long-term debt outstanding Long-term Debt, Gross Estimated fair value of debt Long-term Debt, Fair Value Gain on extinguishment of debt Gain (Loss) on Extinguishment of Debt Debt instrument, redemption price, percentage of outstanding principal amount, fundamental change Debt Instrument, Redemption Price, Percentage Of Outstanding Principal Amount, Fundamental Change Debt Instrument, Redemption Price, Percentage Of Outstanding Principal Amount, Fundamental Change Debt and equity offering costs Debt And Equity Offering Costs Debt And Equity Offering Costs Amortization of debt issuance costs Amortization of Debt Issuance Costs Stock issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Maximum ability to borrow under line of credit Line of Credit Facility, Maximum Borrowing Capacity Percentage of eligible receivables Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables Percentage of eligible inventory Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory Additional interest rate Debt Instrument, Basis Spread on Variable Rate Unused revolving line of credit Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Prepayment fee, percentage Line of Credit Facility, Commitment Fee Percentage Commitment fee amount Line of Credit Facility, Commitment Fee Amount Percentage of interest on obligation upon default Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default Schedule of finite-lived intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Estimated future intangible asset amortization expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Stock-based compensation determined using Black-Sholes option-pricing model and weighted average assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Activity under restricted stock units Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Activity under stock options Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of nonvested performance-based units activity Schedule of Nonvested Performance-based Units Activity [Table Text Block] Schedule of stock-based compensation expense Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Accounts receivable allowance SEC Schedule, 12-09, Allowance, Credit Loss [Member] Warranty allowance SEC Schedule, 12-09, Reserve, Warranty [Member] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Allowance for Doubtful Accounts Receivable [Roll Forward] Allowance for Doubtful Accounts Receivable [Roll Forward] Balance at Beginning of Period Additions/Charged to Expense Provision for Doubtful Accounts Deductions Allowance for Doubtful Accounts Receivable, Write-offs Balance at End of Period Minimum Lease Payments Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2019 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2020 Operating Leases, Future Minimum Payments, Due in Two Years 2021 Operating Leases, Future Minimum Payments, Due in Three Years 2022 Operating Leases, Future Minimum Payments, Due in Four Years 2023 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total Operating Leases, Future Minimum Payments Due Minimum Sublease Income Future Minimum Sublease Rentals, Sale Leaseback Transactions, Fiscal Year Maturity [Abstract] 2019 Sublease Income, Future Minimum Payments, Receivable Next Twelve Months Sublease Income, Future Minimum Payments, Receivable Next Twelve Months 2020 Sublease Income, Future Minimum Payments, Receivable In Two Years Sublease Income, Future Minimum Payments, Receivable In Two Years 2021 Sublease Income, Future Minimum Payments, Receivable In Three Years Sublease Income, Future Minimum Payments, Receivable In Three Years 2022 Sublease Income, Future Minimum Payments, Receivable In Four Years Sublease Income, Future Minimum Payments, Receivable In Four Years 2023 Sublease Income, Future Minimum Payments, Receivable In Five Years Sublease Income, Future Minimum Payments, Receivable In Five Years Thereafter Sublease Income, Future Minimum Payments, Receivable Thereafter Sublease Income, Future Minimum Payments, Receivable Thereafter Total Sublease Income, Future Minimum Payments Receivable Sublease Income, Future Minimum Payments Receivable Net Operating Leases [Abstract] Net Operating Leases [Abstract] Net Operating Leases [Abstract] 2019 Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Next Twelve Months Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Next Twelve Months 2020 Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Two Years Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Two Years 2021 Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Three Years Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Three Years 2022 Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Four Years Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Four Years 2023 Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Five Years Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Five Years Thereafter Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due Thereafter Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due Thereafter Total Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due Statement of Cash Flows [Abstract] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Amortization and Accretion, Net Stock-based compensation expense Share-based Compensation Amortization of developed technology Amortization of Intangible Assets Amortization of debt discounts, premiums and issuance costs Amortization of Debt Issuance Costs and Discounts Other non-cash items Other Operating Activities, Cash Flow Statement Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable Increase (Decrease) in Accounts Payable Deferred revenue Increase (Decrease) in Contract with Customer, Liability Other liabilities Increase (Decrease) in Other Operating Liabilities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of investments Payments to Acquire Investments Proceeds from sales and maturities of investments Proceeds from Sale, Maturity and Collection of Investments Proceeds from sale of investment in Verinata Proceeds from Sale of Other Investments Purchases of intangible assets Payments to Acquire Intangible Assets Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Payment of debt and equity issuance costs Payments of Debt Issuance Costs Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Payments for taxes related to net share settlement of equity awards Proceeds from Stock Options Exercised Proceeds from stock issuance from ESPP Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Excluding Stock Options Payments for taxes related to net share settlement of equity awards Payments Related to Tax Withholding for Share-based Compensation Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect of foreign exchange rate fluctuations on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents at beginning of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Supplemental disclosures of cash flow information Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for income taxes, net of refunds Income Taxes Paid, Net Employee Stock Purchase Plan Employee Stock [Member] 2018 Retention Bonus Program Two Thousand And Eighteen Retention Bonus Program [Member] Two Thousand And Eighteen Retention Bonus Program [Member] Options and Restricted Stock Units Options And Restricted Stock Units [Member] Options And Restricted Stock Units [Member] Total Share-Based Compensation Allocated Share-based Compensation Expense Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Beginning Balance Unrecognized Tax Benefits Increases in balances related to tax positions taken during prior period Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Increases in balances related to tax positions taken during prior period Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Decreases in balances related to tax positions taken during prior period Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Ending Balance Shareholders' Equity [Table] Shareholders' Equity [Table] Shareholders' Equity [Table] Common Stock Common Stock [Member] Sale of Stock [Axis] Sale of Stock [Axis] Sale of Stock [Domain] Sale of Stock [Domain] 2018 Market Offering Two Thousand And Eighteen Market Offering [Member] Two Thousand And Eighteen Market Offering [Member] 2017 At-the-Market Offering Two Thousand And Seventeen At-The-Market Equity Offering Program [Member] Two Thousand And Seventeen At-The-Market Equity Offering Program Shareholders' Equity [Line Items] Shareholders' Equity [Line Items] [Line Items] for Shareholders' Equity [Table] Shares sold (shares) Stock Issued During Period, Shares, New Issues Price per share (in dollars per share) Sale of Stock, Price Per Share Gross proceeds from issuance of common stock through at-the-market offering Proceeds From Issuance Of Common Stock, Including Related Expenses Proceeds From Issuance Of Common Stock, Including Related Expenses Commission expense Sales Commissions and Fees Estimated expenses of offering Estimated Expenses Of Offering Estimated Expenses Of Offering Balance Sheet Related Disclosures [Abstract] Cash Cash Money market funds Money Market Funds, at Carrying Value U.S. Government and agency securities US Government Agencies Securities, at Carrying Value Total Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2014-09 Accounting Standards Update 2014-09 [Member] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Calculated under Revenue Guidance in Effect before Topic 606 Calculated under Revenue Guidance in Effect before Topic 606 [Member] Difference between Revenue Guidance in Effect before and after Topic 606 Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Selling, general and administrative Total costs and expenses Costs and Expenses Loss from operations Loss before income taxes Net loss Raw materials Inventory, Raw Materials, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventories, net Inventory, Net Subsequent Event [Table] Subsequent Event [Table] Subsequent Event [Line Items] Subsequent Event [Line Items] Debt converted, amount Debt Conversion, Original Debt, Amount Convertible obligations (in shares) Debt Conversion, Converted Instrument, Shares Issued Debt extinguished Extinguishment of Debt, Amount Statement of Stockholders' Equity [Abstract] Accounting Standards Update 2016-09 Accounting Standards Update 2016-09 [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive (Loss)/Income Accumulated Deficit Retained Earnings [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning Balance (shares) At-the-market offering (shares) Market offering Stock Issued During Period, Value, New Issues Issuance of restricted stock, net of shares withheld for taxes, and other (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Issuance of restricted stock, net of shares withheld for taxes, and other Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Issuance of common stock from option exercises (in shares) Issuance of common stock from option exercises Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock under ESPP (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock under ESPP Stock Issued During Period, Value, Employee Stock Purchase Plan Conversion option on convertible debt Stock Issued During Period, Value, Conversion of Convertible Securities Closing cost related to conversion option on convertible debt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments Cumulative effect of new accounting principle Cumulative Effect of New Accounting Principle in Period of Adoption Stock-based compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Other comprehensive income (loss) Ending Balance (shares) Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Tax benefit at federal statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent State tax expense, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Foreign tax benefit (expense) Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Federal research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Unrecognized tax benefit Effective Income Tax Rate Reconciliation Unrecognized tax benefit Effective Income Tax Rate Reconciliation, Unrecognized tax benefit Impact of the Tax Act Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Other, net Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective tax rate Effective Income Tax Rate Reconciliation, Percent Convertible Notes Payable Convertible Notes Payable [Member] Premium accretion Debt Instrument, Accretion Of Discount Debt Instrument, Accretion Of Discount Unamortized debt discount Debt Instrument, Unamortized Discount Unamortized debt issuance cost Net carrying value of convertible notes Long-term Debt Organization, Consolidation and Presentation of Financial Statements [Abstract] Description of Business Business Description and Basis of Presentation [Text Block] Convertible Notes and Credit Facility Long-term Debt [Text Block] 2017 Employee Stock Purchase Plan Employee Stock Weighted average expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Weighted average expected term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Weighted average risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Weighted-average fair value per share Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Beginning balance Standard and Extended Product Warranty Accrual Accrual for current period warranties Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Warranty costs incurred Standard and Extended Product Warranty Accrual, Decrease for Payments Ending balance Basis of Presentation and Consolidation Basis of Accounting, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Foreign Currency Foreign Currency Transactions and Translations Policy [Policy Text Block] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Investments Investment, Policy [Policy Text Block] Accounts Receivable Receivables, Policy [Policy Text Block] Concentrations of Business and Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Goodwill, Intangible Assets and Other Long-Lived Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Convertible Notes Debt, Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value Measurement, Policy [Policy Text Block] Research and Development Research and Development Expense, Policy [Policy Text Block] Advertising Costs Advertising Costs, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Stock-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Recent Accounting Changes and Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Revenue from Contract with Customer [Abstract] Revenue Revenue from Contract with Customer [Text Block] Balance Sheet Details Supplemental Balance Sheet Disclosures [Text Block] Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Computer equipment and software Computer Equipment And Software [Member] Computer Equipment And Software [Member] Laboratory and manufacturing equipment Laboratory And Production Equipment [Member] Laboratory And Production Equipment [Member] Leasehold improvements Leasehold Improvements [Member] Office furniture and fixtures Office Equipment [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property and equipment Property, Plant and Equipment, Gross Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Construction-in-progress Construction in Progress, Gross Property and equipment, net Schedule of common stock reserved for future issuance Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Net long-lived assets consisting of property and equipment in different geographic areas Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block] Capitalized Contract Cost [Axis] Capitalized Contract Cost [Axis] Capitalized Contract Cost [Domain] Capitalized Contract Cost [Domain] Commission Costs Commission Costs [Member] Commission Costs [Member] Deferred revenue Contract with Customer, Liability Revenue recognized Contract with Customer, Liability, Revenue Recognized Additional advance payments received Contract With Customer, Liability, Increase From Cash Receipts Contract With Customer, Liability, Increase From Cash Receipts Capitalized contract cost Capitalized Contract Cost, Net Gross Amount Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Weighted-Average Amortization Period Finite-Lived Intangible Assets, Remaining Amortization Period Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] 2018 Convertible Notes potential make-whole shares Two Thousand And Eighteen Convertible Notes Potential Make Whole Shares [Member] Two Thousand And Eighteen Convertible Notes Potential Make Whole Shares [Member] 2014 Convertible Notes Two Thousand And Fourteen Convertible Notes [Member] Two Thousand And Fourteen Convertible Notes [Member] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock options, restricted stock units and performance awards Convertible Notes Convertible Debt Securities [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive securities excluded from computations of net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Instruments Instruments [Member] Instruments [Member] Consumables Consumables [Member] Consumables [Member] Product revenue Services License Americas Americas [Member] EMEA Asia-Pacific Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Short-term investments Short-term Investments Accounts receivable (net of allowances of $126 and $391, at December 31, 2018 and 2017, respectively) Accounts Receivable, Net, Current Inventories Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net Other non-current assets Other Assets, Noncurrent Developed technology, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued compensation and related benefits Employee-related Liabilities, Current Other accrued liabilities Accrued Liabilities, Current Deferred revenue, current Contract with Customer, Liability, Current Total current liabilities Liabilities, Current Convertible notes, net Convertible Notes Payable, Noncurrent Deferred tax liability Deferred Income Tax Liabilities, Net Deferred revenue, non-current Contract with Customer, Liability, Noncurrent Other non-current liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either December 31, 2018 or 2017 Preferred Stock, Value, Issued Common stock: $0.001 par value, 200,000 shares authorized at December 31, 2018 and 2017; 49,338 and 38,787 shares issued and outstanding at December 31, 2018 and 2017, respectively Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated deficit Retained Earnings (Accumulated Deficit) Total stockholders’ equity Total liabilities and stockholders’ equity Liabilities and Equity Prepaid expenses and other current assets Total current assets Other non-current assets Total assets Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Number of investment in unrealized loss positions Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Financial Instrument [Axis] Financial Instrument [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Cash Cash [Member] Money market funds Money Market Funds [Member] U.S. treasury securities US Treasury Securities [Member] U.S. government and agency securities US Treasury and Government [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Level I Fair Value, Inputs, Level 1 [Member] Level II Fair Value, Inputs, Level 2 [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Carrying Amount Debt Securities, Available-for-sale, Amortized Cost Gross Unrealized Gain Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Loss Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Fair Value Investments, Fair Value Disclosure Cash and Cash Equivalents Cash and Cash Equivalents, Fair Value Disclosure Short-Term Marketable Securities Valuation Allowance, Deferred Tax Asset SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Valuation Allowances [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Beginning Balance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Charges to earnings SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Charges to other accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Ending Balance Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] DVS Sciences, Inc. DVS Sciences, Inc. [Member] DVS Sciences, Inc. [Member] Business combination, preliminary goodwill Goodwill, Preliminary Goodwill, Preliminary Schedule Of Significant Accounting Policies [Table] Schedule Of Significant Accounting Policies [Table] Schedule Of Significant Accounting Policies [Table] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Scenario, Forecast Scenario, Forecast [Member] Accounting Standards Update 2016-02 Accounting Standards Update 2016-02 [Member] Office furniture and fixtures Furniture and Fixtures [Member] Schedule Of Significant Accounting Policies [Line Items] Schedule Of Significant Accounting Policies [Line Items] Schedule Of Significant Accounting Policies [Line Items] Product warranty term Product Warranty Term Product Warranty Term Terms of payment period Revenue From Contract With Customer, Terms Of Payment Period Revenue From Contract With Customer, Terms Of Payment Period Performance obligation period Revenue From Contract With Customer, Performance Obligation Period Revenue From Contract With Customer, Performance Obligation Period Property and equipment, estimated useful lives Property, Plant and Equipment, Useful Life Depreciation Depreciation Embedded conversion option value Debt Instrument, Embedded Conversion Option Value Debt Instrument, Embedded Conversion Option Value Advertising costs incurred Advertising Expense Total current assets Total noncurrent assets Assets, Noncurrent Operating lease, liability Operating Lease, Liability Operating lease, right-of-use asset Operating Lease, Right-of-Use Asset Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Federal Current Federal Tax Expense (Benefit) State Current State and Local Tax Expense (Benefit) Foreign Current Foreign Tax Expense (Benefit) Total current tax (expense) benefit Current Income Tax Expense (Benefit) Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] State Deferred State and Local Income Tax Expense (Benefit) Foreign Deferred Foreign Income Tax Expense (Benefit) Total deferred benefit Deferred Income Tax Expense (Benefit) Total benefit for income taxes Net loss Net Income (Loss) Available to Common Stockholders, Diluted Net loss per share, basic and diluted (usd per share) Stock-Based Plans Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Quarterly Results of Operations (Unaudited) Quarterly Financial Information [Text Block] Summary of cash and cash equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Inventories Schedule of Inventory, Current [Table Text Block] Property and equipment Property, Plant and Equipment [Table Text Block] Activity of warranty accrual Schedule of Product Warranty Liability [Table Text Block] Vesting [Axis] Vesting [Axis] Vesting [Domain] Vesting [Domain] Share-based Compensation Award, Tranche One Share-based Compensation Award, Tranche One [Member] Share-based Compensation Award, Tranche Two Share-based Compensation Award, Tranche Two [Member] Share-based Compensation Award, Tranche Three Share-based Compensation Award, Tranche Three [Member] Share-based Compensation Award, Tranche Four Share-based Compensation Award, Tranche Four [Member] Share-based Compensation Award, Tranche Four [Member] 2011 Equity Incentive Plan Equity Incentive Plan Twenty Eleven [Member] Equity Incentive Plan Twenty Eleven [Member] 2017 Inducement Award Plan 2017 Inducement Award Plan [Member] 2017 Inducement Award Plan [Member] Equity Incentive Plan Equity Incentive Plan [Member] Equity Incentive Plan [Member] The Program The Program [Member] The Program [Member] Vesting Scenario One Vesting Scenario One [Member] Vesting Scenario One [Member] Vesting Scenario Two Vesting Scenario Two [Member] Vesting Scenario Two [Member] Stock Options, Vesting One Stock Options Vesting One [Member] Stock Options, Vesting One [Member] Stock Options, Vesting Two Stock Options Vesting Two [Member] Stock Options, Vesting Two [Member] Performance-Based Stock Options Performance-Based Stock Options [Member] Performance-Based Stock Options [Member] Performance-Based Restricted Stock Options Performance-Based Restricted Stock Options [Member] Performance-Based Restricted Stock Options [Member] Award vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Award vesting percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Stock option grants exercise price minimum percentage on fair market value Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value Percentage of voting power which impacts the term of equity incentive plan Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock Rate at which outstanding options vest on the first anniversary of the option grant date Portion Of Stock Options Vest On First Anniversary Portion Of Stock Options Vest On First Anniversary Number of months over which options vest ratably Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement Awards authorized for issuance (shares) Aggregate intrinsic value, vested and released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Total unrecognized compensation cost related to stock-based compensation arrangements Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted average remaining contractual terms Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Percentage of eligible employee bonus program Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Percentage Of Eligible Cash Bonus To Be Exchanged Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Percentage Of Eligible Cash Bonus To Be Exchanged Percentage of shares to be exchanged on closing date or commencement date Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Shares To Be Exchanged On Closing Date Or Commencement Date Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Percentage Of Shares To be Exchanged On Closing Date Or Commencement Date Total intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Percentage of performance period Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest Stock option weighted-average fair value per share (usd per share) Maximum employee subscription rate Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate Maximum employee purchase amount Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount Purchase price of common stock, percent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic International Income (Loss) from Continuing Operations before Income Taxes, Foreign EX-101.PRE 12 fldm-20181231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 chart-46e59a14696d2292a72.jpg begin 644 chart-46e59a14696d2292a72.jpg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end GRAPHIC 14 exhibit1018image1.jpg begin 644 exhibit1018image1.jpg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fye2018form10-k_htm.xml IDEA: XBRL DOCUMENT 0001162194 2018-01-01 2018-12-31 0001162194 2018-06-30 0001162194 2019-03-13 0001162194 2018-12-31 0001162194 2017-12-31 0001162194 us-gaap:ServiceMember 2017-01-01 2017-12-31 0001162194 2017-01-01 2017-12-31 0001162194 us-gaap:ProductMember 2018-01-01 2018-12-31 0001162194 us-gaap:ServiceMember 2018-01-01 2018-12-31 0001162194 2016-01-01 2016-12-31 0001162194 us-gaap:ProductMember 2017-01-01 2017-12-31 0001162194 us-gaap:ProductMember 2016-01-01 2016-12-31 0001162194 us-gaap:LicenseMember 2017-01-01 2017-12-31 0001162194 us-gaap:LicenseMember 2016-01-01 2016-12-31 0001162194 us-gaap:ServiceMember 2016-01-01 2016-12-31 0001162194 us-gaap:LicenseMember 2018-01-01 2018-12-31 0001162194 us-gaap:RetainedEarningsMember 2016-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001162194 us-gaap:RetainedEarningsMember 2018-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001162194 us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001162194 us-gaap:CommonStockMember 2016-01-01 2016-12-31 0001162194 us-gaap:RetainedEarningsMember 2017-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001162194 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001162194 us-gaap:CommonStockMember 2016-12-31 0001162194 us-gaap:CommonStockMember 2017-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0001162194 us-gaap:CommonStockMember 2015-12-31 0001162194 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001162194 us-gaap:AccountingStandardsUpdate201609Member us-gaap:RetainedEarningsMember 2017-01-01 0001162194 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 0001162194 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001162194 us-gaap:RetainedEarningsMember 2015-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001162194 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2018-01-01 0001162194 2016-12-31 0001162194 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-12-31 0001162194 us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001162194 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0001162194 us-gaap:AccountingStandardsUpdate201609Member 2017-01-01 0001162194 us-gaap:CommonStockMember 2018-12-31 0001162194 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001162194 2015-12-31 0001162194 us-gaap:AccountingStandardsUpdate201609Member us-gaap:AdditionalPaidInCapitalMember 2017-01-01 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndFourteenConvertibleNotesMember 2016-01-01 2016-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndFourteenConvertibleNotesMember 2018-01-01 2018-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesPotentialMakeWholeSharesMember 2017-01-01 2017-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesPotentialMakeWholeSharesMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesPotentialMakeWholeSharesMember 2016-01-01 2016-12-31 0001162194 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndFourteenConvertibleNotesMember 2017-01-01 2017-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesMember 2016-01-01 2016-12-31 0001162194 us-gaap:ConvertibleDebtSecuritiesMember fldm:TwoThousandAndEighteenConvertibleNotesMember 2017-01-01 2017-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 2017-12-31 0001162194 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0001162194 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-12-31 0001162194 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2017-12-31 0001162194 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 0001162194 2018-01-01 0001162194 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-12-31 0001162194 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-12-31 0001162194 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-12-31 0001162194 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-12-31 0001162194 srt:MaximumMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:ScenarioForecastMember 2019-01-01 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2018-03-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-28 0001162194 srt:MinimumMember us-gaap:AccountingStandardsUpdate201602Member us-gaap:ScenarioForecastMember 2019-01-01 0001162194 us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 srt:MinimumMember fldm:LaboratoryAndProductionEquipmentMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:LaboratoryAndProductionEquipmentMember 2018-01-01 2018-12-31 0001162194 srt:MinimumMember fldm:CommissionCostsMember 2018-01-01 2018-12-31 0001162194 us-gaap:ProductMember srt:MaximumMember 2018-01-01 2018-12-31 0001162194 us-gaap:FurnitureAndFixturesMember 2018-01-01 2018-12-31 0001162194 us-gaap:ProductMember srt:MinimumMember 2018-01-01 2018-12-31 0001162194 us-gaap:ServiceMember srt:MaximumMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:CommissionCostsMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:ComputerEquipmentAndSoftwareMember 2018-01-01 2018-12-31 0001162194 srt:MinimumMember fldm:ComputerEquipmentAndSoftwareMember 2018-01-01 2018-12-31 0001162194 2019-01-01 2018-12-31 0001162194 2020-01-01 2018-12-31 0001162194 2022-01-01 2018-12-31 0001162194 2021-01-01 2018-12-31 0001162194 srt:AsiaPacificMember 2017-01-01 2017-12-31 0001162194 srt:AmericasMember 2017-01-01 2017-12-31 0001162194 srt:AmericasMember 2018-01-01 2018-12-31 0001162194 us-gaap:EMEAMember 2018-01-01 2018-12-31 0001162194 srt:AsiaPacificMember 2016-01-01 2016-12-31 0001162194 srt:AsiaPacificMember 2018-01-01 2018-12-31 0001162194 us-gaap:EMEAMember 2016-01-01 2016-12-31 0001162194 us-gaap:EMEAMember 2017-01-01 2017-12-31 0001162194 srt:AmericasMember 2016-01-01 2016-12-31 0001162194 fldm:ConsumablesMember 2016-01-01 2016-12-31 0001162194 fldm:ConsumablesMember 2018-01-01 2018-12-31 0001162194 fldm:InstrumentsMember 2018-01-01 2018-12-31 0001162194 fldm:ConsumablesMember 2017-01-01 2017-12-31 0001162194 fldm:InstrumentsMember 2016-01-01 2016-12-31 0001162194 fldm:InstrumentsMember 2017-01-01 2017-12-31 0001162194 fldm:CommissionCostsMember 2018-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2018-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2018-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2016-01-01 2016-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2017-01-01 2017-12-31 0001162194 fldm:DVSSciencesInc.Member 2014-02-28 0001162194 us-gaap:DevelopedTechnologyRightsMember 2018-01-01 2018-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2018-01-01 2018-12-31 0001162194 us-gaap:DevelopedTechnologyRightsMember 2017-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2017-12-31 0001162194 fldm:PatentsandLicenseAgreementsMember 2017-01-01 2017-12-31 0001162194 us-gaap:OfficeEquipmentMember 2017-12-31 0001162194 us-gaap:OfficeEquipmentMember 2018-12-31 0001162194 fldm:ComputerEquipmentAndSoftwareMember 2018-12-31 0001162194 fldm:LaboratoryAndProductionEquipmentMember 2017-12-31 0001162194 fldm:ComputerEquipmentAndSoftwareMember 2017-12-31 0001162194 fldm:LaboratoryAndProductionEquipmentMember 2018-12-31 0001162194 us-gaap:LeaseholdImprovementsMember 2017-12-31 0001162194 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember 2018-03-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-01 2014-02-28 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-04 0001162194 us-gaap:RevolvingCreditFacilityMember 2018-08-02 2018-08-02 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2014-02-04 2014-02-04 0001162194 us-gaap:RevolvingCreditFacilityMember 2018-08-02 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember 2018-03-01 2018-03-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:ConvertibleDebtMember 2014-02-04 2014-02-04 0001162194 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember 2018-08-02 2018-08-02 0001162194 us-gaap:RevolvingCreditFacilityMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:ConvertibleDebtMember 2014-02-04 2014-02-04 0001162194 us-gaap:RevolvingCreditFacilityMember fldm:LoanAgreementOnOrAfterAugust22019Member 2018-08-02 2018-08-02 0001162194 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember 2018-08-02 2018-08-02 0001162194 us-gaap:RevolvingCreditFacilityMember fldm:LoanAgreementPriorToAugust22019Member 2018-08-02 2018-08-02 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:ConvertibleDebtMember 2014-02-04 2014-02-04 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleNotesPayableMember 2018-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleNotesPayableMember 2017-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleNotesPayableMember 2017-12-31 0001162194 us-gaap:ConvertibleNotesPayableMember 2017-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleNotesPayableMember 2018-12-31 0001162194 us-gaap:ConvertibleNotesPayableMember 2018-12-31 0001162194 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2018-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 fldm:SeniorConvertibleNotesdue2034Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 fldm:ExchangeConvertibleSeniorNotesDue2034Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:ConvertibleDebtMember 2017-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2018-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2017-12-31 0001162194 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2017-12-31 0001162194 us-gaap:CashMember 2017-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2018-12-31 0001162194 us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001162194 us-gaap:FairValueInputsLevel1Member us-gaap:USTreasurySecuritiesMember 2017-12-31 0001162194 us-gaap:CashMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndNineEquityIncentivePlanMember 2018-12-31 0001162194 fldm:TwoThousandAndSeventeenInducementAwardPlanMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndTenEquityIncentivePlanMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndElevenEquityIncentivePlanMember 2018-12-31 0001162194 fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2018-12-31 0001162194 fldm:TwoThousandAndTenEquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndElevenEquityIncentivePlanMember 2018-12-31 0001162194 fldm:TwoThousandAndElevenEquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndTenEquityIncentivePlanMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandAndSeventeenInducementAwardPlanMember 2018-12-31 0001162194 fldm:RestrictedStockAndPerformanceShareUnitsMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndNineEquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TwoThousandAndSeventeenInducementAwardPlanMember 2018-12-31 0001162194 fldm:TwoThousandAndNineEquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:CommonStockMember fldm:TwoThousandAndEighteenMarketOfferingMember 2018-12-14 2018-12-14 0001162194 us-gaap:CommonStockMember fldm:TwoThousandAndSeventeenAtTheMarketEquityOfferingProgramMember 2017-08-10 2017-08-10 0001162194 us-gaap:CommonStockMember fldm:TwoThousandAndEighteenMarketOfferingMember 2018-12-14 0001162194 us-gaap:CommonStockMember fldm:TwoThousandAndSeventeenAtTheMarketEquityOfferingProgramMember 2017-08-10 0001162194 2015-01-01 2015-12-31 0001162194 fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockMember 2016-01-01 2016-12-31 0001162194 us-gaap:EmployeeStockMember 2018-01-01 2018-12-31 0001162194 fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2017-01-01 2017-12-31 0001162194 fldm:OptionsAndRestrictedStockUnitsMember 2017-01-01 2017-12-31 0001162194 fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2016-01-01 2016-12-31 0001162194 fldm:OptionsAndRestrictedStockUnitsMember 2018-01-01 2018-12-31 0001162194 fldm:OptionsAndRestrictedStockUnitsMember 2016-01-01 2016-12-31 0001162194 us-gaap:EmployeeStockMember 2017-01-01 2017-12-31 0001162194 us-gaap:PerformanceSharesMember 2018-01-01 2018-03-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TheProgramMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:VestingScenarioTwoMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 us-gaap:EmployeeStockMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2017-08-01 2017-08-01 0001162194 fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 fldm:VestingScenarioTwoMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0001162194 fldm:EquityIncentivePlanMember 2018-01-01 2018-12-31 0001162194 us-gaap:PerformanceSharesMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-01-01 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-12-31 0001162194 fldm:StockOptionsVestingTwoMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 fldm:TheProgramMember 2017-08-23 2017-08-23 0001162194 fldm:StockOptionsVestingOneMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 srt:MinimumMember us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0001162194 us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember 2018-12-31 0001162194 fldm:A2017InducementAwardPlanMember 2017-01-05 0001162194 fldm:VestingScenarioOneMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 fldm:PerformanceBasedRestrictedStockOptionsMember 2016-01-01 2016-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember fldm:SharebasedCompensationAwardTrancheFourMember 2018-01-01 2018-12-31 0001162194 srt:MaximumMember fldm:VestingScenarioOneMember fldm:EquityIncentivePlanTwentyElevenMember 2018-01-01 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001162194 fldm:EquityIncentivePlanMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2018-01-01 2018-12-31 0001162194 fldm:PerformanceBasedStockOptionsMember 2016-01-01 2016-12-31 0001162194 fldm:TheProgramMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TwoThousandAndEighteenRetentionBonusProgramMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2018-01-01 2018-12-31 0001162194 fldm:VestingScenarioTwoMember fldm:EquityIncentivePlanTwentyElevenMember 2018-12-31 0001162194 us-gaap:EmployeeStockMember fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember 2018-12-31 0001162194 us-gaap:EmployeeStockOptionMember fldm:TheProgramMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-12-31 0001162194 fldm:TheProgramMember 2017-09-20 0001162194 us-gaap:RestrictedStockUnitsRSUMember fldm:TheProgramMember 2018-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2015-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2017-12-31 0001162194 us-gaap:RestrictedStockUnitsRSUMember 2016-12-31 0001162194 us-gaap:PerformanceSharesMember 2017-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-01-01 2018-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-01-01 2017-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-01-01 2016-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2015-12-31 0001162194 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001162194 us-gaap:DomesticCountryMember fldm:ExpiringIn2021Member 2018-12-31 0001162194 stpr:CA us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2018-12-31 0001162194 us-gaap:StateAndLocalJurisdictionMember fldm:ExpiringIn2028Through2039Member 2018-12-31 0001162194 us-gaap:DomesticCountryMember 2018-12-31 0001162194 us-gaap:DomesticCountryMember us-gaap:ResearchMember fldm:ExpiringIn2021Through2039Member 2018-12-31 0001162194 us-gaap:ForeignCountryMember fldm:ExpiringIn2019Through2027Member 2018-12-31 0001162194 srt:MaximumMember 2018-01-01 2018-12-31 0001162194 srt:AsiaPacificMember 2017-12-31 0001162194 us-gaap:EMEAMember 2018-12-31 0001162194 country:CA 2017-12-31 0001162194 country:SG 2017-12-31 0001162194 country:US 2017-12-31 0001162194 country:CA 2018-12-31 0001162194 srt:AsiaPacificMember 2018-12-31 0001162194 us-gaap:EMEAMember 2017-12-31 0001162194 country:US 2018-12-31 0001162194 country:SG 2018-12-31 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember 2017-01-01 2017-12-31 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember 2016-01-01 2016-12-31 0001162194 country:CN us-gaap:RevenueFromContractWithCustomerMember 2017-01-01 2017-12-31 0001162194 country:US us-gaap:RevenueFromContractWithCustomerMember 2018-01-01 2018-12-31 0001162194 country:CN us-gaap:RevenueFromContractWithCustomerMember 2018-01-01 2018-12-31 0001162194 country:CN us-gaap:RevenueFromContractWithCustomerMember 2016-01-01 2016-12-31 0001162194 fldm:ThermoMember 2017-08-01 2017-08-30 0001162194 fldm:ThermoMember 2017-07-01 2017-07-31 0001162194 fldm:RansomwareAttackMember us-gaap:SubsequentEventMember 2019-03-12 0001162194 2018-01-01 2018-03-31 0001162194 2018-04-01 2018-06-30 0001162194 2017-01-01 2017-03-31 0001162194 2017-07-01 2017-09-30 0001162194 2018-07-01 2018-09-30 0001162194 2018-10-01 2018-12-31 0001162194 2017-04-01 2017-06-30 0001162194 2017-10-01 2017-12-31 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2019-01-09 2019-02-27 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2019-02-27 0001162194 fldm:TwoThousandAndEighteenConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2019-03-01 2019-03-18 0001162194 us-gaap:WarrantyReservesMember 2017-01-01 2017-12-31 0001162194 us-gaap:WarrantyReservesMember 2018-12-31 0001162194 us-gaap:WarrantyReservesMember 2016-12-31 0001162194 us-gaap:WarrantyReservesMember 2015-12-31 0001162194 us-gaap:WarrantyReservesMember 2018-01-01 2018-12-31 0001162194 us-gaap:WarrantyReservesMember 2016-01-01 2016-12-31 0001162194 us-gaap:WarrantyReservesMember 2017-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2016-01-01 2016-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2017-01-01 2017-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2018-01-01 2018-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2017-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2018-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2016-12-31 0001162194 us-gaap:AllowanceForCreditLossMember 2015-12-31 shares iso4217:USD shares iso4217:USD fldm:investment pure fldm:segment false --12-31 FY 2018 2018-12-31 10-K 0001162194 Yes false Accelerated Filer FLUIDIGM CORP false true No Yes FLDM P1Y P3Y P3Y P1Y P60D P30D 391000 126000 0.001 0.001 200000000 200000000 38787000 49338000 38787000 49338000 0.11 0.001 0.001 10000000 10000000 0 0 0 0 P4Y P5Y P3Y P2Y P5Y 11100000 P1Y P1Y P1Y P3Y P4Y 151752358 68989239 95401000 58056000 0 5080000 16651000 15049000 13003000 15088000 2051000 1528000 127106000 94801000 8825000 12301000 6208000 7541000 57400000 68600000 104108000 104108000 303647000 287351000 4027000 4211000 14470000 10535000 7621000 8490000 11464000 10238000 37582000 33474000 172058000 195238000 13714000 16919000 6327000 4960000 1850000 5825000 231531000 256416000 0 0 49000 39000 631605000 531666000 -687000 -574000 -558851000 -500196000 72116000 30935000 303647000 287351000 93650000 84399000 89003000 19314000 17348000 15205000 0 190000 238000 112964000 101937000 104446000 44861000 45039000 41110000 6454000 4916000 4899000 51315000 49955000 46009000 61649000 51982000 58437000 30030000 30826000 38415000 79783000 79516000 93212000 109813000 110342000 131627000 -48164000 -58360000 -73190000 13893000 5824000 5820000 637000 385000 -1167000 -61420000 -63799000 -80177000 -2407000 -3264000 -4192000 -59013000 -60535000 -75985000 -1.49 -1.84 -2.62 39652000 32980000 29008000 -59013000 -60535000 -75985000 -112000 183000 314000 -1000 3000 70000 -113000 186000 384000 -59126000 -60349000 -75601000 28844000 29000 479508000 -1144000 -363492000 114901000 307000 -152000 -152000 57000 227000 227000 13858000 13858000 -75985000 -75985000 384000 384000 29208000 29000 493441000 -760000 -439477000 53233000 9091000 9000 28793000 28802000 413000 1000 -166000 -165000 25000 100000 100000 50000 222000 222000 184000 -184000 0 9092000 9092000 -60535000 -60535000 186000 186000 38787000 39000 531666000 -574000 -500196000 30935000 9373000 9000 59084000 59093000 886000 1000 -379000 -378000 40000 208000 208000 252000 1203000 1203000 29357000 29357000 557000 557000 358000 358000 11023000 11023000 -59013000 -59013000 -113000 -113000 49338000 49000 631605000 -687000 -558851000 72116000 -59013000 -60535000 -75985000 5372000 7409000 6738000 11023000 9092000 13858000 11200000 11200000 11200000 8379000 287000 278000 175000 -890000 -26000 -141000 -135000 -87000 1788000 554000 -10521000 -1488000 -4596000 3387000 -178000 -1583000 457000 -294000 585000 -2271000 2574000 1636000 -274000 -4636000 1358000 580000 -25201000 -24098000 -39138000 1450000 6276000 38594000 6541000 25550000 86431000 0 0 2330000 0 50000 0 372000 1566000 5065000 4719000 17658000 45102000 2862000 0 0 59469000 28793000 0 208000 100000 227000 1203000 222000 0 358000 118000 111000 57660000 28997000 116000 167000 454000 -152000 37345000 23011000 5928000 58056000 35045000 29117000 95401000 58056000 35045000 5534000 5534000 5534000 321000 245000 355000 Description of Business<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fluidigm Corporation (we, our, or us) was incorporated in the State of California in May 1999 to commercialize microfluidic technology initially developed at the California Institute of Technology. In July 2007, we were reincorporated in Delaware. Our headquarters are located in South San Francisco, California.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>We create, manufacture, and market innovative technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including IFCs, assays, and reagents. Our focus is on the most pressing needs in translational and clinical research, including cancer, immunology and immunotherapy. We use proprietary CyTOF® and microfluidics technologies to develop innovative end-to-end solutions that have the flexibility required to meet the needs of translational research and the robustness to support high-impact clinical research studies. We sell our instruments to leading academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, and biopharmaceutical, biotechnology and Ag-Bio companies. Summary of Significant Accounting Policies<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation and Consolidation</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly-owned subsidiaries. As of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we had wholly-owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, and Germany. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Certain prior period amounts in the consolidated statements of stockholders’ equity and consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders' equity, total revenue, total costs and expenses, loss from operations or net loss.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Foreign Currency</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year. </span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue Recognition</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Revenue</span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in </span><span style="font-family:inherit;font-size:10pt;">30</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;">60</span><span style="font-family:inherit;font-size:10pt;"> days.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Service Revenue</span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize revenue from repairs, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed.</span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;">three years</span><span style="font-family:inherit;font-size:10pt;">. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our consolidated balance sheet as deferred revenue.</span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contract Costs</span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally one to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;"> year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Warranties</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the consolidated statements of operations.</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Significant Judgments</span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash and Cash Equivalents</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We consider all highly liquid financial instruments with maturities at the time of purchase of three months or less to be cash equivalents. Cash and cash equivalents may consist of cash on deposit with banks, money market funds, and notes from government-sponsored agencies.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Investments</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Short-term investments are comprised of notes from government-sponsored agencies. All investments are recorded at estimated fair value. Any unrealized gains and losses from investments are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity. We evaluate our investments to assess whether investments with unrealized loss positions are other-than-temporarily impaired. An investment is considered to be other-than-temporarily impaired if the impairment is related to deterioration in credit risk or if it is likely that we will sell the securities before the recovery of their cost basis. No investment has been assessed as other than temporarily impaired, and realized gains and losses were immaterial during the years presented. The cost of securities sold, or the amount reclassified out of accumulated other comprehensive income into earnings is based on the specific-identification method.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounts Receivable</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Business and Credit Risk</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. </span><span style="font-family:inherit;font-size:10pt;">No</span><span style="font-family:inherit;font-size:10pt;"> single customer represented more than </span><span style="font-family:inherit;font-size:10pt;">10%</span><span style="font-family:inherit;font-size:10pt;"> of total revenue for </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, or </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">no</span><span style="font-family:inherit;font-size:10pt;"> single customer represented more than </span><span style="font-family:inherit;font-size:10pt;">10%</span><span style="font-family:inherit;font-size:10pt;"> of total accounts receivable at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, or </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories </span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory costs include direct materials, direct labor, and normal manufacturing overhead. Finished goods that are used for research and development are expensed as consumed or depreciated over their period of use. Provisions for slow-moving, excess, and obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values based on product life cycle, development plans, product expiration, and quality issues.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Property and Equipment </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment, including leasehold improvements, are stated at cost less accumulated depreciation. Accumulated depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets or the remaining term of the lease, whichever is shorter. The estimated useful lives of our property and equipment are generally as follows: computer </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">equipment and software, three to four years; laboratory and manufacturing equipment, two to five years; and office furniture and fixtures, five years.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$4.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$5.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$5.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill, Intangible Assets and Other Long-Lived Assets</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. We first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we then conduct a two-step test for impairment of goodwill. In the first step, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceed its fair value, then the second step of the impairment test must be performed in order to determine the implied fair value of the goodwill. If the carrying value of the goodwill exceeds its implied fair value, then an impairment loss equal to the difference would be recorded.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset, and adjust the carrying value of the asset accordingly. We did not recognize any impairment of long-lived assets for any of the periods presented herein.</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Notes</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2014, we closed an underwritten public offering </span><span style="font-family:inherit;font-size:10pt;"><span>$201.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of our </span><span style="font-family:inherit;font-size:10pt;"><span>2.75%</span></span><span style="font-family:inherit;font-size:10pt;"> Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange </span><span style="font-family:inherit;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of the 2014 Notes for our new </span><span style="font-family:inherit;font-size:10pt;"><span>2.75%</span></span><span style="font-family:inherit;font-size:10pt;"> Exchange Convertible Senior Notes due 2034 (2018 Notes). Following the exchange, approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$51.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of the 2014 Notes remained outstanding in addition to </span><span style="font-family:inherit;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of the 2018 Notes. </span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As the 2018 Notes are convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. The embedded conversion option value was calculated as the difference between (i) the total fair value of the 2018 Notes and (ii) the fair value of a similar debt instrument excluding the embedded conversion option. We determined an embedded conversion option value of </span><span style="font-family:inherit;font-size:10pt;"><span>$29.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, which was recorded in additional paid-in-capital and reduced the carrying value of the 2018 Notes. The resulting discount on the 2018 Notes will be amortized over the expected term of the 2018 Notes, using the effective interest method through the first note holder put date, of February 6, 2023.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For both the 2014 Notes and 2018 Notes, offering-related costs, including underwriting costs are capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are being be amortized over the expected term of the related Notes using the effective interest method.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value of Financial Instruments </span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our financial instruments consist primarily of cash and cash equivalents, investments, accounts receivable, accounts payable, and convertible notes. Our cash equivalents, investments, accounts receivable, and accounts payable have short maturity or payment periods. Accordingly, their carrying values approximated their fair values at December 31, 2018 and 2017. The convertible notes are presented at their carrying value, with fair value disclosures made in Note 7. As a basis for considering fair value, we follow a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level I: observable inputs such as quoted prices in active markets;</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level II: inputs other than quoted prices in active markets that are observable either directly or indirectly; and</span></div><div style="line-height:120%;text-align:left;padding-left:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level III: unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions.</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">This hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. Our cash equivalents, which include money market funds, are classified as Level I because they are valued using quoted market prices. Our investments and convertible notes are generally classified as Level II because their value is based on valuations using significant inputs derived from or corroborated by observable market data. Depending on the security, the income and market approaches are used in the model driven valuations. Inputs of these models include recently executed transaction prices in securities of the issuer or comparable issuers and yield curves.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Research and Development</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize research and development expenses in the period incurred. Research and development expenses consist of personnel costs, independent contractor costs, prototype and materials expenses, allocated facilities and information technology expenses, and related overhead expenses.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Advertising Costs</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expense advertising costs as incurred. We incurred advertising costs of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$1.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$2.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> during </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We use the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a “more likely than not” criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. Any interest and penalties related to uncertain tax positions are reflected in the income tax provision.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-Based Compensation</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We account for stock options and restricted stock units granted to employees and directors and stock purchases under ESPP based on the fair value of the awards. We recognize stock-based compensation expense on a straight-line basis over the requisite service periods for non-performance-based awards. For performance-based stock awards, stock-based compensation expense is recognized over the requisite service period when the achievement of each individual performance goal becomes probable. </span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:8pt;"> </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Comprehensive Loss</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the consolidated statements of comprehensive loss.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The components of accumulated other comprehensive loss, net of tax, for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> are as follows (in thousands): </span></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustment</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain (Loss) on Investments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Other Comprehensive Income (Loss)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(758</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(760</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change during the year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>183</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>186</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(575</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(574</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change during the year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(112</span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(113</span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(687</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(687</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Immaterial amounts of unrealized gains and losses have been reclassified into the consolidated statement of operations for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Loss per Share </span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units and options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands): </span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options, restricted stock units and performance awards</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,354</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,501</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,622</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Convertible Notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,035</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Convertible Notes potential make-whole shares</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>757</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2014 Convertible Notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>916</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,598</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,598</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,062</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,099</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,220</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Accounting Changes and Accounting Pronouncements</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Adoption of New Accounting Guidance </span></div><div style="line-height:120%;text-align:left;text-indent:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers (Topic 606). Topic 606 and its related amendments supersede Revenue Recognition (Topic 605), issued in June 2010, and provide principles for recognizing revenue for goods and services in a manner consistent with the transfer of control of those goods and services to the customer.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted Topic 606 on January 1, 2018, using the modified retrospective method applied to those contracts with unrecognized revenue on the adoption date. We recognized the effect of applying the new revenue standard by recording a cumulative catch-up adjustment that reduced the accumulated deficit component of stockholders’ equity by </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and increased current assets by </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> and non-current assets by </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:inherit;font-size:10pt;">. The adjustment capitalized certain sales commission costs that were incurred to obtain instrument service contracts. Under Topic 605, we accounted for these incremental contract acquisition costs by recognizing them as expense at the point the contract was awarded. Under Topic 606, the costs are capitalized and amortized to expense over the life of the contract, which is generally one to three years. The comparative information for periods prior to January 1, 2018, has not been restated and continues to be reported in accordance with Topic 605.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the cumulative effect of adopting Topic 606 on amounts previously reported in our consolidated balance sheet at December 31, 2017 (in thousands): </span></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Topic 606 Transition Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at January 1, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,528</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>153</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,681</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94,801</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>153</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94,954</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,541</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>205</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,746</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,351</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,709</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated deficit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(500,196</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(499,838</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders' equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30,935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31,293</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,351</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,709</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the impacts on our consolidated statements of operations of adopting Topic 606 compared to Topic 605 for the twelve months ended December 31, 2018 (in thousands):</span></div><div style="line-height:120%;padding-bottom:9px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Reported</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Without Adoption of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> Topic 606</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect of Change</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79,783</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79,859</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total costs and expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161,128</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161,204</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss from operations</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48,164</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48,240</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss before income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61,420</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61,496</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59,013</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59,089</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:174%;padding-top:4px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the impacts on our consolidated balance sheets of adopting Topic 606 compared to Topic 605 at December 31, 2018 (in thousands):</span></div><div style="line-height:120%;padding-bottom:9px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Reported</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Without Adoption of </span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Topic 606</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect of Change</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,051</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,884</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>127,106</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>126,939</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,208</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,941</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>267</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>434</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stockholders' equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72,116</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71,682</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>434</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>434</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. This ASU allows SEC reporting companies to record provisional amounts in earnings for the year ended December 31, 2017, due to the complexities involved in accounting for the enactment of the Tax Act. We recognized the estimated income tax effects of the Tax Act in its 2017 Consolidated Financial Statements in accordance with SEC Staff Accounting Bulletin No. 118 (“SAB No. 118”). In accordance with SAB No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense was required. Refer to Note 10 for further information regarding the provisional amounts recorded by the Company.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This ASU amends the reporting of comprehensive income to allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act (the Tax Act). The Tax Act was enacted in December 2017 and reduced the U.S federal corporate income tax rate and made other changes to U.S. federal tax law. ASU 2018-02 is effective for our fiscal year beginning January 1, 2019, and early adoption is permitted. This standard did not have a material effect on our consolidated financial statements. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU 2016-15 Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The ASU addresses eight specific cash flow issues and their presentation within the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In November 2016, the FASB issued ASU 2016-18 Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB’s Emerging Issues Task Force, amending the presentation of restricted cash within the statement of cash flows. The new guidance requires that restricted cash be included within cash and cash equivalents on the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements</span></div><div style="line-height:120%;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-15 Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact of adoption on our consolidated financial statements.</span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB established Topic 842, Leases, by issuing Accounting Standards Update (ASU) No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating; the classification will impact the expense recognition in the income statement.</span></div><div style="line-height:120%;text-align:left;text-indent:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Modified Retrospective Transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. We expect to adopt the new standard on January 1, 2019 and use the effective date as our date of initial application. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. For dates and periods prior to January 1, 2019, the original disclosures under ASC 840 will be disclosed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The new standard provides several optional practical expedients in transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. We do not expect to elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us. </span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expect that this standard will have a material effect on our financial statements. While we continue to assess all the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our building, vehicle and equipment leases. </span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On adoption, we currently expect to recognize </span><span style="font-family:inherit;font-size:10pt;"><span>$8.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>$11.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of additional operating liabilities, based on the present value of the remaining fixed rental payments under current leasing standards for existing operating leases, with corresponding ROU assets of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$6.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>$9.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The difference between the initial lease liability and right of use asset is attributable to deferred rent. We do not expect any impact on retained earnings from the adoption of ASC 842. </span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The new standard also provides certain accounting elections for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities. We also currently expect to elect to not separate lease and nonlease components for our building leases and to take a portfolio approach for our vehicles leases by country. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU will be effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020, with early adoption permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements. Basis of Presentation and Consolidation<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly-owned subsidiaries. As of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we had wholly-owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, and Germany. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Certain prior period amounts in the consolidated statements of stockholders’ equity and consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders' equity, total revenue, total costs and expenses, loss from operations or net loss.</span></div><br/> Use of Estimates<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><br/> Foreign Currency<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year. Revenue Recognition<div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Revenue</span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in </span><span style="font-family:inherit;font-size:10pt;">30</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;">60</span><span style="font-family:inherit;font-size:10pt;"> days.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Service Revenue</span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We recognize revenue from repairs, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed.</span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;">three years</span><span style="font-family:inherit;font-size:10pt;">. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our consolidated balance sheet as deferred revenue.</span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contract Costs</span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally one to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than </span><span style="font-family:inherit;font-size:10pt;">one</span><span style="font-family:inherit;font-size:10pt;"> year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Warranties</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the consolidated statements of operations.</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Significant Judgments</span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition. Cash and Cash Equivalents<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>We consider all highly liquid financial instruments with maturities at the time of purchase of three months or less to be cash equivalents. Cash and cash equivalents may consist of cash on deposit with banks, money market funds, and notes from government-sponsored agencies. Investments<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>Short-term investments are comprised of notes from government-sponsored agencies. All investments are recorded at estimated fair value. Any unrealized gains and losses from investments are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity. We evaluate our investments to assess whether investments with unrealized loss positions are other-than-temporarily impaired. An investment is considered to be other-than-temporarily impaired if the impairment is related to deterioration in credit risk or if it is likely that we will sell the securities before the recovery of their cost basis. No investment has been assessed as other than temporarily impaired, and realized gains and losses were immaterial during the years presented. The cost of securities sold, or the amount reclassified out of accumulated other comprehensive income into earnings is based on the specific-identification method. Accounts Receivable<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed. Concentrations of Business and Credit Risk<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. </span><span style="font-family:inherit;font-size:10pt;">No</span><span style="font-family:inherit;font-size:10pt;"> single customer represented more than </span><span style="font-family:inherit;font-size:10pt;">10%</span><span style="font-family:inherit;font-size:10pt;"> of total revenue for </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, or </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">no</span><span style="font-family:inherit;font-size:10pt;"> single customer represented more than </span><span style="font-family:inherit;font-size:10pt;">10%</span><span style="font-family:inherit;font-size:10pt;"> of total accounts receivable at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, or </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components. Inventories <div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>Inventories are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory costs include direct materials, direct labor, and normal manufacturing overhead. Finished goods that are used for research and development are expensed as consumed or depreciated over their period of use. Provisions for slow-moving, excess, and obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values based on product life cycle, development plans, product expiration, and quality issues. Property and Equipment <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment, including leasehold improvements, are stated at cost less accumulated depreciation. Accumulated depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets or the remaining term of the lease, whichever is shorter. The estimated useful lives of our property and equipment are generally as follows: computer </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">equipment and software, three to four years; laboratory and manufacturing equipment, two to five years; and office furniture and fixtures, five years.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation expense for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$4.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$5.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$5.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><br/> 4200000 5900000 5100000 Goodwill, Intangible Assets and Other Long-Lived Assets<div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. We first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we then conduct a two-step test for impairment of goodwill. In the first step, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceed its fair value, then the second step of the impairment test must be performed in order to determine the implied fair value of the goodwill. If the carrying value of the goodwill exceeds its implied fair value, then an impairment loss equal to the difference would be recorded.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset, and adjust the carrying value of the asset accordingly. We did not recognize any impairment of long-lived assets for any of the periods presented herein. <br/><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Notes</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2014, we closed an underwritten public offering </span><span style="font-family:inherit;font-size:10pt;"><span>$201.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of our </span><span style="font-family:inherit;font-size:10pt;"><span>2.75%</span></span><span style="font-family:inherit;font-size:10pt;"> Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange </span><span style="font-family:inherit;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of the 2014 Notes for our new </span><span style="font-family:inherit;font-size:10pt;"><span>2.75%</span></span><span style="font-family:inherit;font-size:10pt;"> Exchange Convertible Senior Notes due 2034 (2018 Notes). Following the exchange, approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$51.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of the 2014 Notes remained outstanding in addition to </span><span style="font-family:inherit;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of the 2018 Notes. </span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As the 2018 Notes are convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. The embedded conversion option value was calculated as the difference between (i) the total fair value of the 2018 Notes and (ii) the fair value of a similar debt instrument excluding the embedded conversion option. We determined an embedded conversion option value of </span><span style="font-family:inherit;font-size:10pt;"><span>$29.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, which was recorded in additional paid-in-capital and reduced the carrying value of the 2018 Notes. The resulting discount on the 2018 Notes will be amortized over the expected term of the 2018 Notes, using the effective interest method through the first note holder put date, of February 6, 2023.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For both the 2014 Notes and 2018 Notes, offering-related costs, including underwriting costs are capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are being be amortized over the expected term of the related Notes using the effective interest method.</span></div> 201300000 0.0275 150000000.0 0.0275 51300000 150000000.0 29300000 Fair Value of Financial Instruments <div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our financial instruments consist primarily of cash and cash equivalents, investments, accounts receivable, accounts payable, and convertible notes. Our cash equivalents, investments, accounts receivable, and accounts payable have short maturity or payment periods. Accordingly, their carrying values approximated their fair values at December 31, 2018 and 2017. The convertible notes are presented at their carrying value, with fair value disclosures made in Note 7. As a basis for considering fair value, we follow a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level I: observable inputs such as quoted prices in active markets;</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level II: inputs other than quoted prices in active markets that are observable either directly or indirectly; and</span></div><div style="line-height:120%;text-align:left;padding-left:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level III: unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions.</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>This hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. Our cash equivalents, which include money market funds, are classified as Level I because they are valued using quoted market prices. Our investments and convertible notes are generally classified as Level II because their value is based on valuations using significant inputs derived from or corroborated by observable market data. Depending on the security, the income and market approaches are used in the model driven valuations. Inputs of these models include recently executed transaction prices in securities of the issuer or comparable issuers and yield curves. Research and Development<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>We recognize research and development expenses in the period incurred. Research and development expenses consist of personnel costs, independent contractor costs, prototype and materials expenses, allocated facilities and information technology expenses, and related overhead expenses. Advertising Costs<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>We expense advertising costs as incurred. 2200000 1800000 2300000 Income Taxes<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We use the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a “more likely than not” criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>We recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. Any interest and penalties related to uncertain tax positions are reflected in the income tax provision. Stock-Based Compensation<div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>We account for stock options and restricted stock units granted to employees and directors and stock purchases under ESPP based on the fair value of the awards. We recognize stock-based compensation expense on a straight-line basis over the requisite service periods for non-performance-based awards. For performance-based stock awards, stock-based compensation expense is recognized over the requisite service period when the achievement of each individual performance goal becomes probable.  <span style="font-family:inherit;font-size:10pt;font-weight:bold;">Comprehensive Loss</span><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the consolidated statements of comprehensive loss. The components of accumulated other comprehensive loss, net of tax, for the years ended December 31, <span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> are as follows (in thousands): </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign Currency Translation Adjustment</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain (Loss) on Investments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Other Comprehensive Income (Loss)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(758</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(760</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change during the year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>183</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>186</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(575</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(574</span></span></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change during the year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(112</span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(113</span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(687</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(687</span></span></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div> -758000 -2000 -760000 183000 3000 186000 -575000 1000 -574000 -112000 -1000 -113000 -687000 0 -687000 Net Loss per Share <div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units and options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented. The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands): <div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options, restricted stock units and performance awards</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,354</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,501</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,622</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Convertible Notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,035</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Convertible Notes potential make-whole shares</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>757</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2014 Convertible Notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>916</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,598</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,598</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,062</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,099</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,220</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 4354000 3501000 4622000 19035000 0 0 757000 0 0 916000 3598000 3598000 25062000 7099000 8220000 Recent Accounting Changes and Accounting Pronouncements<div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Adoption of New Accounting Guidance </span></div><div style="line-height:120%;text-align:left;text-indent:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers (Topic 606). Topic 606 and its related amendments supersede Revenue Recognition (Topic 605), issued in June 2010, and provide principles for recognizing revenue for goods and services in a manner consistent with the transfer of control of those goods and services to the customer.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We adopted Topic 606 on January 1, 2018, using the modified retrospective method applied to those contracts with unrecognized revenue on the adoption date. We recognized the effect of applying the new revenue standard by recording a cumulative catch-up adjustment that reduced the accumulated deficit component of stockholders’ equity by </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and increased current assets by </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> and non-current assets by </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:inherit;font-size:10pt;">. The adjustment capitalized certain sales commission costs that were incurred to obtain instrument service contracts. Under Topic 605, we accounted for these incremental contract acquisition costs by recognizing them as expense at the point the contract was awarded. Under Topic 606, the costs are capitalized and amortized to expense over the life of the contract, which is generally one to three years. The comparative information for periods prior to January 1, 2018, has not been restated and continues to be reported in accordance with Topic 605.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the cumulative effect of adopting Topic 606 on amounts previously reported in our consolidated balance sheet at December 31, 2017 (in thousands): </span></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Topic 606 Transition Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at January 1, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,528</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>153</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,681</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94,801</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>153</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94,954</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,541</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>205</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,746</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,351</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,709</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated deficit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(500,196</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(499,838</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders' equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30,935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31,293</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,351</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,709</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the impacts on our consolidated statements of operations of adopting Topic 606 compared to Topic 605 for the twelve months ended December 31, 2018 (in thousands):</span></div><div style="line-height:120%;padding-bottom:9px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Reported</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Without Adoption of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> Topic 606</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect of Change</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79,783</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79,859</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total costs and expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161,128</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161,204</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss from operations</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48,164</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48,240</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss before income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61,420</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61,496</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59,013</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59,089</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:174%;padding-top:4px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the impacts on our consolidated balance sheets of adopting Topic 606 compared to Topic 605 at December 31, 2018 (in thousands):</span></div><div style="line-height:120%;padding-bottom:9px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Reported</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Without Adoption of </span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Topic 606</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect of Change</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,051</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,884</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>127,106</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>126,939</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,208</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,941</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>267</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>434</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stockholders' equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72,116</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71,682</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>434</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>434</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. This ASU allows SEC reporting companies to record provisional amounts in earnings for the year ended December 31, 2017, due to the complexities involved in accounting for the enactment of the Tax Act. We recognized the estimated income tax effects of the Tax Act in its 2017 Consolidated Financial Statements in accordance with SEC Staff Accounting Bulletin No. 118 (“SAB No. 118”). In accordance with SAB No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense was required. Refer to Note 10 for further information regarding the provisional amounts recorded by the Company.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This ASU amends the reporting of comprehensive income to allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act (the Tax Act). The Tax Act was enacted in December 2017 and reduced the U.S federal corporate income tax rate and made other changes to U.S. federal tax law. ASU 2018-02 is effective for our fiscal year beginning January 1, 2019, and early adoption is permitted. This standard did not have a material effect on our consolidated financial statements. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU 2016-15 Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The ASU addresses eight specific cash flow issues and their presentation within the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In November 2016, the FASB issued ASU 2016-18 Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB’s Emerging Issues Task Force, amending the presentation of restricted cash within the statement of cash flows. The new guidance requires that restricted cash be included within cash and cash equivalents on the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements</span></div><div style="line-height:120%;text-align:left;font-size:11pt;"><span style="font-family:inherit;font-size:11pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-15 Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact of adoption on our consolidated financial statements.</span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB established Topic 842, Leases, by issuing Accounting Standards Update (ASU) No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating; the classification will impact the expense recognition in the income statement.</span></div><div style="line-height:120%;text-align:left;text-indent:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> Modified Retrospective Transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. We expect to adopt the new standard on January 1, 2019 and use the effective date as our date of initial application. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. For dates and periods prior to January 1, 2019, the original disclosures under ASC 840 will be disclosed.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The new standard provides several optional practical expedients in transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. We do not expect to elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us. </span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We expect that this standard will have a material effect on our financial statements. While we continue to assess all the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our building, vehicle and equipment leases. </span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On adoption, we currently expect to recognize </span><span style="font-family:inherit;font-size:10pt;"><span>$8.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>$11.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of additional operating liabilities, based on the present value of the remaining fixed rental payments under current leasing standards for existing operating leases, with corresponding ROU assets of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$6.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>$9.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The difference between the initial lease liability and right of use asset is attributable to deferred rent. We do not expect any impact on retained earnings from the adoption of ASC 842. </span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The new standard also provides certain accounting elections for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities. We also currently expect to elect to not separate lease and nonlease components for our building leases and to take a portfolio approach for our vehicles leases by country. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU will be effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020, with early adoption permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements.</span></div> 400000 200000 200000 The following table summarizes the cumulative effect of adopting Topic 606 on amounts previously reported in our consolidated balance sheet at December 31, 2017 (in thousands): <div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Topic 606 Transition Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at January 1, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,528</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>153</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,681</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94,801</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>153</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>94,954</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,541</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>205</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,746</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,351</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,709</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accumulated deficit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(500,196</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(499,838</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stockholders' equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30,935</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31,293</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,351</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>358</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>287,709</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the impacts on our consolidated statements of operations of adopting Topic 606 compared to Topic 605 for the twelve months ended December 31, 2018 (in thousands):</span></div><div style="line-height:120%;padding-bottom:9px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Reported</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Without Adoption of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;"> Topic 606</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect of Change</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Twelve Months Ended December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79,783</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>79,859</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total costs and expenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161,128</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>161,204</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss from operations</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48,164</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(48,240</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss before income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61,420</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61,496</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59,013</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(59,089</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:174%;padding-top:4px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the impacts on our consolidated balance sheets of adopting Topic 606 compared to Topic 605 at December 31, 2018 (in thousands):</span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">As Reported</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Without Adoption of </span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Topic 606</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect of Change</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,051</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,884</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>127,106</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>126,939</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,208</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,941</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>267</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>434</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stockholders' equity</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>72,116</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>71,682</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>434</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>303,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>434</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 1528000 153000 1681000 94801000 153000 94954000 7541000 205000 7746000 287351000 358000 287709000 -500196000 358000 -499838000 30935000 358000 31293000 287351000 358000 287709000 79783000 79859000 -76000 161128000 161204000 -76000 -48164000 -48240000 76000 -61420000 -61496000 76000 -59013000 -59089000 76000 2051000 1884000 167000 127106000 126939000 167000 6208000 5941000 267000 303647000 303213000 434000 72116000 71682000 434000 303647000 303213000 434000 8000000.0 11000000.0 6000000.0 9000000.0 Revenue<div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Disaggregation of Revenue</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents our revenue for the year ended December 31, 2018, 2017, and 2016, respectively, based on geographic area and by products and services (in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographic Markets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Americas</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,172</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,290</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56,229</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EMEA</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,617</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,642</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29,739</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia-Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,175</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,005</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,478</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112,964</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101,937</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>104,446</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Products and Services:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,491</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42,505</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46,834</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Consumables</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41,894</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42,169</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Product revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>93,650</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>84,399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>89,003</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Services </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,314</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,348</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,205</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">License</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>190</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>238</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112,964</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101,937</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>104,446</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Performance Obligations</span></div><div style="line-height:120%;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We reported </span><span style="font-family:inherit;font-size:10pt;"><span>$15.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> of deferred revenue on our December 31, 2017 consolidated balance sheet. During the twelve months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$9.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the opening balance was recognized as revenue and </span><span style="font-family:inherit;font-size:10pt;"><span>$11.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> of net additional advance payments were received from customers, primarily associated with instrument service contracts. At </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, we reported </span><span style="font-family:inherit;font-size:10pt;"><span>$17.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> of deferred revenue.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> (in thousands): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:45%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Expected Revenue </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,037</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,149</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,525</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,436</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,147</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">_______</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span><span style="font-family:inherit;font-size:10pt;">Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:6px;text-align:left;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We apply the practical expedient that permits us to not disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.</span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contract Costs</span></div><div style="line-height:120%;text-align:left;padding-left:8px;text-indent:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">We reported </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> of capitalized commission costs from instrument service contracts at December 31, 2018 in</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span>the consolidated balance sheet. The following table presents our revenue for the year ended December 31, 2018, 2017, and 2016, respectively, based on geographic area and by products and services (in thousands):<div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Geographic Markets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Americas</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,172</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,290</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56,229</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EMEA</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>36,617</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,642</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>29,739</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia-Pacific</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,175</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,005</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,478</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112,964</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101,937</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>104,446</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Products and Services:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,491</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42,505</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46,834</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Consumables</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>48,159</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41,894</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42,169</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Product revenue</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>93,650</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>84,399</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>89,003</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Services </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,314</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,348</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,205</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">License</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>190</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>238</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112,964</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101,937</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>104,446</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 51172000 49290000 56229000 36617000 32642000 29739000 25175000 20005000 18478000 112964000 101937000 104446000 45491000 42505000 46834000 48159000 41894000 42169000 93650000 84399000 89003000 19314000 17348000 15205000 0 190000 238000 112964000 101937000 104446000 15200000 9100000 11700000 17800000 The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at <span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> (in thousands): </span><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:45%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Expected Revenue </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,037</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,149</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,525</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,436</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,147</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">_______</span></div><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></span>Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty. 10037000 5149000 2525000 1436000 19147000 400000 Goodwill and Intangible Assets, net<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with our acquisition of DVS in February 2014, we recognized goodwill of </span><span style="font-family:inherit;font-size:10pt;"><span>$104.1 million</span></span><span style="font-family:inherit;font-size:10pt;">. Intangible assets include developed technology related to the DVS acquisition and other intangible assets included in Other non-current assets. </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Developed Technology, Patents and Licenses</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Developed technology as a result of the DVS acquisition, and patents and licenses, were as follows (in thousands):</span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Amortization Period</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Developed technology</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(54,600</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57,400</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.0 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Patents and licenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,274</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,861</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,413</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.8 years</span></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Amortization Period</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Developed technology</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(43,400</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68,600</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.0 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Patents and licenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,274</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,721</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,553</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.8 years</span></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total amortization expense for the years ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">December 31, 2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2016</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$12.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$12.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$12.4 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Based on the carrying value of intangible assets, net, as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, the annual amortization expense is expected to be as follows (in thousands):</span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Developed Technology Amortization Expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Patents and Licenses Amortization Expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,046</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,246</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,046</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,246</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>888</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,088</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>815</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,015</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>610</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,810</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,400</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,408</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57,400</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,413</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61,813</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 104100000 Developed technology as a result of the DVS acquisition, and patents and licenses, were as follows (in thousands):<div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Amortization Period</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Developed technology</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(54,600</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57,400</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.0 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Patents and licenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,274</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,861</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,413</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.8 years</span></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average Amortization Period</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Developed technology</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>112,000</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(43,400</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68,600</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.0 years</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Patents and licenses</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,274</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,721</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,553</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.8 years</span></span></div></td></tr></table></div></div><br/> 112000000 54600000 57400000 P10Y 11274000 6861000 4413000 P7Y9M18D 112000000 43400000 68600000 P10Y 11274000 5721000 5553000 P7Y9M18D 12300000 12400000 12400000 Based on the carrying value of intangible assets, net, as of <span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, the annual amortization expense is expected to be as follows (in thousands):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Developed Technology Amortization Expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Patents and Licenses Amortization Expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,046</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,246</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,046</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,246</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>888</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,088</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>815</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,015</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,200</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>610</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,810</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,400</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,408</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>57,400</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,413</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61,813</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 11200000 1046000 12246000 11200000 1046000 12246000 11200000 888000 12088000 11200000 815000 12015000 11200000 610000 11810000 1400000 8000 1408000 57400000 4413000 61813000 Balance Sheet Details<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash and Cash Equivalents</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents consisted of the following as of December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,685</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77,716</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,142</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">       U.S. Government and agency securities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,785</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58,056</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories consisted of the following as of December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,996</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,566</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work-in-process</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>650</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>929</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,357</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,593</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total inventories, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,003</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,088</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Property and Equipment, net </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment consisted of the following as of December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> (in thousands):</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Computer equipment and software</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,201</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,179</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Laboratory and manufacturing equipment</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,780</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,069</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leasehold improvements</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,173</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,799</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Office furniture and fixtures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,506</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,892</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment, gross</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31,660</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33,939</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22,855</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,646</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Construction-in-progress</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,301</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Product Warranties</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity for our warranty accrual for the years ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, which are included in other accrued liabilities, is summarized below (in thousands):</span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>699</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,023</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrual for current period warranties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,573</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>695</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Warranty costs incurred</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,409</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,019</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>863</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>699</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> Cash and cash equivalents consisted of the following as of December 31, <span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> (in thousands):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash and cash equivalents:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,685</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77,716</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,142</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">       U.S. Government and agency securities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,785</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58,056</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 17685000 20129000 77716000 16142000 0 21785000 95401000 58056000 Inventories consisted of the following as of December 31, <span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> (in thousands):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,996</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,566</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work-in-process</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>650</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>929</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,357</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,593</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total inventories, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,003</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15,088</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 5996000 7566000 650000 929000 6357000 6593000 13003000 15088000 Property and equipment consisted of the following as of December 31, <span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> (in thousands):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Computer equipment and software</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,201</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,179</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Laboratory and manufacturing equipment</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18,780</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,069</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Leasehold improvements</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,173</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,799</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Office furniture and fixtures</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,506</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,892</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment, gross</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31,660</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>33,939</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(22,855</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(21,646</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Construction-in-progress</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property and equipment, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,301</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 4201000 4179000 18780000 20069000 7173000 7799000 1506000 1892000 31660000 33939000 22855000 21646000 20000 8000 8825000 12301000 Activity for our warranty accrual for the years ended <span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, which are included in other accrued liabilities, is summarized below (in thousands):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beginning balance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>699</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,023</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrual for current period warranties</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,573</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>695</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Warranty costs incurred</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,409</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,019</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Ending balance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>863</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>699</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 699000 1023000 1573000 695000 1409000 1019000 863000 699000 Convertible Notes and Credit Facility<div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2014 Senior Convertible Notes (2014 Notes)</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On February 4, 2014, we closed an underwritten public offering of </span><span style="font-family:inherit;font-size:10pt;"><span>$201.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of our </span><span style="font-family:inherit;font-size:10pt;"><span>2.75%</span></span><span style="font-family:inherit;font-size:10pt;"> Senior Convertible Notes due 2034 (2014 Notes) pursuant to an underwriting agreement, dated January 29, 2014. The 2014 Notes accrue interest at a rate of </span><span style="font-family:inherit;font-size:10pt;"><span>2.75%</span></span><span style="font-family:inherit;font-size:10pt;"> per year, payable semi-annually in arrears on February 1 and August 1 of each year. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The initial conversion rate of the 2014 Notes is </span><span style="font-family:inherit;font-size:10pt;"><span>17.8750</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock, par value </span><span style="font-family:inherit;font-size:10pt;"><span>$0.001</span></span><span style="font-family:inherit;font-size:10pt;"> per share, per </span><span style="font-family:inherit;font-size:10pt;">$1,000</span><span style="font-family:inherit;font-size:10pt;"> principal amount of 2014 Notes (which is equivalent to an initial conversion price of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$55.94</span></span><span style="font-family:inherit;font-size:10pt;"> per share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events including upon conversion in connection with a fundamental change, as defined in the indenture governing the 2014 Notes or, subject to certain conditions, redemption of the 2014 Notes by us.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders may surrender their 2014 Notes for conversion at any time prior to the stated maturity date. On or after February 6, 2018, and prior to February 6, 2021, we may redeem any or all of the 2014 Notes in cash if the closing price of our common stock exceeds </span><span style="font-family:inherit;font-size:10pt;"><span>130%</span></span><span style="font-family:inherit;font-size:10pt;"> of the conversion price for a specified number of days, and on or after February 6, 2021, we may redeem any or all of the 2014 Notes in cash without any such condition. The redemption price of the 2014 Notes will equal </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2014 Notes plus accrued and unpaid interest. Holders may require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2021, February 6, 2024, and February 6, 2029, at a repurchase price in cash equal to </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2014 Notes plus accrued and unpaid interest. If we undergo a fundamental change, as defined in the terms of the 2014 Notes, holders may require us to repurchase the 2014 Notes in whole or in part for cash at a repurchase price equal to </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2014 Notes plus accrued and unpaid interest.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2014, we received </span><span style="font-family:inherit;font-size:10pt;"><span>$195.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, net of underwriting discounts, from the issuance of the 2014 Notes and incurred approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> in offering-related expenses. The underwriting discount of </span><span style="font-family:inherit;font-size:10pt;"><span>$6.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and the debt issuance costs of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> were recorded as offsets to the proceeds. The underwriting discount and offering-related expenses are being amortized to interest expense using the effective-interest rate method.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:174%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018 Senior Convertible Notes (2018 Notes)</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange </span><span style="font-family:inherit;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of the 2014 Notes for new convertible notes (2018 Notes). As of the closing of the 2018 Notes on March 12, 2018, the estimated fair value was </span><span style="font-family:inherit;font-size:10pt;"><span>$145.5 million</span></span><span style="font-family:inherit;font-size:10pt;">. The difference between the </span><span style="font-family:inherit;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> aggregate principal amount of the 2018 Notes and its fair value will be amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We accounted for the exchange transaction as an extinguishment of debt due to the significance of the change in value of the embedded conversion option, resulting in a </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> gain. The gain on extinguishment of debt was calculated as the difference between the reacquisition price (i.e., the fair value of the principal amount of 2018 Notes) and the net carrying value of the 2014 Notes exchanged net of unamortized debt discount and debt issuance cost write-offs.</span></div><div style="line-height:120%;text-align:left;text-indent:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The 2018 Notes accrue interest at a rate of </span><span style="font-family:inherit;font-size:10pt;"><span>2.75%</span></span><span style="font-family:inherit;font-size:10pt;">, payable semi-annually in arrears on February 1 and August 1 of each year. The 2018 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the indenture governing the 2018 Notes. The initial conversion rate of the 2018 Notes is </span><span style="font-family:inherit;font-size:10pt;"><span>126.9438</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock, par value </span><span style="font-family:inherit;font-size:10pt;"><span>$0.001</span></span><span style="font-family:inherit;font-size:10pt;"> per share, per $1,000 principal amount of the 2018 Notes (which is equivalent to an initial conversion price of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$7.88</span></span><span style="font-family:inherit;font-size:10pt;"> per share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events. Those certain specified events include Holders who convert their 2018 Notes voluntarily prior to our exercise of the Issuer's Conversion Option or in connection with a make-whole fundamental change prior to February 6, 2023, are entitled, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2018 Notes. Any time prior to the maturity of the 2018 Notes, we may convert the 2018 Notes, in whole but not in part, into cash, shares of our common stock, or combination thereof, if the closing price of our common stock equals or exceeds </span><span style="font-family:inherit;font-size:10pt;"><span>110%</span></span><span style="font-family:inherit;font-size:10pt;"> of the conversion price then in effect for a specified number of days (Issuer’s Conversion Option). On or after February 6, 2022, we may elect to redeem all or any portion of the </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Notes at a redemption price equal to </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the accreted principal amount of the 2018 Notes on the redemption date of the 2018 Notes, plus accrued and unpaid interest.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Holders of the 2018 Notes have the right, at their option, to require us to purchase all or a portion of the 2018 Notes (i) on February 6, 2023, February 6, 2026, and February 6, 2029, or (ii) in the event of a fundamental change, as defined in the indenture governing the 2018 Notes, in each case, at a repurchase price equal to </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the accreted principal amount (i.e., up to </span><span style="font-family:inherit;font-size:10pt;"><span>120%</span></span><span style="font-family:inherit;font-size:10pt;"> of the outstanding principal amount) of the 2018 Notes on the fundamental change repurchase date, plus accrued and unpaid interest.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Offering-related costs for the 2018 Notes were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.8 million</span></span><span style="font-family:inherit;font-size:10pt;">. Offering-related costs of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> were capitalized as debt issuance costs, recorded as an offset to the carrying value of the 2018 Notes, and are being be amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. Offering-related costs of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> were accounted for as equity issuance costs, recorded as an offset to additional paid-in capital, and are not subject to amortization. Offering-related costs were allocated between debt and equity in the same proportion as the allocation of the 2018 Notes between debt and equity. </span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The carrying values of the components of the 2014 Notes and 2018 Notes are as follows (in thousands): </span></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">   2.75% 2014 Notes due 2034 </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,250</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,250</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,232</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,087</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(224</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(925</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,794</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195,238</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">   2.75% 2018 Notes due 2034 </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149,999</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Premium accretion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,755</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29,558</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,932</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,264</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>172,058</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195,238</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:174%;text-align:left;text-indent:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018 Revolving Credit Facility</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On August 2, 2018, we entered into a revolving credit facility with Silicon Valley Bank (Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) </span><span style="font-family:inherit;font-size:10pt;"><span>$15.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> (Maximum Amount) or (ii) the sum of (a) </span><span style="font-family:inherit;font-size:10pt;"><span>85%</span></span><span style="font-family:inherit;font-size:10pt;"> of our eligible receivables and (b) </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;"> of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. Subject to the level of this borrowing base, we may make and repay borrowings from time to time until the maturity of the revolving credit facility. The borrowing base as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> under the revolving credit facility was </span><span style="font-family:inherit;font-size:10pt;"><span>$12.3 million</span></span><span style="font-family:inherit;font-size:10pt;">. There were </span><span style="font-family:inherit;font-size:10pt;"><span>no</span></span><span style="font-family:inherit;font-size:10pt;"> borrowings outstanding under the Revolving Credit Facility at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Revolving Credit Facility matures on August 2, 2020, and is collateralized by substantially all our property, other than intellectual property. Outstanding loans under the Revolving Credit Facility will bear interest, at the greater of (i) prime rate plus </span><span style="font-family:inherit;font-size:10pt;"><span>0.50%</span></span><span style="font-family:inherit;font-size:10pt;"> or (ii) </span><span style="font-family:inherit;font-size:10pt;"><span>5.50%</span></span><span style="font-family:inherit;font-size:10pt;">. Interest on any outstanding loans is due and payable monthly and the principal balance is due at maturity though loans can be prepaid at any time without penalty. In addition, we pay a quarterly unused revolving line facility fee of </span><span style="font-family:inherit;font-size:10pt;"><span>0.75%</span></span><span style="font-family:inherit;font-size:10pt;"> per annum on the average unused facility.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Subject to certain exceptions, we must pay a prepayment fee equal to (i) </span><span style="font-family:inherit;font-size:10pt;"><span>2.00%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Maximum Amount if it prepays all advances and terminates the Loan Agreement prior to August 2, 2019, or (ii) </span><span style="font-family:inherit;font-size:10pt;"><span>1.00%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Maximum Amount if it prepays all advances and terminates the Loan Agreement on or after August 2, 2019, and prior to the maturity date.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We incurred approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$335,000</span></span><span style="font-family:inherit;font-size:10pt;"> of debt issuance costs in connection with the facility, including </span><span style="font-family:inherit;font-size:10pt;"><span>$225,000</span></span><span style="font-family:inherit;font-size:10pt;"> in commitment fees. Half of the commitment fee was paid at the inception of the facility with the remainder due on the earliest of (i) August 2, 2019, (ii) the date on which we terminate the agreement or (iii) the occurrence and continuance of an event of default. Debt issuance costs were capitalized and are being amortized to interest expense over the life of the Revolving Credit Facility. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Revolving Credit Facility contains customary affirmative and negative covenants which, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. The Revolving Credit Facility also contains customary events of default, subject to customary cure periods for certain defaults, that include, among other things, non-payment defaults, covenant defaults, material judgment defaults, bankruptcy and insolvency defaults, cross-defaults to certain other material indebtedness, and defaults due to inaccuracy of representation and warranties. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Revolving Credit Facility. During the existence of an event of default, interest on the obligations under the Revolving Credit Facility could be increased to </span><span style="font-family:inherit;font-size:10pt;"><span>5.0%</span></span><span style="font-family:inherit;font-size:10pt;"> above the otherwise applicable rate of interest.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">We were in compliance with all the terms and conditions of the Revolving Credit Facility at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span>. 201300000 0.0275 0.0275 17.8750 0.001 55.94 1.30 1 1 1 195200000 1100000 6000000.0 1100000 150000000.0 145500000 150000000.0 100000 0.0275 126.9438 0.001 7.88 1.10 1 1 1.20 2800000 2200000 600000 The carrying values of the components of the 2014 Notes and 2018 Notes are as follows (in thousands): <div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">   2.75% 2014 Notes due 2034 </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,250</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,250</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,232</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,087</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(224</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(925</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,794</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195,238</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">   2.75% 2018 Notes due 2034 </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Principal amount </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149,999</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Premium accretion</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,755</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt discount</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(29,558</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unamortized debt issuance cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,932</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,264</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>172,058</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195,238</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div>The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2018 Notes at December 31, 2018 and 2017, respectively (in thousands):<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.71150097465888%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:23%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Par Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Par Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2014 Notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,794</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43,665</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195,238</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166,162</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149,999</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,264</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>171,843</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,249</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>172,058</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>215,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,250</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195,238</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166,162</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 51250000 201250000 1232000 5087000 224000 925000 49794000 195238000 149999000 0 3755000 0 29558000 0 1932000 0 122264000 0 172058000 195238000 15000000.0 0.85 0.50 12300000 0 0.0050 0.0550 0.0075 0.0200 0.0100 335000 225000 0.050 Fair Value of Financial Instruments<div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:35%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Gain</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Short-Term Marketable Securities</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,685</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,685</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,685</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">    Level I:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         Money market funds</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77,716</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77,716</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77,716</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         U.S. treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">    Level II:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         U.S. government and agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Gain</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Short-Term Marketable Securities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">    Level I:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         Money market funds</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,142</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,142</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,142</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         U.S. treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>497</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>497</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>497</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">    Level II:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         U.S. government and agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,369</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,368</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,785</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,583</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63,137</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63,136</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58,056</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,080</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were no transfers between Level I and Level II measurements during the year ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, and there were no changes in the valuation techniques used.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Based on an evaluation of securities that were in a loss position, we did not recognize any other-than-temporary impairment charges for the years ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;"><span>None</span></span><span style="font-family:inherit;font-size:10pt;"> of our investments have been in a continuous loss position for more than 12 months. We concluded that the declines in market value of our available-for-sale securities investment portfolio were temporary in nature and did not consider any of our investments to be other-than-temporarily impaired. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The estimated fair value of the 2014 and 2018 Notes is based on a market approach and represents a Level II valuation. When determining the estimated fair value of our long-term debt, we used a commonly accepted valuation methodology and market-based risk measurements that are indirectly observable, such as credit risk.</span></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2018 Notes at December 31, 2018 and 2017, respectively (in thousands):</span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.71150097465888%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:23%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Par Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Par Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2014 Notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>51,250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>49,794</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43,665</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195,238</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166,162</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Notes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149,999</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,264</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>171,843</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,249</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>172,058</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>215,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>201,250</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>195,238</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166,162</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): <div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:35%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Gain</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Short-Term Marketable Securities</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,685</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,685</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,685</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">    Level I:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         Money market funds</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77,716</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77,716</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>77,716</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         U.S. treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">    Level II:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         U.S. government and agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95,401</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Gain</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Unrealized Loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash and Cash Equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Short-Term Marketable Securities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20,129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Available-for-sale:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">    Level I:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         Money market funds</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,142</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,142</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,142</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         U.S. treasury securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>497</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>497</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>497</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">    Level II:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">         U.S. government and agency securities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,369</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,368</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21,785</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,583</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63,137</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>63,136</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>58,056</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,080</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 17685000 0 0 17685000 17685000 0 77716000 0 0 77716000 77716000 0 0 0 0 0 0 0 0 0 0 0 0 0 95401000 0 0 95401000 95401000 0 20129000 0 0 20129000 20129000 0 16142000 0 0 16142000 16142000 0 497000 0 0 497000 0 497000 26369000 0 1000 26368000 21785000 4583000 63137000 0 1000 63136000 58056000 5080000 0 51250000 49794000 43665000 201250000 195238000 166162000 149999000 122264000 171843000 0 0 0 201249000 172058000 215508000 201250000 195238000 166162000 Shareholders' Equity<div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Tax Benefit Preservation Plan</span></div><div style="line-height:120%;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On August 1, 2017, the Tax Benefit Preservation Plan (Tax Plan) dated as of November 21, 2016 expired and all of the preferred share purchase rights distributed to the holders of our common stock pursuant to the Tax Plan expired.</span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018 Market Offering</span></div><div style="line-height:120%;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 14, 2018, we closed on our</span><span style="font-family:inherit;font-size:10pt;color:#232222;"> previously announced underwritten public offering of </span><span style="font-family:inherit;font-size:10pt;color:#232222;"><span>9,372,500</span></span><span style="font-family:inherit;font-size:10pt;color:#232222;"> shares our common stock, </span><span style="font-family:inherit;font-size:10pt;color:#232222;"><span>$0.001</span></span><span style="font-family:inherit;font-size:10pt;color:#232222;"> par value. The common stock was sold at a price to the public of </span><span style="font-family:inherit;font-size:10pt;"><span>$6.75</span></span><span style="font-family:inherit;font-size:10pt;color:#232222;"> per share, for aggregate gross proceeds of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$63.3 million</span></span><span style="font-family:inherit;font-size:10pt;color:#232222;">, from our existing shelf registration statement. Net proceeds from the offering were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$59.1 million</span></span><span style="font-family:inherit;font-size:10pt;color:#232222;"> after deducting underwriting discounts and commissions of </span><span style="font-family:inherit;font-size:10pt;color:#232222;"><span>$3.8 million</span></span><span style="font-family:inherit;font-size:10pt;color:#232222;"> and the </span><span style="font-family:inherit;font-size:10pt;color:#232222;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;color:#232222;"> of estimated expenses of the offering. We intend to use the net proceeds of the offering for general corporate purposes, including working capital, capital expenditures and continued research and development with respect to products and technologies, and to fund possible investments in or acquisitions of complementary businesses, products, or technologies.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2017 At-the-Market Offering</span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On August 10, 2017, we sold </span><span style="font-family:inherit;font-size:10pt;"><span>9,090,909</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.001</span></span><span style="font-family:inherit;font-size:10pt;"> par value per share, pursuant to an earlier Sales Agreement, for aggregate gross proceeds of </span><span style="font-family:inherit;font-size:10pt;"><span>$30.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. Our aggregate net proceeds were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$28.8 million</span></span><span style="font-family:inherit;font-size:10pt;">, after deducting related expenses, including commissions of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$0.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> and issuance costs of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$0.5 million</span></span><span style="font-family:inherit;font-size:10pt;">. These sales fully exhausted the shares that were available for sale under the Sales Agreement. </span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:26px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At December 31, 2018, we had reserved shares of common stock for future issuance under equity compensation plans as follows: </span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in 000's)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Securities To Be Issued Upon Exercise Of Options </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number Of Remaining Securities Available For Future Issuance </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2009 Equity Incentive Plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2011 Equity Incentive Plan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,064</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,631</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,022</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DVS Sciences Inc. 2010 Equity Incentive Plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017 Inducement Award Plan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>240</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>338</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,422</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017 Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>698</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,385</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,969</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,142</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 9372500 0.001 6.75 63300000 59100000 3800000 400000 9090909 0.001 30000000.0 28800000 700000 500000 At December 31, 2018, we had reserved shares of common stock for future issuance under equity compensation plans as follows: <div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(in 000's)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Securities To Be Issued Upon Exercise Of Options </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number Of Remaining Securities Available For Future Issuance </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2009 Equity Incentive Plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2011 Equity Incentive Plan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,064</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,631</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,022</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">DVS Sciences Inc. 2010 Equity Incentive Plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017 Inducement Award Plan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>240</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>338</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,422</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017 Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>698</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,385</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,969</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,142</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div>Total stock-based compensation expense recognized was as follows (in thousands): <div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:681px;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:408px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:72px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:72px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:72px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">For the Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Retention Bonus Program</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,809</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options and Restricted Stock Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,716</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,972</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,858</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>498</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>120</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Share-Based Compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,023</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,092</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 43000 0 0 2064000 1631000 2022000 38000 0 0 240000 338000 1422000 0 698000 2385000 1969000 4142000 Stock-Based Plans<div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our board of directors sets the terms, conditions, and restrictions related to our ESPP and the grant of stock options, RSUs and performance-based awards under our various stock-based plans. Our board of directors determines the number of awards to grant and also sets vesting criteria. </span></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In general, RSUs vest on a quarterly basis over a period of </span><span style="font-family:inherit;font-size:10pt;">four</span><span style="font-family:inherit;font-size:10pt;"> years from the date of grant at a rate of </span><span style="font-family:inherit;font-size:10pt;"><span>25%</span></span><span style="font-family:inherit;font-size:10pt;"> on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, subject to the employees' continued employment.</span></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Incentive stock options and non-statutory stock options granted under the 2011 Plan have a term of no more than </span><span style="font-family:inherit;font-size:10pt;"><span>ten years</span></span><span style="font-family:inherit;font-size:10pt;"> from the date of grant and an exercise price of at least </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the fair market value of the underlying common stock on the date of grant. If a participant owns stock representing more than </span><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span><span style="font-family:inherit;font-size:10pt;"> of the voting power of all classes of our stock on the grant date, an incentive stock option awarded to the participant will have a term of no more than </span><span style="font-family:inherit;font-size:10pt;"><span>five years</span></span><span style="font-family:inherit;font-size:10pt;"> from the date of grant and an exercise price of at least </span><span style="font-family:inherit;font-size:10pt;"><span>110%</span></span><span style="font-family:inherit;font-size:10pt;"> of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either </span><span style="font-family:inherit;font-size:10pt;"><span>25%</span></span><span style="font-family:inherit;font-size:10pt;"> on the first anniversary of the option grant date and ratably each month over the remaining period of </span><span style="font-family:inherit;font-size:10pt;"><span>36 months</span></span><span style="font-family:inherit;font-size:10pt;">, or ratably each month over </span><span style="font-family:inherit;font-size:10pt;"><span>48 months</span></span><span style="font-family:inherit;font-size:10pt;">. We may grant options with different vesting terms from time to time. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2011 Equity Incentive Plan </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 28, 2011, our board of directors adopted the 2011 Equity Incentive Plan (the 2011 Plan) under which incentive stock options, non-statutory stock options, restricted stock units (RSUs), stock appreciation rights, performance units, and performance shares may be granted to our employees, directors, and consultants.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2009 Equity Incentive Plan and 1999 Stock Option Plan</span></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our 2009 Equity Incentive Plan (the 2009 Plan) terminated on the date the 2011 Plan was adopted. Options granted, or shares issued under the 2009 Plan that were outstanding on the date the 2011 Plan became effective, remained subject to the terms of the 2009 Plan.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2017 Inducement Award Plan</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 5, 2017, we adopted the Fluidigm Corporation 2017 Inducement Award Plan (the “Inducement Plan”) and reserved </span><span style="font-family:inherit;font-size:10pt;"><span>2 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provides for the grant of equity-based awards and its terms are substantially similar to the 2011 Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan may only be made to individuals not previously our employees or non-employee members of our board of directors (or following such individual's bona fide period of non-employment), as an inducement material to the individual's entry into employment with us or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the Nasdaq Listing Rules.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation and Expense Information</span></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We use the Black-Scholes option-pricing model to estimate the fair value of stock options granted under our equity incentive plans. The weighted average assumptions used to estimate the fair value were as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average expected volatility</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average expected term</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.7 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.2 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.0 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average risk-free interest rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividend yield</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted-average fair value per share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.45</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.97</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We determine the expected volatility based on our historical stock price volatility generally commensurate with the estimated expected term of the stock awards. The expected term of an award is based on historical forfeiture experience, exercise activity, and the terms and conditions of the stock awards. The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to each grant’s expected </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">life. Each of these inputs is subjective and generally requires significant judgment by us. The fair value of the underlying common stock is also required to compute the fair value calculation of options and ESPP. We account for forfeitures as they occur.</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We grant stock options at exercise prices not less than the fair value of our common stock at the date of grant. The fair value of RSUs granted to employees was estimated on the date of grant by multiplying the number of shares granted by the fair market value of our common stock on the grant date. </span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity under the 2011 Plan, the 2009 Plan, the 1999 Plan, and the Inducement Plan is as follows:</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Units</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:74%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Units (in 000's)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average<br/>Grant Date Fair Value per Unit</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2015</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>663</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>940</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.06</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU released</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24.71</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(210</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.82</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.31</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>916</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.73</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU released</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(445</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.57</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(368</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,168</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.55</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,822</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.98</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU released</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(945</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.63</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(233</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,812</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.09</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total intrinsic value of RSUs vested and released during the year ended December 31, 2018, 2017 and 2016 were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$6.8 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$2.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$2.4 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The intrinsic value of vested and released RSUs is calculated by multiplying the fair market value of our common stock on the vesting date by the number of shares vested. As of December 31, 2018, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were </span><span style="font-family:inherit;font-size:10pt;"><span>$9.7 million</span></span><span style="font-family:inherit;font-size:10pt;">. We expect to recognize those costs over a weighted average period of </span><span style="font-family:inherit;font-size:10pt;"><span>2.9</span></span><span style="font-family:inherit;font-size:10pt;"> years.</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018 Retention Bonus Program</span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Included in the 2018 RSU activity are </span><span style="font-family:inherit;font-size:10pt;"><span>379,593</span></span><span style="font-family:inherit;font-size:10pt;"> of grants and releases related to a retention bonus program. As disclosed in our Current Report on Form 8-K filed on February 10, 2017, we previously implemented a company-wide retention bonus incentive program in which our executive officers at the time also participated. The bonus program provides for the payment of cash bonuses to program participants who were employees at the time the plan was implemented and who remain with Fluidigm through January 1, 2019. On September 18, 2018, the compensation committee of our board of directors approved an exchange program for our executive officers and for employees resident in the United States and Canada who are retention bonus program participants. In the exchange program, eligible participants could elect to surrender their right to receive a cash bonus in exchange for fully vested restricted stock units issued under our 2011 Equity Incentive Plan on the terms described below. Among other reasons, our compensation committee adopted the exchange program to encourage employee stock ownership and to effectively manage cash resources.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the bonus exchange program, each eligible employee could elect to exchange </span><span style="font-family:inherit;font-size:10pt;"><span>25%</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>75%</span></span><span style="font-family:inherit;font-size:10pt;">, or </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the retention cash bonus otherwise payable under the terms of the program. Each employee participating in the exchange would receive a number of fully vested restricted stock units equal to the quotient, rounded up to the next whole number, determined by dividing the cash amount of the retention cash bonus that such eligible employee elects to exchange by an amount equal to </span><span style="font-family:inherit;font-size:10pt;"><span>85%</span></span><span style="font-family:inherit;font-size:10pt;"> of the lower of the closing prices of one share of our common stock on the commencement date of the </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">exchange offer or the closing date of the exchange offer. The exchange offer closed on November 5, 2018. The total value of the </span><span style="font-family:inherit;font-size:10pt;"><span>379,593</span></span><span style="font-family:inherit;font-size:10pt;"> shares of common stock issued under this program was </span><span style="font-family:inherit;font-size:10pt;"><span>$2.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> and is included in the total intrinsic value of RSUs released in 2018.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Options</span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of <br/>Options (000's)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average<br/>Exercise Price<br/>per Option</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate<br/> Intrinsic <br/>Value (1) in (000's)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2015</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,242</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>978</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.44</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(57</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.04</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>310</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Option forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(603</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23.53</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,560</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.62</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,364</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.61</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.07</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Option forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,735</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.33</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,164</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>758</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.05</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(40</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.24</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Option forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(497</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.09</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,385</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,991</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested at December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,026</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.92</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,111</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected to vest at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,359</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.78</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,879</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Aggregate intrinsic value as of December 31, 2018 was calculated as the difference between the closing price per share of our common stock on the last trading day of 2018, which was </span><span style="font-family:inherit;font-size:10pt;"><span>$8.62</span></span><span style="font-family:inherit;font-size:10pt;">, and the exercise price of the options, multiplied by the number of in-the-money options.</span></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of December 31, 2018, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were </span><span style="font-family:inherit;font-size:10pt;"><span>$4.2 million</span></span><span style="font-family:inherit;font-size:10pt;">. We expect to recognize those costs over a weighted average period of </span><span style="font-family:inherit;font-size:10pt;"><span>2.6</span></span><span style="font-family:inherit;font-size:10pt;"> years. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2017 Stock Option Exchange </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Included in the 2017 option activity above is the impact of our 2017 Stock Option Exchange Program. On August 23, 2017, we launched a one-time Stock Option Exchange Program (the Program), which eligible employees were able to exchange certain outstanding stock options (Eligible Options), whether vested or unvested, with an exercise price greater than </span><span style="font-family:inherit;font-size:10pt;"><span>$4.37</span></span><span style="font-family:inherit;font-size:10pt;"> per share and greater than the closing price of a share of our common stock on the Nasdaq Global Select Market on the expiration date of the exchange offer (the Offer), for restricted stock units or stock options (New Awards) covering a lesser number of shares than were subject to the Eligible Options exchanged immediately before being canceled in the Offer. Non-employee members of our board of directors were not eligible to participate in the Program. The Program expired on September 20, 2017, with a closing price of </span><span style="font-family:inherit;font-size:10pt;"><span>$5.13</span></span><span style="font-family:inherit;font-size:10pt;"> per share.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employees elected to surrender Eligible Options to purchase a total of </span><span style="font-family:inherit;font-size:10pt;"><span>1,204,198</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock. All surrendered options were canceled effective as of the expiration date, and immediately thereafter, in exchange for such surrendered options, we issued (i) new options to purchase an aggregate of </span><span style="font-family:inherit;font-size:10pt;"><span>399,117</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock with an exercise price of </span><span style="font-family:inherit;font-size:10pt;"><span>$5.13</span></span><span style="font-family:inherit;font-size:10pt;">; and (ii) restricted stock units representing </span><span style="font-family:inherit;font-size:10pt;"><span>54,944</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock, each, pursuant to the terms of the Offer and our 2011 Equity Incentive Plan. The new awards granted under the Program generally vest over three years.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Program did not result in a material incremental stock-based compensation expense because the fair value of the new awards was approximately equal to the fair value of the surrendered options immediately prior to the exchange date. The </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">original fair value of the surrendered options plus the incremental stock-based compensation expense is being recognized over the vesting periods of the New Awards.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Performance-based Awards</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2018 Performance Stock Units</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the three months ended March 31, 2018, we granted </span><span style="font-family:inherit;font-size:10pt;"><span>167,000</span></span><span style="font-family:inherit;font-size:10pt;"> performance stock units to certain executive officers and senior level employees. The number of performance stock units ultimately earned is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the performance period from January 1, 2018, to December 31, 2020. The percentage of performance stock units that vest will depend on our relative position at the end of the performance period and can range from </span><span style="font-family:inherit;font-size:10pt;"><span>0%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>200%</span></span><span style="font-family:inherit;font-size:10pt;"> of the number of units granted.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under FASB ASC Topic 718, the provisions of the performance stock unit awards related to TSR are considered a market condition, and the effects of that market condition should be reflected in the grant date fair value of the awards. We used a Monte Carlo simulation pricing model to incorporate the market condition effects at our grant date with a fair value of </span><span style="font-family:inherit;font-size:10pt;"><span>$10.09</span></span><span style="font-family:inherit;font-size:10pt;"> per unit.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Activity under the 2018 performance stock units is as follows: </span></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Units (in 000's)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average<br/>Grant Date Fair Value per Unit</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.09</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU released</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.09</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>155</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.09</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of December 31, 2018, the unrecognized compensation costs related to these awards were </span><span style="font-family:inherit;font-size:10pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:10pt;">. We expect to recognize those costs over a weighted average period of </span><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span><span style="font-family:inherit;font-size:10pt;"> years. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">2016 Performance-based Stock Options and Restricted Stock Units</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In 2016, we granted </span><span style="font-family:inherit;font-size:10pt;"><span>184,050</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>87,620</span></span><span style="font-family:inherit;font-size:10pt;"> performance-based stock options and performance-based restricted stock units (each, a performance award), respectively, to executive officers and employees, which were accounted for as equity awards. The number of performance awards that ultimately vested depended on the achievement of certain performance criteria set by the compensation committee of our board of directors. The performance-based stock options had an exercise price per share of </span><span style="font-family:inherit;font-size:10pt;"><span>$7.10</span></span><span style="font-family:inherit;font-size:10pt;">. We recognize stock-based compensation expense over the vesting period of the performance awards when achievement of the performance criteria becomes probable. The performance criteria were not met, and the awards did not vest. We did not recognize any expense related to these performance awards in 2018, 2017 or 2016.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2017 Employee Stock Purchase Plan</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On August 1, 2017, our stockholders approved our 2017 Employee Stock Purchase Plan (ESPP) at the annual meeting of stockholders. Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our ESPP has a </span><span style="font-family:inherit;font-size:10pt;">six</span><span style="font-family:inherit;font-size:10pt;">-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible to participate through payroll deductions of up to </span><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span><span style="font-family:inherit;font-size:10pt;"> of their compensation and may not purchase more than </span><span style="font-family:inherit;font-size:10pt;"><span>$25,000</span></span><span style="font-family:inherit;font-size:10pt;"> of stock in any calendar year. The purchase price at which shares are sold under the ESPP is </span><span style="font-family:inherit;font-size:10pt;"><span>85%</span></span><span style="font-family:inherit;font-size:10pt;"> of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. Our first ESPP offering period began on October 1, 2017 with a shorter offering period ending on November 30, 2017. </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-Based Compensation</span></div><div style="line-height:120%;padding-top:12px;text-align:left;padding-left:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total stock-based compensation expense recognized was as follows (in thousands): </span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:681px;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:408px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:72px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:72px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:72px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">For the Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2018 Retention Bonus Program</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,809</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options and Restricted Stock Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,716</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,972</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,858</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee Stock Purchase Plan</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>498</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>120</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total Share-Based Compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>11,023</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,092</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 0.25 P10Y 1 0.10 P5Y 1.10 0.25 P36M P48M 2000000 The weighted average assumptions used to estimate the fair value were as follows:<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock options:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average expected volatility</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>68.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>65.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average expected term</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.7 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.2 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.0 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average risk-free interest rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Dividend yield</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted-average fair value per share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.45</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.97</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div> 0.684 0.650 0.434 P4Y8M12D P4Y2M12D P6Y 0.027 0.017 0.014 0 0 0 3.45 2.97 3.19 Activity under the 2011 Plan, the 2009 Plan, the 1999 Plan, and the Inducement Plan is as follows:<div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Units</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:74%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Units (in 000's)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average<br/>Grant Date Fair Value per Unit</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2015</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>663</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.48</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>940</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.06</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU released</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24.71</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(210</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.82</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.31</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>916</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.73</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU released</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(445</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15.57</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(368</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13.11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,168</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.55</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,822</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.98</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU released</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(945</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.63</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(233</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.50</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,812</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.09</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 663000 32.48 940000 7.06 328000 24.71 210000 17.82 1065000 15.31 916000 5.73 445000 15.57 368000 13.11 1168000 8.55 1822000 5.98 945000 9.63 233000 8.50 1812000 7.09 6800000 2300000 2400000 9700000 P2Y10M24D 379593 0.25 0.50 0.75 1 0.85 379593 2800000 Stock Options<span style="font-family:inherit;font-size:10pt;font-weight:bold;">: </span><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of <br/>Options (000's)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average<br/>Exercise Price<br/>per Option</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate<br/> Intrinsic <br/>Value (1) in (000's)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2015</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,242</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20.45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>978</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.44</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(57</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.04</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>310</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Option forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(603</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23.53</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,560</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.62</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,364</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.61</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.07</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Option forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,735</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.33</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,164</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.41</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>758</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.05</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options exercised</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(40</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.24</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>81</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Option forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(497</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16.09</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,385</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,991</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Vested at December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,026</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.92</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,111</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Expected to vest at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,359</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.78</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,879</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">(1)</span></div><span style="font-family:inherit;font-size:10pt;">Aggregate intrinsic value as of December 31, 2018 was calculated as the difference between the closing price per share of our common stock on the last trading day of 2018, which was </span><span style="font-family:inherit;font-size:10pt;"><span>$8.62</span></span>, and the exercise price of the options, multiplied by the number of in-the-money options. 3242000 20.45 P2Y2M12D 978000 7.44 57000 4.04 310000 603000 23.53 3560000 16.62 P6Y9M18D 1364000 5.61 25000 4.07 42000 2735000 16.33 2164000 10.41 P6Y7M6D 758000 6.05 40000 5.24 81000 497000 16.09 2385000 7.56 P7Y9M18D 5991000 1026000 9.92 P6Y3M18D 2111000 1359000 5.78 P8Y10M24D 3879000 8.62 4200000 P2Y7M6D 4.37 5.13 1204198 399117 5.13 54944 167000 0 2 10.09 Activity under the 2018 performance stock units is as follows: <div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Units (in 000's)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted-Average<br/>Grant Date Fair Value per Unit</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>167</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.09</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU released</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">RSU forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.09</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>155</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10.09</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 0 0 167000 10.09 0 0 12000 10.09 155000 10.09 1200000 P2Y2M12D 184050 87620 7.10 0.10 25000 0.85 2809000 0 0 7716000 8972000 13858000 498000 120000 0 11023000 9092000 13858000 Income Taxes <div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our loss before income taxes consists of the following (in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Domestic</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47,600</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(56,885</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(65,211</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">International</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13,820</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,914</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14,966</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss before income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61,420</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(63,799</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(80,177</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of our benefit for income taxes are as follows (in thousands):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(501</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>286</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current tax (expense) benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(78</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(518</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>272</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,485</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,782</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,920</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total deferred benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,485</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,782</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,920</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total benefit for income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,407</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,264</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,192</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reconciliation of income taxes at the statutory rate to the benefit from (provision for) income taxes recorded in the statements of operations is as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax benefit at federal statutory rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State tax expense, net of federal benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign tax benefit (expense)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in valuation allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal research and development credit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrecognized tax benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of the Tax Act</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(74.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective tax rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Tax Act was enacted in December 2017. The Tax Act introduced a broad range of tax reform measures that significantly change the federal income tax laws. At December 31, 2017, we recorded the provisional income tax effects of the Tax Act under Accounting Standards Codification Topic 740, Income Taxes. Due to our having recorded a full valuation allowance against its U.S. federal and state deferred tax assets, there was no net impact on our tax provision as a result of the remeasurement of U.S. deferred taxes using the relevant tax rate at which we expect them to reverse. The one-time transition tax on post-1986 foreign unremitted earnings did not have a material impact to our effective tax rate as a result of generating net foreign deficit earnings. In accordance with Staff Accounting Bulletin (“SAB”) No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense was required. We continue to monitor supplemental legislation and technical interpretations of the tax law that may cause the final impact from the Tax Act to differ from the amounts previously recorded.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At December 31, 2017, we changed our permanent reinvestment assertion and will not permanently reinvest our foreign earnings outside the United States. The cash generated from some of our foreign subsidiaries may be used domestically to fund operations. Any domestic, foreign withholding tax and state taxes that may be due upon future repatriation of earnings is not expected to be significant.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of our deferred tax assets and liabilities are as follows (in thousands): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net operating loss carryforwards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>98,920</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91,701</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reserves and accruals</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,167</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,927</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation and amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,262</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,591</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax credit carryforwards</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,675</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,838</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,899</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,994</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total gross deferred tax assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,923</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,051</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Valuation allowance on deferred tax assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(126,109</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(119,228</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,814</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,823</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed asset and intangibles</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,528</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18,912</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,528</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18,912</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net deferred tax liability</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13,714</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,089</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We evaluate a number of factors to determine the realizability of our deferred tax assets. Recognition of deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">dependent upon several factors including historical financial results. The net deferred tax assets have been partially offset by a valuation allowance because we have incurred losses since our inception. The valuation allowance increased by </span><span style="font-family:inherit;font-size:10pt;"><span>$6.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> during 2018, decreased by </span><span style="font-family:inherit;font-size:10pt;"><span>$27.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> during 2017 and increased by </span><span style="font-family:inherit;font-size:10pt;"><span>$22.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> during 2016, respectively. The change in valuation allowance during 2018 is mainly due to significant taxable losses and an increase in tax attributes. The change in valuation allowance during 2017 is mainly due to the change in Federal statutory rate from 34% to 21%, offset by a significant increase in the taxable loss in 2017.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The valuation allowances of </span><span style="font-family:inherit;font-size:10pt;"><span>$126.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$119.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of December 31, 2018 and 2017, respectively, primarily relate to temporary tax differences, net operating losses and research and development credits generated in the current and prior years. We believe it is more likely than not that U.S. federal and state of California deferred tax assets relating to temporary differences, net operating losses and research and development credits are not realizable. As such, full valuation allowances have been applied against the deferred tax assets relating to jurisdictions of the federal U.S. and the state of California.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A reconciliation of the beginning and ending amount of the valuation allowance for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> is as follows (in thousands): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Valuation Allowance</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2015</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>124,137</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to earnings </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to other accounts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,148</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2016</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>146,285</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to earnings </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>830</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to other accounts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27,887</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2017</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119,228</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to earnings </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to other accounts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,880</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>126,108</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of December 31, 2018, we had net operating loss carryforwards for U.S. federal income tax purposes of </span><span style="font-family:inherit;font-size:10pt;"><span>$432.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, which expire beginning in 2021, and U.S. federal research and development tax credits of </span><span style="font-family:inherit;font-size:10pt;"><span>$8.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, which expire in the years 2021 through 2039. As of December 31, 2018, we had net operating loss carryforwards for state income tax purposes of </span><span style="font-family:inherit;font-size:10pt;"><span>$170.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, which expire beginning in 2028 through 2039, and California research and development tax credits of </span><span style="font-family:inherit;font-size:10pt;"><span>$11.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, which do not expire. As of December 31, 2018, we had foreign net operating loss carryforwards of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, which expire in the years 2019 through 2027.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Utilization of the net operating loss carryforwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. In 2015, we completed a Section 382 analysis for the period from our inception in May 1999 through December 31, 2015, which excluded the net operating loss carryforwards for DVS prior to the acquisition and determined that an ownership change as defined under Section 382 occurred in November 2001, which resulted in a reduction to our U.S. federal net operating losses by </span><span style="font-family:inherit;font-size:10pt;"><span>$1.2 million</span></span><span style="font-family:inherit;font-size:10pt;">. In 2016, 2017 and 2018, we continued the Section 382 analysis through December 31, 2018 and determined that an ownership change did not occur during the periods. </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Uncertain Tax Positions </span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The aggregate changes in the balance of our gross unrecognized tax benefits during </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> were as follows (in thousands): </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2015</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,662</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases in balances related to tax positions taken during prior period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">       Increases in balances related to tax positions taken during current period</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,673</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">       Decreases in balances related to tax positions taken during prior period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,048</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2016</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,333</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases in balances related to tax positions taken during current period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases in balances related to tax positions taken during prior period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,077</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,317</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases in balances related to tax positions taken during current period</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>255</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases in balances related to tax positions taken during prior period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(228</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,344</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued interest and penalties related to unrecognized tax benefits were included in the income tax provision and are immaterial as of December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, there are </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> unrecognized tax benefits that, if recognized, would affect our effective tax rate. We do not anticipate that our existing unrecognized tax benefits will significantly increase or decrease within the next </span><span style="font-family:inherit;font-size:10pt;">12 months</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div>We file income tax returns in the United States, various states, and certain foreign jurisdictions. As a result of net operating loss carryforwards, all of our tax years are open to federal and state examination in the United States. Tax years from 2013 are open to examination in various foreign countries. Our loss before income taxes consists of the following (in thousands):<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Domestic</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(47,600</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(56,885</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(65,211</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">International</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13,820</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(6,914</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14,966</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Loss before income taxes</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(61,420</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(63,799</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(80,177</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div> -47600000 -56885000 -65211000 -13820000 -6914000 -14966000 -61420000 -63799000 -80177000 Significant components of our benefit for income taxes are as follows (in thousands):<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(32</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(501</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>286</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total current tax (expense) benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(78</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(518</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>272</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,485</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,782</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,920</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total deferred benefit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,485</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,782</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,920</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total benefit for income taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,407</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,264</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,192</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 27000 0 0 19000 17000 14000 32000 501000 -286000 78000 518000 -272000 0 0 0 -2485000 -3782000 -3920000 -2485000 -3782000 -3920000 -2407000 -3264000 -4192000 Reconciliation of income taxes at the statutory rate to the benefit from (provision for) income taxes recorded in the statements of operations is as follows:<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Year Ended December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2016</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax benefit at federal statutory rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">State tax expense, net of federal benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign tax benefit (expense)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Change in valuation allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(19.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>39.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(31.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Federal research and development credit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Unrecognized tax benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of the Tax Act</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(74.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective tax rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> %</span></div></td></tr></table></div> 0.210 0.340 0.340 0.023 0.055 0.022 -0.011 0.004 -0.007 -0.192 0.392 -0.312 -0.015 -0.019 -0.013 -0.002 -0.006 -0.013 0 -0.746 0 -0.004 -0.007 0.009 0.039 0.051 0.052 Significant components of our deferred tax assets and liabilities are as follows (in thousands): <div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax assets:</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net operating loss carryforwards</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>98,920</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91,701</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reserves and accruals</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,167</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,927</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Depreciation and amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,262</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,591</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Tax credit carryforwards</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16,675</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14,838</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Stock-based compensation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,899</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,994</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total gross deferred tax assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>128,923</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122,051</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Valuation allowance on deferred tax assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(126,109</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(119,228</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,814</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,823</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fixed asset and intangibles</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,528</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18,912</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,528</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18,912</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net deferred tax liability</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13,714</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,089</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div> 98920000 91701000 7167000 3927000 4262000 5591000 16675000 14838000 1899000 5994000 128923000 122051000 126109000 119228000 2814000 2823000 16528000 18912000 16528000 18912000 13714000 16089000 6900000 -27100000 22100000 126100000 119200000 A reconciliation of the beginning and ending amount of the valuation allowance for the years ended December 31, <span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> is as follows (in thousands): </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Valuation Allowance</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2015</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>124,137</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to earnings </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to other accounts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,148</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2016</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>146,285</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to earnings </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>830</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to other accounts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(27,887</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2017</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>119,228</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to earnings </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Charges to other accounts</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,880</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>126,108</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 124137000 0 22148000 146285000 830000 -27887000 119228000 0 6880000 126108000 432200000 8500000 170300000 11000000.0 1900000 1200000 The aggregate changes in the balance of our gross unrecognized tax benefits during <span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> were as follows (in thousands): </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2015</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,662</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases in balances related to tax positions taken during prior period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">       Increases in balances related to tax positions taken during current period</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,673</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">       Decreases in balances related to tax positions taken during prior period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,048</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2016</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,333</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases in balances related to tax positions taken during current period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases in balances related to tax positions taken during prior period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(2,077</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,317</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Increases in balances related to tax positions taken during current period</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>255</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Decreases in balances related to tax positions taken during prior period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(228</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,344</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 8662000 46000 1673000 1048000 9333000 61000 2077000 7317000 255000 228000 7344000 400000 Employee Benefit Plans<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">We sponsor a 401(k) savings plan for our employees in the United States that stipulates that eligible employees may elect to contribute to the plan, subject to certain limitations, up to the lesser of </span><span style="font-family:inherit;font-size:10pt;"><span>90%</span></span><span style="font-family:inherit;font-size:10pt;"> of eligible compensation or the maximum amount allowed by the U.S. Internal Revenue Service. In 2015, we implemented a match formula of </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> up to </span><span style="font-family:inherit;font-size:10pt;"><span>$2,000</span></span><span style="font-family:inherit;font-size:10pt;"> annually, following a </span><span style="font-family:inherit;font-size:10pt;"><span>4</span></span><span style="font-family:inherit;font-size:10pt;">-year vesting schedule. Employer matching contributions to the 401(k) plan for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> were </span><span style="font-family:inherit;font-size:10pt;"><span>$0.4 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span>, respectively. 0.90 1 2000 P4Y 400000 500000 600000 Information About Geographic Areas<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We operate in </span><span style="font-family:inherit;font-size:10pt;"><span>one</span></span><span style="font-family:inherit;font-size:10pt;"> reporting segment that develops, manufacturers and commercializes tools for life sciences research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A summary table of our total revenue by geographic areas of our customers and by product and services for the years ended December 31, 2018, 2017 and 2016 is included in Note 3 to the Consolidated Financial Statements of this Form 10K. </span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Sales to customers in the United States represented $</span><span style="font-family:inherit;font-size:10pt;"><span>48.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;"><span>43%</span></span><span style="font-family:inherit;font-size:10pt;">, of total revenues for the year ended December 31, 2018. Sales to customers in the United States represented </span><span style="font-family:inherit;font-size:10pt;"><span>$45.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;"><span>45%</span></span><span style="font-family:inherit;font-size:10pt;"> of total revenues for the year ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$52.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;"> for the year ended December 31, 2016.</span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Sales to customers in China represented $</span><span style="font-family:inherit;font-size:10pt;"><span>14.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;"><span>12%</span></span><span style="font-family:inherit;font-size:10pt;">, of total revenues for the year ended December 31, 2018. Sales to customers in China represented </span><span style="font-family:inherit;font-size:10pt;"><span>11%</span></span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;"><span>$11.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, of total revenues for each of the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and 2016 respectively. </span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">We had long-lived assets consisting of property, plant and equipment, net of accumulated depreciation, in the following geographic areas for each year presented (in thousands):</span><span style="font-family:inherit;font-size:10pt;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,881</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,500</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Singapore</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,748</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,167</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Canada</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,104</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,481</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EMEA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia-Pacific</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,301</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 1 48100000 0.43 45800000 0.45 52600000 0.50 14000000.0 0.12 0.11 11100000 We had long-lived assets consisting of property, plant and equipment, net of accumulated depreciation, in the following geographic areas for each year presented (in thousands):<span style="font-family:inherit;font-size:10pt;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:72%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,881</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,500</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Singapore</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,748</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,167</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Canada</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,104</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,481</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">EMEA</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asia-Pacific</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,825</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,301</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 1881000 3500000 3748000 5167000 3104000 3481000 66000 125000 26000 28000 8825000 12301000 Commitments and Contingencies<div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating Leases</span></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have entered into various long-term non-cancelable operating lease agreements for equipment and facilities expiring at various times through March 2026. We lease office space under non-cancelable leases in the United States, Canada, Singapore, Japan, China, France and United Kingdom. Certain facility leases also contain rent escalation clauses. Our lease payments are expensed on a straight-line basis over the life of the leases. Rental expense under operating leases, net of amortization of lease incentives and sublease income, for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;">2016</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$5.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$4.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$6.3 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future minimum lease payments and minimum sublease income under non-cancelable operating leases as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> are as follows (in thousands):</span></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Minimum Lease Payments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Minimum Sublease Income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Operating Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,184</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(520</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,664</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(164</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,049</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>827</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>827</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>552</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>552</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Thereafter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,241</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,241</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,262</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(684</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,578</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Commitments</span></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the normal course of business, we enter into various contractual and legally binding purchase commitments. As of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, these commitments were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.6 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Indemnifications</span></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for related expenses including, among others, attorneys' fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. </span></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We incurred legal expenses between October 2015 and the third quarter of 2017 to defend claims by Thermo Fisher Scientific, Inc., (Thermo) against one of our employees. In December 2015, Thermo Fisher Scientific, Inc., (Thermo) filed a complaint in the Circuit Court for the County of Kalamazoo, Michigan against one of its former employees who had recently been hired by us alleging, among other claims, misappropriation of proprietary information and breach of contractual and fiduciary obligations to Thermo while such individual was still an employee of Thermo. In November 2016, Thermo amended its complaint to add us as a party to the litigation, making various commercial and employment-related claims and seeking damages and injunctive relief. In July 2017, we entered into a settlement agreement with Thermo. Pursuant to the terms of the settlement agreement, we agreed to pay Thermo a one-time payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in exchange for a release and dismissal of all claims with prejudice upon payment of the settlement. In August 2017, we paid the settlement of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and received an insurance recovery payment of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to this matter. </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingencies</span></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In early March 2019, we experienced a ransomware attack that infiltrated and encrypted certain of our information technology systems, including systems containing critical business data. Immediately following the attack, actions were taken to recover the compromised systems and we believe we were able to restore their operation without significant loss of business data. Based on the nature of the attack and its impact on our systems, we do not believe confidential data was lost or disclosed, but we are continuing to monitor the situation. As of the date of this filing, we estimate the costs associated with the intrusion to be approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and are seeking to recover these costs under an applicable insurance policy. </span></div>From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates. 5000000.0 4700000 6300000 Future minimum lease payments and minimum sublease income under non-cancelable operating leases as of <span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> are as follows (in thousands):</span><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Minimum Lease Payments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Minimum Sublease Income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Operating Leases</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,184</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(520</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,664</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(164</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,049</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2021</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2022</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>827</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>827</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2023</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>552</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>552</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Thereafter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,241</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,241</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,262</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(684</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,578</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div> 4184000 520000 3664000 2213000 164000 2049000 1245000 0 1245000 827000 0 827000 552000 0 552000 1241000 0 1241000 10262000 684000 9578000 1600000 3000000.0 3000000.0 1000000.0 1500000 Quarterly Results of Operations (Unaudited) <div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Selected quarterly results of operations for the years ended December 31, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> are as follows (in thousands, except for per share amounts):</span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">First</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Second</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Third</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fourth</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,248</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,428</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28,963</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,325</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13,247</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,241</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14,750</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14,775</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss per share, basic and diluted</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.36</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">First</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Second</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Third</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fourth</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,533</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,912</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24,747</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,745</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17,202</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,933</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15,944</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10,456</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss per share, basic and diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.59</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.58</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.46</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div> Selected quarterly results of operations for the years ended December 31, <span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> are as follows (in thousands, except for per share amounts):</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">First</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Second</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Third</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fourth</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,248</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26,428</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28,963</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32,325</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13,247</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,241</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14,750</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14,775</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss per share, basic and diluted</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.36</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">First</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Second</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Third</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fourth</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Quarter</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25,533</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>23,912</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24,747</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27,745</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(17,202</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(16,933</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(15,944</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(10,456</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net loss per share, basic and diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.59</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.58</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.46</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div> 25248000 26428000 28963000 32325000 -13247000 -16241000 -14750000 -14775000 -0.34 -0.42 -0.38 -0.36 25533000 23912000 24747000 27745000 -17202000 -16933000 -15944000 -10456000 -0.59 -0.58 -0.46 -0.27 Subsequent Event<div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From January 9, 2019 through February 27, 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$138.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount pursuant to the terms of the Second Supplemental Indenture dated March 6, 2018, between us and U.S. Bank National Association (Trustee) to the Indenture dated </span></div><span style="font-family:inherit;font-size:10pt;">as of February 14, 2014, between us and the Trustee. As a result of such voluntary conversions, we have elected to fully satisfy our conversion obligations by delivering approximately </span><span style="font-family:inherit;font-size:10pt;"><span>17.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of our common stock to such holders and have retired approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$138.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the 2018 Notes. On February 27, we notified the Trustee of our intention to exercise our Issuer’s Conversion Option pursuant to the terms of the Second Supplemental Indenture with respect to the remaining approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$11.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of 2018 Notes. These bonds were converted into approximately </span><span style="font-family:inherit;font-size:10pt;"><span>1.5 million</span></span> shares of our common stock and the bonds retired in March 2019. 138100000 17900000 138100000 11900000 1500000 SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS AND RESERVES<div style="line-height:120%;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> </span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">In thousands</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Beginning of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Additions/</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Charged to</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Deductions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">End of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Period</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year ended December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>391</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>162</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(427</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>126</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year ended December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>502</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(135</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>391</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year ended December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>484</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(85</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>502</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">In thousands</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Beginning of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Additions/</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Charged to</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Deductions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">End of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Period</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year ended December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Warranty allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>699</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,573</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,409</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>863</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year ended December 31, 2017</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Warranty allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,023</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>695</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1,019</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>699</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Year ended December 31, 2016</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Warranty allowance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,076</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>885</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(938</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,023</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 391000 162000 427000 126000 502000 24000 135000 391000 103000 484000 85000 502000 699000 1573000 1409000 863000 1023000 695000 1019000 699000 1076000 885000 938000 1023000 XML 16 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2018
Mar. 13, 2019
Jun. 30, 2018
Document And Entity Information [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2018    
Document Fiscal Year Focus 2018    
Document Fiscal Period Focus FY    
Trading Symbol FLDM    
Entity Registrant Name FLUIDIGM CORP    
Entity Central Index Key 0001162194    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Accelerated Filer    
Entity Emerging Growth Company false    
Entity Small Business true    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding (shares)   68,989,239  
Entity Public Float     $ 151,752,358
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 95,401 $ 58,056
Short-term investments 0 5,080
Accounts receivable (net of allowances of $126 and $391, at December 31, 2018 and 2017, respectively) 16,651 15,049
Inventories 13,003 15,088
Prepaid expenses and other current assets 2,051 1,528
Total current assets 127,106 94,801
Property and equipment, net 8,825 12,301
Other non-current assets 6,208 7,541
Developed technology, net 57,400 68,600
Goodwill 104,108 104,108
Total assets 303,647 287,351
Current liabilities:    
Accounts payable 4,027 4,211
Accrued compensation and related benefits 14,470 10,535
Other accrued liabilities 7,621 8,490
Deferred revenue, current 11,464 10,238
Total current liabilities 37,582 33,474
Convertible notes, net 172,058 195,238
Deferred tax liability 13,714 16,919
Deferred revenue, non-current 6,327 4,960
Other non-current liabilities 1,850 5,825
Total liabilities 231,531 256,416
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either December 31, 2018 or 2017 0 0
Common stock: $0.001 par value, 200,000 shares authorized at December 31, 2018 and 2017; 49,338 and 38,787 shares issued and outstanding at December 31, 2018 and 2017, respectively 49 39
Additional paid-in capital 631,605 531,666
Accumulated other comprehensive loss (687) (574)
Accumulated deficit (558,851) (500,196)
Total stockholders’ equity 72,116 30,935
Total liabilities and stockholders’ equity $ 303,647 $ 287,351
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Statement of Financial Position [Abstract]    
Accounts receivable, allowances $ 126 $ 391
Preferred stock, par value (usd per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (shares) 10,000,000 10,000,000
Preferred stock, shares issued (shares) 0 0
Preferred stock, shares outstanding (shares) 0 0
Common stock, par value (usd per share) $ 0.001 $ 0.001
Common stock, shares authorized (shares) 200,000,000 200,000,000
Common stock, shares issued (shares) 49,338,000 38,787,000
Common stock, shares outstanding (shares) 49,338,000 38,787,000
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenue:      
Total revenue $ 112,964 $ 101,937 $ 104,446
Cost of sales:      
Total cost of sales 51,315 49,955 46,009
Gross profit 61,649 51,982 58,437
Operating expenses:      
Research and development 30,030 30,826 38,415
Selling, general and administrative 79,783 79,516 93,212
Total operating expenses 109,813 110,342 131,627
Loss from operations (48,164) (58,360) (73,190)
Interest expense (13,893) (5,824) (5,820)
Other income (expense), net 637 385 (1,167)
Loss before income taxes (61,420) (63,799) (80,177)
Benefit from income taxes 2,407 3,264 4,192
Net loss $ (59,013) $ (60,535) $ (75,985)
Net loss per share, basic and diluted (usd per share) $ (1.49) $ (1.84) $ (2.62)
Shares used in computing net loss per share, basic and diluted (shares) 39,652 32,980 29,008
Product revenue      
Revenue:      
Total revenue $ 93,650 $ 84,399 $ 89,003
Cost of sales:      
Total cost of sales 44,861 45,039 41,110
Service revenue      
Revenue:      
Total revenue 19,314 17,348 15,205
Cost of sales:      
Total cost of sales 6,454 4,916 4,899
License revenue      
Revenue:      
Total revenue $ 0 $ 190 $ 238
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Statement of Comprehensive Income [Abstract]      
Net loss $ (59,013) $ (60,535) $ (75,985)
Other comprehensive income (loss), net of tax      
Foreign currency translation adjustment (112) 183 314
Unrealized gain (loss) on available-for-sale securities, net (1) 3 70
Other comprehensive income (loss) (113) 186 384
Comprehensive loss $ (59,126) $ (60,349) $ (75,601)
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss)/Income
Accumulated Deficit
Beginning Balance (shares) at Dec. 31, 2015   28,844,000      
Beginning Balance at Dec. 31, 2015 $ 114,901 $ 29 $ 479,508 $ (1,144) $ (363,492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)   307,000      
Issuance of restricted stock, net of shares withheld for taxes, and other $ (152)   (152)    
Issuance of common stock from option exercises (in shares) 57,000 57,000      
Issuance of common stock from option exercises $ 227   227    
Stock-based compensation expense 13,858   13,858    
Net loss (75,985)       (75,985)
Other comprehensive income (loss) 384     384  
Ending Balance (shares) at Dec. 31, 2016   29,208,000      
Ending Balance at Dec. 31, 2016 53,233 $ 29 493,441 (760) (439,477)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
At-the-market offering (shares)   9,091,000      
Market offering 28,802 $ 9 28,793    
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)   413,000      
Issuance of restricted stock, net of shares withheld for taxes, and other $ (165) $ 1 (166)    
Issuance of common stock from option exercises (in shares) 25,000 25,000      
Issuance of common stock from option exercises $ 100   100    
Issuance of common stock under ESPP (in shares)   50,000      
Issuance of common stock under ESPP 222   222    
Stock-based compensation expense 9,092   9,092    
Net loss (60,535)       (60,535)
Other comprehensive income (loss) $ 186     186  
Ending Balance (shares) at Dec. 31, 2017 38,787,000 38,787,000      
Ending Balance at Dec. 31, 2017 $ 30,935 $ 39 531,666 (574) (500,196)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
At-the-market offering (shares)   9,373,000      
Market offering 59,093 $ 9 59,084    
Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)   886,000      
Issuance of restricted stock, net of shares withheld for taxes, and other $ (378) $ 1 (379)    
Issuance of common stock from option exercises (in shares) 40,000 40,000      
Issuance of common stock from option exercises $ 208   208    
Issuance of common stock under ESPP (in shares)   252,000      
Issuance of common stock under ESPP 1,203   1,203    
Conversion option on convertible debt 29,357   29,357    
Closing cost related to conversion option on convertible debt (557)   (557)    
Stock-based compensation expense 11,023   11,023    
Net loss (59,013)       (59,013)
Other comprehensive income (loss) $ (113)     (113)  
Ending Balance (shares) at Dec. 31, 2018 49,338,000 49,338,000      
Ending Balance at Dec. 31, 2018 $ 72,116 $ 49 $ 631,605 $ (687) $ (558,851)
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating activities      
Net loss $ (59,013) $ (60,535) $ (75,985)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 5,372 7,409 6,738
Stock-based compensation expense 11,023 9,092 13,858
Amortization of developed technology 11,200 11,200 11,200
Amortization of debt discounts, premiums and issuance costs 8,379 287 278
Other non-cash items 175 (890) (26)
Loss on disposal of property and equipment 141 135 87
Changes in assets and liabilities:      
Accounts receivable (1,788) (554) 10,521
Inventories 1,488 4,596 (3,387)
Prepaid expenses and other assets 178 1,583 (457)
Accounts payable (294) 585 (2,271)
Deferred revenue 2,574 1,636 (274)
Other liabilities (4,636) 1,358 580
Net cash used in operating activities (25,201) (24,098) (39,138)
Investing activities      
Purchases of investments (1,450) (6,276) (38,594)
Proceeds from sales and maturities of investments 6,541 25,550 86,431
Proceeds from sale of investment in Verinata 0 0 2,330
Purchases of intangible assets 0 (50) 0
Purchases of property and equipment (372) (1,566) (5,065)
Net cash provided by investing activities 4,719 17,658 45,102
Financing activities      
Payment of debt and equity issuance costs (2,862) 0 0
Net proceeds from issuance of common stock 59,469 28,793 0
Payments for taxes related to net share settlement of equity awards 208 100 227
Proceeds from stock issuance from ESPP 1,203 222 0
Payments for taxes related to net share settlement of equity awards (358) (118) (111)
Net cash provided by financing activities 57,660 28,997 116
Effect of foreign exchange rate fluctuations on cash and cash equivalents 167 454 (152)
Net increase in cash and cash equivalents 37,345 23,011 5,928
Cash and cash equivalents at beginning of period 58,056 35,045 29,117
Cash and cash equivalents at end of period 95,401 58,056 35,045
Supplemental disclosures of cash flow information      
Cash paid for interest 5,534 5,534 5,534
Cash paid for income taxes, net of refunds $ 321 $ 245 $ 355
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Description of Business
 12 Months Ended
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business Description of Business

Fluidigm Corporation (we, our, or us) was incorporated in the State of California in May 1999 to commercialize microfluidic technology initially developed at the California Institute of Technology. In July 2007, we were reincorporated in Delaware. Our headquarters are located in South San Francisco, California.

We create, manufacture, and market innovative technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, PCR, Library Prep, Single Cell Genomics, and consumables, including IFCs, assays, and reagents. Our focus is on the most pressing needs in translational and clinical research, including cancer, immunology and immunotherapy. We use proprietary CyTOF® and microfluidics technologies to develop innovative end-to-end solutions that have the flexibility required to meet the needs of translational research and the robustness to support high-impact clinical research studies. We sell our instruments to leading academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, and biopharmaceutical, biotechnology and Ag-Bio companies.
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2018
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies

Basis of Presentation and Consolidation

The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly-owned subsidiaries. As of December 31, 2018, we had wholly-owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, and Germany. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.

Certain prior period amounts in the consolidated statements of stockholders’ equity and consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders' equity, total revenue, total costs and expenses, loss from operations or net loss.

Use of Estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.


Foreign Currency

Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year.

Revenue Recognition

We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities.

We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.

Product Revenue

We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.

We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.

Service Revenue

We recognize revenue from repairs, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed.

Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally one to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our consolidated balance sheet as deferred revenue.

Contract Costs

Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally one to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred.

Product Warranties

We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the consolidated statements of operations.

Significant Judgments

Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.

Cash and Cash Equivalents

We consider all highly liquid financial instruments with maturities at the time of purchase of three months or less to be cash equivalents. Cash and cash equivalents may consist of cash on deposit with banks, money market funds, and notes from government-sponsored agencies.

Investments

Short-term investments are comprised of notes from government-sponsored agencies. All investments are recorded at estimated fair value. Any unrealized gains and losses from investments are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity. We evaluate our investments to assess whether investments with unrealized loss positions are other-than-temporarily impaired. An investment is considered to be other-than-temporarily impaired if the impairment is related to deterioration in credit risk or if it is likely that we will sell the securities before the recovery of their cost basis. No investment has been assessed as other than temporarily impaired, and realized gains and losses were immaterial during the years presented. The cost of securities sold, or the amount reclassified out of accumulated other comprehensive income into earnings is based on the specific-identification method.

Accounts Receivable

Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.

Concentrations of Business and Credit Risk

Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns.

We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. No single customer represented more than 10% of total revenue for 2018, 2017, or 2016, and no single customer represented more than 10% of total accounts receivable at December 31, 2018, 2017, or 2016.

Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.

Inventories

Inventories are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory costs include direct materials, direct labor, and normal manufacturing overhead. Finished goods that are used for research and development are expensed as consumed or depreciated over their period of use. Provisions for slow-moving, excess, and obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values based on product life cycle, development plans, product expiration, and quality issues.

Property and Equipment

Property and equipment, including leasehold improvements, are stated at cost less accumulated depreciation. Accumulated depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets or the remaining term of the lease, whichever is shorter. The estimated useful lives of our property and equipment are generally as follows: computer
equipment and software, three to four years; laboratory and manufacturing equipment, two to five years; and office furniture and fixtures, five years.

Depreciation expense for the years ended December 31, 2018, 2017, and 2016 was $4.2 million, $5.9 million, and $5.1 million, respectively.

Goodwill, Intangible Assets and Other Long-Lived Assets

Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.

Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. We first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we then conduct a two-step test for impairment of goodwill. In the first step, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceed its fair value, then the second step of the impairment test must be performed in order to determine the implied fair value of the goodwill. If the carrying value of the goodwill exceeds its implied fair value, then an impairment loss equal to the difference would be recorded.

We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset, and adjust the carrying value of the asset accordingly. We did not recognize any impairment of long-lived assets for any of the periods presented herein.

Convertible Notes

In February 2014, we closed an underwritten public offering $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our new 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). Following the exchange, approximately $51.3 million in aggregate principal amount of the 2014 Notes remained outstanding in addition to $150.0 million in aggregate principal amount of the 2018 Notes.

As the 2018 Notes are convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. The embedded conversion option value was calculated as the difference between (i) the total fair value of the 2018 Notes and (ii) the fair value of a similar debt instrument excluding the embedded conversion option. We determined an embedded conversion option value of $29.3 million, which was recorded in additional paid-in-capital and reduced the carrying value of the 2018 Notes. The resulting discount on the 2018 Notes will be amortized over the expected term of the 2018 Notes, using the effective interest method through the first note holder put date, of February 6, 2023.

For both the 2014 Notes and 2018 Notes, offering-related costs, including underwriting costs are capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are being be amortized over the expected term of the related Notes using the effective interest method.
Fair Value of Financial Instruments

Our financial instruments consist primarily of cash and cash equivalents, investments, accounts receivable, accounts payable, and convertible notes. Our cash equivalents, investments, accounts receivable, and accounts payable have short maturity or payment periods. Accordingly, their carrying values approximated their fair values at December 31, 2018 and 2017. The convertible notes are presented at their carrying value, with fair value disclosures made in Note 7. As a basis for considering fair value, we follow a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level I: observable inputs such as quoted prices in active markets;
Level II: inputs other than quoted prices in active markets that are observable either directly or indirectly; and
Level III: unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions.

This hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. Our cash equivalents, which include money market funds, are classified as Level I because they are valued using quoted market prices. Our investments and convertible notes are generally classified as Level II because their value is based on valuations using significant inputs derived from or corroborated by observable market data. Depending on the security, the income and market approaches are used in the model driven valuations. Inputs of these models include recently executed transaction prices in securities of the issuer or comparable issuers and yield curves.

Research and Development

We recognize research and development expenses in the period incurred. Research and development expenses consist of personnel costs, independent contractor costs, prototype and materials expenses, allocated facilities and information technology expenses, and related overhead expenses.

Advertising Costs

We expense advertising costs as incurred. We incurred advertising costs of $2.2 million, $1.8 million and $2.3 million during 2018, 2017, and 2016, respectively.

Income Taxes

We use the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a “more likely than not” criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.

We recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. Any interest and penalties related to uncertain tax positions are reflected in the income tax provision.

Stock-Based Compensation

We account for stock options and restricted stock units granted to employees and directors and stock purchases under ESPP based on the fair value of the awards. We recognize stock-based compensation expense on a straight-line basis over the requisite service periods for non-performance-based awards. For performance-based stock awards, stock-based compensation expense is recognized over the requisite service period when the achievement of each individual performance goal becomes probable.

 Comprehensive Loss

Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the consolidated statements of comprehensive loss.

The components of accumulated other comprehensive loss, net of tax, for the years ended December 31, 2018, 2017, and 2016 are as follows (in thousands):
 
 
Foreign Currency Translation Adjustment
 
Unrealized Gain (Loss) on Investments
 
Accumulated Other Comprehensive Income (Loss)
Ending balance at December 31, 2016
 
$
(758
)
 
$
(2
)
 
$
(760
)
Change during the year
 
183

 
3

 
186

Ending balance at December 31, 2017
 
$
(575
)
 
$
1

 
$
(574
)
Change during the year
 
(112
)
 
(1
)
 
(113
)
Ending balance at December 31, 2018
 
$
(687
)
 
$
—

 
$
(687
)


Immaterial amounts of unrealized gains and losses have been reclassified into the consolidated statement of operations for the years ended December 31, 2018, 2017 and 2016.

Net Loss per Share

Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units and options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.

The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):

 
 
December 31,
 
 
2018
 
2017
 
2016
Stock options, restricted stock units and performance awards
 
4,354

 
3,501

 
4,622

2018 Convertible Notes
 
19,035

 
—

 
—

2018 Convertible Notes potential make-whole shares
 
757

 
—

 
—

2014 Convertible Notes
 
916

 
3,598

 
3,598

Total
 
25,062

 
7,099

 
8,220



Recent Accounting Changes and Accounting Pronouncements

Adoption of New Accounting Guidance

In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers (Topic 606). Topic 606 and its related amendments supersede Revenue Recognition (Topic 605), issued in June 2010, and provide principles for recognizing revenue for goods and services in a manner consistent with the transfer of control of those goods and services to the customer.

We adopted Topic 606 on January 1, 2018, using the modified retrospective method applied to those contracts with unrecognized revenue on the adoption date. We recognized the effect of applying the new revenue standard by recording a cumulative catch-up adjustment that reduced the accumulated deficit component of stockholders’ equity by $0.4 million and increased current assets by $0.2 million and non-current assets by $0.2 million. The adjustment capitalized certain sales commission costs that were incurred to obtain instrument service contracts. Under Topic 605, we accounted for these incremental contract acquisition costs by recognizing them as expense at the point the contract was awarded. Under Topic 606, the costs are capitalized and amortized to expense over the life of the contract, which is generally one to three years. The comparative information for periods prior to January 1, 2018, has not been restated and continues to be reported in accordance with Topic 605.

The following table summarizes the cumulative effect of adopting Topic 606 on amounts previously reported in our consolidated balance sheet at December 31, 2017 (in thousands):
 
 
Balance at December 31, 2017
 
Topic 606 Transition Adjustments
 
Balance at January 1, 2018
Prepaid expenses and other current assets
 
$
1,528

 
$
153

 
$
1,681

Total current assets
 
$
94,801

 
$
153

 
$
94,954

Other non-current assets
 
$
7,541

 
$
205

 
$
7,746

Total assets
 
$
287,351

 
$
358

 
$
287,709

Accumulated deficit
 
$
(500,196
)
 
$
358

 
$
(499,838
)
Total stockholders' equity
 
$
30,935

 
$
358

 
$
31,293

Total liabilities and stockholders' equity
 
$
287,351

 
$
358

 
$
287,709



The following table summarizes the impacts on our consolidated statements of operations of adopting Topic 606 compared to Topic 605 for the twelve months ended December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
 Topic 606
 
Effect of Change
 
 
Twelve Months Ended December 31, 2018
Selling, general and administrative
 
$
79,783

 
$
79,859

 
$
(76
)
Total costs and expenses
 
$
161,128

 
$
161,204

 
$
(76
)
Loss from operations
 
$
(48,164
)
 
$
(48,240
)
 
$
76

Loss before income taxes
 
$
(61,420
)
 
$
(61,496
)
 
$
76

Net loss
 
$
(59,013
)
 
$
(59,089
)
 
$
76


The following table summarizes the impacts on our consolidated balance sheets of adopting Topic 606 compared to Topic 605 at December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
Topic 606
 
Effect of Change
 
 
 
 
December 31, 2018
 
 
Prepaid expenses and other current assets
 
$
2,051

 
$
1,884

 
$
167

Total current assets
 
$
127,106

 
$
126,939

 
$
167

Other non-current assets
 
$
6,208

 
$
5,941

 
$
267

Total assets
 
$
303,647

 
$
303,213

 
$
434

Stockholders' equity
 
$
72,116

 
$
71,682

 
$
434

Total liabilities and stockholders' equity
 
$
303,647

 
$
303,213

 
$
434



In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. This ASU allows SEC reporting companies to record provisional amounts in earnings for the year ended December 31, 2017, due to the complexities involved in accounting for the enactment of the Tax Act. We recognized the estimated income tax effects of the Tax Act in its 2017 Consolidated Financial Statements in accordance with SEC Staff Accounting Bulletin No. 118 (“SAB No. 118”). In accordance with SAB No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense was required. Refer to Note 10 for further information regarding the provisional amounts recorded by the Company.

In February 2018, the FASB issued ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This ASU amends the reporting of comprehensive income to allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act (the Tax Act). The Tax Act was enacted in December 2017 and reduced the U.S federal corporate income tax rate and made other changes to U.S. federal tax law. ASU 2018-02 is effective for our fiscal year beginning January 1, 2019, and early adoption is permitted. This standard did not have a material effect on our consolidated financial statements.

In August 2016, the FASB issued ASU 2016-15 Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The ASU addresses eight specific cash flow issues and their presentation within the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18 Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB’s Emerging Issues Task Force, amending the presentation of restricted cash within the statement of cash flows. The new guidance requires that restricted cash be included within cash and cash equivalents on the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.

Recent Accounting Pronouncements

In August 2018, the FASB issued ASU 2018-15 Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact of adoption on our consolidated financial statements.

In February 2016, the FASB established Topic 842, Leases, by issuing Accounting Standards Update (ASU) No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard
establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating; the classification will impact the expense recognition in the income statement.

Modified Retrospective Transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. We expect to adopt the new standard on January 1, 2019 and use the effective date as our date of initial application. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. For dates and periods prior to January 1, 2019, the original disclosures under ASC 840 will be disclosed.

The new standard provides several optional practical expedients in transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. We do not expect to elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us.

We expect that this standard will have a material effect on our financial statements. While we continue to assess all the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our building, vehicle and equipment leases.
 
On adoption, we currently expect to recognize $8.0 million to $11.0 million of additional operating liabilities, based on the present value of the remaining fixed rental payments under current leasing standards for existing operating leases, with corresponding ROU assets of approximately $6.0 million to $9.0 million. The difference between the initial lease liability and right of use asset is attributable to deferred rent. We do not expect any impact on retained earnings from the adoption of ASC 842.

The new standard also provides certain accounting elections for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities. We also currently expect to elect to not separate lease and nonlease components for our building leases and to take a portfolio approach for our vehicles leases by country.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU will be effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020, with early adoption permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements.
XML 25 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue
 12 Months Ended
Dec. 31, 2018
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregation of Revenue
The following table presents our revenue for the year ended December 31, 2018, 2017, and 2016, respectively, based on geographic area and by products and services (in thousands):
 
Year Ended December 31,
 
2018
 
2017
 
2016
Geographic Markets:
 
 
 
 
 
Americas
$
51,172

 
$
49,290

 
$
56,229

EMEA
36,617

 
32,642

 
29,739

Asia-Pacific
25,175

 
20,005

 
18,478

Total
$
112,964

 
$
101,937

 
$
104,446


 
Year Ended December 31,
 
2018
 
2017
 
2016
Products and Services:
 
 
 
 
 
Instruments
$
45,491

 
$
42,505

 
$
46,834

Consumables
48,159

 
41,894

 
42,169

Product revenue
93,650

 
84,399

 
89,003

Services
19,314

 
17,348

 
15,205

License
—

 
190

 
238

Total
$
112,964

 
$
101,937

 
$
104,446



Performance Obligations

We reported $15.2 million of deferred revenue on our December 31, 2017 consolidated balance sheet. During the twelve months ended December 31, 2018, $9.1 million of the opening balance was recognized as revenue and $11.7 million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At December 31, 2018, we reported $17.8 million of deferred revenue.

The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at December 31, 2018 (in thousands):
Fiscal Year
 
 
 
 
Expected Revenue (1)
2019
 
 
 
 
$
10,037

2020
 
 
 
 
5,149

2021
 
 
 
 
2,525

Thereafter
 
 
 
 
1,436

Total
 
 
 
 
$
19,147

_______
(1) Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.

We apply the practical expedient that permits us to not disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.

Contract Costs

We reported $0.4 million of capitalized commission costs from instrument service contracts at December 31, 2018 in the consolidated balance sheet.
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Goodwill and Intangible Assets, net
 12 Months Ended
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, net Goodwill and Intangible Assets, net

In connection with our acquisition of DVS in February 2014, we recognized goodwill of $104.1 million. Intangible assets include developed technology related to the DVS acquisition and other intangible assets included in Other non-current assets.
Developed Technology, Patents and Licenses

Developed technology as a result of the DVS acquisition, and patents and licenses, were as follows (in thousands):

 
December 31, 2018
 
 
Gross Amount
 
Accumulated Amortization
 
Net
 
Weighted-Average Amortization Period
Developed technology
 
$
112,000

 
$
(54,600
)
 
$
57,400

 
10.0 years
Patents and licenses
 
$
11,274

 
$
(6,861
)
 
$
4,413

 
7.8 years

 
 
December 31, 2017
 
 
Gross Amount
 
Accumulated Amortization
 
Net
 
Weighted-Average Amortization Period
Developed technology
 
$
112,000

 
$
(43,400
)
 
$
68,600

 
10.0 years
Patents and licenses
 
$
11,274

 
$
(5,721
)
 
$
5,553

 
7.8 years

Total amortization expense for the years ended December 31, 2018, December 31, 2017, and December 31, 2016 was $12.3 million, $12.4 million and $12.4 million, respectively.

Based on the carrying value of intangible assets, net, as of December 31, 2018, the annual amortization expense is expected to be as follows (in thousands):
Fiscal Year
Developed Technology Amortization Expense
 
Patents and Licenses Amortization Expense
 
Total
2019
$
11,200

 
$
1,046

 
$
12,246

2020
11,200

 
1,046

 
12,246

2021
11,200

 
888

 
12,088

2022
11,200

 
815

 
12,015

2023
11,200

 
610

 
11,810

Thereafter
1,400

 
8

 
1,408

Total
$
57,400

 
$
4,413

 
$
61,813
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details
 12 Months Ended
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Details Balance Sheet Details

Cash and Cash Equivalents

Cash and cash equivalents consisted of the following as of December 31, 2018 and 2017 (in thousands):
 
 
December 31,
Cash and cash equivalents:
 
2018
 
2017
Cash
 
$
17,685

 
$
20,129

Money market funds
 
77,716

 
16,142

       U.S. Government and agency securities
 
—

 
21,785

Total
 
$
95,401

 
$
58,056



Inventories

Inventories consisted of the following as of December 31, 2018 and 2017 (in thousands):
 
 
December 31,
Inventories:
 
2018
 
2017
Raw materials
 
$
5,996

 
$
7,566

Work-in-process
 
650

 
929

Finished goods
 
6,357

 
6,593

Total inventories, net
 
$
13,003

 
$
15,088



Property and Equipment, net

Property and equipment consisted of the following as of December 31, 2018 and 2017 (in thousands):
 
 
December 31,
Property and equipment:
 
2018
 
2017
Computer equipment and software
 
$
4,201

 
$
4,179

Laboratory and manufacturing equipment
 
18,780

 
20,069

Leasehold improvements
 
7,173

 
7,799

Office furniture and fixtures
 
1,506

 
1,892

Property and equipment, gross
 
31,660

 
33,939

Less accumulated depreciation and amortization
 
(22,855
)
 
(21,646
)
Construction-in-progress
 
20

 
8

Property and equipment, net
 
$
8,825

 
$
12,301


 
Product Warranties

Activity for our warranty accrual for the years ended December 31, 2018 and 2017, which are included in other accrued liabilities, is summarized below (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
Beginning balance
 
$
699

 
$
1,023

Accrual for current period warranties
 
1,573

 
695

Warranty costs incurred
 
(1,409
)
 
(1,019
)
Ending balance
 
$
863

 
$
699
XML 28 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Convertible Notes and Credit Facility
 12 Months Ended
Dec. 31, 2018
Debt Disclosure [Abstract]  
Convertible Notes and Credit Facility Convertible Notes and Credit Facility
2014 Senior Convertible Notes (2014 Notes)
On February 4, 2014, we closed an underwritten public offering of $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes) pursuant to an underwriting agreement, dated January 29, 2014. The 2014 Notes accrue interest at a rate of 2.75% per year, payable semi-annually in arrears on February 1 and August 1 of each year. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes.

The initial conversion rate of the 2014 Notes is 17.8750 shares of our common stock, par value $0.001 per share, per $1,000 principal amount of 2014 Notes (which is equivalent to an initial conversion price of approximately $55.94 per share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events including upon conversion in connection with a fundamental change, as defined in the indenture governing the 2014 Notes or, subject to certain conditions, redemption of the 2014 Notes by us.

Holders may surrender their 2014 Notes for conversion at any time prior to the stated maturity date. On or after February 6, 2018, and prior to February 6, 2021, we may redeem any or all of the 2014 Notes in cash if the closing price of our common stock exceeds 130% of the conversion price for a specified number of days, and on or after February 6, 2021, we may redeem any or all of the 2014 Notes in cash without any such condition. The redemption price of the 2014 Notes will equal 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest. Holders may require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2021, February 6, 2024, and February 6, 2029, at a repurchase price in cash equal to 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest. If we undergo a fundamental change, as defined in the terms of the 2014 Notes, holders may require us to repurchase the 2014 Notes in whole or in part for cash at a repurchase price equal to 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest.

In February 2014, we received $195.2 million, net of underwriting discounts, from the issuance of the 2014 Notes and incurred approximately $1.1 million in offering-related expenses. The underwriting discount of $6.0 million and the debt issuance costs of $1.1 million were recorded as offsets to the proceeds. The underwriting discount and offering-related expenses are being amortized to interest expense using the effective-interest rate method.

2018 Senior Convertible Notes (2018 Notes)

In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for new convertible notes (2018 Notes). As of the closing of the 2018 Notes on March 12, 2018, the estimated fair value was $145.5 million. The difference between the $150.0 million aggregate principal amount of the 2018 Notes and its fair value will be amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023.

We accounted for the exchange transaction as an extinguishment of debt due to the significance of the change in value of the embedded conversion option, resulting in a $0.1 million gain. The gain on extinguishment of debt was calculated as the difference between the reacquisition price (i.e., the fair value of the principal amount of 2018 Notes) and the net carrying value of the 2014 Notes exchanged net of unamortized debt discount and debt issuance cost write-offs.

The 2018 Notes accrue interest at a rate of 2.75%, payable semi-annually in arrears on February 1 and August 1 of each year. The 2018 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the indenture governing the 2018 Notes. The initial conversion rate of the 2018 Notes is 126.9438 shares of our common stock, par value $0.001 per share, per $1,000 principal amount of the 2018 Notes (which is equivalent to an initial conversion price of approximately $7.88 per share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events. Those certain specified events include Holders who convert their 2018 Notes voluntarily prior to our exercise of the Issuer's Conversion Option or in connection with a make-whole fundamental change prior to February 6, 2023, are entitled, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2018 Notes. Any time prior to the maturity of the 2018 Notes, we may convert the 2018 Notes, in whole but not in part, into cash, shares of our common stock, or combination thereof, if the closing price of our common stock equals or exceeds 110% of the conversion price then in effect for a specified number of days (Issuer’s Conversion Option). On or after February 6, 2022, we may elect to redeem all or any portion of the
2018 Notes at a redemption price equal to 100% of the accreted principal amount of the 2018 Notes on the redemption date of the 2018 Notes, plus accrued and unpaid interest.

Holders of the 2018 Notes have the right, at their option, to require us to purchase all or a portion of the 2018 Notes (i) on February 6, 2023, February 6, 2026, and February 6, 2029, or (ii) in the event of a fundamental change, as defined in the indenture governing the 2018 Notes, in each case, at a repurchase price equal to 100% of the accreted principal amount (i.e., up to 120% of the outstanding principal amount) of the 2018 Notes on the fundamental change repurchase date, plus accrued and unpaid interest.

Offering-related costs for the 2018 Notes were approximately $2.8 million. Offering-related costs of $2.2 million were capitalized as debt issuance costs, recorded as an offset to the carrying value of the 2018 Notes, and are being be amortized over the expected term of the 2018 Notes using the effective interest method through the first note holder put date of February 6, 2023. Offering-related costs of $0.6 million were accounted for as equity issuance costs, recorded as an offset to additional paid-in capital, and are not subject to amortization. Offering-related costs were allocated between debt and equity in the same proportion as the allocation of the 2018 Notes between debt and equity.

The carrying values of the components of the 2014 Notes and 2018 Notes are as follows (in thousands):
 
 
December 31,
 
 
2018
 
2017
   2.75% 2014 Notes due 2034
 
 
 
 
Principal amount
 
$
51,250

 
$
201,250

Unamortized debt discount
 
(1,232
)
 
(5,087
)
Unamortized debt issuance cost
 
(224
)
 
(925
)
 
 
$
49,794

 
$
195,238

   2.75% 2018 Notes due 2034
 
 
 
 
Principal amount
 
$
149,999

 
$
—

Premium accretion
 
3,755

 
—

Unamortized debt discount
 
(29,558
)
 
—

Unamortized debt issuance cost
 
(1,932
)
 
—

 
 
$
122,264

 
$
—

 
 
$
172,058

 
$
195,238



2018 Revolving Credit Facility

On August 2, 2018, we entered into a revolving credit facility with Silicon Valley Bank (Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $15.0 million (Maximum Amount) or (ii) the sum of (a) 85% of our eligible receivables and (b) 50% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. Subject to the level of this borrowing base, we may make and repay borrowings from time to time until the maturity of the revolving credit facility. The borrowing base as of December 31, 2018 under the revolving credit facility was $12.3 million. There were no borrowings outstanding under the Revolving Credit Facility at December 31, 2018.

The Revolving Credit Facility matures on August 2, 2020, and is collateralized by substantially all our property, other than intellectual property. Outstanding loans under the Revolving Credit Facility will bear interest, at the greater of (i) prime rate plus 0.50% or (ii) 5.50%. Interest on any outstanding loans is due and payable monthly and the principal balance is due at maturity though loans can be prepaid at any time without penalty. In addition, we pay a quarterly unused revolving line facility fee of 0.75% per annum on the average unused facility.

Subject to certain exceptions, we must pay a prepayment fee equal to (i) 2.00% of the Maximum Amount if it prepays all advances and terminates the Loan Agreement prior to August 2, 2019, or (ii) 1.00% of the Maximum Amount if it prepays all advances and terminates the Loan Agreement on or after August 2, 2019, and prior to the maturity date.

We incurred approximately $335,000 of debt issuance costs in connection with the facility, including $225,000 in commitment fees. Half of the commitment fee was paid at the inception of the facility with the remainder due on the earliest of (i) August 2, 2019, (ii) the date on which we terminate the agreement or (iii) the occurrence and continuance of an event of default. Debt issuance costs were capitalized and are being amortized to interest expense over the life of the Revolving Credit Facility.

The Revolving Credit Facility contains customary affirmative and negative covenants which, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. The Revolving Credit Facility also contains customary events of default, subject to customary cure periods for certain defaults, that include, among other things, non-payment defaults, covenant defaults, material judgment defaults, bankruptcy and insolvency defaults, cross-defaults to certain other material indebtedness, and defaults due to inaccuracy of representation and warranties. Upon an event of default, the lender may declare all or a portion of the outstanding obligations payable by us to be immediately due and payable and exercise other rights and remedies provided for under the Revolving Credit Facility. During the existence of an event of default, interest on the obligations under the Revolving Credit Facility could be increased to 5.0% above the otherwise applicable rate of interest.

We were in compliance with all the terms and conditions of the Revolving Credit Facility at December 31, 2018.
XML 29 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value of Financial Instruments
 12 Months Ended
Dec. 31, 2018
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands):
 
December 31, 2018
 
Carrying Amount
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Fair Value
 
Cash and Cash Equivalents
 
Short-Term Marketable Securities
Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash
$
17,685

 
$
—

 
$
—

 
$
17,685

 
$
17,685

 
$
—

Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
    Level I:
 
 
 
 
 
 
 
 
 
 
 
         Money market funds
77,716

 
—

 
—

 
77,716

 
77,716

 
—

         U.S. treasury securities
—

 
—

 
—

 
—

 
—

 
—

    Level II:
 
 
 
 
 
 
 
 
 
 
 
         U.S. government and agency securities
—

 
—

 
—

 
—

 
—

 
—

Total
$
95,401

 
$
—

 
$
—

 
$
95,401

 
$
95,401

 
$
—

 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2017
 
Carrying Amount
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Fair Value
 
Cash and Cash Equivalents
 
Short-Term Marketable Securities
Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash
$
20,129

 
$
—

 
$
—

 
$
20,129

 
$
20,129

 
$
—

Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
    Level I:
 
 
 
 
 
 
 
 
 
 
 
         Money market funds
16,142

 
—

 
—

 
16,142

 
16,142

 
—

         U.S. treasury securities
497

 
—

 
—

 
497

 
—

 
497

    Level II:
 
 
 
 
 
 
 
 
 
 
 
         U.S. government and agency securities
26,369

 
—

 
(1
)
 
26,368

 
21,785

 
4,583

Total
$
63,137

 
$
—

 
$
(1
)
 
$
63,136

 
$
58,056

 
$
5,080


There were no transfers between Level I and Level II measurements during the year ended December 31, 2018, and there were no changes in the valuation techniques used.
Based on an evaluation of securities that were in a loss position, we did not recognize any other-than-temporary impairment charges for the years ended December 31, 2018, 2017, and 2016. None of our investments have been in a continuous loss position for more than 12 months. We concluded that the declines in market value of our available-for-sale securities investment portfolio were temporary in nature and did not consider any of our investments to be other-than-temporarily impaired.
Convertible Notes
The estimated fair value of the 2014 and 2018 Notes is based on a market approach and represents a Level II valuation. When determining the estimated fair value of our long-term debt, we used a commonly accepted valuation methodology and market-based risk measurements that are indirectly observable, such as credit risk.
The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2018 Notes at December 31, 2018 and 2017, respectively (in thousands):
 
December 31, 2018
 
December 31, 2017
 
Par Value
 
Carrying Value
 
Fair Value
 
Par Value
 
Carrying Value
 
Fair Value
2014 Notes
$
51,250

 
$
49,794

 
$
43,665

 
$
201,250

 
$
195,238

 
$
166,162

2018 Notes
149,999

 
122,264

 
171,843

 
—

 
—

 
—

Total
$
201,249

 
$
172,058

 
$
215,508

 
$
201,250

 
$
195,238

 
$
166,162
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Shareholders' Equity
 12 Months Ended
Dec. 31, 2018
Equity [Abstract]  
Shareholders' Equity Shareholders' Equity

Tax Benefit Preservation Plan

On August 1, 2017, the Tax Benefit Preservation Plan (Tax Plan) dated as of November 21, 2016 expired and all of the preferred share purchase rights distributed to the holders of our common stock pursuant to the Tax Plan expired.

2018 Market Offering

On December 14, 2018, we closed on our previously announced underwritten public offering of 9,372,500 shares our common stock, $0.001 par value. The common stock was sold at a price to the public of $6.75 per share, for aggregate gross proceeds of approximately $63.3 million, from our existing shelf registration statement. Net proceeds from the offering were approximately $59.1 million after deducting underwriting discounts and commissions of $3.8 million and the $0.4 million of estimated expenses of the offering. We intend to use the net proceeds of the offering for general corporate purposes, including working capital, capital expenditures and continued research and development with respect to products and technologies, and to fund possible investments in or acquisitions of complementary businesses, products, or technologies.

2017 At-the-Market Offering

On August 10, 2017, we sold 9,090,909 shares of our common stock, $0.001 par value per share, pursuant to an earlier Sales Agreement, for aggregate gross proceeds of $30.0 million. Our aggregate net proceeds were approximately $28.8 million, after deducting related expenses, including commissions of approximately $0.7 million and issuance costs of approximately $0.5 million. These sales fully exhausted the shares that were available for sale under the Sales Agreement. 

At December 31, 2018, we had reserved shares of common stock for future issuance under equity compensation plans as follows:
(in 000's)
 
Securities To Be Issued Upon Exercise Of Options
 
Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units
 
Number Of Remaining Securities Available For Future Issuance
2009 Equity Incentive Plan
 
43

 
—

 
—

2011 Equity Incentive Plan
 
2,064

 
1,631

 
2,022

DVS Sciences Inc. 2010 Equity Incentive Plan
 
38

 
—

 
—

2017 Inducement Award Plan
 
240

 
338

 
1,422

2017 Employee Stock Purchase Plan
 

 
—

 
698

 
 
2,385

 
1,969

 
4,142
XML 31 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Plans
 12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Plans Stock-Based Plans
Our board of directors sets the terms, conditions, and restrictions related to our ESPP and the grant of stock options, RSUs and performance-based awards under our various stock-based plans. Our board of directors determines the number of awards to grant and also sets vesting criteria.
In general, RSUs vest on a quarterly basis over a period of four years from the date of grant at a rate of 25% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, subject to the employees' continued employment.
Incentive stock options and non-statutory stock options granted under the 2011 Plan have a term of no more than ten years from the date of grant and an exercise price of at least 100% of the fair market value of the underlying common stock on the date of grant. If a participant owns stock representing more than 10% of the voting power of all classes of our stock on the grant date, an incentive stock option awarded to the participant will have a term of no more than five years from the date of grant and an exercise price of at least 110% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either 25% on the first anniversary of the option grant date and ratably each month over the remaining period of 36 months, or ratably each month over 48 months. We may grant options with different vesting terms from time to time.
For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.
2011 Equity Incentive Plan
On January 28, 2011, our board of directors adopted the 2011 Equity Incentive Plan (the 2011 Plan) under which incentive stock options, non-statutory stock options, restricted stock units (RSUs), stock appreciation rights, performance units, and performance shares may be granted to our employees, directors, and consultants.
2009 Equity Incentive Plan and 1999 Stock Option Plan
Our 2009 Equity Incentive Plan (the 2009 Plan) terminated on the date the 2011 Plan was adopted. Options granted, or shares issued under the 2009 Plan that were outstanding on the date the 2011 Plan became effective, remained subject to the terms of the 2009 Plan.
2017 Inducement Award Plan
On January 5, 2017, we adopted the Fluidigm Corporation 2017 Inducement Award Plan (the “Inducement Plan”) and reserved 2 million shares of our common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provides for the grant of equity-based awards and its terms are substantially similar to the 2011 Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan may only be made to individuals not previously our employees or non-employee members of our board of directors (or following such individual's bona fide period of non-employment), as an inducement material to the individual's entry into employment with us or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the Nasdaq Listing Rules.
Valuation and Expense Information
We use the Black-Scholes option-pricing model to estimate the fair value of stock options granted under our equity incentive plans. The weighted average assumptions used to estimate the fair value were as follows:
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Stock options:
 
 
 
 
 
 
Weighted average expected volatility
 
68.4
%
 
65.0
%
 
43.4
%
Weighted average expected term
 
4.7 years

 
4.2 years

 
6.0 years

Weighted average risk-free interest rate
 
2.7
%
 
1.7
%
 
1.4
%
Dividend yield
 
—

 
—

 
—

Weighted-average fair value per share
 
$
3.45

 
$
2.97

 
$
3.19

 
 
 
 
 
 
 


We determine the expected volatility based on our historical stock price volatility generally commensurate with the estimated expected term of the stock awards. The expected term of an award is based on historical forfeiture experience, exercise activity, and the terms and conditions of the stock awards. The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities approximately equal to each grant’s expected
life. Each of these inputs is subjective and generally requires significant judgment by us. The fair value of the underlying common stock is also required to compute the fair value calculation of options and ESPP. We account for forfeitures as they occur.

We grant stock options at exercise prices not less than the fair value of our common stock at the date of grant. The fair value of RSUs granted to employees was estimated on the date of grant by multiplying the number of shares granted by the fair market value of our common stock on the grant date.

Activity under the 2011 Plan, the 2009 Plan, the 1999 Plan, and the Inducement Plan is as follows:

Restricted Stock Units:
 
 
Number of Units (in 000's)
 
Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 2015
 
663

 
$
32.48

RSU granted
 
940

 
$
7.06

RSU released
 
(328
)
 
$
24.71

RSU forfeited
 
(210
)
 
$
17.82

Balance at December 31, 2016
 
1,065

 
$
15.31

RSU granted
 
916

 
$
5.73

RSU released
 
(445
)
 
$
15.57

RSU forfeited
 
(368
)
 
$
13.11

Balance at December 31, 2017
 
1,168

 
$
8.55

RSU granted
 
1,822

 
$
5.98

RSU released
 
(945
)
 
$
9.63

RSU forfeited
 
(233
)
 
$
8.50

Balance at December 31, 2018
 
1,812

 
$
7.09



The total intrinsic value of RSUs vested and released during the year ended December 31, 2018, 2017 and 2016 were approximately $6.8 million, $2.3 million and $2.4 million, respectively. The intrinsic value of vested and released RSUs is calculated by multiplying the fair market value of our common stock on the vesting date by the number of shares vested. As of December 31, 2018, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $9.7 million. We expect to recognize those costs over a weighted average period of 2.9 years.

2018 Retention Bonus Program

Included in the 2018 RSU activity are 379,593 of grants and releases related to a retention bonus program. As disclosed in our Current Report on Form 8-K filed on February 10, 2017, we previously implemented a company-wide retention bonus incentive program in which our executive officers at the time also participated. The bonus program provides for the payment of cash bonuses to program participants who were employees at the time the plan was implemented and who remain with Fluidigm through January 1, 2019. On September 18, 2018, the compensation committee of our board of directors approved an exchange program for our executive officers and for employees resident in the United States and Canada who are retention bonus program participants. In the exchange program, eligible participants could elect to surrender their right to receive a cash bonus in exchange for fully vested restricted stock units issued under our 2011 Equity Incentive Plan on the terms described below. Among other reasons, our compensation committee adopted the exchange program to encourage employee stock ownership and to effectively manage cash resources.
 
In connection with the bonus exchange program, each eligible employee could elect to exchange 25%, 50%, 75%, or 100% of the retention cash bonus otherwise payable under the terms of the program. Each employee participating in the exchange would receive a number of fully vested restricted stock units equal to the quotient, rounded up to the next whole number, determined by dividing the cash amount of the retention cash bonus that such eligible employee elects to exchange by an amount equal to 85% of the lower of the closing prices of one share of our common stock on the commencement date of the
exchange offer or the closing date of the exchange offer. The exchange offer closed on November 5, 2018. The total value of the 379,593 shares of common stock issued under this program was $2.8 million and is included in the total intrinsic value of RSUs released in 2018.

Stock Options:
 
 
Number of
Options (000's)
 
Weighted-Average
Exercise Price
per Option
 
Weighted-
Average Remaining Contractual Life (in Years)
 
Aggregate
Intrinsic
Value (1) in (000's)
Balance at December 31, 2015
 
3,242

 
$
20.45

 
2.2
 
 
Options granted
 
978

 
$
7.44

 
 
 
 
Options exercised
 
(57
)
 
$
4.04

 
 
 
$
310

Option forfeited
 
(603
)
 
$
23.53

 
 
 
 
Balance at December 31, 2016
 
3,560

 
$
16.62

 
6.8
 
 
Options granted
 
1,364

 
$
5.61

 
 
 
 
Options exercised
 
(25
)
 
$
4.07

 
 
 
$
42

Option forfeited
 
(2,735
)
 
$
16.33

 
 
 
 
Balance at December 31, 2017
 
2,164

 
$
10.41

 
6.6
 
 
Options granted
 
758

 
$
6.05

 
 
 
 
Options exercised
 
(40
)
 
$
5.24

 
 
 
$
81

Option forfeited
 
(497
)
 
$
16.09

 
 
 
 
Balance at December 31, 2018
 
2,385

 
$
7.56

 
7.8
 
$
5,991

Vested at December 31, 2018
 
1,026

 
$
9.92

 
6.3
 
$
2,111

Expected to vest at December 31, 2018
 
1,359

 
$
5.78

 
8.9
 
$
3,879


(1)
Aggregate intrinsic value as of December 31, 2018 was calculated as the difference between the closing price per share of our common stock on the last trading day of 2018, which was $8.62, and the exercise price of the options, multiplied by the number of in-the-money options.
As of December 31, 2018, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $4.2 million. We expect to recognize those costs over a weighted average period of 2.6 years.
2017 Stock Option Exchange
Included in the 2017 option activity above is the impact of our 2017 Stock Option Exchange Program. On August 23, 2017, we launched a one-time Stock Option Exchange Program (the Program), which eligible employees were able to exchange certain outstanding stock options (Eligible Options), whether vested or unvested, with an exercise price greater than $4.37 per share and greater than the closing price of a share of our common stock on the Nasdaq Global Select Market on the expiration date of the exchange offer (the Offer), for restricted stock units or stock options (New Awards) covering a lesser number of shares than were subject to the Eligible Options exchanged immediately before being canceled in the Offer. Non-employee members of our board of directors were not eligible to participate in the Program. The Program expired on September 20, 2017, with a closing price of $5.13 per share.
Employees elected to surrender Eligible Options to purchase a total of 1,204,198 shares of our common stock. All surrendered options were canceled effective as of the expiration date, and immediately thereafter, in exchange for such surrendered options, we issued (i) new options to purchase an aggregate of 399,117 shares of our common stock with an exercise price of $5.13; and (ii) restricted stock units representing 54,944 shares of our common stock, each, pursuant to the terms of the Offer and our 2011 Equity Incentive Plan. The new awards granted under the Program generally vest over three years.
The Program did not result in a material incremental stock-based compensation expense because the fair value of the new awards was approximately equal to the fair value of the surrendered options immediately prior to the exchange date. The
original fair value of the surrendered options plus the incremental stock-based compensation expense is being recognized over the vesting periods of the New Awards.
Performance-based Awards
2018 Performance Stock Units
During the three months ended March 31, 2018, we granted 167,000 performance stock units to certain executive officers and senior level employees. The number of performance stock units ultimately earned is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the performance period from January 1, 2018, to December 31, 2020. The percentage of performance stock units that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted.
Under FASB ASC Topic 718, the provisions of the performance stock unit awards related to TSR are considered a market condition, and the effects of that market condition should be reflected in the grant date fair value of the awards. We used a Monte Carlo simulation pricing model to incorporate the market condition effects at our grant date with a fair value of $10.09 per unit.
Activity under the 2018 performance stock units is as follows:
 
 
Number of Units (in 000's)
 
Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 2017
 
—

 
$
—

RSU granted
 
167

 
10.09

RSU released
 
—

 
—

RSU forfeited
 
(12
)
 
10.09

Balance at December 31, 2018
 
155

 
$
10.09


As of December 31, 2018, the unrecognized compensation costs related to these awards were $1.2 million. We expect to recognize those costs over a weighted average period of 2.2 years.
2016 Performance-based Stock Options and Restricted Stock Units
In 2016, we granted 184,050 and 87,620 performance-based stock options and performance-based restricted stock units (each, a performance award), respectively, to executive officers and employees, which were accounted for as equity awards. The number of performance awards that ultimately vested depended on the achievement of certain performance criteria set by the compensation committee of our board of directors. The performance-based stock options had an exercise price per share of $7.10. We recognize stock-based compensation expense over the vesting period of the performance awards when achievement of the performance criteria becomes probable. The performance criteria were not met, and the awards did not vest. We did not recognize any expense related to these performance awards in 2018, 2017 or 2016.
2017 Employee Stock Purchase Plan
On August 1, 2017, our stockholders approved our 2017 Employee Stock Purchase Plan (ESPP) at the annual meeting of stockholders. Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our ESPP has a six-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible to participate through payroll deductions of up to 10% of their compensation and may not purchase more than $25,000 of stock in any calendar year. The purchase price at which shares are sold under the ESPP is 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. Our first ESPP offering period began on October 1, 2017 with a shorter offering period ending on November 30, 2017.
Stock-Based Compensation
Total stock-based compensation expense recognized was as follows (in thousands):
 
 
For the Year Ended December 31,
 
 
2018
 
2017
 
2016
2018 Retention Bonus Program
 
$
2,809

 
$
—

 
$
—

Options and Restricted Stock Units
 
7,716

 
8,972

 
13,858

Employee Stock Purchase Plan
 
498

 
120

 
—

Total Share-Based Compensation
 
$
11,023

 
$
9,092


$
13,858
XML 32 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes
 12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes

Our loss before income taxes consists of the following (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Domestic
 
$
(47,600
)
 
$
(56,885
)
 
$
(65,211
)
International
 
(13,820
)
 
(6,914
)
 
(14,966
)
Loss before income taxes
 
$
(61,420
)
 
$
(63,799
)
 
$
(80,177
)


Significant components of our benefit for income taxes are as follows (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Current:
 
 
 
 
 
 
Federal
 
$
(27
)
 
$
—

 
$
—

State
 
(19
)
 
(17
)
 
(14
)
Foreign
 
(32
)
 
(501
)
 
286

Total current tax (expense) benefit
 
(78
)
 
(518
)
 
272

Deferred:
 
 
 
 
 
 
State
 
—

 
—

 
—

Foreign
 
2,485

 
3,782

 
3,920

Total deferred benefit
 
2,485

 
3,782

 
3,920

Total benefit for income taxes
 
$
2,407

 
$
3,264

 
$
4,192



Reconciliation of income taxes at the statutory rate to the benefit from (provision for) income taxes recorded in the statements of operations is as follows:
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Tax benefit at federal statutory rate
 
21.0
 %
 
34.0
 %
 
34.0
 %
State tax expense, net of federal benefit
 
2.3

 
5.5

 
2.2

Foreign tax benefit (expense)
 
(1.1
)
 
0.4

 
(0.7
)
Change in valuation allowance
 
(19.2
)
 
39.2

 
(31.2
)
Federal research and development credit
 
1.5

 
1.9

 
1.3

Unrecognized tax benefit
 
(0.2
)
 
(0.6
)
 
(1.3
)
Impact of the Tax Act
 
—

 
(74.6
)
 
—

Other, net
 
(0.4
)
 
(0.7
)
 
0.9

Effective tax rate
 
3.9
 %
 
5.1
 %
 
5.2
 %



The Tax Act was enacted in December 2017. The Tax Act introduced a broad range of tax reform measures that significantly change the federal income tax laws. At December 31, 2017, we recorded the provisional income tax effects of the Tax Act under Accounting Standards Codification Topic 740, Income Taxes. Due to our having recorded a full valuation allowance against its U.S. federal and state deferred tax assets, there was no net impact on our tax provision as a result of the remeasurement of U.S. deferred taxes using the relevant tax rate at which we expect them to reverse. The one-time transition tax on post-1986 foreign unremitted earnings did not have a material impact to our effective tax rate as a result of generating net foreign deficit earnings. In accordance with Staff Accounting Bulletin (“SAB”) No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense was required. We continue to monitor supplemental legislation and technical interpretations of the tax law that may cause the final impact from the Tax Act to differ from the amounts previously recorded.

At December 31, 2017, we changed our permanent reinvestment assertion and will not permanently reinvest our foreign earnings outside the United States. The cash generated from some of our foreign subsidiaries may be used domestically to fund operations. Any domestic, foreign withholding tax and state taxes that may be due upon future repatriation of earnings is not expected to be significant.

Significant components of our deferred tax assets and liabilities are as follows (in thousands):
 
 
December 31,
 
 
2018
 
2017
Deferred tax assets:
 
 
 
 
Net operating loss carryforwards
 
$
98,920

 
$
91,701

Reserves and accruals
 
7,167

 
3,927

Depreciation and amortization
 
4,262

 
5,591

Tax credit carryforwards
 
16,675

 
14,838

Stock-based compensation
 
1,899

 
5,994

Total gross deferred tax assets
 
128,923

 
122,051

Valuation allowance on deferred tax assets
 
(126,109
)
 
(119,228
)
Total deferred tax assets, net of valuation allowance
 
2,814

 
2,823

Deferred tax liabilities:
 
 
 
 
Fixed asset and intangibles
 
(16,528
)
 
(18,912
)
Total deferred tax liabilities
 
(16,528
)
 
(18,912
)
Net deferred tax liability
 
$
(13,714
)
 
$
(16,089
)


We evaluate a number of factors to determine the realizability of our deferred tax assets. Recognition of deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is
dependent upon several factors including historical financial results. The net deferred tax assets have been partially offset by a valuation allowance because we have incurred losses since our inception. The valuation allowance increased by $6.9 million during 2018, decreased by $27.1 million during 2017 and increased by $22.1 million during 2016, respectively. The change in valuation allowance during 2018 is mainly due to significant taxable losses and an increase in tax attributes. The change in valuation allowance during 2017 is mainly due to the change in Federal statutory rate from 34% to 21%, offset by a significant increase in the taxable loss in 2017.

The valuation allowances of $126.1 million and $119.2 million as of December 31, 2018 and 2017, respectively, primarily relate to temporary tax differences, net operating losses and research and development credits generated in the current and prior years. We believe it is more likely than not that U.S. federal and state of California deferred tax assets relating to temporary differences, net operating losses and research and development credits are not realizable. As such, full valuation allowances have been applied against the deferred tax assets relating to jurisdictions of the federal U.S. and the state of California.

A reconciliation of the beginning and ending amount of the valuation allowance for the years ended December 31, 2018, 2017, and 2016 is as follows (in thousands):
 
Valuation Allowance
December 31, 2015
$
124,137

Charges to earnings
—

Charges to other accounts
22,148

December 31, 2016
146,285

Charges to earnings
830

Charges to other accounts
(27,887
)
December 31, 2017
119,228

Charges to earnings
—

Charges to other accounts
6,880

December 31, 2018
$
126,108



As of December 31, 2018, we had net operating loss carryforwards for U.S. federal income tax purposes of $432.2 million, which expire beginning in 2021, and U.S. federal research and development tax credits of $8.5 million, which expire in the years 2021 through 2039. As of December 31, 2018, we had net operating loss carryforwards for state income tax purposes of $170.3 million, which expire beginning in 2028 through 2039, and California research and development tax credits of $11.0 million, which do not expire. As of December 31, 2018, we had foreign net operating loss carryforwards of $1.9 million, which expire in the years 2019 through 2027.

Utilization of the net operating loss carryforwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. In 2015, we completed a Section 382 analysis for the period from our inception in May 1999 through December 31, 2015, which excluded the net operating loss carryforwards for DVS prior to the acquisition and determined that an ownership change as defined under Section 382 occurred in November 2001, which resulted in a reduction to our U.S. federal net operating losses by $1.2 million. In 2016, 2017 and 2018, we continued the Section 382 analysis through December 31, 2018 and determined that an ownership change did not occur during the periods.
Uncertain Tax Positions

The aggregate changes in the balance of our gross unrecognized tax benefits during 2018, 2017, and 2016 were as follows (in thousands):
December 31, 2015
$
8,662

Increases in balances related to tax positions taken during prior period
46

       Increases in balances related to tax positions taken during current period
1,673

       Decreases in balances related to tax positions taken during prior period
(1,048
)
December 31, 2016
9,333

Increases in balances related to tax positions taken during current period
61

Decreases in balances related to tax positions taken during prior period
(2,077
)
December 31, 2017
7,317

Increases in balances related to tax positions taken during current period
255

Decreases in balances related to tax positions taken during prior period
(228
)
December 31, 2018
$
7,344



Accrued interest and penalties related to unrecognized tax benefits were included in the income tax provision and are immaterial as of December 31, 2018 and 2017.

As of December 31, 2018, there are $0.4 million unrecognized tax benefits that, if recognized, would affect our effective tax rate. We do not anticipate that our existing unrecognized tax benefits will significantly increase or decrease within the next 12 months.

We file income tax returns in the United States, various states, and certain foreign jurisdictions. As a result of net operating loss carryforwards, all of our tax years are open to federal and state examination in the United States. Tax years from 2013 are open to examination in various foreign countries.
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Employee Benefit Plans
 12 Months Ended
Dec. 31, 2018
Retirement Benefits [Abstract]  
Employee Benefit Plans Employee Benefit Plans

We sponsor a 401(k) savings plan for our employees in the United States that stipulates that eligible employees may elect to contribute to the plan, subject to certain limitations, up to the lesser of 90% of eligible compensation or the maximum amount allowed by the U.S. Internal Revenue Service. In 2015, we implemented a match formula of 100% up to $2,000 annually, following a 4-year vesting schedule. Employer matching contributions to the 401(k) plan for the years ended December 31, 2018, 2017, and 2016 were $0.4 million, $0.5 million, and $0.6 million, respectively.
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Information About Geographic Areas
 12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Information About Geographic Areas Information About Geographic Areas

We operate in one reporting segment that develops, manufacturers and commercializes tools for life sciences research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.

A summary table of our total revenue by geographic areas of our customers and by product and services for the years ended December 31, 2018, 2017 and 2016 is included in Note 3 to the Consolidated Financial Statements of this Form 10K.

Sales to customers in the United States represented $48.1 million or 43%, of total revenues for the year ended December 31, 2018. Sales to customers in the United States represented $45.8 million or 45% of total revenues for the year ended December 31, 2017, and $52.6 million or 50% for the year ended December 31, 2016.

Sales to customers in China represented $14.0 million or 12%, of total revenues for the year ended December 31, 2018. Sales to customers in China represented 11% or $11.1 million, of total revenues for each of the years ended December 31, 2017, and 2016 respectively.

We had long-lived assets consisting of property, plant and equipment, net of accumulated depreciation, in the following geographic areas for each year presented (in thousands):
 
 
December 31,
 
 
2018
 
2017
United States
 
$
1,881

 
$
3,500

Singapore
 
3,748

 
5,167

Canada
 
3,104

 
3,481

EMEA
 
66

 
125

Asia-Pacific
 
26

 
28

Total
 
$
8,825

 
$
12,301
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Operating Leases
We have entered into various long-term non-cancelable operating lease agreements for equipment and facilities expiring at various times through March 2026. We lease office space under non-cancelable leases in the United States, Canada, Singapore, Japan, China, France and United Kingdom. Certain facility leases also contain rent escalation clauses. Our lease payments are expensed on a straight-line basis over the life of the leases. Rental expense under operating leases, net of amortization of lease incentives and sublease income, for the years ended December 31, 2018, 2017, and 2016 was $5.0 million, $4.7 million, and $6.3 million, respectively.
Future minimum lease payments and minimum sublease income under non-cancelable operating leases as of December 31, 2018 are as follows (in thousands):
Fiscal Year
 
Minimum Lease Payments
 
Minimum Sublease Income
 
Net Operating Leases
2019
 
$
4,184

 
$
(520
)
 
$
3,664

2020
 
2,213

 
(164
)
 
2,049

2021
 
1,245

 
—

 
1,245

2022
 
827

 
—

 
827

2023
 
552

 
—

 
552

   Thereafter
 
1,241

 
—

 
1,241

Total
 
$
10,262

 
$
(684
)
 
$
9,578

Other Commitments
In the normal course of business, we enter into various contractual and legally binding purchase commitments. As of December 31, 2018, these commitments were approximately $1.6 million.
Indemnifications
From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our
officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for related expenses including, among others, attorneys' fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding.
We incurred legal expenses between October 2015 and the third quarter of 2017 to defend claims by Thermo Fisher Scientific, Inc., (Thermo) against one of our employees. In December 2015, Thermo Fisher Scientific, Inc., (Thermo) filed a complaint in the Circuit Court for the County of Kalamazoo, Michigan against one of its former employees who had recently been hired by us alleging, among other claims, misappropriation of proprietary information and breach of contractual and fiduciary obligations to Thermo while such individual was still an employee of Thermo. In November 2016, Thermo amended its complaint to add us as a party to the litigation, making various commercial and employment-related claims and seeking damages and injunctive relief. In July 2017, we entered into a settlement agreement with Thermo. Pursuant to the terms of the settlement agreement, we agreed to pay Thermo a one-time payment of $3.0 million in exchange for a release and dismissal of all claims with prejudice upon payment of the settlement. In August 2017, we paid the settlement of $3.0 million and received an insurance recovery payment of $1.0 million related to this matter.
Contingencies
In early March 2019, we experienced a ransomware attack that infiltrated and encrypted certain of our information technology systems, including systems containing critical business data. Immediately following the attack, actions were taken to recover the compromised systems and we believe we were able to restore their operation without significant loss of business data. Based on the nature of the attack and its impact on our systems, we do not believe confidential data was lost or disclosed, but we are continuing to monitor the situation. As of the date of this filing, we estimate the costs associated with the intrusion to be approximately $1.5 million and are seeking to recover these costs under an applicable insurance policy.
From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Quarterly Results of Operations (Unaudited)
 12 Months Ended
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Results of Operations (Unaudited) Quarterly Results of Operations (Unaudited)

Selected quarterly results of operations for the years ended December 31, 2018 and 2017 are as follows (in thousands, except for per share amounts):
2018
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
25,248

 
$
26,428

 
$
28,963

 
$
32,325

Net loss
 
$
(13,247
)
 
$
(16,241
)
 
$
(14,750
)
 
$
(14,775
)
Net loss per share, basic and diluted
 
$
(0.34
)
 
$
(0.42
)
 
$
(0.38
)
 
$
(0.36
)
 
 
 
 
 
 
 
 
 
2017
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
25,533

 
$
23,912

 
$
24,747

 
$
27,745

Net loss
 
$
(17,202
)
 
$
(16,933
)
 
$
(15,944
)
 
$
(10,456
)
Net loss per share, basic and diluted
 
$
(0.59
)
 
$
(0.58
)
 
$
(0.46
)
 
$
(0.27
)
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events
 12 Months Ended
Dec. 31, 2018
Subsequent Events [Abstract]  
Subsequent Events Subsequent Event
From January 9, 2019 through February 27, 2019, we received notices from holders of the 2018 Notes electing to voluntarily convert approximately $138.1 million in aggregate principal amount pursuant to the terms of the Second Supplemental Indenture dated March 6, 2018, between us and U.S. Bank National Association (Trustee) to the Indenture dated
as of February 14, 2014, between us and the Trustee. As a result of such voluntary conversions, we have elected to fully satisfy our conversion obligations by delivering approximately 17.9 million shares of our common stock to such holders and have retired approximately $138.1 million of the 2018 Notes. On February 27, we notified the Trustee of our intention to exercise our Issuer’s Conversion Option pursuant to the terms of the Second Supplemental Indenture with respect to the remaining approximately $11.9 million in aggregate principal amount of 2018 Notes. These bonds were converted into approximately 1.5 million shares of our common stock and the bonds retired in March 2019.
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Schedule II-Valuation And Qualifying Accounts And Reserves
 12 Months Ended
Dec. 31, 2018
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II-Valuation And Qualifying Accounts And Reserves SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
 
 
 
In thousands
 
 
Balance at
Beginning of
Period
 
Additions/
Charged to
Expense
 
Deductions
 
Balance at
End of
Period
Year ended December 31, 2018
 
 
 
 
 
 
 
 
Accounts receivable allowance
 
$
391

 
$
162

 
$
(427
)
 
$
126

Year ended December 31, 2017
 
 
 
 
 
 
 
 
Accounts receivable allowance
 
$
502

 
$
24

 
$
(135
)
 
$
391

Year ended December 31, 2016
 
 
 
 
 
 
 
 
Accounts receivable allowance
 
$
103

 
$
484

 
$
(85
)
 
$
502


 
 
In thousands
 
 
Balance at
Beginning of
Period
 
Additions/
Charged to
Expense
 
Deductions
 
Balance at
End of
Period
Year ended December 31, 2018
 
 
 
 
 
 
 
 
Warranty allowance
 
$
699

 
$
1,573

 
$
(1,409
)
 
$
863

Year ended December 31, 2017
 
 
 
 
 
 
 
 
Warranty allowance
 
$
1,023

 
$
695

 
$
(1,019
)
 
$
699

Year ended December 31, 2016
 
 
 
 
 
 
 
 
Warranty allowance
 
$
1,076

 
$
885

 
$
(938
)
 
$
1,023
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2018
Accounting Policies [Abstract]  
Basis of Presentation and Consolidation Basis of Presentation and Consolidation

The accompanying consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly-owned subsidiaries. As of December 31, 2018, we had wholly-owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, the United Kingdom, China, and Germany. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.

Certain prior period amounts in the consolidated statements of stockholders’ equity and consolidated statements of cash flows were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders' equity, total revenue, total costs and expenses, loss from operations or net loss.
Use of Estimates Use of Estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our consolidated financial statements.
Foreign Currency Foreign Currency

Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders’ equity. Income and expense accounts are translated at monthly average exchange rates during the year.
Revenue Recognition Revenue Recognition

We generate revenue primarily from the sale of our products and services. Product revenue is derived from the sale of instruments and consumables, including IFCs, assays and reagents. Service revenue is derived from the sale of instrument service contracts, repairs, installation, training and other specialized product support services. Revenue is reported net of any sales, use and value-added taxes we collect from customers as required by government authorities.

We recognize revenue based on the amount of consideration we expect to receive in exchange for the goods and services we transfer to the customer. Our commercial arrangements typically include multiple distinct products and services, and we allocate revenue to these performance obligations based on their relative standalone selling prices. Standalone selling prices (SSP) are generally determined using observable data from recent transactions. In cases where sufficient data is not available, we estimate a product’s SSP using a cost plus a margin approach or by applying a discount to the product’s list price.

Product Revenue

We recognize product revenue at the point in time when control of the goods passes to the customer and we have an enforceable right to payment. This generally occurs either when the product is shipped from one of our facilities or when it arrives at the customer’s facility, based on the contractual terms. Customers generally do not have a unilateral right to return products after delivery. Invoices are generally issued at shipment and generally become due in 30 to 60 days.

We sometimes perform shipping and handling activities after control of the product passes to the customer. We have made an accounting policy election to account for these activities as product fulfillment activities rather than as separate performance obligations.

Service Revenue

We recognize revenue from repairs, installation, training and other specialized product support services at the point in time the work is completed. Installation and training services are generally billed in advance of service. Repairs and other services are generally billed at the point the work is completed.

Revenue associated with instrument service contracts is recognized on a straight-line basis over the life of the agreement, which is generally one to three years. We believe this time-elapsed approach is appropriate for service contracts because we provide services on demand throughout the term of the agreement. Invoices are generally issued in advance of service on a monthly, quarterly, annual or multi-year basis. Payments made in advance of service are reported on our consolidated balance sheet as deferred revenue.

Contract Costs

Incremental sales commission costs incurred to obtain instrument service contracts are capitalized and amortized to selling, general and administrative expense over the life of the contract, which is generally one to three years. As a practical expedient, we expense sales commissions associated with product support services that are delivered in less than one year as they are incurred. Sales commissions associated with the sale of products are expensed as they are incurred.

Product Warranties

We generally provide a one-year warranty on our instruments. We accrue for estimated warranty obligations at the time of product shipment. We periodically review our warranty liability and record adjustments based on the terms of warranties provided to customers, and historical and anticipated warranty claim experience. This expense is recorded as a component of cost of product revenue in the consolidated statements of operations.

Significant Judgments

Applying the revenue recognition practices discussed above often requires significant judgment. Judgment is required when identifying performance obligations, estimating SSP and allocating purchasing consideration in multi-element arrangements and estimating the future amount of our warranty obligations. Moreover, significant judgment is required when interpreting commercial terms and determining when control of goods and services passes to the customer. Any material changes created by errors in judgment could have a material effect on our operating results and overall financial condition.
Cash and Cash Equivalents Cash and Cash Equivalents

We consider all highly liquid financial instruments with maturities at the time of purchase of three months or less to be cash equivalents. Cash and cash equivalents may consist of cash on deposit with banks, money market funds, and notes from government-sponsored agencies.
Investments Investments

Short-term investments are comprised of notes from government-sponsored agencies. All investments are recorded at estimated fair value. Any unrealized gains and losses from investments are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity. We evaluate our investments to assess whether investments with unrealized loss positions are other-than-temporarily impaired. An investment is considered to be other-than-temporarily impaired if the impairment is related to deterioration in credit risk or if it is likely that we will sell the securities before the recovery of their cost basis. No investment has been assessed as other than temporarily impaired, and realized gains and losses were immaterial during the years presented. The cost of securities sold, or the amount reclassified out of accumulated other comprehensive income into earnings is based on the specific-identification method.
Accounts Receivable Accounts Receivable

Trade accounts receivable are recorded at net invoice value. We review our exposure to accounts receivable and provide allowances of specific amounts if collectability is no longer reasonably assured based on historical experience and specific customer collection issues. We evaluate such allowances on a regular basis and adjust them as needed.
Concentrations of Business and Credit Risk Concentrations of Business and Credit Risk

Financial instruments that potentially subject us to credit risk consist of cash, cash equivalents, investments, and accounts receivable. Our cash, cash equivalents, and investments may consist of deposits held with banks, money market funds, and other highly liquid investments that may at times exceed federally insured limits. Cash equivalents and investments are financial instruments that potentially subject us to concentrations of risk. Under our investment policy, we invest primarily in securities issued by the U.S. government. The goals of our investment policy, in order of priority, are as follows: preserve capital, meet liquidity needs, and optimize returns.

We generally do not require collateral to support credit sales. To reduce credit risk, we perform credit evaluations of our customers. No single customer represented more than 10% of total revenue for 2018, 2017, or 2016, and no single customer represented more than 10% of total accounts receivable at December 31, 2018, 2017, or 2016.

Our products include components that are currently procured from a single source or a limited number of sources. We believe that other vendors would be able to provide similar components; however, the qualification of such vendors may require start-up time. In order to mitigate any adverse impacts from a disruption of supply, we attempt to maintain an adequate supply of critical limited-source components.
Inventories Inventories

Inventories are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. Inventory costs include direct materials, direct labor, and normal manufacturing overhead. Finished goods that are used for research and development are expensed as consumed or depreciated over their period of use. Provisions for slow-moving, excess, and obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values based on product life cycle, development plans, product expiration, and quality issues.
Property and Equipment Property and Equipment

Property and equipment, including leasehold improvements, are stated at cost less accumulated depreciation. Accumulated depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets or the remaining term of the lease, whichever is shorter. The estimated useful lives of our property and equipment are generally as follows: computer
equipment and software, three to four years; laboratory and manufacturing equipment, two to five years; and office furniture and fixtures, five years.

Depreciation expense for the years ended December 31, 2018, 2017, and 2016 was $4.2 million, $5.9 million, and $5.1 million, respectively.
Goodwill, Intangible Assets and Other Long-Lived Assets Goodwill, Intangible Assets and Other Long-Lived Assets

Goodwill, which has an indefinite useful life, represents the excess of cost over fair value of net assets acquired. Our intangible assets include developed technology, patents and licenses. The cost of identifiable intangible assets with finite lives is generally amortized on a straight-line basis over the assets’ respective estimated useful lives.

Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. We first conduct an assessment of qualitative factors to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying amount. If we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying amount, we then conduct a two-step test for impairment of goodwill. In the first step, we compare the fair value of our reporting unit to its carrying value. If the fair value of our reporting unit exceeds its carrying value, goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceed its fair value, then the second step of the impairment test must be performed in order to determine the implied fair value of the goodwill. If the carrying value of the goodwill exceeds its implied fair value, then an impairment loss equal to the difference would be recorded.

We evaluate our long-lived assets, including finite-lived intangibles, for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If any indicator of impairment exists, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of the asset can be recovered through undiscounted future operating cash flows. If impairment is indicated, we estimate the asset’s fair value using future discounted cash flows associated with the use of the asset, and adjust the carrying value of the asset accordingly. We did not recognize any impairment of long-lived assets for any of the periods presented herein.
Convertible Notes
Convertible Notes

In February 2014, we closed an underwritten public offering $201.3 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes). In March 2018, we entered into separate privately negotiated transactions with certain holders of our 2014 Notes to exchange $150.0 million in aggregate principal amount of the 2014 Notes for our new 2.75% Exchange Convertible Senior Notes due 2034 (2018 Notes). Following the exchange, approximately $51.3 million in aggregate principal amount of the 2014 Notes remained outstanding in addition to $150.0 million in aggregate principal amount of the 2018 Notes.

As the 2018 Notes are convertible, at our election, into cash, shares of our common stock, or a combination of cash and shares of our common stock, we accounted for the 2018 Notes under the cash conversion guidance in ASC 470, whereby the embedded conversion option in the 2018 Notes was separated and accounted for in equity. The embedded conversion option value was calculated as the difference between (i) the total fair value of the 2018 Notes and (ii) the fair value of a similar debt instrument excluding the embedded conversion option. We determined an embedded conversion option value of $29.3 million, which was recorded in additional paid-in-capital and reduced the carrying value of the 2018 Notes. The resulting discount on the 2018 Notes will be amortized over the expected term of the 2018 Notes, using the effective interest method through the first note holder put date, of February 6, 2023.

For both the 2014 Notes and 2018 Notes, offering-related costs, including underwriting costs are capitalized as debt issuance costs, recorded as an offset to the carrying value of the related Notes, and are being be amortized over the expected term of the related Notes using the effective interest method.
Fair Value of Financial Instruments Fair Value of Financial Instruments

Our financial instruments consist primarily of cash and cash equivalents, investments, accounts receivable, accounts payable, and convertible notes. Our cash equivalents, investments, accounts receivable, and accounts payable have short maturity or payment periods. Accordingly, their carrying values approximated their fair values at December 31, 2018 and 2017. The convertible notes are presented at their carrying value, with fair value disclosures made in Note 7. As a basis for considering fair value, we follow a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level I: observable inputs such as quoted prices in active markets;
Level II: inputs other than quoted prices in active markets that are observable either directly or indirectly; and
Level III: unobservable inputs for which there is little or no market data, which requires us to develop our own assumptions.

This hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. Our cash equivalents, which include money market funds, are classified as Level I because they are valued using quoted market prices. Our investments and convertible notes are generally classified as Level II because their value is based on valuations using significant inputs derived from or corroborated by observable market data. Depending on the security, the income and market approaches are used in the model driven valuations. Inputs of these models include recently executed transaction prices in securities of the issuer or comparable issuers and yield curves.
Research and Development Research and Development

We recognize research and development expenses in the period incurred. Research and development expenses consist of personnel costs, independent contractor costs, prototype and materials expenses, allocated facilities and information technology expenses, and related overhead expenses.
Advertising Costs Advertising Costs

We expense advertising costs as incurred.
Income Taxes Income Taxes

We use the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a “more likely than not” criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.

We recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. Any interest and penalties related to uncertain tax positions are reflected in the income tax provision.
Stock-Based Compensation Stock-Based Compensation

We account for stock options and restricted stock units granted to employees and directors and stock purchases under ESPP based on the fair value of the awards. We recognize stock-based compensation expense on a straight-line basis over the requisite service periods for non-performance-based awards. For performance-based stock awards, stock-based compensation expense is recognized over the requisite service period when the achievement of each individual performance goal becomes probable.
Comprehensive Loss  Comprehensive Loss

Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the consolidated statements of comprehensive loss.
Net Loss per Share Net Loss per Share

Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Restricted stock units and options to purchase our common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive for all periods presented.
Recent Accounting Changes and Accounting Pronouncements Recent Accounting Changes and Accounting Pronouncements

Adoption of New Accounting Guidance

In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers (Topic 606). Topic 606 and its related amendments supersede Revenue Recognition (Topic 605), issued in June 2010, and provide principles for recognizing revenue for goods and services in a manner consistent with the transfer of control of those goods and services to the customer.

We adopted Topic 606 on January 1, 2018, using the modified retrospective method applied to those contracts with unrecognized revenue on the adoption date. We recognized the effect of applying the new revenue standard by recording a cumulative catch-up adjustment that reduced the accumulated deficit component of stockholders’ equity by $0.4 million and increased current assets by $0.2 million and non-current assets by $0.2 million. The adjustment capitalized certain sales commission costs that were incurred to obtain instrument service contracts. Under Topic 605, we accounted for these incremental contract acquisition costs by recognizing them as expense at the point the contract was awarded. Under Topic 606, the costs are capitalized and amortized to expense over the life of the contract, which is generally one to three years. The comparative information for periods prior to January 1, 2018, has not been restated and continues to be reported in accordance with Topic 605.

The following table summarizes the cumulative effect of adopting Topic 606 on amounts previously reported in our consolidated balance sheet at December 31, 2017 (in thousands):
 
 
Balance at December 31, 2017
 
Topic 606 Transition Adjustments
 
Balance at January 1, 2018
Prepaid expenses and other current assets
 
$
1,528

 
$
153

 
$
1,681

Total current assets
 
$
94,801

 
$
153

 
$
94,954

Other non-current assets
 
$
7,541

 
$
205

 
$
7,746

Total assets
 
$
287,351

 
$
358

 
$
287,709

Accumulated deficit
 
$
(500,196
)
 
$
358

 
$
(499,838
)
Total stockholders' equity
 
$
30,935

 
$
358

 
$
31,293

Total liabilities and stockholders' equity
 
$
287,351

 
$
358

 
$
287,709



The following table summarizes the impacts on our consolidated statements of operations of adopting Topic 606 compared to Topic 605 for the twelve months ended December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
 Topic 606
 
Effect of Change
 
 
Twelve Months Ended December 31, 2018
Selling, general and administrative
 
$
79,783

 
$
79,859

 
$
(76
)
Total costs and expenses
 
$
161,128

 
$
161,204

 
$
(76
)
Loss from operations
 
$
(48,164
)
 
$
(48,240
)
 
$
76

Loss before income taxes
 
$
(61,420
)
 
$
(61,496
)
 
$
76

Net loss
 
$
(59,013
)
 
$
(59,089
)
 
$
76


The following table summarizes the impacts on our consolidated balance sheets of adopting Topic 606 compared to Topic 605 at December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
Topic 606
 
Effect of Change
 
 
 
 
December 31, 2018
 
 
Prepaid expenses and other current assets
 
$
2,051

 
$
1,884

 
$
167

Total current assets
 
$
127,106

 
$
126,939

 
$
167

Other non-current assets
 
$
6,208

 
$
5,941

 
$
267

Total assets
 
$
303,647

 
$
303,213

 
$
434

Stockholders' equity
 
$
72,116

 
$
71,682

 
$
434

Total liabilities and stockholders' equity
 
$
303,647

 
$
303,213

 
$
434



In March 2018, the FASB issued ASU No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118. This ASU allows SEC reporting companies to record provisional amounts in earnings for the year ended December 31, 2017, due to the complexities involved in accounting for the enactment of the Tax Act. We recognized the estimated income tax effects of the Tax Act in its 2017 Consolidated Financial Statements in accordance with SEC Staff Accounting Bulletin No. 118 (“SAB No. 118”). In accordance with SAB No. 118, we completed the accounting related to tax reform in the fourth quarter of 2018 and no material adjustments to the provisional tax expense was required. Refer to Note 10 for further information regarding the provisional amounts recorded by the Company.

In February 2018, the FASB issued ASU 2018-02 Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This ASU amends the reporting of comprehensive income to allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act (the Tax Act). The Tax Act was enacted in December 2017 and reduced the U.S federal corporate income tax rate and made other changes to U.S. federal tax law. ASU 2018-02 is effective for our fiscal year beginning January 1, 2019, and early adoption is permitted. This standard did not have a material effect on our consolidated financial statements.

In August 2016, the FASB issued ASU 2016-15 Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The ASU addresses eight specific cash flow issues and their presentation within the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18 Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB’s Emerging Issues Task Force, amending the presentation of restricted cash within the statement of cash flows. The new guidance requires that restricted cash be included within cash and cash equivalents on the statement of cash flows. We adopted this ASU in the first quarter of 2018. The adoption of this ASU did not have a material impact on our consolidated financial statements.

Recent Accounting Pronouncements

In August 2018, the FASB issued ASU 2018-15 Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40) which establishes new guidance on the accounting for costs incurred to implement a cloud computing arrangement that is considered a service arrangement. The new guidance requires the capitalization of such costs, aligning it with the accounting for costs associated with developing or obtaining internal-use software. The new guidance is effective for fiscal years beginning after December 15, 2019. We are currently evaluating the impact of adoption on our consolidated financial statements.

In February 2016, the FASB established Topic 842, Leases, by issuing Accounting Standards Update (ASU) No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard
establishes a right-of-use (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating; the classification will impact the expense recognition in the income statement.

Modified Retrospective Transition approach is required, applying the new standard to all leases existing at the date of initial application. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. We expect to adopt the new standard on January 1, 2019 and use the effective date as our date of initial application. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. For dates and periods prior to January 1, 2019, the original disclosures under ASC 840 will be disclosed.

The new standard provides several optional practical expedients in transition. We expect to elect the ‘package of practical expedients’, which permits us not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. We do not expect to elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter not being applicable to us.

We expect that this standard will have a material effect on our financial statements. While we continue to assess all the effects of adoption, we currently believe the most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet for our building, vehicle and equipment leases.
 
On adoption, we currently expect to recognize $8.0 million to $11.0 million of additional operating liabilities, based on the present value of the remaining fixed rental payments under current leasing standards for existing operating leases, with corresponding ROU assets of approximately $6.0 million to $9.0 million. The difference between the initial lease liability and right of use asset is attributable to deferred rent. We do not expect any impact on retained earnings from the adoption of ASC 842.

The new standard also provides certain accounting elections for an entity’s ongoing accounting. We currently expect to elect the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, we will not recognize ROU assets or lease liabilities. We also currently expect to elect to not separate lease and nonlease components for our building leases and to take a portfolio approach for our vehicles leases by country.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The ASU eliminates the requirement for an entity to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, an entity performs its annual, or interim, goodwill impairment testing by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount by which the carrying amount exceeds the fair value. The ASU will be effective for annual and interim goodwill impairment testing performed for our fiscal year beginning January 1, 2020, with early adoption permitted. We are currently evaluating the effect that the updated standard will have on our consolidated financial statements.
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2018
Accounting Policies [Abstract]  
Components of accumulated other comprehensive loss The components of accumulated other comprehensive loss, net of tax, for the years ended December 31, 2018, 2017, and 2016 are as follows (in thousands):
 
 
Foreign Currency Translation Adjustment
 
Unrealized Gain (Loss) on Investments
 
Accumulated Other Comprehensive Income (Loss)
Ending balance at December 31, 2016
 
$
(758
)
 
$
(2
)
 
$
(760
)
Change during the year
 
183

 
3

 
186

Ending balance at December 31, 2017
 
$
(575
)
 
$
1

 
$
(574
)
Change during the year
 
(112
)
 
(1
)
 
(113
)
Ending balance at December 31, 2018
 
$
(687
)
 
$
—

 
$
(687
)
Summary of potential common shares excluded from computations of net loss per share attributed to common stockholders The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands):

 
 
December 31,
 
 
2018
 
2017
 
2016
Stock options, restricted stock units and performance awards
 
4,354

 
3,501

 
4,622

2018 Convertible Notes
 
19,035

 
—

 
—

2018 Convertible Notes potential make-whole shares
 
757

 
—

 
—

2014 Convertible Notes
 
916

 
3,598

 
3,598

Total
 
25,062

 
7,099

 
8,220
Schedule of new accounting pronouncements The following table summarizes the cumulative effect of adopting Topic 606 on amounts previously reported in our consolidated balance sheet at December 31, 2017 (in thousands):
 
 
Balance at December 31, 2017
 
Topic 606 Transition Adjustments
 
Balance at January 1, 2018
Prepaid expenses and other current assets
 
$
1,528

 
$
153

 
$
1,681

Total current assets
 
$
94,801

 
$
153

 
$
94,954

Other non-current assets
 
$
7,541

 
$
205

 
$
7,746

Total assets
 
$
287,351

 
$
358

 
$
287,709

Accumulated deficit
 
$
(500,196
)
 
$
358

 
$
(499,838
)
Total stockholders' equity
 
$
30,935

 
$
358

 
$
31,293

Total liabilities and stockholders' equity
 
$
287,351

 
$
358

 
$
287,709



The following table summarizes the impacts on our consolidated statements of operations of adopting Topic 606 compared to Topic 605 for the twelve months ended December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
 Topic 606
 
Effect of Change
 
 
Twelve Months Ended December 31, 2018
Selling, general and administrative
 
$
79,783

 
$
79,859

 
$
(76
)
Total costs and expenses
 
$
161,128

 
$
161,204

 
$
(76
)
Loss from operations
 
$
(48,164
)
 
$
(48,240
)
 
$
76

Loss before income taxes
 
$
(61,420
)
 
$
(61,496
)
 
$
76

Net loss
 
$
(59,013
)
 
$
(59,089
)
 
$
76


The following table summarizes the impacts on our consolidated balance sheets of adopting Topic 606 compared to Topic 605 at December 31, 2018 (in thousands):
 
 
As Reported
 
Balance Without Adoption of
Topic 606
 
Effect of Change
 
 
 
 
December 31, 2018
 
 
Prepaid expenses and other current assets
 
$
2,051

 
$
1,884

 
$
167

Total current assets
 
$
127,106

 
$
126,939

 
$
167

Other non-current assets
 
$
6,208

 
$
5,941

 
$
267

Total assets
 
$
303,647

 
$
303,213

 
$
434

Stockholders' equity
 
$
72,116

 
$
71,682

 
$
434

Total liabilities and stockholders' equity
 
$
303,647

 
$
303,213

 
$
434
XML 41 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue (Tables)
 12 Months Ended
Dec. 31, 2018
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue The following table presents our revenue for the year ended December 31, 2018, 2017, and 2016, respectively, based on geographic area and by products and services (in thousands):
 
Year Ended December 31,
 
2018
 
2017
 
2016
Geographic Markets:
 
 
 
 
 
Americas
$
51,172

 
$
49,290

 
$
56,229

EMEA
36,617

 
32,642

 
29,739

Asia-Pacific
25,175

 
20,005

 
18,478

Total
$
112,964

 
$
101,937

 
$
104,446


 
Year Ended December 31,
 
2018
 
2017
 
2016
Products and Services:
 
 
 
 
 
Instruments
$
45,491

 
$
42,505

 
$
46,834

Consumables
48,159

 
41,894

 
42,169

Product revenue
93,650

 
84,399

 
89,003

Services
19,314

 
17,348

 
15,205

License
—

 
190

 
238

Total
$
112,964

 
$
101,937

 
$
104,446
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed at December 31, 2018 (in thousands):
Fiscal Year
 
 
 
 
Expected Revenue (1)
2019
 
 
 
 
$
10,037

2020
 
 
 
 
5,149

2021
 
 
 
 
2,525

Thereafter
 
 
 
 
1,436

Total
 
 
 
 
$
19,147

_______
(1) Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Goodwill and Intangible Assets, net (Tables)
 12 Months Ended
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of finite-lived intangible assets Developed technology as a result of the DVS acquisition, and patents and licenses, were as follows (in thousands):

 
December 31, 2018
 
 
Gross Amount
 
Accumulated Amortization
 
Net
 
Weighted-Average Amortization Period
Developed technology
 
$
112,000

 
$
(54,600
)
 
$
57,400

 
10.0 years
Patents and licenses
 
$
11,274

 
$
(6,861
)
 
$
4,413

 
7.8 years

 
 
December 31, 2017
 
 
Gross Amount
 
Accumulated Amortization
 
Net
 
Weighted-Average Amortization Period
Developed technology
 
$
112,000

 
$
(43,400
)
 
$
68,600

 
10.0 years
Patents and licenses
 
$
11,274

 
$
(5,721
)
 
$
5,553

 
7.8 years
Estimated future intangible asset amortization expense Based on the carrying value of intangible assets, net, as of December 31, 2018, the annual amortization expense is expected to be as follows (in thousands):
Fiscal Year
Developed Technology Amortization Expense
 
Patents and Licenses Amortization Expense
 
Total
2019
$
11,200

 
$
1,046

 
$
12,246

2020
11,200

 
1,046

 
12,246

2021
11,200

 
888

 
12,088

2022
11,200

 
815

 
12,015

2023
11,200

 
610

 
11,810

Thereafter
1,400

 
8

 
1,408

Total
$
57,400

 
$
4,413

 
$
61,813
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details (Tables)
 12 Months Ended
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]  
Summary of cash and cash equivalents Cash and cash equivalents consisted of the following as of December 31, 2018 and 2017 (in thousands):
 
 
December 31,
Cash and cash equivalents:
 
2018
 
2017
Cash
 
$
17,685

 
$
20,129

Money market funds
 
77,716

 
16,142

       U.S. Government and agency securities
 
—

 
21,785

Total
 
$
95,401

 
$
58,056
Inventories Inventories consisted of the following as of December 31, 2018 and 2017 (in thousands):
 
 
December 31,
Inventories:
 
2018
 
2017
Raw materials
 
$
5,996

 
$
7,566

Work-in-process
 
650

 
929

Finished goods
 
6,357

 
6,593

Total inventories, net
 
$
13,003

 
$
15,088
Property and equipment Property and equipment consisted of the following as of December 31, 2018 and 2017 (in thousands):
 
 
December 31,
Property and equipment:
 
2018
 
2017
Computer equipment and software
 
$
4,201

 
$
4,179

Laboratory and manufacturing equipment
 
18,780

 
20,069

Leasehold improvements
 
7,173

 
7,799

Office furniture and fixtures
 
1,506

 
1,892

Property and equipment, gross
 
31,660

 
33,939

Less accumulated depreciation and amortization
 
(22,855
)
 
(21,646
)
Construction-in-progress
 
20

 
8

Property and equipment, net
 
$
8,825

 
$
12,301
Activity of warranty accrual Activity for our warranty accrual for the years ended December 31, 2018 and 2017, which are included in other accrued liabilities, is summarized below (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
Beginning balance
 
$
699

 
$
1,023

Accrual for current period warranties
 
1,573

 
695

Warranty costs incurred
 
(1,409
)
 
(1,019
)
Ending balance
 
$
863

 
$
699
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Convertible Notes and Credit Facility (Tables)
 12 Months Ended
Dec. 31, 2018
Debt Disclosure [Abstract]  
Schedule of debt The carrying values of the components of the 2014 Notes and 2018 Notes are as follows (in thousands):
 
 
December 31,
 
 
2018
 
2017
   2.75% 2014 Notes due 2034
 
 
 
 
Principal amount
 
$
51,250

 
$
201,250

Unamortized debt discount
 
(1,232
)
 
(5,087
)
Unamortized debt issuance cost
 
(224
)
 
(925
)
 
 
$
49,794

 
$
195,238

   2.75% 2018 Notes due 2034
 
 
 
 
Principal amount
 
$
149,999

 
$
—

Premium accretion
 
3,755

 
—

Unamortized debt discount
 
(29,558
)
 
—

Unamortized debt issuance cost
 
(1,932
)
 
—

 
 
$
122,264

 
$
—

 
 
$
172,058

 
$
195,238

The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2018 Notes at December 31, 2018 and 2017, respectively (in thousands):
 
December 31, 2018
 
December 31, 2017
 
Par Value
 
Carrying Value
 
Fair Value
 
Par Value
 
Carrying Value
 
Fair Value
2014 Notes
$
51,250

 
$
49,794

 
$
43,665

 
$
201,250

 
$
195,238

 
$
166,162

2018 Notes
149,999

 
122,264

 
171,843

 
—

 
—

 
—

Total
$
201,249

 
$
172,058

 
$
215,508

 
$
201,250

 
$
195,238

 
$
166,162
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value of Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2018
Fair Value Disclosures [Abstract]  
Schedule of cash and available-for-sale securities The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands):
 
December 31, 2018
 
Carrying Amount
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Fair Value
 
Cash and Cash Equivalents
 
Short-Term Marketable Securities
Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash
$
17,685

 
$
—

 
$
—

 
$
17,685

 
$
17,685

 
$
—

Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
    Level I:
 
 
 
 
 
 
 
 
 
 
 
         Money market funds
77,716

 
—

 
—

 
77,716

 
77,716

 
—

         U.S. treasury securities
—

 
—

 
—

 
—

 
—

 
—

    Level II:
 
 
 
 
 
 
 
 
 
 
 
         U.S. government and agency securities
—

 
—

 
—

 
—

 
—

 
—

Total
$
95,401

 
$
—

 
$
—

 
$
95,401

 
$
95,401

 
$
—

 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2017
 
Carrying Amount
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Fair Value
 
Cash and Cash Equivalents
 
Short-Term Marketable Securities
Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash
$
20,129

 
$
—

 
$
—

 
$
20,129

 
$
20,129

 
$
—

Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
    Level I:
 
 
 
 
 
 
 
 
 
 
 
         Money market funds
16,142

 
—

 
—

 
16,142

 
16,142

 
—

         U.S. treasury securities
497

 
—

 
—

 
497

 
—

 
497

    Level II:
 
 
 
 
 
 
 
 
 
 
 
         U.S. government and agency securities
26,369

 
—

 
(1
)
 
26,368

 
21,785

 
4,583

Total
$
63,137

 
$
—

 
$
(1
)
 
$
63,136

 
$
58,056

 
$
5,080
Schedule of debt The carrying values of the components of the 2014 Notes and 2018 Notes are as follows (in thousands):
 
 
December 31,
 
 
2018
 
2017
   2.75% 2014 Notes due 2034
 
 
 
 
Principal amount
 
$
51,250

 
$
201,250

Unamortized debt discount
 
(1,232
)
 
(5,087
)
Unamortized debt issuance cost
 
(224
)
 
(925
)
 
 
$
49,794

 
$
195,238

   2.75% 2018 Notes due 2034
 
 
 
 
Principal amount
 
$
149,999

 
$
—

Premium accretion
 
3,755

 
—

Unamortized debt discount
 
(29,558
)
 
—

Unamortized debt issuance cost
 
(1,932
)
 
—

 
 
$
122,264

 
$
—

 
 
$
172,058

 
$
195,238

The following table summarizes the par value, carrying value and the estimated fair value of the 2014 and 2018 Notes at December 31, 2018 and 2017, respectively (in thousands):
 
December 31, 2018
 
December 31, 2017
 
Par Value
 
Carrying Value
 
Fair Value
 
Par Value
 
Carrying Value
 
Fair Value
2014 Notes
$
51,250

 
$
49,794

 
$
43,665

 
$
201,250

 
$
195,238

 
$
166,162

2018 Notes
149,999

 
122,264

 
171,843

 
—

 
—

 
—

Total
$
201,249

 
$
172,058

 
$
215,508

 
$
201,250

 
$
195,238

 
$
166,162
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Shareholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2018
Equity [Abstract]  
Schedule of common stock reserved for future issuance At December 31, 2018, we had reserved shares of common stock for future issuance under equity compensation plans as follows:
(in 000's)
 
Securities To Be Issued Upon Exercise Of Options
 
Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units
 
Number Of Remaining Securities Available For Future Issuance
2009 Equity Incentive Plan
 
43

 
—

 
—

2011 Equity Incentive Plan
 
2,064

 
1,631

 
2,022

DVS Sciences Inc. 2010 Equity Incentive Plan
 
38

 
—

 
—

2017 Inducement Award Plan
 
240

 
338

 
1,422

2017 Employee Stock Purchase Plan
 

 
—

 
698

 
 
2,385

 
1,969

 
4,142

Total stock-based compensation expense recognized was as follows (in thousands):
 
 
For the Year Ended December 31,
 
 
2018
 
2017
 
2016
2018 Retention Bonus Program
 
$
2,809

 
$
—

 
$
—

Options and Restricted Stock Units
 
7,716

 
8,972

 
13,858

Employee Stock Purchase Plan
 
498

 
120

 
—

Total Share-Based Compensation
 
$
11,023

 
$
9,092


$
13,858
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Plans (Tables)
 12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based compensation determined using Black-Sholes option-pricing model and weighted average assumptions The weighted average assumptions used to estimate the fair value were as follows:
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Stock options:
 
 
 
 
 
 
Weighted average expected volatility
 
68.4
%
 
65.0
%
 
43.4
%
Weighted average expected term
 
4.7 years

 
4.2 years

 
6.0 years

Weighted average risk-free interest rate
 
2.7
%
 
1.7
%
 
1.4
%
Dividend yield
 
—

 
—

 
—

Weighted-average fair value per share
 
$
3.45

 
$
2.97

 
$
3.19

 
 
 
 
 
 
 
Activity under restricted stock units Activity under the 2011 Plan, the 2009 Plan, the 1999 Plan, and the Inducement Plan is as follows:

Restricted Stock Units:
 
 
Number of Units (in 000's)
 
Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 2015
 
663

 
$
32.48

RSU granted
 
940

 
$
7.06

RSU released
 
(328
)
 
$
24.71

RSU forfeited
 
(210
)
 
$
17.82

Balance at December 31, 2016
 
1,065

 
$
15.31

RSU granted
 
916

 
$
5.73

RSU released
 
(445
)
 
$
15.57

RSU forfeited
 
(368
)
 
$
13.11

Balance at December 31, 2017
 
1,168

 
$
8.55

RSU granted
 
1,822

 
$
5.98

RSU released
 
(945
)
 
$
9.63

RSU forfeited
 
(233
)
 
$
8.50

Balance at December 31, 2018
 
1,812

 
$
7.09
Activity under stock options Stock Options:
 
 
Number of
Options (000's)
 
Weighted-Average
Exercise Price
per Option
 
Weighted-
Average Remaining Contractual Life (in Years)
 
Aggregate
Intrinsic
Value (1) in (000's)
Balance at December 31, 2015
 
3,242

 
$
20.45

 
2.2
 
 
Options granted
 
978

 
$
7.44

 
 
 
 
Options exercised
 
(57
)
 
$
4.04

 
 
 
$
310

Option forfeited
 
(603
)
 
$
23.53

 
 
 
 
Balance at December 31, 2016
 
3,560

 
$
16.62

 
6.8
 
 
Options granted
 
1,364

 
$
5.61

 
 
 
 
Options exercised
 
(25
)
 
$
4.07

 
 
 
$
42

Option forfeited
 
(2,735
)
 
$
16.33

 
 
 
 
Balance at December 31, 2017
 
2,164

 
$
10.41

 
6.6
 
 
Options granted
 
758

 
$
6.05

 
 
 
 
Options exercised
 
(40
)
 
$
5.24

 
 
 
$
81

Option forfeited
 
(497
)
 
$
16.09

 
 
 
 
Balance at December 31, 2018
 
2,385

 
$
7.56

 
7.8
 
$
5,991

Vested at December 31, 2018
 
1,026

 
$
9.92

 
6.3
 
$
2,111

Expected to vest at December 31, 2018
 
1,359

 
$
5.78

 
8.9
 
$
3,879


(1)
Aggregate intrinsic value as of December 31, 2018 was calculated as the difference between the closing price per share of our common stock on the last trading day of 2018, which was $8.62, and the exercise price of the options, multiplied by the number of in-the-money options.
Schedule of nonvested performance-based units activity Activity under the 2018 performance stock units is as follows:
 
 
Number of Units (in 000's)
 
Weighted-Average
Grant Date Fair Value per Unit
Balance at December 31, 2017
 
—

 
$
—

RSU granted
 
167

 
10.09

RSU released
 
—

 
—

RSU forfeited
 
(12
)
 
10.09

Balance at December 31, 2018
 
155

 
$
10.09
Schedule of stock-based compensation expense At December 31, 2018, we had reserved shares of common stock for future issuance under equity compensation plans as follows:
(in 000's)
 
Securities To Be Issued Upon Exercise Of Options
 
Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units
 
Number Of Remaining Securities Available For Future Issuance
2009 Equity Incentive Plan
 
43

 
—

 
—

2011 Equity Incentive Plan
 
2,064

 
1,631

 
2,022

DVS Sciences Inc. 2010 Equity Incentive Plan
 
38

 
—

 
—

2017 Inducement Award Plan
 
240

 
338

 
1,422

2017 Employee Stock Purchase Plan
 

 
—

 
698

 
 
2,385

 
1,969

 
4,142

Total stock-based compensation expense recognized was as follows (in thousands):
 
 
For the Year Ended December 31,
 
 
2018
 
2017
 
2016
2018 Retention Bonus Program
 
$
2,809

 
$
—

 
$
—

Options and Restricted Stock Units
 
7,716

 
8,972

 
13,858

Employee Stock Purchase Plan
 
498

 
120

 
—

Total Share-Based Compensation
 
$
11,023

 
$
9,092


$
13,858
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Loss before income taxes Our loss before income taxes consists of the following (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Domestic
 
$
(47,600
)
 
$
(56,885
)
 
$
(65,211
)
International
 
(13,820
)
 
(6,914
)
 
(14,966
)
Loss before income taxes
 
$
(61,420
)
 
$
(63,799
)
 
$
(80,177
)
Significant components of provision for income taxes Significant components of our benefit for income taxes are as follows (in thousands):
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Current:
 
 
 
 
 
 
Federal
 
$
(27
)
 
$
—

 
$
—

State
 
(19
)
 
(17
)
 
(14
)
Foreign
 
(32
)
 
(501
)
 
286

Total current tax (expense) benefit
 
(78
)
 
(518
)
 
272

Deferred:
 
 
 
 
 
 
State
 
—

 
—

 
—

Foreign
 
2,485

 
3,782

 
3,920

Total deferred benefit
 
2,485

 
3,782

 
3,920

Total benefit for income taxes
 
$
2,407

 
$
3,264

 
$
4,192
Reconciliation of income taxes at statutory rate to (provision for)/benefit from income taxes recorded in statements of operations Reconciliation of income taxes at the statutory rate to the benefit from (provision for) income taxes recorded in the statements of operations is as follows:
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Tax benefit at federal statutory rate
 
21.0
 %
 
34.0
 %
 
34.0
 %
State tax expense, net of federal benefit
 
2.3

 
5.5

 
2.2

Foreign tax benefit (expense)
 
(1.1
)
 
0.4

 
(0.7
)
Change in valuation allowance
 
(19.2
)
 
39.2

 
(31.2
)
Federal research and development credit
 
1.5

 
1.9

 
1.3

Unrecognized tax benefit
 
(0.2
)
 
(0.6
)
 
(1.3
)
Impact of the Tax Act
 
—

 
(74.6
)
 
—

Other, net
 
(0.4
)
 
(0.7
)
 
0.9

Effective tax rate
 
3.9
 %
 
5.1
 %
 
5.2
 %
Significant components of deferred tax assets and liabilities Significant components of our deferred tax assets and liabilities are as follows (in thousands):
 
 
December 31,
 
 
2018
 
2017
Deferred tax assets:
 
 
 
 
Net operating loss carryforwards
 
$
98,920

 
$
91,701

Reserves and accruals
 
7,167

 
3,927

Depreciation and amortization
 
4,262

 
5,591

Tax credit carryforwards
 
16,675

 
14,838

Stock-based compensation
 
1,899

 
5,994

Total gross deferred tax assets
 
128,923

 
122,051

Valuation allowance on deferred tax assets
 
(126,109
)
 
(119,228
)
Total deferred tax assets, net of valuation allowance
 
2,814

 
2,823

Deferred tax liabilities:
 
 
 
 
Fixed asset and intangibles
 
(16,528
)
 
(18,912
)
Total deferred tax liabilities
 
(16,528
)
 
(18,912
)
Net deferred tax liability
 
$
(13,714
)
 
$
(16,089
)
Summary of valuation allowance A reconciliation of the beginning and ending amount of the valuation allowance for the years ended December 31, 2018, 2017, and 2016 is as follows (in thousands):
 
Valuation Allowance
December 31, 2015
$
124,137

Charges to earnings
—

Charges to other accounts
22,148

December 31, 2016
146,285

Charges to earnings
830

Charges to other accounts
(27,887
)
December 31, 2017
119,228

Charges to earnings
—

Charges to other accounts
6,880

December 31, 2018
$
126,108
Aggregate changes in balance of gross unrecognized tax benefits The aggregate changes in the balance of our gross unrecognized tax benefits during 2018, 2017, and 2016 were as follows (in thousands):
December 31, 2015
$
8,662

Increases in balances related to tax positions taken during prior period
46

       Increases in balances related to tax positions taken during current period
1,673

       Decreases in balances related to tax positions taken during prior period
(1,048
)
December 31, 2016
9,333

Increases in balances related to tax positions taken during current period
61

Decreases in balances related to tax positions taken during prior period
(2,077
)
December 31, 2017
7,317

Increases in balances related to tax positions taken during current period
255

Decreases in balances related to tax positions taken during prior period
(228
)
December 31, 2018
$
7,344
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.19.1
Information About Geographic Areas (Tables)
 12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Net long-lived assets consisting of property and equipment in different geographic areas We had long-lived assets consisting of property, plant and equipment, net of accumulated depreciation, in the following geographic areas for each year presented (in thousands):
 
 
December 31,
 
 
2018
 
2017
United States
 
$
1,881

 
$
3,500

Singapore
 
3,748

 
5,167

Canada
 
3,104

 
3,481

EMEA
 
66

 
125

Asia-Pacific
 
26

 
28

Total
 
$
8,825

 
$
12,301
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
Future minimum lease payments under non-cancelable operating leases Future minimum lease payments and minimum sublease income under non-cancelable operating leases as of December 31, 2018 are as follows (in thousands):
Fiscal Year
 
Minimum Lease Payments
 
Minimum Sublease Income
 
Net Operating Leases
2019
 
$
4,184

 
$
(520
)
 
$
3,664

2020
 
2,213

 
(164
)
 
2,049

2021
 
1,245

 
—

 
1,245

2022
 
827

 
—

 
827

2023
 
552

 
—

 
552

   Thereafter
 
1,241

 
—

 
1,241

Total
 
$
10,262

 
$
(684
)
 
$
9,578
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.19.1
Quarterly Results of Operations (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Quarterly results of operations Selected quarterly results of operations for the years ended December 31, 2018 and 2017 are as follows (in thousands, except for per share amounts):
2018
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
25,248

 
$
26,428

 
$
28,963

 
$
32,325

Net loss
 
$
(13,247
)
 
$
(16,241
)
 
$
(14,750
)
 
$
(14,775
)
Net loss per share, basic and diluted
 
$
(0.34
)
 
$
(0.42
)
 
$
(0.38
)
 
$
(0.36
)
 
 
 
 
 
 
 
 
 
2017
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
25,533

 
$
23,912

 
$
24,747

 
$
27,745

Net loss
 
$
(17,202
)
 
$
(16,933
)
 
$
(15,944
)
 
$
(10,456
)
Net loss per share, basic and diluted
 
$
(0.59
)
 
$
(0.58
)
 
$
(0.46
)
 
$
(0.27
)
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Jan. 01, 2019
Mar. 31, 2018
Jan. 01, 2018
Feb. 28, 2014
Feb. 04, 2014
Schedule Of Significant Accounting Policies [Line Items]                
Product warranty term 1 year              
Depreciation $ 4,200,000 $ 5,900,000 $ 5,100,000          
Advertising costs incurred 2,200,000 1,800,000 $ 2,300,000          
Accumulated deficit (558,851,000) (500,196,000)       $ (499,838,000)    
Total current assets $ 127,106,000 94,801,000       94,954,000    
Computer equipment and software | Minimum                
Schedule Of Significant Accounting Policies [Line Items]                
Property and equipment, estimated useful lives 3 years              
Computer equipment and software | Maximum                
Schedule Of Significant Accounting Policies [Line Items]                
Property and equipment, estimated useful lives 4 years              
Laboratory and manufacturing equipment | Minimum                
Schedule Of Significant Accounting Policies [Line Items]                
Property and equipment, estimated useful lives 2 years              
Laboratory and manufacturing equipment | Maximum                
Schedule Of Significant Accounting Policies [Line Items]                
Property and equipment, estimated useful lives 5 years              
Office furniture and fixtures                
Schedule Of Significant Accounting Policies [Line Items]                
Property and equipment, estimated useful lives 5 years              
Commission Costs | Minimum                
Schedule Of Significant Accounting Policies [Line Items]                
Performance obligation period 1 year              
Commission Costs | Maximum                
Schedule Of Significant Accounting Policies [Line Items]                
Performance obligation period 3 years              
Convertible Debt                
Schedule Of Significant Accounting Policies [Line Items]                
Par Value $ 201,249,000 201,250,000            
Embedded conversion option value 29,300,000              
Senior Convertible Notes due 2034 | Convertible Debt                
Schedule Of Significant Accounting Policies [Line Items]                
Par Value 51,250,000 201,250,000         $ 201,300,000 $ 201,300,000
Interest rate on notes             2.75% 2.75%
Exchange Convertible Senior Notes due 2034 | Convertible Debt                
Schedule Of Significant Accounting Policies [Line Items]                
Par Value 149,999,000 $ 0     $ 150,000,000.0      
Interest rate on notes         2.75%      
Long-term debt outstanding         $ 51,300,000      
Difference between Revenue Guidance in Effect before and after Topic 606 | Accounting Standards Update 2014-09                
Schedule Of Significant Accounting Policies [Line Items]                
Accumulated deficit           358,000    
Total current assets $ 167,000         153,000    
Total noncurrent assets           $ 200,000    
Scenario, Forecast | Accounting Standards Update 2016-02 | Minimum                
Schedule Of Significant Accounting Policies [Line Items]                
Operating lease, liability       $ 8,000,000.0        
Operating lease, right-of-use asset       6,000,000.0        
Scenario, Forecast | Accounting Standards Update 2016-02 | Maximum                
Schedule Of Significant Accounting Policies [Line Items]                
Operating lease, liability       11,000,000.0        
Operating lease, right-of-use asset       $ 9,000,000.0        
Product revenue | Minimum                
Schedule Of Significant Accounting Policies [Line Items]                
Terms of payment period 30 days              
Product revenue | Maximum                
Schedule Of Significant Accounting Policies [Line Items]                
Terms of payment period 60 days              
Service revenue | Maximum                
Schedule Of Significant Accounting Policies [Line Items]                
Performance obligation period 3 years              
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Beginning Balance $ 30,935 $ 53,233 $ 114,901
Change during the year (113) 186 384
Ending Balance 72,116 30,935 53,233
Foreign Currency Translation Adjustment      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Beginning Balance (575) (758)  
Change during the year (112) 183  
Ending Balance (687) (575) (758)
Unrealized Gain (Loss) on Investments      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Beginning Balance 1 (2)  
Change during the year (1) 3  
Ending Balance 0 1 (2)
Accumulated Other Comprehensive Income (Loss)      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Beginning Balance (574) (760) (1,144)
Change during the year (113) 186 384
Ending Balance $ (687) $ (574) $ (760)
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) - shares
shares in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computations of net loss per share (in shares) 25,062 7,099 8,220
Stock options, restricted stock units and performance awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computations of net loss per share (in shares) 4,354 3,501 4,622
2018 Convertible Notes | Convertible Notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computations of net loss per share (in shares) 19,035 0 0
2018 Convertible Notes potential make-whole shares | Convertible Notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computations of net loss per share (in shares) 757 0 0
2014 Convertible Notes | Convertible Notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computations of net loss per share (in shares) 916 3,598 3,598
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Impact on Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2018
Jan. 01, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Prepaid expenses and other current assets $ 2,051 $ 1,681 $ 1,528    
Total current assets 127,106 94,954 94,801    
Other non-current assets 6,208 7,746 7,541    
Total assets 303,647 287,709 287,351    
Accumulated deficit (558,851) (499,838) (500,196)    
Total stockholders' equity 72,116 31,293 30,935 $ 53,233 $ 114,901
Total liabilities and stockholders' equity 303,647 287,709 287,351    
Calculated under Revenue Guidance in Effect before Topic 606          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Prepaid expenses and other current assets 1,884   1,528    
Total current assets 126,939   94,801    
Other non-current assets 5,941   7,541    
Total assets 303,213   287,351    
Accumulated deficit     (500,196)    
Total stockholders' equity 71,682   30,935    
Total liabilities and stockholders' equity 303,213   $ 287,351    
Accounting Standards Update 2014-09 | Difference between Revenue Guidance in Effect before and after Topic 606          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
Prepaid expenses and other current assets 167 153      
Total current assets 167 153      
Other non-current assets 267 205      
Total assets 434 358      
Accumulated deficit   358      
Total stockholders' equity 434 358      
Total liabilities and stockholders' equity $ 434 $ 358      
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Impact On Income Statement (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Selling, general and administrative $ 79,783 $ 79,516 $ 93,212
Total costs and expenses 161,128    
Loss from operations (48,164) (58,360) (73,190)
Loss before income taxes (61,420) (63,799) (80,177)
Net loss (59,013) $ (60,535) $ (75,985)
Calculated under Revenue Guidance in Effect before Topic 606      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Selling, general and administrative 79,859    
Total costs and expenses 161,204    
Loss from operations (48,240)    
Loss before income taxes (61,496)    
Net loss (59,089)    
Accounting Standards Update 2014-09 | Difference between Revenue Guidance in Effect before and after Topic 606      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Selling, general and administrative (76)    
Total costs and expenses (76)    
Loss from operations 76    
Loss before income taxes 76    
Net loss $ 76    
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Disaggregation of Revenue [Line Items]                      
Total revenue $ 32,325 $ 28,963 $ 26,428 $ 25,248 $ 27,745 $ 24,747 $ 23,912 $ 25,533 $ 112,964 $ 101,937 $ 104,446
Americas                      
Disaggregation of Revenue [Line Items]                      
Total revenue                 51,172 49,290 56,229
EMEA                      
Disaggregation of Revenue [Line Items]                      
Total revenue                 36,617 32,642 29,739
Asia-Pacific                      
Disaggregation of Revenue [Line Items]                      
Total revenue                 25,175 20,005 18,478
Instruments                      
Disaggregation of Revenue [Line Items]                      
Total revenue                 45,491 42,505 46,834
Consumables                      
Disaggregation of Revenue [Line Items]                      
Total revenue                 48,159 41,894 42,169
Product revenue                      
Disaggregation of Revenue [Line Items]                      
Total revenue                 93,650 84,399 89,003
Services                      
Disaggregation of Revenue [Line Items]                      
Total revenue                 19,314 17,348 15,205
License                      
Disaggregation of Revenue [Line Items]                      
Total revenue                 $ 0 $ 190 $ 238
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Deferred revenue $ 17.8 $ 15.2
Revenue recognized 9.1  
Additional advance payments received 11.7  
Commission Costs    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Capitalized contract cost $ 0.4  
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue - Performance Obligations (Details)
$ in Thousands
Dec. 31, 2018
USD ($)
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 19,147
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 10,037
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 5,149
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01  
Revenue from Contract with Customer [Abstract]  
Remaining performance obligation $ 1,436
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 1 year
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.19.1
Goodwill and Intangible Assets, net - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Feb. 28, 2014
Finite-Lived Intangible Assets [Line Items]        
Amortization of developed technology $ 11,200 $ 11,200 $ 11,200  
DVS Sciences, Inc.        
Finite-Lived Intangible Assets [Line Items]        
Business combination, preliminary goodwill       $ 104,100
Developed technology        
Finite-Lived Intangible Assets [Line Items]        
Amortization of developed technology $ 12,300 $ 12,400 $ 12,400  
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.19.1
Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]    
Net $ 61,813  
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 112,000 $ 112,000
Accumulated Amortization (54,600) (43,400)
Net $ 57,400 $ 68,600
Weighted-Average Amortization Period 10 years 10 years
Patents and licenses    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount $ 11,274 $ 11,274
Accumulated Amortization (6,861) (5,721)
Net $ 4,413 $ 5,553
Weighted-Average Amortization Period 7 years 9 months 18 days 7 years 9 months 18 days
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.19.1
Goodwill and Intangible Assets, net - Future Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]    
2019 $ 12,246  
2020 12,246  
2021 12,088  
2022 12,015  
2023 11,810  
Thereafter 1,408  
Net 61,813  
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
2019 11,200  
2020 11,200  
2021 11,200  
2022 11,200  
2023 11,200  
Thereafter 1,400  
Net 57,400 $ 68,600
Patents and licenses    
Finite-Lived Intangible Assets [Line Items]    
2019 1,046  
2020 1,046  
2021 888  
2022 815  
2023 610  
Thereafter 8  
Net $ 4,413 $ 5,553
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Balance Sheet Related Disclosures [Abstract]        
Cash $ 17,685 $ 20,129    
Money market funds 77,716 16,142    
U.S. Government and agency securities 0 21,785    
Total $ 95,401 $ 58,056 $ 35,045 $ 29,117
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Inventories (Details) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Balance Sheet Related Disclosures [Abstract]    
Raw materials $ 5,996 $ 7,566
Work-in-process 650 929
Finished goods 6,357 6,593
Total inventories, net $ 13,003 $ 15,088
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Property and Equipment (Details) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Property, Plant and Equipment [Line Items]    
Property and equipment $ 31,660 $ 33,939
Less accumulated depreciation and amortization (22,855) (21,646)
Construction-in-progress 20 8
Property and equipment, net 8,825 12,301
Computer equipment and software    
Property, Plant and Equipment [Line Items]    
Property and equipment 4,201 4,179
Laboratory and manufacturing equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment 18,780 20,069
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property and equipment 7,173 7,799
Office furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Property and equipment $ 1,506 $ 1,892
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Warranty Accrual (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Movement in Standard Product Warranty Accrual [Roll Forward]    
Beginning balance $ 699 $ 1,023
Accrual for current period warranties 1,573 695
Warranty costs incurred (1,409) (1,019)
Ending balance $ 863 $ 699
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.19.1
Convertible Notes and Credit Facility - Narrative (Details) - USD ($)
 1 Months Ended
Aug. 02, 2018
Feb. 04, 2014
Mar. 31, 2018
Feb. 28, 2014
Dec. 31, 2018
Dec. 31, 2017
Debt Instrument [Line Items]            
Common stock, par value (usd per share)         $ 0.001 $ 0.001
Convertible Debt            
Debt Instrument [Line Items]            
Principal amount         $ 201,249,000 $ 201,250,000
Convertible Debt | Senior Convertible Notes due 2034            
Debt Instrument [Line Items]            
Principal amount   $ 201,300,000   $ 201,300,000 51,250,000 $ 201,250,000
Interest rate on notes   2.75%   2.75%    
Initial conversion rate of notes   17.8750        
Common stock, par value (usd per share)   $ 0.001        
Initial conversion price of stock (usd per share)   $ 55.94        
Debt instrument, redemption price when undergo fundamental change   100.00%        
Net proceeds from issuance of convertible notes, net       $ 195,200,000    
Debt issuance costs       1,100,000    
Underwriting discount       $ 6,000,000.0    
Convertible Debt | 2018 Convertible Notes            
Debt Instrument [Line Items]            
Principal amount     $ 150,000,000.0      
Interest rate on notes     2.75%      
Initial conversion rate of notes     126.9438      
Common stock, par value (usd per share)     $ 0.001      
Initial conversion price of stock (usd per share)     $ 7.88      
Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price     110.00%      
Debt instrument, redemption price when undergo fundamental change     100.00%      
Long-term debt outstanding     $ 150,000,000.0      
Estimated fair value of debt     145,500,000      
Gain on extinguishment of debt     $ 100,000      
Debt instrument, redemption price, percentage of outstanding principal amount, fundamental change     120.00%      
Debt and equity offering costs     $ 2,800,000      
Amortization of debt issuance costs     2,200,000      
Stock issuance costs     $ 600,000      
Redemption, Period One | Convertible Debt | Senior Convertible Notes due 2034            
Debt Instrument [Line Items]            
Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price   130.00%        
Redemption, Period Two | Convertible Debt | Senior Convertible Notes due 2034            
Debt Instrument [Line Items]            
Debt instrument redemption price   100.00%        
Redemption, Period Three | Convertible Debt | Senior Convertible Notes due 2034            
Debt Instrument [Line Items]            
Debt instrument redemption price   100.00%        
Revolving Credit Facility            
Debt Instrument [Line Items]            
Principal amount         12,300,000  
Debt issuance costs $ 335,000          
Maximum ability to borrow under line of credit $ 15,000,000.0       $ 0  
Percentage of eligible receivables 85.00%          
Percentage of eligible inventory 50.00%          
Unused revolving line of credit 0.75%          
Commitment fee amount $ 225,000          
Percentage of interest on obligation upon default 5.00%          
Revolving Credit Facility | Loan Agreement Prior To August 2, 2019            
Debt Instrument [Line Items]            
Prepayment fee, percentage 2.00%          
Revolving Credit Facility | Loan Agreement On Or After August 2, 2019            
Debt Instrument [Line Items]            
Prepayment fee, percentage 1.00%          
Revolving Credit Facility | Minimum | Prime Rate            
Debt Instrument [Line Items]            
Additional interest rate 0.50%          
Revolving Credit Facility | Maximum | Prime Rate            
Debt Instrument [Line Items]            
Additional interest rate 5.50%          
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.19.1
Convertible Notes and Credit Facility - Schedule of Debt (Details) - Convertible Notes Payable - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Debt Instrument [Line Items]    
Net carrying value of convertible notes $ 172,058,000 $ 195,238,000
Senior Convertible Notes due 2034    
Debt Instrument [Line Items]    
Principal amount 51,250,000 201,250,000
Unamortized debt discount (1,232,000) (5,087,000)
Unamortized debt issuance cost (224,000) (925,000)
Net carrying value of convertible notes 49,794,000 195,238,000
Exchange Convertible Senior Notes due 2034    
Debt Instrument [Line Items]    
Principal amount 149,999,000 0
Premium accretion 3,755,000 0
Unamortized debt discount (29,558,000) 0
Unamortized debt issuance cost (1,932,000) 0
Net carrying value of convertible notes $ 122,264,000 $ 0
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value of Financial Instruments - Fair Value of Financial Instruments (Details)
$ in Thousands
Dec. 31, 2018
USD ($)
investment
Dec. 31, 2017
USD ($)
Fair Value Disclosures [Abstract]    
Number of investment in unrealized loss positions | investment 0  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Carrying Amount $ 95,401 $ 63,137
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 (1)
Fair Value 95,401 63,136
Cash and Cash Equivalents 95,401 58,056
Short-Term Marketable Securities 0 5,080
Cash    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Carrying Amount 17,685 20,129
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 17,685 20,129
Cash and Cash Equivalents 17,685 20,129
Short-Term Marketable Securities 0 0
Money market funds | Level I    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Carrying Amount 77,716 16,142
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 77,716 16,142
Cash and Cash Equivalents 77,716 16,142
Short-Term Marketable Securities 0 0
U.S. treasury securities | Level I    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Carrying Amount 0 497
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 0
Fair Value 0 497
Cash and Cash Equivalents 0 0
Short-Term Marketable Securities 0 497
U.S. government and agency securities | Level II    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Carrying Amount 0 26,369
Gross Unrealized Gain 0 0
Gross Unrealized Loss 0 (1)
Fair Value 0 26,368
Cash and Cash Equivalents 0 21,785
Short-Term Marketable Securities $ 0 $ 4,583
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value of Financial Instruments - Schedule of Debt (Details) - Convertible Debt - USD ($)
Dec. 31, 2018
Mar. 31, 2018
Dec. 31, 2017
Feb. 28, 2014
Feb. 04, 2014
Debt Instrument [Line Items]          
Par Value $ 201,249,000   $ 201,250,000    
Senior Convertible Notes due 2034          
Debt Instrument [Line Items]          
Par Value 51,250,000   201,250,000 $ 201,300,000 $ 201,300,000
Exchange Convertible Senior Notes due 2034          
Debt Instrument [Line Items]          
Par Value 149,999,000 $ 150,000,000.0 0    
Carrying Value          
Debt Instrument [Line Items]          
Debt 172,058,000   195,238,000    
Carrying Value | Senior Convertible Notes due 2034          
Debt Instrument [Line Items]          
Debt 49,794,000   195,238,000    
Carrying Value | Exchange Convertible Senior Notes due 2034          
Debt Instrument [Line Items]          
Debt 122,264,000   0    
Fair Value          
Debt Instrument [Line Items]          
Debt 215,508,000   166,162,000    
Fair Value | Senior Convertible Notes due 2034          
Debt Instrument [Line Items]          
Debt 43,665,000   166,162,000    
Fair Value | Exchange Convertible Senior Notes due 2034          
Debt Instrument [Line Items]          
Debt $ 171,843,000   $ 0    
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.19.1
Shareholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 14, 2018
Aug. 10, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Shareholders' Equity [Line Items]          
Common stock, par value (usd per share)     $ 0.001 $ 0.001  
Net proceeds from issuance of common stock     $ 59,469 $ 28,793 $ 0
Common Stock          
Shareholders' Equity [Line Items]          
Shares sold (shares)     9,373,000 9,091,000  
Common Stock | 2018 Market Offering          
Shareholders' Equity [Line Items]          
Shares sold (shares) 9,372,500        
Common stock, par value (usd per share) $ 0.001        
Price per share (in dollars per share) $ 6.75        
Gross proceeds from issuance of common stock through at-the-market offering $ 63,300        
Net proceeds from issuance of common stock 59,100        
Commission expense 3,800        
Estimated expenses of offering $ 400        
Common Stock | 2017 At-the-Market Offering          
Shareholders' Equity [Line Items]          
Shares sold (shares)   9,090,909      
Common stock, par value (usd per share)   $ 0.001      
Gross proceeds from issuance of common stock through at-the-market offering   $ 30,000      
Net proceeds from issuance of common stock   28,800      
Commission expense   700      
Stock issuance costs   $ 500      
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.19.1
Shareholders' Equity - Schedule of Stock Options (Details)
shares in Thousands
Dec. 31, 2018
shares
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 4,142
2009 Equity Incentive Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 0
2011 Equity Incentive Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 2,022
DVS Sciences Inc. 2010 Equity Incentive Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 0
2017 Inducement Award Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 1,422
2017 Employee Stock Purchase Plan  
Class of Stock [Line Items]  
Number Of Remaining Securities Available For Future Issuance (in shares) 698
Stock Option  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 2,385
Stock Option | 2009 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 43
Stock Option | 2011 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 2,064
Stock Option | DVS Sciences Inc. 2010 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 38
Stock Option | 2017 Inducement Award Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 240
Stock Option | 2017 Employee Stock Purchase Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares)
Restricted Stock And Performance Share Units  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 1,969
Restricted Stock And Performance Share Units | 2009 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 0
Restricted Stock And Performance Share Units | 2011 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 1,631
Restricted Stock And Performance Share Units | DVS Sciences Inc. 2010 Equity Incentive Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 0
Restricted Stock And Performance Share Units | 2017 Inducement Award Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 338
Restricted Stock And Performance Share Units | 2017 Employee Stock Purchase Plan  
Class of Stock [Line Items]  
Securities To Be Issued (in shares) 0
XML 73 R58.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Plans - Narrative (Details) - USD ($)
 3 Months Ended 12 Months Ended
Aug. 23, 2017
Aug. 01, 2017
Mar. 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Sep. 20, 2017
Jan. 05, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Options exercised (usd per share)       $ 5.24 $ 4.07 $ 4.04    
Share price (usd per share)       $ 8.62        
Common stock, shares issued (shares)       49,338,000 38,787,000      
Stock option weighted-average fair value per share (usd per share)       $ 3.45 $ 2.97 $ 3.19    
Restricted Stock Units (RSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period       4 years        
Award vesting percentage       25.00%        
Aggregate intrinsic value, vested and released       $ 6,800,000 $ 2,300,000 $ 2,400,000    
Total unrecognized compensation cost related to stock-based compensation arrangements       $ 9,700,000        
Weighted average remaining contractual terms       2 years 10 months 24 days        
Granted (shares)       1,822,000 916,000 940,000    
Performance Shares                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total unrecognized compensation cost related to stock-based compensation arrangements       $ 1,200,000        
Weighted average remaining contractual terms       2 years 2 months 12 days        
Granted (shares)     167,000 167,000        
Stock option weighted-average fair value per share (usd per share)       $ 10.09        
Performance Shares | Minimum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of performance period       0.00%        
Performance Shares | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of performance period       200.00%        
Performance-Based Stock Options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Granted (shares)           184,050    
Stock option weighted-average fair value per share (usd per share)           $ 7.10    
Stock options, restricted stock units and performance awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards authorized for issuance (shares)       2,385,000        
Performance-Based Restricted Stock Options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Granted (shares)           87,620    
2011 Equity Incentive Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Rate at which outstanding options vest on the first anniversary of the option grant date       25.00%        
2011 Equity Incentive Plan | Vesting Scenario One                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock option grants exercise price minimum percentage on fair market value       100.00%        
2011 Equity Incentive Plan | Vesting Scenario One | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period       10 years        
2011 Equity Incentive Plan | Vesting Scenario Two                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock option grants exercise price minimum percentage on fair market value       110.00%        
Percentage of voting power which impacts the term of equity incentive plan       10.00%        
2011 Equity Incentive Plan | Vesting Scenario Two | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period       5 years        
2011 Equity Incentive Plan | Stock Options, Vesting One                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of months over which options vest ratably       36 months        
2011 Equity Incentive Plan | Stock Options, Vesting Two                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of months over which options vest ratably       48 months        
2017 Inducement Award Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards authorized for issuance (shares)               2,000,000
2018 Retention Bonus Program | Restricted Stock Units (RSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of shares to be exchanged on closing date or commencement date       85.00%        
Total intrinsic value       $ 2,800,000        
Granted (shares)       379,593        
Equity Incentive Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total unrecognized compensation cost related to stock-based compensation arrangements       $ 4,200,000        
Weighted average remaining contractual terms       2 years 7 months 6 days        
The Program                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Award vesting period 3 years              
Options exercised (usd per share) $ 4.37              
Share price (usd per share)             $ 5.13  
Common stock, shares issued (shares)       1,204,198        
The Program | Restricted Stock Units (RSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common stock, shares issued (shares)       54,944        
The Program | Stock options, restricted stock units and performance awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Options exercised (usd per share)       $ 5.13        
Common stock, shares issued (shares)       399,117        
2017 Employee Stock Purchase Plan | Stock options, restricted stock units and performance awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Awards authorized for issuance (shares)              
2017 Employee Stock Purchase Plan | Employee Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Maximum employee subscription rate       10.00%        
Maximum employee purchase amount   $ 25,000            
Purchase price of common stock, percent   85.00%            
Share-based Compensation Award, Tranche One | 2018 Retention Bonus Program | Restricted Stock Units (RSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of eligible employee bonus program       25.00%        
Share-based Compensation Award, Tranche Two | 2018 Retention Bonus Program | Restricted Stock Units (RSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of eligible employee bonus program       50.00%        
Share-based Compensation Award, Tranche Three | 2018 Retention Bonus Program | Restricted Stock Units (RSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of eligible employee bonus program       75.00%        
Share-based Compensation Award, Tranche Four | 2018 Retention Bonus Program | Restricted Stock Units (RSUs)                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Percentage of eligible employee bonus program       100.00%        
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Plans - Weighted-average Assumptions (Details) - $ / shares
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average expected volatility 68.40% 65.00% 43.40%
Weighted average expected term 4 years 8 months 12 days 4 years 2 months 12 days 6 years
Weighted average risk-free interest rate 2.70% 1.70% 1.40%
Dividend yield 0.00% 0.00% 0.00%
Weighted-average fair value per share $ 3.45 $ 2.97 $ 3.19
XML 75 R60.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Plans - Restricted and Performance Stock Units (Details) - $ / shares
 3 Months Ended 12 Months Ended
Mar. 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Restricted Stock Units (RSUs)        
Number of Nonvested and Outstanding Units        
Beginning Balance (shares) 1,168,000 1,168,000 1,065,000 663,000
Granted (shares)   1,822,000 916,000 940,000
Released (shares)   (945,000) (445,000) (328,000)
Forfeited (shares)   (233,000) (368,000) (210,000)
Ending Balance (shares)   1,812,000 1,168,000 1,065,000
Weighted-Average Grant Date Fair Value per Share        
Beginning Balance (usd per share) $ 8.55 $ 8.55 $ 15.31 $ 32.48
Granted (usd per share)   5.98 5.73 7.06
Released (usd per share)   9.63 15.57 24.71
Forfeited (usd per share)   8.50 13.11 17.82
Ending Balance (usd per share)   $ 7.09 $ 8.55 $ 15.31
Performance Shares        
Number of Nonvested and Outstanding Units        
Beginning Balance (shares) 0 0    
Granted (shares) 167,000 167,000    
Released (shares)   0    
Forfeited (shares)   (12,000)    
Ending Balance (shares)   155,000 0  
Weighted-Average Grant Date Fair Value per Share        
Beginning Balance (usd per share) $ 0 $ 0    
Granted (usd per share)   10.09    
Released (usd per share)   0    
Forfeited (usd per share)   10.09    
Ending Balance (usd per share)   $ 10.09 $ 0  
XML 76 R61.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Plans - Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Number of Shares        
Beginning Balance (shares) 2,164 3,560 3,242  
Options granted (shares) 758 1,364 978  
Option exercised (shares) (40) (25) (57)  
Options forfeited (shares) (497) (2,735) (603)  
Ending Balance (shares) 2,385 2,164 3,560 3,242
Vested (in shares) 1,026      
Expected to vest (in shares) 1,359      
Weighted-Average Exercise Price per Share        
Beginning Balance (usd per share) $ 10.41 $ 16.62 $ 20.45  
Options granted (usd per share) 6.05 5.61 7.44  
Options exercised (usd per share) 5.24 4.07 4.04  
Options forfeited (usd per share) 16.09 16.33 23.53  
Ending Balance (usd per share) 7.56 $ 10.41 $ 16.62 $ 20.45
Vested (usd per share) 9.92      
Expected to vest (usd per share) $ 5.78      
Weighted- Average Remaining Contractual Life (in Years)        
Contractual term 7 years 9 months 18 days 6 years 7 months 6 days 6 years 9 months 18 days 2 years 2 months 12 days
Vested 6 years 3 months 18 days      
Expected to vest 8 years 10 months 24 days      
Aggregate Intrinsic Value        
Options exercised $ 81 $ 42 $ 310  
Balance at December 31, 2018 5,991      
Vested at December 31, 2018 2,111      
Expected to vest at December 31, 2018 $ 3,879      
Share price (usd per share) $ 8.62      
XML 77 R62.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Plans - Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total Share-Based Compensation $ 11,023 $ 9,092 $ 13,858
2018 Retention Bonus Program      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total Share-Based Compensation 2,809 0 0
Options and Restricted Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total Share-Based Compensation 7,716 8,972 13,858
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total Share-Based Compensation $ 498 $ 120 $ 0
XML 78 R63.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes - Loss Before Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income Tax Disclosure [Abstract]      
Domestic $ (47,600) $ (56,885) $ (65,211)
International (13,820) (6,914) (14,966)
Loss before income taxes $ (61,420) $ (63,799) $ (80,177)
XML 79 R64.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Current:      
Federal $ (27) $ 0 $ 0
State (19) (17) (14)
Foreign (32) (501) 286
Total current tax (expense) benefit (78) (518) 272
Deferred:      
State 0 0 0
Foreign 2,485 3,782 3,920
Total deferred benefit 2,485 3,782 3,920
Total benefit for income taxes $ 2,407 $ 3,264 $ 4,192
XML 80 R65.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes - Reconciliation of Income Taxes at Statutory Rate (Details)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income Tax Disclosure [Abstract]      
Tax benefit at federal statutory rate 21.00% 34.00% 34.00%
State tax expense, net of federal benefit 2.30% 5.50% 2.20%
Foreign tax benefit (expense) (1.10%) 0.40% (0.70%)
Change in valuation allowance (19.20%) 39.20% (31.20%)
Federal research and development credit 1.50% 1.90% 1.30%
Unrecognized tax benefit (0.20%) (0.60%) (1.30%)
Impact of the Tax Act 0.00% (74.60%) 0.00%
Other, net (0.40%) (0.70%) 0.90%
Effective tax rate 3.90% 5.10% 5.20%
XML 81 R66.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Deferred tax assets:    
Net operating loss carryforwards $ 98,920 $ 91,701
Reserves and accruals 7,167 3,927
Depreciation and amortization 4,262 5,591
Tax credit carryforwards 16,675 14,838
Stock-based compensation 1,899 5,994
Total gross deferred tax assets 128,923 122,051
Valuation allowance on deferred tax assets (126,109) (119,228)
Total deferred tax assets, net of valuation allowance 2,814 2,823
Deferred Tax Liabilities, Gross [Abstract]    
Fixed asset and intangibles (16,528) (18,912)
Total deferred tax liabilities (16,528) (18,912)
Net deferred tax liability $ (13,714) $ (16,089)
XML 82 R67.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income Taxes [Line Items]      
Increase (decrease) in valuation allowance $ 6,900 $ (27,100) $ 22,100
Valuation allowance 126,109 $ 119,228  
Unrecognized tax benefits, that if recognized would affect effective tax rate 400    
Domestic Tax Authority      
Income Taxes [Line Items]      
Reduction in net operating losses 1,200    
California | State and Local Jurisdiction | Research Tax Credit Carryforward      
Income Taxes [Line Items]      
Operating loss carryforward 11,000    
Expiring In 2021 | Domestic Tax Authority      
Income Taxes [Line Items]      
Operating loss carryforward 432,200    
Expiring In 2021 Through 2039 | Domestic Tax Authority | Research Tax Credit Carryforward      
Income Taxes [Line Items]      
Operating loss carryforward 8,500    
Expiring In 2028 Through 2039 | State and Local Jurisdiction      
Income Taxes [Line Items]      
Operating loss carryforward 170,300    
Expiring In 2019 Through 2027 | Foreign Tax Authority      
Income Taxes [Line Items]      
Operating loss carryforward $ 1,900    
XML 83 R68.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes - Valuation Allowance (Details) - Valuation Allowance, Deferred Tax Asset - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Valuation Allowances [Roll Forward]      
Beginning Balance $ 119,228 $ 146,285 $ 124,137
Charges to earnings 0 830 0
Charges to other accounts 6,880 (27,887) 22,148
Ending Balance $ 126,108 $ 119,228 $ 146,285
XML 84 R69.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes - Aggregate Changes in Balance of Gross Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Beginning Balance $ 7,317 $ 9,333 $ 8,662
Increases in balances related to tax positions taken during prior period     46
Increases in balances related to tax positions taken during prior period 255 61 1,673
Decreases in balances related to tax positions taken during prior period (228) (2,077) (1,048)
Ending Balance $ 7,344 $ 7,317 $ 9,333
XML 85 R70.htm IDEA: XBRL DOCUMENT v3.19.1
Employee Benefit Plans (Details) - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Compensation Plan [Line Items]      
Percent of employee match   100.00%  
Maximum annual employee contribution matched by employer   $ 2,000  
Vesting period   4 years  
Employer matching contributions expense $ 400,000 $ 500,000 $ 600,000
Maximum      
Compensation Plan [Line Items]      
Percentage of employees eligible compensation 90.00%    
XML 86 R71.htm IDEA: XBRL DOCUMENT v3.19.1
Information About Geographic Areas - Narrative (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2018
USD ($)
segment
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Segment Reporting [Abstract]                      
Number of reporting segment | segment                 1    
Product Information [Line Items]                      
Sales to customers $ 32,325 $ 28,963 $ 26,428 $ 25,248 $ 27,745 $ 24,747 $ 23,912 $ 25,533 $ 112,964 $ 101,937 $ 104,446
United States | Revenue from Contract with Customer                      
Product Information [Line Items]                      
Sales to customers                 $ 48,100 $ 45,800 $ 52,600
Concentration risk, percentage                 43.00% 45.00% 50.00%
China | Revenue from Contract with Customer                      
Product Information [Line Items]                      
Sales to customers                 $ 14,000 $ 11,100 $ 11,100
Concentration risk, percentage                 12.00% 11.00% 11.00%
XML 87 R72.htm IDEA: XBRL DOCUMENT v3.19.1
Information About Geographic Areas - Long-lived Assets by Geographic Areas (Details) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]    
Total property and equipment, net $ 8,825 $ 12,301
United States    
Segment Reporting Information [Line Items]    
Total property and equipment, net 1,881 3,500
Singapore    
Segment Reporting Information [Line Items]    
Total property and equipment, net 3,748 5,167
Canada    
Segment Reporting Information [Line Items]    
Total property and equipment, net 3,104 3,481
EMEA    
Segment Reporting Information [Line Items]    
Total property and equipment, net 66 125
Asia-Pacific    
Segment Reporting Information [Line Items]    
Total property and equipment, net $ 26 $ 28
XML 88 R73.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Aug. 30, 2017
Jul. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Mar. 12, 2019
Loss Contingencies [Line Items]            
Rent expense     $ 5.0 $ 4.7 $ 6.3  
Purchase commitment due in the next year     $ 1.6      
Thermo            
Loss Contingencies [Line Items]            
Litigation settlement amount awarded to other party   $ 3.0        
Payments for legal settlements $ 3.0          
Insurance recoveries $ 1.0          
Ransomware Attack | Subsequent Event            
Loss Contingencies [Line Items]            
Estimate of possible loss           $ 1.5
XML 89 R74.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies - Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Details)
$ in Thousands
Dec. 31, 2018
USD ($)
Minimum Lease Payments  
2019 $ 4,184
2020 2,213
2021 1,245
2022 827
2023 552
Thereafter 1,241
Total 10,262
Minimum Sublease Income  
2019 (520)
2020 (164)
2021 0
2022 0
2023 0
Thereafter 0
Total (684)
Net Operating Leases [Abstract]  
2019 3,664
2020 2,049
2021 1,245
2022 827
2023 552
Thereafter 1,241
Total $ 9,578
XML 90 R75.htm IDEA: XBRL DOCUMENT v3.19.1
Quarterly Results of Operations (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]                      
Total revenue $ 32,325 $ 28,963 $ 26,428 $ 25,248 $ 27,745 $ 24,747 $ 23,912 $ 25,533 $ 112,964 $ 101,937 $ 104,446
Net loss $ (14,775) $ (14,750) $ (16,241) $ (13,247) $ (10,456) $ (15,944) $ (16,933) $ (17,202)      
Net loss per share, basic and diluted (usd per share) $ (0.36) $ (0.38) $ (0.42) $ (0.34) $ (0.27) $ (0.46) $ (0.58) $ (0.59) $ (1.49) $ (1.84) $ (2.62)
XML 91 R76.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events (Details) - Convertible Debt - USD ($)
shares in Millions
 1 Months Ended 2 Months Ended
Mar. 18, 2019
Feb. 27, 2019
Dec. 31, 2018
Mar. 31, 2018
Dec. 31, 2017
Subsequent Event [Line Items]          
Principal amount     $ 201,249,000   $ 201,250,000
2018 Convertible Notes          
Subsequent Event [Line Items]          
Principal amount       $ 150,000,000.0  
2018 Convertible Notes | Subsequent Event          
Subsequent Event [Line Items]          
Principal amount   $ 11,900,000      
Debt converted, amount   $ 138,100,000      
Convertible obligations (in shares) 1.5 17.9      
Debt extinguished   $ 138,100,000      
XML 92 R77.htm IDEA: XBRL DOCUMENT v3.19.1
Schedule II-Valuation And Qualifying Accounts And Reserve (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Allowance for Doubtful Accounts Receivable [Roll Forward]      
Balance at Beginning of Period $ 391    
Balance at End of Period 126 $ 391  
Accounts receivable allowance      
Allowance for Doubtful Accounts Receivable [Roll Forward]      
Balance at Beginning of Period 391 502 $ 103
Additions/Charged to Expense 162 24 484
Deductions (427) (135) (85)
Balance at End of Period 126 391 502
Warranty allowance      
Allowance for Doubtful Accounts Receivable [Roll Forward]      
Balance at Beginning of Period 699 1,023 1,076
Additions/Charged to Expense 1,573 695 885
Deductions (1,409) (1,019) (938)
Balance at End of Period $ 863 $ 699 $ 1,023
XML 93 R9999.htm IDEA: XBRL DOCUMENT v3.19.1
Label Element Value
Accounting Standards Update 2014-09 [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ 358,000
Accounting Standards Update 2014-09 [Member] | Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption 358,000
Accounting Standards Update 2016-09 [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption 0
Accounting Standards Update 2016-09 [Member] | Additional Paid-in Capital [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption 184,000
Accounting Standards Update 2016-09 [Member] | Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ (184,000)
EXCEL 94 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 95 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 96 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 97 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 308 389 1 false 104 0 false 6 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://fluidigm.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://fluidigm.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Operations Sheet http://fluidigm.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1003000 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 1004000 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1005000 - Statement - Consolidated Statements of Cash Flows Sheet http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - Description of Business Sheet http://fluidigm.com/role/DescriptionOfBusiness Description of Business Notes 8 false false R9.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://fluidigm.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 2103100 - Disclosure - Revenue Sheet http://fluidigm.com/role/Revenue Revenue Notes 10 false false R11.htm 2104100 - Disclosure - Goodwill and Intangible Assets, net Sheet http://fluidigm.com/role/GoodwillAndIntangibleAssetsNet Goodwill and Intangible Assets, net Notes 11 false false R12.htm 2105100 - Disclosure - Balance Sheet Details Sheet http://fluidigm.com/role/BalanceSheetDetails Balance Sheet Details Notes 12 false false R13.htm 2106100 - Disclosure - Convertible Notes and Credit Facility Notes http://fluidigm.com/role/ConvertibleNotesAndCreditFacility Convertible Notes and Credit Facility Notes 13 false false R14.htm 2107100 - Disclosure - Fair Value of Financial Instruments Sheet http://fluidigm.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 14 false false R15.htm 2108100 - Disclosure - Shareholders' Equity Sheet http://fluidigm.com/role/ShareholdersEquity Shareholders' Equity Notes 15 false false R16.htm 2109100 - Disclosure - Stock-Based Plans Sheet http://fluidigm.com/role/StockBasedPlans Stock-Based Plans Notes 16 false false R17.htm 2110100 - Disclosure - Income Taxes Sheet http://fluidigm.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 2111100 - Disclosure - Employee Benefit Plans Sheet http://fluidigm.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 18 false false R19.htm 2112100 - Disclosure - Information About Geographic Areas Sheet http://fluidigm.com/role/InformationAboutGeographicAreas Information About Geographic Areas Notes 19 false false R20.htm 2113100 - Disclosure - Commitments and Contingencies Sheet http://fluidigm.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 20 false false R21.htm 2114100 - Disclosure - Quarterly Results of Operations (Unaudited) Sheet http://fluidigm.com/role/QuarterlyResultsOfOperationsUnaudited Quarterly Results of Operations (Unaudited) Notes 21 false false R22.htm 2115100 - Disclosure - Subsequent Events Sheet http://fluidigm.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 2116100 - Disclosure - Schedule II-Valuation And Qualifying Accounts And Reserves Sheet http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserves Schedule II-Valuation And Qualifying Accounts And Reserves Notes 23 false false R24.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://fluidigm.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://fluidigm.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 2303301 - Disclosure - Revenue (Tables) Sheet http://fluidigm.com/role/RevenueTables Revenue (Tables) Tables http://fluidigm.com/role/Revenue 26 false false R27.htm 2304301 - Disclosure - Goodwill and Intangible Assets, net (Tables) Sheet http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetTables Goodwill and Intangible Assets, net (Tables) Tables http://fluidigm.com/role/GoodwillAndIntangibleAssetsNet 27 false false R28.htm 2305301 - Disclosure - Balance Sheet Details (Tables) Sheet http://fluidigm.com/role/BalanceSheetDetailsTables Balance Sheet Details (Tables) Tables http://fluidigm.com/role/BalanceSheetDetails 28 false false R29.htm 2306301 - Disclosure - Convertible Notes and Credit Facility (Tables) Notes http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityTables Convertible Notes and Credit Facility (Tables) Tables http://fluidigm.com/role/ConvertibleNotesAndCreditFacility 29 false false R30.htm 2307301 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://fluidigm.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://fluidigm.com/role/FairValueOfFinancialInstruments 30 false false R31.htm 2308301 - Disclosure - Shareholders' Equity (Tables) Sheet http://fluidigm.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://fluidigm.com/role/ShareholdersEquity 31 false false R32.htm 2309301 - Disclosure - Stock-Based Plans (Tables) Sheet http://fluidigm.com/role/StockBasedPlansTables Stock-Based Plans (Tables) Tables http://fluidigm.com/role/StockBasedPlans 32 false false R33.htm 2310301 - Disclosure - Income Taxes (Tables) Sheet http://fluidigm.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://fluidigm.com/role/IncomeTaxes 33 false false R34.htm 2312301 - Disclosure - Information About Geographic Areas (Tables) Sheet http://fluidigm.com/role/InformationAboutGeographicAreasTables Information About Geographic Areas (Tables) Tables http://fluidigm.com/role/InformationAboutGeographicAreas 34 false false R35.htm 2313301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://fluidigm.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://fluidigm.com/role/CommitmentsAndContingencies 35 false false R36.htm 2314301 - Disclosure - Quarterly Results of Operations (Unaudited) (Tables) Sheet http://fluidigm.com/role/QuarterlyResultsOfOperationsUnauditedTables Quarterly Results of Operations (Unaudited) (Tables) Tables http://fluidigm.com/role/QuarterlyResultsOfOperationsUnaudited 36 false false R37.htm 2402403 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 37 false false R38.htm 2402404 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) Sheet http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) Details 38 false false R39.htm 2402405 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) Sheet http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) Details 39 false false R40.htm 2402406 - Disclosure - Summary of Significant Accounting Policies - Impact on Balance Sheet (Details) Sheet http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails Summary of Significant Accounting Policies - Impact on Balance Sheet (Details) Details 40 false false R41.htm 2402407 - Disclosure - Summary of Significant Accounting Policies - Impact On Income Statement (Details) Sheet http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails Summary of Significant Accounting Policies - Impact On Income Statement (Details) Details 41 false false R42.htm 2403402 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details) Sheet http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails Revenue - Schedule of Disaggregation of Revenue (Details) Details 42 false false R43.htm 2403403 - Disclosure - Revenue - Narrative (Details) Sheet http://fluidigm.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 43 false false R44.htm 2403404 - Disclosure - Revenue - Performance Obligations (Details) Sheet http://fluidigm.com/role/RevenuePerformanceObligationsDetails Revenue - Performance Obligations (Details) Details 44 false false R45.htm 2404402 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details) Sheet http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails Goodwill and Intangible Assets, net - Narrative (Details) Details 45 false false R46.htm 2404403 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) Sheet http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) Details 46 false false R47.htm 2404404 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details) Sheet http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails Goodwill and Intangible Assets, net - Future Amortization Expense (Details) Details 47 false false R48.htm 2405402 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) Sheet http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) Details 48 false false R49.htm 2405403 - Disclosure - Balance Sheet Details - Inventories (Details) Sheet http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails Balance Sheet Details - Inventories (Details) Details 49 false false R50.htm 2405404 - Disclosure - Balance Sheet Details - Property and Equipment (Details) Sheet http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails Balance Sheet Details - Property and Equipment (Details) Details 50 false false R51.htm 2405405 - Disclosure - Balance Sheet Details - Warranty Accrual (Details) Sheet http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails Balance Sheet Details - Warranty Accrual (Details) Details 51 false false R52.htm 2406402 - Disclosure - Convertible Notes and Credit Facility - Narrative (Details) Notes http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails Convertible Notes and Credit Facility - Narrative (Details) Details 52 false false R53.htm 2406403 - Disclosure - Convertible Notes and Credit Facility - Schedule of Debt (Details) Notes http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails Convertible Notes and Credit Facility - Schedule of Debt (Details) Details 53 false false R54.htm 2407402 - Disclosure - Fair Value of Financial Instruments - Fair Value of Financial Instruments (Details) Sheet http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments - Fair Value of Financial Instruments (Details) Details 54 false false R55.htm 2407403 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details) Sheet http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails Fair Value of Financial Instruments - Schedule of Debt (Details) Details 55 false false R56.htm 2408402 - Disclosure - Shareholders' Equity - Narrative (Details) Sheet http://fluidigm.com/role/ShareholdersEquityNarrativeDetails Shareholders' Equity - Narrative (Details) Details 56 false false R57.htm 2408403 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details) Sheet http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails Shareholders' Equity - Schedule of Stock Options (Details) Details 57 false false R58.htm 2409402 - Disclosure - Stock-Based Plans - Narrative (Details) Sheet http://fluidigm.com/role/StockBasedPlansNarrativeDetails Stock-Based Plans - Narrative (Details) Details 58 false false R59.htm 2409403 - Disclosure - Stock-Based Plans - Weighted-average Assumptions (Details) Sheet http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails Stock-Based Plans - Weighted-average Assumptions (Details) Details 59 false false R60.htm 2409404 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details) Sheet http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails Stock-Based Plans - Restricted and Performance Stock Units (Details) Details 60 false false R61.htm 2409405 - Disclosure - Stock-Based Plans - Stock Option Activity (Details) Sheet http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails Stock-Based Plans - Stock Option Activity (Details) Details 61 false false R62.htm 2409406 - Disclosure - Stock-Based Plans - Stock-based Compensation Expense (Details) Sheet http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails Stock-Based Plans - Stock-based Compensation Expense (Details) Details 62 false false R63.htm 2410402 - Disclosure - Income Taxes - Loss Before Income Taxes (Details) Sheet http://fluidigm.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails Income Taxes - Loss Before Income Taxes (Details) Details 63 false false R64.htm 2410403 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details) Sheet http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails Income Taxes - Components of Provision for Income Taxes (Details) Details 64 false false R65.htm 2410404 - Disclosure - Income Taxes - Reconciliation of Income Taxes at Statutory Rate (Details) Sheet http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails Income Taxes - Reconciliation of Income Taxes at Statutory Rate (Details) Details 65 false false R66.htm 2410405 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) Sheet http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) Details 66 false false R67.htm 2410406 - Disclosure - Income Taxes - Narrative (Details) Sheet http://fluidigm.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 67 false false R68.htm 2410407 - Disclosure - Income Taxes - Valuation Allowance (Details) Sheet http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails Income Taxes - Valuation Allowance (Details) Details 68 false false R69.htm 2410408 - Disclosure - Income Taxes - Aggregate Changes in Balance of Gross Unrecognized Tax Benefits (Details) Sheet http://fluidigm.com/role/IncomeTaxesAggregateChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetails Income Taxes - Aggregate Changes in Balance of Gross Unrecognized Tax Benefits (Details) Details 69 false false R70.htm 2411401 - Disclosure - Employee Benefit Plans (Details) Sheet http://fluidigm.com/role/EmployeeBenefitPlansDetails Employee Benefit Plans (Details) Details http://fluidigm.com/role/EmployeeBenefitPlans 70 false false R71.htm 2412402 - Disclosure - Information About Geographic Areas - Narrative (Details) Sheet http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails Information About Geographic Areas - Narrative (Details) Details 71 false false R72.htm 2412403 - Disclosure - Information About Geographic Areas - Long-lived Assets by Geographic Areas (Details) Sheet http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails Information About Geographic Areas - Long-lived Assets by Geographic Areas (Details) Details 72 false false R73.htm 2413402 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 73 false false R74.htm 2413403 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Details) Sheet http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails Commitments and Contingencies - Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Details) Details 74 false false R75.htm 2414402 - Disclosure - Quarterly Results of Operations (Unaudited) (Details) Sheet http://fluidigm.com/role/QuarterlyResultsOfOperationsUnauditedDetails Quarterly Results of Operations (Unaudited) (Details) Details http://fluidigm.com/role/QuarterlyResultsOfOperationsUnauditedTables 75 false false R76.htm 2415401 - Disclosure - Subsequent Events (Details) Sheet http://fluidigm.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://fluidigm.com/role/SubsequentEvents 76 false false R77.htm 2416401 - Disclosure - Schedule II-Valuation And Qualifying Accounts And Reserve (Detail) Sheet http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail Schedule II-Valuation And Qualifying Accounts And Reserve (Detail) Details http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserves 77 false false R9999.htm Uncategorized Items - fye2018form10-k.htm Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - fye2018form10-k.htm Cover 78 false false All Reports Book All Reports fye2018form10-k.htm exhibit1018.htm exhibit23110k2018.htm exhibit31110k2018.htm exhibit31210k2018.htm exhibit32110k2018.htm exhibit32210k2018.htm fldm-20181231.xsd fldm-20181231_cal.xml fldm-20181231_def.xml fldm-20181231_lab.xml fldm-20181231_pre.xml chart-46e59a14696d2292a72.jpg http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/stpr/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/us-gaap/2018-01-31 true true JSON 100 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "fye2018form10-k.htm": { "axisCustom": 0, "axisStandard": 33, "contextCount": 308, "dts": { "calculationLink": { "local": [ "fldm-20181231_cal.xml" ] }, "definitionLink": { "local": [ "fldm-20181231_def.xml" ], "remote": [ "http://xbrl.fasb.org/srt/2018/elts/srt-eedm1-def-2018-01-31.xml", "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-eedm-def-2018-01-31.xml" ] }, "inline": { "local": [ "fye2018form10-k.htm" ] }, "labelLink": { "local": [ "fldm-20181231_lab.xml" ], "remote": [ "http://xbrl.fasb.org/srt/2018/elts/srt-doc-2018-01-31.xml", "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-doc-2018-01-31.xml", "https://xbrl.sec.gov/dei/2018/dei-doc-2018-01-31.xml" ] }, "presentationLink": { "local": [ "fldm-20181231_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/srt/2018/elts/srt-ref-2018-01-31.xml", "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-ref-2018-01-31.xml", "https://xbrl.sec.gov/dei/2018/dei-ref-2018-01-31.xml" ] }, "schema": { "local": [ "fldm-20181231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-roles-2018-01-31.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-types-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-parts-codification-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd", "http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd", "https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" ] } }, "elementCount": 655, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2018-01-31": 30, "http://fluidigm.com/20181231": 6, "http://xbrl.sec.gov/dei/2018-01-31": 16, "total": 52 }, "keyCustom": 54, "keyStandard": 335, "memberCustom": 41, "memberStandard": 62, "nsprefix": "fldm", "nsuri": "http://fluidigm.com/20181231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "I2019Q1Mar13", "decimals": "INF", "first": true, "lang": null, "name": "dei:EntityCommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Document and Entity Information", "role": "http://fluidigm.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "I2019Q1Mar13", "decimals": "INF", "first": true, "lang": null, "name": "dei:EntityCommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103100 - Disclosure - Revenue", "role": "http://fluidigm.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104100 - Disclosure - Goodwill and Intangible Assets, net", "role": "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNet", "shortName": "Goodwill and Intangible Assets, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - Balance Sheet Details", "role": "http://fluidigm.com/role/BalanceSheetDetails", "shortName": "Balance Sheet Details", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2106100 - Disclosure - Convertible Notes and Credit Facility", "role": "http://fluidigm.com/role/ConvertibleNotesAndCreditFacility", "shortName": "Convertible Notes and Credit Facility", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107100 - Disclosure - Fair Value of Financial Instruments", "role": "http://fluidigm.com/role/FairValueOfFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - Shareholders' Equity", "role": "http://fluidigm.com/role/ShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - Stock-Based Plans", "role": "http://fluidigm.com/role/StockBasedPlans", "shortName": "Stock-Based Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110100 - Disclosure - Income Taxes", "role": "http://fluidigm.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - Employee Benefit Plans", "role": "http://fluidigm.com/role/EmployeeBenefitPlans", "shortName": "Employee Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - Information About Geographic Areas", "role": "http://fluidigm.com/role/InformationAboutGeographicAreas", "shortName": "Information About Geographic Areas", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - Consolidated Balance Sheets", "role": "http://fluidigm.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113100 - Disclosure - Commitments and Contingencies", "role": "http://fluidigm.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114100 - Disclosure - Quarterly Results of Operations (Unaudited)", "role": "http://fluidigm.com/role/QuarterlyResultsOfOperationsUnaudited", "shortName": "Quarterly Results of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115100 - Disclosure - Subsequent Events", "role": "http://fluidigm.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2116100 - Disclosure - Schedule II-Valuation And Qualifying Accounts And Reserves", "role": "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserves", "shortName": "Schedule II-Valuation And Qualifying Accounts And Reserves", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2302302 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - Revenue (Tables)", "role": "http://fluidigm.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - Goodwill and Intangible Assets, net (Tables)", "role": "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetTables", "shortName": "Goodwill and Intangible Assets, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - Balance Sheet Details (Tables)", "role": "http://fluidigm.com/role/BalanceSheetDetailsTables", "shortName": "Balance Sheet Details (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306301 - Disclosure - Convertible Notes and Credit Facility (Tables)", "role": "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityTables", "shortName": "Convertible Notes and Credit Facility (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R3": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1001501 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2307301 - Disclosure - Fair Value of Financial Instruments (Tables)", "role": "http://fluidigm.com/role/FairValueOfFinancialInstrumentsTables", "shortName": "Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - Shareholders' Equity (Tables)", "role": "http://fluidigm.com/role/ShareholdersEquityTables", "shortName": "Shareholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - Stock-Based Plans (Tables)", "role": "http://fluidigm.com/role/StockBasedPlansTables", "shortName": "Stock-Based Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2310301 - Disclosure - Income Taxes (Tables)", "role": "http://fluidigm.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312301 - Disclosure - Information About Geographic Areas (Tables)", "role": "http://fluidigm.com/role/InformationAboutGeographicAreasTables", "shortName": "Information About Geographic Areas (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2313301 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://fluidigm.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314301 - Disclosure - Quarterly Results of Operations (Unaudited) (Tables)", "role": "http://fluidigm.com/role/QuarterlyResultsOfOperationsUnauditedTables", "shortName": "Quarterly Results of Operations (Unaudited) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402403 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)", "role": "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails", "shortName": "Summary of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2017Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402404 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)", "role": "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails", "shortName": "Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402405 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)", "role": "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails", "shortName": "Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - Consolidated Statements of Operations", "role": "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402406 - Disclosure - Summary of Significant Accounting Policies - Impact on Balance Sheet (Details)", "role": "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "shortName": "Summary of Significant Accounting Policies - Impact on Balance Sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "I2018Q1Jan01", "decimals": "-3", "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402407 - Disclosure - Summary of Significant Accounting Policies - Impact On Income Statement (Details)", "role": "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails", "shortName": "Summary of Significant Accounting Policies - Impact On Income Statement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "lang": null, "name": "us-gaap:CostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403402 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details)", "role": "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails", "shortName": "Revenue - Schedule of Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD_srt_StatementGeographicalAxis_srt_AmericasMember", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403403 - Disclosure - Revenue - Narrative (Details)", "role": "http://fluidigm.com/role/RevenueNarrativeDetails", "shortName": "Revenue - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403404 - Disclosure - Revenue - Performance Obligations (Details)", "role": "http://fluidigm.com/role/RevenuePerformanceObligationsDetails", "shortName": "Revenue - Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404402 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)", "role": "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails", "shortName": "Goodwill and Intangible Assets, net - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "I2014Q1Feb28_us-gaap_BusinessAcquisitionAxis_fldm_DVSSciencesInc.Member", "decimals": "-5", "lang": null, "name": "fldm:GoodwillPreliminary", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404403 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)", "role": "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember", "decimals": "-3", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404404 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details)", "role": "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails", "shortName": "Goodwill and Intangible Assets, net - Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)", "role": "http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails", "shortName": "Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405403 - Disclosure - Balance Sheet Details - Inventories (Details)", "role": "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails", "shortName": "Balance Sheet Details - Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - Consolidated Statements of Comprehensive Loss", "role": "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss", "shortName": "Consolidated Statements of Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405404 - Disclosure - Balance Sheet Details - Property and Equipment (Details)", "role": "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails", "shortName": "Balance Sheet Details - Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2017Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405405 - Disclosure - Balance Sheet Details - Warranty Accrual (Details)", "role": "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails", "shortName": "Balance Sheet Details - Warranty Accrual (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2016Q4", "decimals": "-3", "lang": null, "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Convertible Notes and Credit Facility - Narrative (Details)", "role": "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "shortName": "Convertible Notes and Credit Facility - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "I2014Q1Feb4_us-gaap_DebtInstrumentAxis_fldm_SeniorConvertibleNotesdue2034Member_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember", "decimals": "4", "lang": null, "name": "fldm:InitialConversionRateOfNotes", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406403 - Disclosure - Convertible Notes and Credit Facility - Schedule of Debt (Details)", "role": "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "shortName": "Convertible Notes and Credit Facility - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1", "reportCount": 1, "unique": true, "unitRef": "investment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - Fair Value of Financial Instruments - Fair Value of Financial Instruments (Details)", "role": "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails", "shortName": "Fair Value of Financial Instruments - Fair Value of Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1", "reportCount": 1, "unique": true, "unitRef": "investment", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details)", "role": "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails", "shortName": "Fair Value of Financial Instruments - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - Shareholders' Equity - Narrative (Details)", "role": "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "shortName": "Shareholders' Equity - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "D2018Q4Dec14_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_fldm_TwoThousandAndEighteenMarketOfferingMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details)", "role": "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails", "shortName": "Shareholders' Equity - Schedule of Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - Stock-Based Plans - Narrative (Details)", "role": "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "shortName": "Stock-Based Plans - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "2", "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409403 - Disclosure - Stock-Based Plans - Weighted-average Assumptions (Details)", "role": "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails", "shortName": "Stock-Based Plans - Weighted-average Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - Consolidated Statements of Stockholders' Equity", "role": "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409404 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details)", "role": "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails", "shortName": "Stock-Based Plans - Restricted and Performance Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2015Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2017Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409405 - Disclosure - Stock-Based Plans - Stock Option Activity (Details)", "role": "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails", "shortName": "Stock-Based Plans - Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409406 - Disclosure - Stock-Based Plans - Stock-based Compensation Expense (Details)", "role": "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails", "shortName": "Stock-Based Plans - Stock-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410402 - Disclosure - Income Taxes - Loss Before Income Taxes (Details)", "role": "http://fluidigm.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails", "shortName": "Income Taxes - Loss Before Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410403 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)", "role": "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails", "shortName": "Income Taxes - Components of Provision for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - Income Taxes - Reconciliation of Income Taxes at Statutory Rate (Details)", "role": "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails", "shortName": "Income Taxes - Reconciliation of Income Taxes at Statutory Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410405 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities (Details)", "role": "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "Income Taxes - Components of Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410406 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://fluidigm.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410407 - Disclosure - Income Taxes - Valuation Allowance (Details)", "role": "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails", "shortName": "Income Taxes - Valuation Allowance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember", "decimals": "-3", "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2017Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410408 - Disclosure - Income Taxes - Aggregate Changes in Balance of Gross Unrecognized Tax Benefits (Details)", "role": "http://fluidigm.com/role/IncomeTaxesAggregateChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Aggregate Changes in Balance of Gross Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2015Q4", "decimals": "-3", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005000 - Statement - Consolidated Statements of Cash Flows", "role": "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationAmortizationAndAccretionNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2017Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411401 - Disclosure - Employee Benefit Plans (Details)", "role": "http://fluidigm.com/role/EmployeeBenefitPlansDetails", "shortName": "Employee Benefit Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2017Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412402 - Disclosure - Information About Geographic Areas - Narrative (Details)", "role": "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails", "shortName": "Information About Geographic Areas - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412403 - Disclosure - Information About Geographic Areas - Long-lived Assets by Geographic Areas (Details)", "role": "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails", "shortName": "Information About Geographic Areas - Long-lived Assets by Geographic Areas (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4_srt_StatementGeographicalAxis_country_US", "decimals": "-3", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LeaseAndRentalExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413402 - Disclosure - Commitments and Contingencies - Narrative (Details)", "role": "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LeaseAndRentalExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413403 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Details)", "role": "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails", "shortName": "Commitments and Contingencies - Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4QTD", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414402 - Disclosure - Quarterly Results of Operations (Unaudited) (Details)", "role": "http://fluidigm.com/role/QuarterlyResultsOfOperationsUnauditedDetails", "shortName": "Quarterly Results of Operations (Unaudited) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4QTD", "decimals": "-3", "lang": null, "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415401 - Disclosure - Subsequent Events (Details)", "role": "http://fluidigm.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "I2019Q1Feb27_us-gaap_DebtInstrumentAxis_fldm_TwoThousandAndEighteenConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416401 - Disclosure - Schedule II-Valuation And Qualifying Accounts And Reserve (Detail)", "role": "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail", "shortName": "Schedule II-Valuation And Qualifying Accounts And Reserve (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember", "decimals": "-3", "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - Description of Business", "role": "http://fluidigm.com/role/DescriptionOfBusiness", "shortName": "Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102100 - Disclosure - Summary of Significant Accounting Policies", "role": "http://fluidigm.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "FD2018Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9999": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "fye2018form10-k.htm", "contextRef": "I2018Q1Jan01_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "", "isDefault": "false", "longName": "Uncategorized Items - fye2018form10-k.htm", "role": "http://xbrl.sec.gov/role/uncategorizedFacts", "shortName": "Uncategorized Items - fye2018form10-k.htm", "subGroupType": "", "uniqueAnchor": null } }, "segmentCount": 104, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CANADA", "terseLabel": "Canada" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails" ], "xbrltype": "domainItemType" }, "country_CN": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CHINA", "terseLabel": "China" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_SG": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SINGAPORE", "terseLabel": "Singapore" } } }, "localname": "SG", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails", "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "If the value is true, then the document is an amendment to previously-filed/accepted document.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Indicate if company meets the shell company criteria: a company with no or nominal operations, and with no or nominal assets or assets consisting solely of cash and cash equivalents.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://fluidigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "fldm_A2017InducementAwardPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2017 Inducement Award Plan [Member]", "label": "2017 Inducement Award Plan [Member]", "terseLabel": "2017 Inducement Award Plan" } } }, "localname": "A2017InducementAwardPlanMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_CommissionCostsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission Costs [Member]", "label": "Commission Costs [Member]", "terseLabel": "Commission Costs" } } }, "localname": "CommissionCostsMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_CompensationPlanLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Compensation Plan [Line Items]", "label": "Compensation Plan [Line Items]", "terseLabel": "Compensation Plan [Line Items]" } } }, "localname": "CompensationPlanLineItems", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "fldm_CompensationPlanTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Compensation Plan [Table]", "label": "Compensation Plan [Table]", "terseLabel": "Compensation Plan [Table]" } } }, "localname": "CompensationPlanTable", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "fldm_ComputerEquipmentAndSoftwareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Computer Equipment And Software [Member]", "label": "Computer Equipment And Software [Member]", "terseLabel": "Computer equipment and software" } } }, "localname": "ComputerEquipmentAndSoftwareMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ConsumablesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Consumables [Member]", "label": "Consumables [Member]", "terseLabel": "Consumables" } } }, "localname": "ConsumablesMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Contract With Customer, Liability, Increase From Cash Receipts", "label": "Contract With Customer, Liability, Increase From Cash Receipts", "terseLabel": "Additional advance payments received" } } }, "localname": "ContractWithCustomerLiabilityIncreaseFromCashReceipts", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_DVSSciencesInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "DVS Sciences, Inc. [Member]", "label": "DVS Sciences, Inc. [Member]", "terseLabel": "DVS Sciences, Inc." } } }, "localname": "DVSSciencesInc.Member", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_DebtAndEquityOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt And Equity Offering Costs", "label": "Debt And Equity Offering Costs", "terseLabel": "Debt and equity offering costs" } } }, "localname": "DebtAndEquityOfferingCosts", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_DebtInstrumentAccretionOfDiscount": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Accretion Of Discount", "label": "Debt Instrument, Accretion Of Discount", "terseLabel": "Premium accretion" } } }, "localname": "DebtInstrumentAccretionOfDiscount", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "fldm_DebtInstrumentEmbeddedConversionOptionValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Embedded Conversion Option Value", "label": "Debt Instrument, Embedded Conversion Option Value", "terseLabel": "Embedded conversion option value" } } }, "localname": "DebtInstrumentEmbeddedConversionOptionValue", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price", "label": "Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price", "terseLabel": "Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price" } } }, "localname": "DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_DebtInstrumentRedemptionPricePercentageFundamentalChange": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Redemption Price, Percentage, Fundamental Change", "label": "Debt Instrument, Redemption Price, Percentage, Fundamental Change", "terseLabel": "Debt instrument, redemption price when undergo fundamental change" } } }, "localname": "DebtInstrumentRedemptionPricePercentageFundamentalChange", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_DebtInstrumentRedemptionPricePercentageOfOutstandingPrincipalAmountFundamentalChange": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Redemption Price, Percentage Of Outstanding Principal Amount, Fundamental Change", "label": "Debt Instrument, Redemption Price, Percentage Of Outstanding Principal Amount, Fundamental Change", "terseLabel": "Debt instrument, redemption price, percentage of outstanding principal amount, fundamental change" } } }, "localname": "DebtInstrumentRedemptionPricePercentageOfOutstandingPrincipalAmountFundamentalChange", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_DeferredTaxAssetsDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Deferred Tax Assets, Depreciation and Amortization", "label": "Deferred Tax Assets Depreciation And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxAssetsDepreciationAndAmortization", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_DefinedContributionPlanEligibleCompensationContributedByEmployeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Defined Contribution Plan Eligible Compensation Contributed By Employee Percentage", "label": "Defined Contribution Plan Eligible Compensation Contributed By Employee Percentage", "terseLabel": "Percentage of employees eligible compensation" } } }, "localname": "DefinedContributionPlanEligibleCompensationContributedByEmployeePercentage", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "fldm_DefinedContributionPlanEmployerMatchingContributionMaximumAnnualMatchPerEmployeeAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Defined Contribution Plan, Employer Matching Contribution, Maximum Annual Match Per Employee, Amount", "label": "Defined Contribution Plan, Employer Matching Contribution, Maximum Annual Match Per Employee, Amount", "terseLabel": "Maximum annual employee contribution matched by employer" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionMaximumAnnualMatchPerEmployeeAmount", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "fldm_DefinedContributionPlanEmployersMatchingContributionVestingPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Defined Contribution Plan, Employers Matching Contribution, Vesting Period", "label": "Defined Contribution Plan, Employers Matching Contribution, Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "DefinedContributionPlanEmployersMatchingContributionVestingPeriod", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "durationItemType" }, "fldm_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document And Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://fluidigm.com/20181231", "xbrltype": "stringItemType" }, "fldm_EffectiveIncomeTaxRateReconciliationUnrecognizedtaxbenefit": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Unrecognized tax benefit", "label": "Effective Income Tax Rate Reconciliation Unrecognized tax benefit", "terseLabel": "Unrecognized tax benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationUnrecognizedtaxbenefit", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "fldm_EquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Incentive Plan [Member]", "label": "Equity Incentive Plan [Member]", "terseLabel": "Equity Incentive Plan" } } }, "localname": "EquityIncentivePlanMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_EquityIncentivePlanTwentyElevenMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Incentive Plan Twenty Eleven [Member]", "label": "Equity Incentive Plan Twenty Eleven [Member]", "terseLabel": "2011 Equity Incentive Plan" } } }, "localname": "EquityIncentivePlanTwentyElevenMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_EstimatedExpensesOfOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Estimated Expenses Of Offering", "label": "Estimated Expenses Of Offering", "terseLabel": "Estimated expenses of offering" } } }, "localname": "EstimatedExpensesOfOffering", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_ExchangeConvertibleSeniorNotesDue2034Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Exchange Convertible Senior Notes Due 2034 [Member]", "label": "Exchange Convertible Senior Notes Due 2034 [Member]", "terseLabel": "Exchange Convertible Senior Notes due 2034" } } }, "localname": "ExchangeConvertibleSeniorNotesDue2034Member", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ExpiringIn2019Through2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Expiring In 2019 Through 2027 [Member]", "label": "Expiring In 2019 Through 2027 [Member]", "terseLabel": "Expiring In 2019 Through 2027" } } }, "localname": "ExpiringIn2019Through2027Member", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ExpiringIn2021Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Expiring In 2021 [Member]", "label": "Expiring In 2021 [Member]", "terseLabel": "Expiring In 2021" } } }, "localname": "ExpiringIn2021Member", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ExpiringIn2021Through2039Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Expiring In 2021 Through 2039 [Member]", "label": "Expiring In 2021 Through 2039 [Member]", "terseLabel": "Expiring In 2021 Through 2039" } } }, "localname": "ExpiringIn2021Through2039Member", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ExpiringIn2028Through2039Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Expiring In 2028 Through 2039 [Member]", "label": "Expiring In 2028 Through 2039 [Member]", "terseLabel": "Expiring In 2028 Through 2039" } } }, "localname": "ExpiringIn2028Through2039Member", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_GoodwillPreliminary": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Goodwill, Preliminary", "label": "Goodwill, Preliminary", "terseLabel": "Business combination, preliminary goodwill" } } }, "localname": "GoodwillPreliminary", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_IncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Income Taxes [Line Items]", "label": "Income Taxes [Line Items]", "terseLabel": "Income Taxes [Line Items]" } } }, "localname": "IncomeTaxesLineItems", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_IncomeTaxesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Income Taxes [Table]", "label": "Income Taxes [Table]", "terseLabel": "Income Taxes [Table]" } } }, "localname": "IncomeTaxesTable", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_InitialConversionPriceOfStock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Initial Conversion Price Of Stock", "label": "Initial Conversion Price Of Stock", "terseLabel": "Initial conversion price of stock (usd per share)" } } }, "localname": "InitialConversionPriceOfStock", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "fldm_InitialConversionRateOfNotes": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Initial Conversion Rate Of Notes", "label": "Initial Conversion Rate Of Notes", "terseLabel": "Initial conversion rate of notes" } } }, "localname": "InitialConversionRateOfNotes", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "pureItemType" }, "fldm_InstrumentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Instruments [Member]", "label": "Instruments [Member]", "terseLabel": "Instruments" } } }, "localname": "InstrumentsMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "fldm_LaboratoryAndProductionEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Laboratory And Production Equipment [Member]", "label": "Laboratory And Production Equipment [Member]", "terseLabel": "Laboratory and manufacturing equipment" } } }, "localname": "LaboratoryAndProductionEquipmentMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory", "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory", "terseLabel": "Percentage of eligible inventory" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables", "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables", "terseLabel": "Percentage of eligible receivables" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default", "label": "Line Of Credit Facility, Percentage Of Interest On Obligation Upon Default", "terseLabel": "Percentage of interest on obligation upon default" } } }, "localname": "LineOfCreditFacilityPercentageOfInterestOnObligationUponDefault", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_LoanAgreementOnOrAfterAugust22019Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loan Agreement On Or After August 2, 2019 [Member]", "label": "Loan Agreement On Or After August 2, 2019 [Member]", "terseLabel": "Loan Agreement On Or After August 2, 2019" } } }, "localname": "LoanAgreementOnOrAfterAugust22019Member", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_LoanAgreementPriorToAugust22019Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loan Agreement Prior To August 2, 2019 [Member]", "label": "Loan Agreement Prior To August 2, 2019 [Member]", "terseLabel": "Loan Agreement Prior To August 2, 2019" } } }, "localname": "LoanAgreementPriorToAugust22019Member", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_NetOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Net Operating Leases [Abstract]", "label": "Net Operating Leases [Abstract]", "terseLabel": "Net Operating Leases [Abstract]" } } }, "localname": "NetOperatingLeasesAbstract", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement", "label": "Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement", "terseLabel": "Number of months over which options vest ratably" } } }, "localname": "NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetailsCalc2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due", "label": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due", "totalLabel": "Total" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueThereafter": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 6.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due Thereafter", "label": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due Thereafter", "totalLabel": "Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueThereafter", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueinFiveYears": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 5.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Five Years", "label": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Five Years", "totalLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueinFiveYears", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueinFourYears": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 4.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Four Years", "label": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Four Years", "totalLabel": "2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueinFourYears", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueinThreeYears": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 3.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Three Years", "label": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Three Years", "totalLabel": "2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueinThreeYears", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueinTwoYears": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 2.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Two Years", "label": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Due in Two Years", "totalLabel": "2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueinTwoYears", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeNextTwelveMonths": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 1.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Next Twelve Months", "label": "Operating Leases, Future Minimum Payments Due, Net of Sublease Income, Next Twelve Months", "totalLabel": "2019" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeNextTwelveMonths", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OperatingLossCarryforwardsLimitationsonUseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating Loss Carryforwards, Limitations on Use, Amount", "label": "Operating Loss Carryforwards, Limitations on Use, Amount", "terseLabel": "Reduction in net operating losses" } } }, "localname": "OperatingLossCarryforwardsLimitationsonUseAmount", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_OptionsAndRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Options And Restricted Stock Units [Member]", "label": "Options And Restricted Stock Units [Member]", "terseLabel": "Options and Restricted Stock Units" } } }, "localname": "OptionsAndRestrictedStockUnitsMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "fldm_PatentsandLicenseAgreementsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Patents and License Agreements [Member]", "label": "Patents and License Agreements [Member]", "terseLabel": "Patents and licenses" } } }, "localname": "PatentsandLicenseAgreementsMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "fldm_PerformanceBasedRestrictedStockOptionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Performance-Based Restricted Stock Options [Member]", "label": "Performance-Based Restricted Stock Options [Member]", "terseLabel": "Performance-Based Restricted Stock Options" } } }, "localname": "PerformanceBasedRestrictedStockOptionsMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_PerformanceBasedStockOptionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Performance-Based Stock Options [Member]", "label": "Performance-Based Stock Options [Member]", "terseLabel": "Performance-Based Stock Options" } } }, "localname": "PerformanceBasedStockOptionsMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_PortionOfStockOptionsVestOnFirstAnniversary": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Portion Of Stock Options Vest On First Anniversary", "label": "Portion Of Stock Options Vest On First Anniversary", "terseLabel": "Rate at which outstanding options vest on the first anniversary of the option grant date" } } }, "localname": "PortionOfStockOptionsVestOnFirstAnniversary", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds From Issuance Of Common Stock, Including Related Expenses", "label": "Proceeds From Issuance Of Common Stock, Including Related Expenses", "terseLabel": "Gross proceeds from issuance of common stock through at-the-market offering" } } }, "localname": "ProceedsFromIssuanceOfCommonStockIncludingRelatedExpenses", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_ProductWarrantyTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Product Warranty Term", "label": "Product Warranty Term", "terseLabel": "Product warranty term" } } }, "localname": "ProductWarrantyTerm", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_RansomwareAttackMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Ransomware Attack [Member]", "label": "Ransomware Attack [Member]", "terseLabel": "Ransomware Attack" } } }, "localname": "RansomwareAttackMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_RestrictedStockAndPerformanceShareUnitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restricted Stock And Performance Share Units [Member]", "label": "Restricted Stock And Performance Share Units [Member]", "terseLabel": "Restricted Stock And Performance Share Units" } } }, "localname": "RestrictedStockAndPerformanceShareUnitsMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_RevenueFromContractWithCustomerPerformanceObligationPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue From Contract With Customer, Performance Obligation Period", "label": "Revenue From Contract With Customer, Performance Obligation Period", "terseLabel": "Performance obligation period" } } }, "localname": "RevenueFromContractWithCustomerPerformanceObligationPeriod", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_RevenueFromContractWithCustomerTermsOfPaymentPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue From Contract With Customer, Terms Of Payment Period", "label": "Revenue From Contract With Customer, Terms Of Payment Period", "terseLabel": "Terms of payment period" } } }, "localname": "RevenueFromContractWithCustomerTermsOfPaymentPeriod", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "fldm_ScheduleOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule Of Significant Accounting Policies [Line Items]", "label": "Schedule Of Significant Accounting Policies [Line Items]", "terseLabel": "Schedule Of Significant Accounting Policies [Line Items]" } } }, "localname": "ScheduleOfSignificantAccountingPoliciesLineItems", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_ScheduleOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule Of Significant Accounting Policies [Table]", "label": "Schedule Of Significant Accounting Policies [Table]", "terseLabel": "Schedule Of Significant Accounting Policies [Table]" } } }, "localname": "ScheduleOfSignificantAccountingPoliciesTable", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_SeniorConvertibleNotesdue2034Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Convertible Notes due 2034 [Member]", "label": "Senior Convertible Notes due 2034 [Member]", "terseLabel": "Senior Convertible Notes due 2034" } } }, "localname": "SeniorConvertibleNotesdue2034Member", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest", "terseLabel": "Percentage of performance period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfSharesToBeExchangedOnClosingDateOrCommencementDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Percentage Of Shares To be Exchanged On Closing Date Or Commencement Date", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Shares To Be Exchanged On Closing Date Or Commencement Date", "terseLabel": "Percentage of shares to be exchanged on closing date or commencement date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfSharesToBeExchangedOnClosingDateOrCommencementDate", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value", "terseLabel": "Expected to vest at December 31, 2018" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number", "terseLabel": "Expected to vest (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price", "terseLabel": "Expected to vest (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term 1", "terseLabel": "Expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Aggregate Intrinsic Value", "terseLabel": "Vested at December 31, 2018" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price", "terseLabel": "Vested (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One", "verboseLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "fldm_ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfEligibleCashBonusToBeExchanged": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Percentage Of Eligible Cash Bonus To Be Exchanged", "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Percentage Of Eligible Cash Bonus To Be Exchanged", "terseLabel": "Percentage of eligible employee bonus program" } } }, "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfEligibleCashBonusToBeExchanged", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount", "terseLabel": "Maximum employee purchase amount" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Restrictions, Ownership Percentage of Voting Stock", "terseLabel": "Percentage of voting power which impacts the term of equity incentive plan" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardVestingRestrictionsOwnershipPercentageofVotingStock", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_SharebasedCompensationAwardTrancheFourMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Award, Tranche Four [Member]", "label": "Share-based Compensation Award, Tranche Four [Member]", "terseLabel": "Share-based Compensation Award, Tranche Four" } } }, "localname": "SharebasedCompensationAwardTrancheFourMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ShareholdersEquityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Shareholders' Equity [Table]", "label": "Shareholders' Equity [Line Items]", "terseLabel": "Shareholders' Equity [Line Items]" } } }, "localname": "ShareholdersEquityLineItems", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_ShareholdersEquityTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Shareholders' Equity [Table]", "label": "Shareholders' Equity [Table]", "terseLabel": "Shareholders' Equity [Table]" } } }, "localname": "ShareholdersEquityTable", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value", "label": "Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value", "terseLabel": "Stock option grants exercise price minimum percentage on fair market value" } } }, "localname": "StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "fldm_StockOptionsVestingOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock Options, Vesting One [Member]", "label": "Stock Options Vesting One [Member]", "terseLabel": "Stock Options, Vesting One" } } }, "localname": "StockOptionsVestingOneMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_StockOptionsVestingTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock Options, Vesting Two [Member]", "label": "Stock Options Vesting Two [Member]", "terseLabel": "Stock Options, Vesting Two" } } }, "localname": "StockOptionsVestingTwoMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_SubleaseIncomeFutureMinimumPaymentsReceivable": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetailsCalc2": { "order": 2.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sublease Income, Future Minimum Payments Receivable", "label": "Sublease Income, Future Minimum Payments Receivable", "negatedTotalLabel": "Total" } } }, "localname": "SubleaseIncomeFutureMinimumPaymentsReceivable", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_SubleaseIncomeFutureMinimumPaymentsReceivableInFiveYears": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 5.0, "parentTag": "fldm_SubleaseIncomeFutureMinimumPaymentsReceivable", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sublease Income, Future Minimum Payments, Receivable In Five Years", "label": "Sublease Income, Future Minimum Payments, Receivable In Five Years", "negatedTerseLabel": "2023" } } }, "localname": "SubleaseIncomeFutureMinimumPaymentsReceivableInFiveYears", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_SubleaseIncomeFutureMinimumPaymentsReceivableInFourYears": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 4.0, "parentTag": "fldm_SubleaseIncomeFutureMinimumPaymentsReceivable", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sublease Income, Future Minimum Payments, Receivable In Four Years", "label": "Sublease Income, Future Minimum Payments, Receivable In Four Years", "negatedTerseLabel": "2022" } } }, "localname": "SubleaseIncomeFutureMinimumPaymentsReceivableInFourYears", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_SubleaseIncomeFutureMinimumPaymentsReceivableInThreeYears": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 3.0, "parentTag": "fldm_SubleaseIncomeFutureMinimumPaymentsReceivable", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sublease Income, Future Minimum Payments, Receivable In Three Years", "label": "Sublease Income, Future Minimum Payments, Receivable In Three Years", "negatedTerseLabel": "2021" } } }, "localname": "SubleaseIncomeFutureMinimumPaymentsReceivableInThreeYears", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_SubleaseIncomeFutureMinimumPaymentsReceivableInTwoYears": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 2.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDueinTwoYears", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sublease Income, Future Minimum Payments, Receivable In Two Years", "label": "Sublease Income, Future Minimum Payments, Receivable In Two Years", "negatedTerseLabel": "2020" } } }, "localname": "SubleaseIncomeFutureMinimumPaymentsReceivableInTwoYears", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_SubleaseIncomeFutureMinimumPaymentsReceivableNextTwelveMonths": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 2.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeNextTwelveMonths", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sublease Income, Future Minimum Payments, Receivable Next Twelve Months", "label": "Sublease Income, Future Minimum Payments, Receivable Next Twelve Months", "negatedTerseLabel": "2019" } } }, "localname": "SubleaseIncomeFutureMinimumPaymentsReceivableNextTwelveMonths", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_SubleaseIncomeFutureMinimumPaymentsReceivableThereafter": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 6.0, "parentTag": "fldm_SubleaseIncomeFutureMinimumPaymentsReceivable", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sublease Income, Future Minimum Payments, Receivable Thereafter", "label": "Sublease Income, Future Minimum Payments, Receivable Thereafter", "negatedTerseLabel": "Thereafter" } } }, "localname": "SubleaseIncomeFutureMinimumPaymentsReceivableThereafter", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "fldm_TheProgramMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The Program [Member]", "label": "The Program [Member]", "terseLabel": "The Program" } } }, "localname": "TheProgramMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_ThermoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Thermo [Member]", "label": "Thermo [Member]", "terseLabel": "Thermo" } } }, "localname": "ThermoMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndEighteenConvertibleNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Eighteen Convertible Notes [Member]", "label": "Two Thousand And Eighteen Convertible Notes [Member]", "terseLabel": "2018 Convertible Notes" } } }, "localname": "TwoThousandAndEighteenConvertibleNotesMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/SubsequentEventsDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndEighteenConvertibleNotesPotentialMakeWholeSharesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Eighteen Convertible Notes Potential Make Whole Shares [Member]", "label": "Two Thousand And Eighteen Convertible Notes Potential Make Whole Shares [Member]", "terseLabel": "2018 Convertible Notes potential make-whole shares" } } }, "localname": "TwoThousandAndEighteenConvertibleNotesPotentialMakeWholeSharesMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndEighteenMarketOfferingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Eighteen Market Offering [Member]", "label": "Two Thousand And Eighteen Market Offering [Member]", "terseLabel": "2018 Market Offering" } } }, "localname": "TwoThousandAndEighteenMarketOfferingMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndEighteenRetentionBonusProgramMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Eighteen Retention Bonus Program [Member]", "label": "Two Thousand And Eighteen Retention Bonus Program [Member]", "verboseLabel": "2018 Retention Bonus Program" } } }, "localname": "TwoThousandAndEighteenRetentionBonusProgramMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndElevenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Eleven Equity Incentive Plan [Member]", "label": "Two Thousand And Eleven Equity Incentive Plan [Member]", "verboseLabel": "2011 Equity Incentive Plan" } } }, "localname": "TwoThousandAndElevenEquityIncentivePlanMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndFourteenConvertibleNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Fourteen Convertible Notes [Member]", "label": "Two Thousand And Fourteen Convertible Notes [Member]", "terseLabel": "2014 Convertible Notes" } } }, "localname": "TwoThousandAndFourteenConvertibleNotesMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndNineEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Nine Equity Incentive Plan [Member]", "label": "Two Thousand And Nine Equity Incentive Plan [Member]", "verboseLabel": "2009 Equity Incentive Plan" } } }, "localname": "TwoThousandAndNineEquityIncentivePlanMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndSeventeenAtTheMarketEquityOfferingProgramMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Seventeen At-The-Market Equity Offering Program", "label": "Two Thousand And Seventeen At-The-Market Equity Offering Program [Member]", "terseLabel": "2017 At-the-Market Offering" } } }, "localname": "TwoThousandAndSeventeenAtTheMarketEquityOfferingProgramMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndSeventeenInducementAwardPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Seventeen Inducement Award Plan [Member]", "label": "Two Thousand And Seventeen Inducement Award Plan [Member]", "verboseLabel": "2017 Inducement Award Plan" } } }, "localname": "TwoThousandAndSeventeenInducementAwardPlanMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandAndTenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand And Ten Equity Incentive Plan [Member]", "label": "Two Thousand And Ten Equity Incentive Plan [Member]", "verboseLabel": "DVS Sciences Inc. 2010 Equity Incentive Plan" } } }, "localname": "TwoThousandAndTenEquityIncentivePlanMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two Thousand Seventeen Employee Stock Purchase Plan [Member]", "label": "Two Thousand Seventeen Employee Stock Purchase Plan [Member]", "terseLabel": "2017 Employee Stock Purchase Plan", "verboseLabel": "2017 Employee Stock Purchase Plan" } } }, "localname": "TwoThousandSeventeenEmployeeStockPurchasePlanMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "fldm_UnderwritingDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Underwriting Discount", "label": "Underwriting Discount", "terseLabel": "Underwriting discount" } } }, "localname": "UnderwritingDiscount", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "fldm_VestingScenarioOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Vesting Scenario One [Member]", "label": "Vesting Scenario One [Member]", "terseLabel": "Vesting Scenario One" } } }, "localname": "VestingScenarioOneMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "fldm_VestingScenarioTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Vesting Scenario Two [Member]", "label": "Vesting Scenario Two [Member]", "terseLabel": "Vesting Scenario Two" } } }, "localname": "VestingScenarioTwoMember", "nsuri": "http://fluidigm.com/20181231", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Continents of North and South America.", "label": "Americas [Member]", "terseLabel": "Americas" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region of Asia Pacific.", "label": "Asia Pacific [Member]", "terseLabel": "Asia-Pacific", "verboseLabel": "Asia-Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.", "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.", "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/EmployeeBenefitPlansDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r150", "r240", "r243", "r411" ], "lang": { "en-US": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by range, including, but not limited to, upper and lower bounds.", "label": "Range [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/EmployeeBenefitPlansDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extent of variation, for example, but not limited to, upper and lower bounds.", "label": "Range [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/EmployeeBenefitPlansDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r116", "r421" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "Schedule II-Valuation And Qualifying Accounts And Reserves" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserves" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails", "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails", "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r152", "r240", "r244", "r414", "r416", "r419", "r420" ], "lang": { "en-US": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails", "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails", "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2018-01-31", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails", "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r116", "r421" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails", "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "stringItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CALIFORNIA", "terseLabel": "California" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201409Member": { "auth_ref": [ "r246" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).", "label": "Accounting Standards Update 2014-09 [Member]", "terseLabel": "Accounting Standards Update 2014-09" } } }, "localname": "AccountingStandardsUpdate201409Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r374" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "Accounting Standards Update 2016-02" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201609Member": { "auth_ref": [ "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.", "label": "Accounting Standards Update 2016-09 [Member]", "terseLabel": "Accounting Standards Update 2016-09" } } }, "localname": "AccountingStandardsUpdate201609Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r23", "r241" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable (net of allowances of $126 and $391, at December 31, 2018 and 2017, respectively)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Other accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r41", "r192" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r63", "r64", "r65", "r69", "r70" ], "lang": { "en-US": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]", "terseLabel": "Unrealized Gain (Loss) on Investments" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r67", "r68", "r69" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r66", "r69", "r70", "r349" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "verboseLabel": "Accumulated Other Comprehensive (Loss)/Income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r62", "r69", "r70", "r349" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustment" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r24" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r118" ], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments for New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of subsequent adjustments to additional paid in capital for convertible financial instruments where a component of equity and a component of debt are recognized.", "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments", "negatedTerseLabel": "Closing cost related to conversion option on convertible debt" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r256", "r258", "r301", "r302" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r223", "r230" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "terseLabel": "Stock issuance costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r107", "r172", "r173" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.", "label": "Advertising Costs, Policy [Policy Text Block]", "terseLabel": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r304" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising costs incurred" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r258", "r285", "r300" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.", "label": "Allocated Share-based Compensation Expense", "terseLabel": "Total Share-Based Compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForCreditLossMember": { "auth_ref": [ "r115" ], "lang": { "en-US": { "role": { "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "terseLabel": "Accounts receivable allowance" } } }, "localname": "AllowanceForCreditLossMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r56", "r156" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.", "label": "Allowance for Doubtful Accounts Receivable, Current", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period", "terseLabel": "Accounts receivable, allowances" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Allowance for Doubtful Accounts Receivable [Roll Forward]", "terseLabel": "Allowance for Doubtful Accounts Receivable [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r56", "r156" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Allowance for Doubtful Accounts Receivable, Write-offs", "negatedLabel": "Deductions" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r79", "r100", "r369" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r100", "r369" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discounts, premiums and issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r100", "r179", "r186" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of developed technology" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive securities excluded from computations of net loss per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r147", "r384", "r403" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r3", "r4", "r59" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "terseLabel": "Total current assets", "totalLabel": "Total current assets", "verboseLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r7", "r8", "r9", "r10", "r11", "r12", "r13", "r14" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "terseLabel": "Total noncurrent assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r160" ], "calculation": { "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gain" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r161" ], "calculation": { "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax", "negatedTerseLabel": "Gross Unrealized Loss" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r159" ], "calculation": { "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Amortized Cost", "totalLabel": "Carrying Amount" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1": { "auth_ref": [ "r163" ], "lang": { "en-US": { "role": { "documentation": "Number of investment positions in available-for-sale investments in a continuous unrealized loss position for which an other-than-temporary impairment (OTTI) has not been recognized in the income statement.", "label": "Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions", "terseLabel": "Number of investment in unrealized loss positions" } } }, "localname": "AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r259", "r287" ], "lang": { "en-US": { "role": { "documentation": "Information by award type pertaining to equity-based compensation.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails", "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]" } } }, "localname": "BalanceSheetRelatedDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation and Consolidation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r343", "r344" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r0", "r117", "r143" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Description of Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/DescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member": { "auth_ref": [ "r245" ], "lang": { "en-US": { "role": { "documentation": "Calculated under guidance for revenue recognition in effect prior to change to new guidance for revenue from contract with customer when using transition method for cumulative effect in period including initial date of application.", "label": "Calculated under Revenue Guidance in Effect before Topic 606 [Member]", "terseLabel": "Calculated under Revenue Guidance in Effect before Topic 606" } } }, "localname": "CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalizedContractCostAxis": { "auth_ref": [ "r174" ], "lang": { "en-US": { "role": { "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer.", "label": "Capitalized Contract Cost [Axis]", "terseLabel": "Capitalized Contract Cost [Axis]" } } }, "localname": "CapitalizedContractCostAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CapitalizedContractCostDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cost capitalized in obtaining and fulfilling contract with customer.", "label": "Capitalized Contract Cost [Domain]", "terseLabel": "Capitalized Contract Cost [Domain]" } } }, "localname": "CapitalizedContractCostDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalizedContractCostNet": { "auth_ref": [ "r174" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Net", "terseLabel": "Capitalized contract cost" } } }, "localname": "CapitalizedContractCostNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r358", "r359" ], "lang": { "en-US": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r38" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r1", "r38", "r102" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "terseLabel": "Cash and cash equivalents", "totalLabel": "Total" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails", "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails": { "order": 1.0, "parentTag": "us-gaap_InvestmentsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "Net increase in cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r6", "r103", "r107", "r154" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashMember": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.", "label": "Cash [Member]", "terseLabel": "Cash" } } }, "localname": "CashMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r52", "r195", "r394", "r409" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r194", "r204" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r54" ], "lang": { "en-US": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Number Of Remaining Securities Available For Future Issuance (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (usd per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r223" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending Balance (shares)", "periodStartLabel": "Beginning Balance (shares)", "terseLabel": "Common stock, shares outstanding (shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical", "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock: $0.001 par value, 200,000 shares authorized at December 31, 2018 and 2017; 49,338 and 38,787 shares issued and outstanding at December 31, 2018 and 2017, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r248", "r249", "r254", "r303" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Employee Benefit Plans" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/EmployeeBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r73", "r75", "r76" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r138", "r139", "r360", "r361" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r138", "r139", "r360", "r361", "r412" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r135", "r399" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentrations of Business and Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r138", "r139", "r360", "r361" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r191" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress, Gross", "terseLabel": "Construction-in-progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r233", "r234", "r241" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r233", "r234", "r241" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenue, current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r233", "r234", "r241" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Deferred revenue, non-current" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r242" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r214" ], "lang": { "en-US": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails", "http://fluidigm.com/role/SubsequentEventsDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]", "terseLabel": "Convertible Notes" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r50" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Noncurrent", "terseLabel": "Convertible notes, net" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r15", "r385", "r401", "r413" ], "lang": { "en-US": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]", "terseLabel": "Convertible Notes Payable" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r82" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Total cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r80" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "terseLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Cost of sales:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.", "label": "Cumulative Effect of New Accounting Principle in Period of Adoption", "terseLabel": "Cumulative effect of new accounting principle" } } }, "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r109", "r335", "r339" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "negatedTerseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r114", "r337" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "negatedTerseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r109", "r335", "r339" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "negatedTotalLabel": "Total current tax (expense) benefit" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r109", "r335", "r339" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "negatedTerseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r105", "r106" ], "lang": { "en-US": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Convertible obligations (in shares)" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r105", "r106" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Original Debt, Amount", "terseLabel": "Debt converted, amount" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r15", "r17", "r18", "r385", "r387", "r401" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails", "http://fluidigm.com/role/SubsequentEventsDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Additional interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r18", "r215", "r387", "r401" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Long-term debt outstanding" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r368", "r370" ], "calculation": { "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Par Value", "verboseLabel": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails", "http://fluidigm.com/role/SubsequentEventsDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r357" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "verboseLabel": "Debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r49" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate on notes" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r50" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails", "http://fluidigm.com/role/SubsequentEventsDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period One [Member]", "terseLabel": "Redemption, Period One" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Three [Member]", "terseLabel": "Redemption, Period Three" } } }, "localname": "DebtInstrumentRedemptionPeriodThreeMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Two [Member]", "terseLabel": "Redemption, Period Two" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Debt instrument redemption price" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r50", "r111", "r224", "r227", "r228", "r229", "r367", "r368", "r370", "r398" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r367", "r370" ], "calculation": { "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedTerseLabel": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r107", "r212" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Convertible Notes" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": { "auth_ref": [ "r165" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale [Table Text Block]", "terseLabel": "Schedule of cash and available-for-sale securities" } } }, "localname": "DebtSecuritiesAvailableForSaleTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r42", "r369" ], "calculation": { "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Unamortized debt issuance cost", "terseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r109", "r336", "r339" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "negatedTerseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r100", "r109", "r336", "r339" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "negatedTotalLabel": "Total deferred benefit" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r19", "r20", "r325", "r386", "r400" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r313", "r329" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r109", "r336", "r339" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "negatedTerseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r326" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r327" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total deferred tax assets, net of valuation allowance" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Tax Assets, Net [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r306", "r333", "r334" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r331", "r333", "r334" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Tax credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r306", "r333", "r334" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "terseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r307", "r333", "r334" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "terseLabel": "Reserves and accruals" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r328" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance on deferred tax assets", "terseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails", "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r313", "r329" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax liability" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred Tax Liabilities, Gross [Abstract]" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r308", "r333", "r334" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedTerseLabel": "Fixed asset and intangibles" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r253" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost", "terseLabel": "Employer matching contributions expense" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match", "terseLabel": "Percent of employee match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r100", "r190" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAmortizationAndAccretionNet": { "auth_ref": [ "r100" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Depreciation, Amortization and Accretion, Net", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAmortizationAndAccretionNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r345" ], "lang": { "en-US": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member": { "auth_ref": [ "r245" ], "lang": { "en-US": { "role": { "documentation": "Effect in current period from application of guidance for revenue from contract with customer compared with guidance for revenue recognition applicable prior to change when using transition method for cumulative effect in period including initial date of application.", "label": "Difference between Revenue Guidance in Effect before and after Topic 606 [Member]", "terseLabel": "Difference between Revenue Guidance in Effect before and after Topic 606" } } }, "localname": "DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r240" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r231", "r303" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.", "label": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]", "terseLabel": "Stock-Based Plans" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r259", "r287" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "terseLabel": "Schedule of stock-based compensation expense", "verboseLabel": "Schedule of common stock reserved for future issuance" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityTables", "http://fluidigm.com/role/StockBasedPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Domestic Tax Authority" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "EMEA", "verboseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r123" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Net loss per share, basic and diluted (usd per share)", "verboseLabel": "Net loss per share, basic and diluted (usd per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/QuarterlyResultsOfOperationsUnauditedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r107", "r124", "r125", "r126" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r363" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of foreign exchange rate fluctuations on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r113", "r314", "r315" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r314", "r315", "r338" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Tax benefit at federal statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r314", "r315", "r338" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r314", "r315", "r338" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "terseLabel": "Impact of the Tax Act" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r314", "r315", "r338" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "terseLabel": "Foreign tax benefit (expense)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r314", "r315", "r338" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Other, net" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r314", "r315", "r338" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State tax expense, net of federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "auth_ref": [ "r314", "r315", "r338" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "negatedTerseLabel": "Federal research and development credit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesReconciliationOfIncomeTaxesAtStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation and related benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r286" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Unrecognized cost of unvested share-based compensation awards.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Total unrecognized compensation cost related to stock-based compensation arrangements" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock", "verboseLabel": "Employee Stock Purchase Plan" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An arrangement whereby an employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the employee-holder pays the strike value in cash to the issuing employer-entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize employees, in addition to their regular salary and other benefits.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock options, restricted stock units and performance awards", "verboseLabel": "Stock Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r223" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r357" ], "lang": { "en-US": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExtinguishmentOfDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "Extinguishment of Debt, Amount", "terseLabel": "Debt extinguished" } } }, "localname": "ExtinguishmentOfDebtAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r352", "r353" ], "lang": { "en-US": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r250", "r251", "r252", "r351", "r379" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r350", "r354" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r355" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r250", "r251", "r252", "r351", "r380" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level I" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r250", "r251", "r252", "r351", "r381" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level II" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r185" ], "calculation": { "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five", "verboseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r187" ], "calculation": { "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months", "terseLabel": "2019" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r187" ], "calculation": { "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r187" ], "calculation": { "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r187" ], "calculation": { "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r187" ], "calculation": { "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "2020" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r180", "r181", "r185", "r188", "r383" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r185", "r383" ], "calculation": { "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "verboseLabel": "Gross Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r180", "r184" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r185" ], "calculation": { "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Weighted-Average Amortization Period" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Tax Authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r107", "r362", "r365" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Office furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Future Minimum Sublease Rentals, Sale Leaseback Transactions, Fiscal Year Maturity [Abstract]", "terseLabel": "Minimum Sublease Income" } } }, "localname": "FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r100" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss on disposal of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r100", "r217", "r218" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "terseLabel": "Gain on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r175", "r176" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r107", "r177", "r182" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill, Intangible Assets and Other Long-Lived Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r81" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r112" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "Domestic" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r112" ], "calculation": { "http://fluidigm.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "International" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r112" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://fluidigm.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "terseLabel": "Loss before income taxes", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/IncomeTaxesLossBeforeIncomeTaxesDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r342" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r109", "r146", "r340" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Benefit from income taxes", "negatedTotalLabel": "Total benefit for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r107", "r311", "r312", "r323", "r324", "r330", "r341", "r415" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes, net of refunds" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": { "auth_ref": [ "r245" ], "lang": { "en-US": { "role": { "documentation": "Information about effect of transition method for cumulative effect in initial period of application.", "label": "Initial Application Period Cumulative Effect Transition [Axis]", "terseLabel": "Initial Application Period Cumulative Effect Transition [Axis]" } } }, "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Effect of transition method for cumulative effect in initial period of application.", "label": "Initial Application Period Cumulative Effect Transition [Domain]", "terseLabel": "Initial Application Period Cumulative Effect Transition [Domain]" } } }, "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InsuranceRecoveries": { "auth_ref": [ "r83" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount recovered from insurance. These recoveries reduce costs and losses that are reported as a separate line item under operating expenses.", "label": "Insurance Recoveries", "terseLabel": "Insurance recoveries" } } }, "localname": "InsuranceRecoveries", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r189" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets, net" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r178", "r183" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Developed technology, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r77", "r145", "r366", "r369", "r396" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r94", "r96", "r104" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r30", "r171" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r2", "r57", "r168" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails", "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r5", "r58", "r107", "r129", "r169", "r170" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r32", "r171" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r31", "r171" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r46", "r107", "r162", "r164", "r166" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for investments in financial assets, including marketable securities (debt and equity securities with readily determinable fair values), investments accounted for under the equity method and cost method, securities borrowed and loaned, and repurchase and resale agreements. For marketable securities, the disclosure may include the entity's accounting treatment for transfers between investment categories and how the fair values for such securities are determined. Also, for all investments, an entity may describe its policy for assessing, recognizing and measuring impairment of the investment.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r350" ], "calculation": { "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "totalLabel": "Fair Value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense", "terseLabel": "Rent expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r191" ], "lang": { "en-US": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r45" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r28", "r388", "r406" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "terseLabel": "Total liabilities and stockholders' equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r48" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicenseMember": { "auth_ref": [ "r243" ], "lang": { "en-US": { "role": { "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.", "label": "License [Member]", "terseLabel": "License revenue", "verboseLabel": "License" } } }, "localname": "LicenseMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Commitment Fee Amount", "terseLabel": "Commitment fee amount" } } }, "localname": "LineOfCreditFacilityCommitmentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Prepayment fee, percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum ability to borrow under line of credit" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Unused revolving line of credit" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount awarded to other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded to Other Party", "terseLabel": "Litigation settlement amount awarded to other party" } } }, "localname": "LitigationSettlementAmountAwardedToOtherParty", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r18", "r216", "r387", "r404" ], "calculation": { "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Net carrying value of convertible notes" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Estimated fair value of debt" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r219" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-term Debt [Text Block]", "terseLabel": "Convertible Notes and Credit Facility" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacility" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r50" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails", "http://fluidigm.com/role/SubsequentEventsDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r50", "r213" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails", "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityScheduleOfDebtDetails", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails", "http://fluidigm.com/role/SubsequentEventsDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r195", "r196", "r197", "r199", "r200", "r201", "r203", "r205", "r206" ], "lang": { "en-US": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]", "terseLabel": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r195", "r196", "r197", "r199", "r200", "r201", "r203", "r205", "r206" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r198", "r202", "r205" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss", "terseLabel": "Estimate of possible loss" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r195", "r196", "r197", "r199", "r200", "r201", "r203", "r205", "r206" ], "lang": { "en-US": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]", "terseLabel": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Money Market Funds, at Carrying Value", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]" } } }, "localname": "MovementInStandardProductWarrantyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "Valuation Allowances [Roll Forward]" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r95" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r95" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r95", "r98", "r101" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r71", "r74", "r78", "r101", "r125", "r395", "r410" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows", "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss", "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r121", "r122" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "terseLabel": "Net loss" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/QuarterlyResultsOfOperationsUnauditedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Changes and Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reporting segment" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]", "terseLabel": "Office furniture and fixtures" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Loss from operations", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r376" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease, liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease, right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r371", "r372" ], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetailsCalc2": { "order": 1.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Operating Leases, Future Minimum Payments Due", "totalLabel": "Total" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]", "terseLabel": "Minimum Lease Payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r371", "r372" ], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 1.0, "parentTag": "fldm_OperatingLeasesFutureMinimumPaymentsDueNetofSubleaseIncomeNextTwelveMonths", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "terseLabel": "2019" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r371", "r372" ], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r371", "r372" ], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r371", "r372" ], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r371", "r372" ], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r371", "r372" ], "calculation": { "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails": { "order": 6.0, "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r331" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r42" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets", "verboseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r61", "r364" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r72", "r75", "r346", "r347", "r348" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Change during the year", "totalLabel": "Other comprehensive income (loss)", "verboseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss", "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r63", "r67" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax", "terseLabel": "Unrealized gain (loss) on available-for-sale securities, net" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r51" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r86" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Other non-cash items" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r97" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Payments for Legal Settlements", "terseLabel": "Payments for legal settlements" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r93" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt and equity issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r92", "r255" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy an employee's income tax withholding obligation as part of a net-share settlement of a share-based award.", "label": "Payments Related to Tax Withholding for Share-based Compensation", "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r88" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchases of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r89" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r88" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Shares or units awarded to employees for meeting certain performance targets.", "label": "Performance Shares [Member]", "terseLabel": "Performance Shares" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r259", "r287" ], "lang": { "en-US": { "role": { "documentation": "Information by plan name pertaining to equity-based compensation arrangements.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the equity-based compensation arrangement plan.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r356" ], "lang": { "en-US": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement [Member]" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsScheduleOfDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (usd per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r21" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either December 31, 2018 or 2017" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r3", "r36", "r37" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "verboseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Net proceeds from issuance of convertible notes, net" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r90" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Net proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": { "auth_ref": [ "r90", "r288" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based compensation arrangement, excluding stock option exercises.", "label": "Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Excluding Stock Options", "terseLabel": "Proceeds from stock issuance from ESPP" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [ "r87" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.", "label": "Proceeds from Sale, Maturity and Collection of Investments", "terseLabel": "Proceeds from sales and maturities of investments" } } }, "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfOtherInvestments": { "auth_ref": [ "r87" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from the sale of investments classified as other.", "label": "Proceeds from Sale of Other Investments", "terseLabel": "Proceeds from sale of investment in Verinata" } } }, "localname": "ProceedsFromSaleOfOtherInvestments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r90", "r288" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Payments for taxes related to net share settlement of equity awards" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]", "terseLabel": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r243" ], "lang": { "en-US": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product revenue", "verboseLabel": "Product revenue" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r209", "r210", "r393" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r207" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Warranty costs incurred" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r208" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Accrual for current period warranties" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r41", "r193" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r40", "r191" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r11", "r193", "r408" ], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net", "verboseLabel": "Total property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails", "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r39", "r107", "r193" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r10", "r193" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r10", "r191" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property and equipment, estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r85", "r235" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.", "label": "Provision for Doubtful Accounts", "terseLabel": "Additions/Charged to Expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Minimum amount of purchase arrangement maturing in the next fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.", "label": "Purchase Obligation, Due in Next Twelve Months", "terseLabel": "Purchase commitment due in the next year" } } }, "localname": "PurchaseObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]", "terseLabel": "Quarterly Results of Operations (Unaudited)" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/QuarterlyResultsOfOperationsUnaudited" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r23", "r29", "r107", "r155", "r158", "r407" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.", "label": "Receivables, Policy [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesAggregateChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r305", "r417" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r107", "r305" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r332" ], "lang": { "en-US": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research Tax Credit Carryforward" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r25", "r230", "r405" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r236", "r239", "r240" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total revenue", "verboseLabel": "Sales to customers" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails", "http://fluidigm.com/role/QuarterlyResultsOfOperationsUnauditedDetails", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised good or service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer [Member]", "terseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r108", "r247" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r117", "r247" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r237" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r238" ], "lang": { "en-US": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r238" ], "lang": { "en-US": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenuePerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "auth_ref": [ "r238" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Price per share (in dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesCommissionsAndFees": { "auth_ref": [ "r84" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).", "label": "Sales Commissions and Fees", "terseLabel": "Commission expense" } } }, "localname": "SalesCommissionsAndFees", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScenarioForecastMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The reporting scenario used to indicate financial results forecast for a future period.", "label": "Scenario, Forecast [Member]", "terseLabel": "Scenario, Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Any scenario, that is, the particular reporting scenario is left unspecified. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.", "label": "Scenario, Unspecified [Domain]", "terseLabel": "Scenario, Unspecified [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r69" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Components of accumulated other comprehensive loss" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Summary of potential common shares excluded from computations of net loss per share attributed to common stockholders" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Summary of cash and cash equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r337" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Significant components of provision for income taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityTables", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r329" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Significant components of deferred tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r314" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Reconciliation of income taxes at statutory rate to (provision for)/benefit from income taxes recorded in statements of operations" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": { "auth_ref": [ "r151" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.", "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]", "terseLabel": "Net long-lived assets consisting of property and equipment in different geographic areas" } } }, "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r180", "r184" ], "lang": { "en-US": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetFutureAmortizationExpenseDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetNarrativeDetails", "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetScheduleOfFiniteLivedIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r180", "r184" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of finite-lived intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r373" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]", "terseLabel": "Future minimum lease payments under non-cancelable operating leases" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r112" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Loss before income taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r5", "r33", "r34", "r35" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r118", "r119", "r120", "r127", "r128", "r131" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]", "terseLabel": "Schedule of new accounting pronouncements" } } }, "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": { "auth_ref": [ "r270" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.", "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]", "terseLabel": "Schedule of nonvested performance-based units activity" } } }, "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r270" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Activity under restricted stock units" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]", "terseLabel": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r211" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Activity of warranty accrual" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r41", "r193" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule of Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.", "label": "Quarterly Financial Information [Table Text Block]", "terseLabel": "Quarterly results of operations" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/QuarterlyResultsOfOperationsUnauditedTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r144", "r147", "r148", "r149", "r177" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r259", "r287" ], "lang": { "en-US": { "role": { "documentation": "Components of an equity-based arrangement under which compensation is awarded to employees, typically comprised of compensation expense; changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan; and cash flow effects resulting from the equity-based payment arrangement. Component disclosures are by type of award and plan name.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails", "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r264", "r275", "r278" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]", "terseLabel": "Activity under stock options" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r280" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Stock-based compensation determined using Black-Sholes option-pricing model and weighted average assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r53", "r110", "r220", "r221", "r222", "r224", "r225", "r226", "r227", "r228", "r229", "r230" ], "lang": { "en-US": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r184" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Estimated future intangible asset amortization expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/GoodwillAndIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r153" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Information About Geographic Areas" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreas" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/InformationAboutGeographicAreasLongLivedAssetsByGeographicAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r84", "r167" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative", "verboseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r243" ], "lang": { "en-US": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service revenue", "verboseLabel": "Services" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/RevenueScheduleOfDisaggregationOfRevenueDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r99" ], "calculation": { "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.", "label": "Share-based Compensation", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r260" ], "lang": { "en-US": { "role": { "documentation": "Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Award vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r269" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r274" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r272" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "verboseLabel": "Granted (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r272" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r271" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Ending Balance (shares)", "periodStartLabel": "Beginning Balance (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Nonvested and Outstanding Units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r271" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending Balance (usd per share)", "periodStartLabel": "Beginning Balance (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms", "terseLabel": "Weighted average remaining contractual terms" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r273" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Released (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r273" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Released (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r283" ], "lang": { "en-US": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Weighted average expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r284" ], "lang": { "en-US": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Weighted average risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails", "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Maximum employee subscription rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r261" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Securities To Be Issued (in shares)", "verboseLabel": "Awards authorized for issuance (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Weighted- Average Remaining Contractual Life (in Years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r277" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r269" ], "lang": { "en-US": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Options forfeited (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r267" ], "lang": { "en-US": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Options granted (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r276" ], "lang": { "en-US": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average fair value per share", "verboseLabel": "Stock option weighted-average fair value per share (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r287" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Balance at December 31, 2018" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r266", "r287" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Ending Balance (shares)", "periodStartLabel": "Beginning Balance (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r265" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Ending Balance (usd per share)", "periodStartLabel": "Beginning Balance (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted-Average Exercise Price per Share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r257", "r262" ], "lang": { "en-US": { "role": { "documentation": "Equity-based compensation award.", "label": "Equity Award [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityScheduleOfStockOptionsDetails", "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails", "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails", "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Options exercised (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Options forfeited (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Options granted (usd per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First portion of share-based compensation award differentiated by a particular vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Compensation Award, Tranche One [Member]", "terseLabel": "Share-based Compensation Award, Tranche One" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Third portion of share-based compensation award differentiated by a particular vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Compensation Award, Tranche Three [Member]", "terseLabel": "Share-based Compensation Award, Tranche Three" } } }, "localname": "ShareBasedCompensationAwardTrancheThreeMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Second portion of share-based compensation award differentiated by a particular vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Compensation Award, Tranche Two [Member]", "terseLabel": "Share-based Compensation Award, Tranche Two" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r107", "r259", "r263" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.", "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "verboseLabel": "Share price (usd per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails", "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r260" ], "lang": { "en-US": { "role": { "documentation": "Percentage of vesting of share-based compensation awards.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Award vesting percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "terseLabel": "Total intrinsic value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Intrinsic value of equity-based compensation awards vested. Excludes stock and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested", "terseLabel": "Aggregate intrinsic value, vested and released" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r281", "r299" ], "lang": { "en-US": { "role": { "documentation": "Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Weighted average expected term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansWeightedAverageAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted-Average Grant Date Fair Value per Share" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansRestrictedAndPerformanceStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "terseLabel": "Vested (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Purchase price of common stock, percent" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r16", "r389", "r390", "r392", "r402" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails": { "order": 2.0, "parentTag": "us-gaap_InvestmentsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Short-term investments", "verboseLabel": "Short-Term Marketable Securities" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r55", "r223" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementScenarioAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by scenario to be reported. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations", "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r21", "r22", "r223", "r230" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock under ESPP (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r21", "r22", "r223", "r230" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "At-the-market offering (shares)", "verboseLabel": "Shares sold (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r21", "r22", "r223", "r230" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r21", "r22", "r223", "r230", "r268" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Option exercised (shares)", "terseLabel": "Issuance of common stock from option exercises (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r55", "r223", "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion option on convertible debt" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r21", "r22", "r223", "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of common stock under ESPP" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r21", "r22", "r223", "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Market offering" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r223", "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Issuance of restricted stock, net of shares withheld for taxes, and other" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r55", "r223", "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of common stock from option exercises" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r26", "r27", "r157" ], "calculation": { "http://fluidigm.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Total stockholders' equity", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets", "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r377" ], "lang": { "en-US": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r377" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r377" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/CommitmentsAndContingenciesNarrativeDetails", "http://fluidigm.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r378" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "auth_ref": [ "r316", "r322", "r324" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Summary of Income Tax Contingencies [Table Text Block]", "terseLabel": "Aggregate changes in balance of gross unrecognized tax benefits" } } }, "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r328" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Summary of Valuation Allowance [Table Text Block]", "terseLabel": "Summary of valuation allowance" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Balance Sheet Details" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetails" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r332" ], "lang": { "en-US": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r332" ], "lang": { "en-US": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r382" ], "lang": { "en-US": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type of Adoption [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfStockholdersEquity", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnBalanceSheetDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesImpactOnIncomeStatementDetails", "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue": { "auth_ref": [], "calculation": { "http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt securities issued by a United States government agency such as Government National Mortgage Association (Ginnie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), and Federal National Mortgage Association (Fannie Mae), which are short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "US Government Agencies Securities, at Carrying Value", "terseLabel": "U.S. Government and agency securities" } } }, "localname": "USGovernmentAgenciesSecuritiesAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/BalanceSheetDetailsSummaryOfCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r250", "r391" ], "lang": { "en-US": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "verboseLabel": "U.S. government and agency securities" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r250", "r252", "r391" ], "lang": { "en-US": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]", "terseLabel": "U.S. treasury securities" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r309", "r318" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesAggregateChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r319" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedLabel": "Decreases in balances related to tax positions taken during prior period" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesAggregateChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r320" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increases in balances related to tax positions taken during prior period" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesAggregateChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r319" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increases in balances related to tax positions taken during prior period" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesAggregateChangesInBalanceOfGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r321" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits, that if recognized would affect effective tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r133", "r134", "r136", "r137", "r140", "r141", "r142" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "verboseLabel": "Increase (decrease) in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "auth_ref": [ "r115" ], "lang": { "en-US": { "role": { "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "terseLabel": "Valuation Allowance, Deferred Tax Asset" } } }, "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r116" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r116" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Charges to earnings" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "auth_ref": [ "r116" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account", "terseLabel": "Charges to other accounts" } } }, "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails", "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r116" ], "lang": { "en-US": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/IncomeTaxesValuationAllowanceDetails", "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConvertibleNotesAndCreditFacilityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "Information by vesting schedule for share-based compensation.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "Vesting schedule for share-based compensation.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/StockBasedPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantyReservesMember": { "auth_ref": [ "r115" ], "lang": { "en-US": { "role": { "documentation": "Reserve for expected cost from warranty provided on specific product or service.", "label": "SEC Schedule, 12-09, Reserve, Warranty [Member]", "terseLabel": "Warranty allowance" } } }, "localname": "WarrantyReservesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ScheduleIiValuationAndQualifyingAccountsAndReserveDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Shares used in computing net loss per share, basic and diluted (shares)" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://fluidigm.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(d),(e))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(ColumnA))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22580-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1377-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1505-109256" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=109236672&loc=d3e725-108305" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=109236672&loc=d3e765-108305" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=109236672&loc=d3e543-108305" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=109225645&loc=d3e1280-108306" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.10-01.(b)(6))", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "http://asc.fasb.org/topic&trid=2126967" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r143": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r153": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "305", "URI": "http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84173941&loc=d3e4975-111524" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27290-111563" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27290-111563" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.M)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=65877573&loc=d3e87990-122713" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=66092785&loc=d3e4492-108314" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=66092785&loc=d3e4556-108314" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=84159346&loc=d3e8275-108329" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68054294&loc=d3e8384-108330" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r189": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14615-108349" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14394-108349" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14453-108349" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14472-108349" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349" }, "r204": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=115931803&loc=d3e12021-110248" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=115931803&loc=d3e12053-110248" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=114001942&loc=d3e12317-112629" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=114001942&loc=d3e12355-112629" }, "r219": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r231": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/subtopic&trid=2208855" }, "r232": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130534-203044" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130556-203045" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130556-203045" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=108792157&loc=SL49130690-203046-203046" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=108792157&loc=SL49130690-203046-203046" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r247": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r249": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r254": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "19A", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=107668666&loc=SL79513924-113897" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=79507207&loc=d3e4534-113899" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=SL79508275-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79507997-165333" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79507997-165333" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508013-165333" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508013-165333" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508029-165333" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508029-165333" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508043-165333" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508043-165333" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508057-165333" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109253770&loc=SL79508057-165333" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109196918&loc=d3e11149-113907" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109196918&loc=d3e11178-113907" }, "r303": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=115928272&loc=d3e28680-109314" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=115928272&loc=d3e28680-109314" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=115928272&loc=d3e28680-109314" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=SL37586934-109318" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32123-109318" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32247-109318" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e32280-109318" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e31931-109318" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "30", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327" }, "r342": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5504-128473" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19279-110258" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=SL6742756-110258" }, "r355": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "http://asc.fasb.org/topic&trid=2155941" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75026489&loc=d3e13220-108610" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13433-108611" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13467-108611" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13476-108611" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13531-108611" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13537-108611" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240241&loc=d3e32211-110900" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=113997351&loc=SL77916155-209984" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r378": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=68078379&loc=d3e122625-111746" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6)(a)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99384497&loc=SL65671331-158438" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r418": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r419": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r420": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r421": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.2,12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e681-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL34724394-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e557-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.5)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3179-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3367-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585" } }, "version": "2.1" } ZIP 101 0001162194-19-000020-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001162194-19-000020-xbrl.zip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͉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�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

EC]/QL4S$2S_ MK"_^Y[,7ZX>O#W>Y^GU0_/-Z>'7[SSDO+W[@?_RE9N2_EGI?"PY;TD/MEG3K M)@?$D)B(?A']&O0CL"E"F:9<(06(D0"D$&,G:7T2[:0 !.^,?KS#Z =Y[$^T M02<^$M7W+YE?Y"P<<)8J[VTVFEW[#9U-PNG 0AT^%- MVM201:ETV)M;+-42IM Z!^N39 Z56:TA>QAUXV"\B4 /L#/)E3H%C]I?\JS( M;\;#JV1P>S?QV!"H(29,Q1Y)#;@M%7ZQG"J*!6,,NI0[S8Q):\6#.@A7$J+V MKGC,?[L@XT]+5-P:J'%O1[4:-MRY1(O(W>?*W4M55)Q)M>=N 1!A+!3F-:Q. MR'8$8'UXU>50W,WE0;PD'5=ECD1C^7Q]/>CGR?5LXC=^-LE+=\BUWU?_.M9? MZ5!_"(]"C87R>0 M#KET(S.?!S.3)C0_=1RF3EM"="BNI+1%\\[2$!''WTTKV1\S"]EFA^K.,O-Y M>%C6AW7VDF^!'*,I%DVQ!>BQIC:60XZG*36*4B %A)8I4X,>S2O4+^D)V._:3^W?Y032'CO;\ M^(<-6,.6*Z> U%+%%"*AM*P"UO&YZ"<$*?84:U1#/W:)?/SK81Y>>/A12U3T M+#3M34E J"=HFZWN5RETEZUNBYE_C/QYNOR)Y%)12.&<9T^'A0- 802%G%>0 MHUEQI:IQ4V%(+A4(U CH,<:I6VJ0OT5]9M[NDOOUZ)E"K7HFC*YP9 M^3CR\7H^YHU7PZ!4:T0H2)66FDA'9)T7*"15@NS&Q^TH)_LKMG8,;'Q2WH[G M#D)B!=Q8P/)$"EAR0)82 8154A@I(.($0>-MQ@I=4Z8@?'W6]3XKXHJ>0&VZ M9KI;SS+B2<23X\,3U"3]8:ZX!,)!+J1%B!E@Z\0B8;75*U;7&_&DI0*YJ(?; M+;C064#I6('H+K<>3USUPRP4MWZ[4QPWY:,D_LLG$T^K@:1CO2^/92XW: M8RV3^Z5_DU_-AOGGZWI)ZQ5]^,L@NQP,!].'KX%<7RR:Z^W %!*"*73(<,HD M8G)>3E0!P9:*YBJ G%4&&JP1@A1K.:_Q;U*B(7FQB.S&YZP4S57^PN]^#@%_ MDO%LDMS7LPM'J)-9-BR_"&5S'_)L4B2YWY*K':KDOF:$NTQPJRJY\YJ(%=^& M,L [UW?__$B/$F#!*\6I:4 >M'56Y/?;7?_;$RR)$ M((E EM7P.) C8E4B>5P,):^=4J ?0:==/.K5> M-&K)H]Z?32:AT\*=_^GX:NYU7SFE.3L;Y9@3'C9A"VZP10@E+8(PU5HZA)#P M?^M3'D"T79?[N 9;FK.]3T4QRZ\^/'^FU48UE%;+M75608G<=!S<1)O21%H9 MIU2J(.0\95J[E(":FQ@29%T%Q>VXB;?%34RV&2#6?0E]["Z4.:EXDBBF13A5 M#?+[*MH_9U3:8%,^H^1-U4=HK$*.6T9("HU 0%LSMQV(->N*I:U!I%^RA[(J MXW[E.@$'\4@<3P)C9.&S9>&EPJT"4N9-?I@"E H'H=7S?A &,Z/6E4A[&PNW MIDS 'H"1A4_:=9".KG8[OSD!:-HMI'DK]^OQ]2!K(4S_"'J1(8":^OD$.L2@ M)%HRYOP74 )< S5)9?I*H-Y?-A!KU4N[:8.[V34LPE.$IW.")\+.]#SZ..'I M56E'>TM$FG_\-"EF-3;J\0*UGT?TX4^\N_-9'Z3N^Q;_O%RDF>_?9Z!!BE?2@I*,1 (<2< M(!"CR36SAWL) 69\:AD[\"X/X^G M>5%6%S"3_&HP3?R RJRGYW* JOW;G&;QFF'M,BNT@5E6J*AUO*G>AI__-)CZ M&_>K6$22?,E'@_$D65WF'\JOR]<_KL#$]C-YE$S'VDFF^SQ*7'[I1=/D(2%E MPI3_>Y\G_>&XR*\\P7C1Y)'^WE\\S4?)G9<"GH?&U]=YV5QU?+U]KADKB=V*X7"9URRU+LF_?)OFW;)HG=W[_ M^X.[;!CJL/I%#:00$@]W)(=-U"":,N!.:4: 5) B!S5-H9I3@W*4N9>IX5,0 MQ'DQ_=7/YP%XQ'0A]_U\H/U).)!\T4:N>"KQY9_V)DVGH5# M/_\D+, C7/10,BEF7C5.IN-',!-@)?-4EE<5<*[*XK__-QN5$(5DA5$7R=>; M/&EN5Z=#)H-Z6Y/,_R^9!$+=':(VT"1"D2:[2I-W^:3,>.XE=]E#F9A9Y+># MC]G(D]-P^!#2:;V!5J9$CYVA-_+1" MNZU']^B51-_S"S0,M:S]M<.!'TZ_6L;\JI=X32R0N7_E^6:2>X[HWV1%E>7K M"=K;6,%-[)\PO2ESM\/6%&$TTT=#N$A>KV0<0J?8ID; GH<4]FS@"77@Y56U M 47@Y#E /%[/D$:]7\C 3="+(MI_RH!!F'%J!36B+EUB+*%HX5<(O/S3IVH* M9C&# !6?K\M1'R5"D 4^@)?/QOB%X'1CW/5#52C"PU8H'>A)-E^H56M S]^L7Z)>=GU&X M9QHG36H/=) *+HQ'.*\6,0F,K>/\M(3*HI2 M[)&P?ZSTF:Y7 ? 5/?7] M.F1>=2GN_.BO!UZ/R;^'H(FZ>DE0[,LKEQXV*-^-*F=0I>ADR;6W!;+PH$"W M-]GHFV>_S)L1^;57'4KE:%J*\Z A!*WK6S@B*A,CG\CQL=?[EF8P'Y]_XM4@ M/+"H5+#;N_+IJWK Y4,R*RZZIO!OPUH.)LNK M6>9+-%L?++310S(=W);.A%">:%QN0%&*L$JE#B6-@@5XD7P>!26Y=%8W.C:K M2OST2G5]<9/'7R-8.K3"X"I]NWQLN)/K/!@6GT3_&"!LA:@^51- M2/+?^WE^M6^-D39&IH72"2@@,MQ!0;4P\Y,HPU.-V"/X?(Q_ORZHWX^!ER[ -QRO=M%W>=&_DN9:O,(@U_^Z>=1WADS%^)5 M'79W*[>FXA49'S@N6X+C:NCAYU?90U%QS?A9OMJ2<0*(CV<5V28=6KU$U*\&\Z*1:VUP"^ST5TVN%HX&B^29>DW"?JW MUTC\-5X.-1Z=BF4",]Z%;C8+9>.Q@/0?EVXF_]TJ)S[YA%3<^^13V:L=G\V3 M*QZ;,V?%5'YL^^4KUIQY4@4-8YH3FJI4 RI$6KM$M<) K9R[GC)?W4SR#HFB MSG/6I^L@?\J#@6_C5]L%SSA)>\G-:QAU5:C=^^ORP+S^]5TVF59Z;&"F]:QV M*!9;.A<%')B40$@@MAH;9>$\:,GP M6U^:\UUMT9:&]&GI!&81S##)^_G@>[Y#(=?7^;AXX^,"@BDNH/.?2Z"]9+:2 MS*.9I10K)X&_3,:E&>DFX]LG)/XBYW6'\9Y&+M)71BQ 22_0WB(6RA8J@=,> MG2]?#8I^8$$O%:[]@E?^I"(<1Z^U1P(GSG-%#^LUY4U\O)/:<0-2)Z%3D$FD M\5R1TAK2E>QHFU_G8,R1>($2.EB]0R@M="74'FY#GOZ M.,FKGL3Y[W?YJ @GL,&R74MB!PB1$LUI(M ,2HF!)0@*+"5#:'Z:2+7!Y)$J M\+>E\=IZN"<.-NQB5<"W%QSE82(@QY4?<0,G5:KY :B 1JCH"%3<>V4M*!TA M2/XJF"@>.(I\6LP]W'>UL'\)-DK?W'-X4]:$O\S+4*FJ/Z[_TM]\$?Y4_]#; M-_-CD=S?*S0)R#\N?E2>]-SFTYOQU?$JEIRL#FE?(;_BY9!?\>:0WY?6$LG. M*>EM#$_%1>[M[#K&]'NE9HWR;^/IH.2!Z20; M%17'%M6)X?Q<;V[@UZ^4RV#,,<[#D^C(ZM02&R#\N-# ,$HR) ML<)JXU]MB 8TV63RX+EW7K5=R^FB%TR\2M7 US4\*FWN)QJ];D3M$\_/* M$I&+:6E%7"77V6 >:72?[7R2N)%"&\\1QP! IH2!CDK@[53&;*!0*U/.-%XY M]%A.BG%^T.6YX>F3)J$7J\&I;9'F15)J 5>#(.S+4(K+?'KOEZ(DDGW30A-/ MKUG(Q:%2*A4:WAI/&,330@JU,8@JMEUVQ?&0P^MS+/8,5:_"*;'LFO":Y3*$ MU+$[C688XF,JR/%J8;\4HG[1UMQMC;K8Z)25INB_G8QGWZJ Y.O!Q'\1<+$6 MOLG=;%H&;*PYQ,(M*9DGK!C](R_COOU6!ZDPGF]:K;DL:3[!J/#W]D/P&S8; M%#=E7%8XV ^V9TBXF ?3^/$.K@?]9<]6?3LO$BN"J3\._'$5#):E.()Q>380 MPJ2*V; T4((@W3T6P^,NX M\$;2YU'Z:'D^7Z_WIGIT\N(9'P%$O5IB@7U:M]_\$E>6:WA5GEJO)\.@R_C1 M]F>5\>K?39\7=),\Z__+WV*P%!GRP^ BOZB4I25\>^$X94DU6WAC@O^W7^O2 MC^^PI.[->>RJ<160("110!H#I?^M6NE)O6WN5H"[#F^#;.2NX M5Q[S^=\.IL.@:I0'A4T6TV#2G]T6TZ!H%+UR*9]I[] M*N(MS::%PFAHM\)H>,.:[:'N MXK+/IHI]?Y+*=9C8=TYD4SX#0*H@HAA20IB#0B(9L$\[H%0*]Q7[?K(@M\\ M^.#GRX,G^!46R'CN%5Y0V-5:ST?O4#'S)WSJ]%]-W,R37;C)OE38-MFAI+LSG606$G#-=H3W2U;A9\172^O%Y MD;K& [$$:$'*1IFZ^Y ^/PW=KM( YC$=RZ=0(5C\H)Y3WN2+." T-Q( P*5 M'!&H@ASAJ;3Q_F$RR3!8[);;I50 6Z6'67MA@ ^ RU[#UI MA/,F:<0"#;PXD!PPSKC&*2_%@B!$2(;-2K2RJN(C2O/W\W65.K*>'CJ.\-O3 MQ/[2%BM4Z&=W9?K!OZOHF35Y1;U':2;9J,XTF7M4GXU[6:BW =R;9)).1@V^ M(WLM MZV=NV5:AX [J;:V5U]NJ6H9\79$:38++^/9N M/"I/5M>GR"^[AP.%!W774^E]\/0$6JYPJ?CQI^3EIB/;TL#ZY,/-GOK7K-)+ MGGIAL43 <":XXWZS %&8 @XP5J&_TT?PV%/_J$<8F/?Y6)K#\J1' 4&'CWN# M@*I'6G7^VL^'P_K;\M _O/>+V9^_7T/\7P>W?HM^SN^37\>WV4I'M?O!U?3F M)RDO4.C/AR3P&B FY _SID]]OZG979'_-'^QLBD?%DT[%WUHY8?G6WI6#^3H M#W^<_^CI=W"[K[:\;)\/>]>.IEUJI7<"\UL0-]_49/E1.[75AFFM]EJN3U2; MFSW/>G02)O K:-#=<[W9U\S8)4I++\-R1Y_&%9[U_T=DJ>!@2UTJ+^ M''AISXOP!B;KDA2-I'&VI/&NFN0>PN9^>7(X>YZZ1>OSZV1K]%W&?:CFYN7A MAEPJ(&PEL8()IE+#,;><&U3W);92,[%;Z8_WJ0UY"]@9R>;=6Z1%P(N <&' $7DHAIM0IJ5)H+( 02(/J0XU46:$W5$9[$7#X M20&.G]"I(,Z9F-$?_O2WYTJ'1"MHO16$#FD%'0H,?W@9#2$ #1P*@JSF!BJ, MM85 2^?J>KVI-(Z8E^%PB=[65W$^&D7L(WXE+'I0Q*O!5]N#XD8*:UBF"WK" MCQ%)(I(T2(*6VDY@1;T.Q9 65' #)'5U*QAAB6"X#20Y!@WKU4A">T#PB"2G M['Y;T<<>!0">IVW\:L0\:F!08Y8C4C3%230Q:8W&^HB7" MZ2E6"&UL-KT%HW0?\R++GPC+LX;EC;6 2*@N3!+9X[)-?7)KPGM?'MOV##;B M;\3?B+]K\!5:)RE)L726*J!AZ@B;*_D"8_U&_#TIS1Y*VD.;:T^?+P"? MEJ?S;0'>BNU#V!^9W-7G;3>7& V.F89;)GCGYVL;JI"N^@ MZG9%FY6--T%CHBFUUJ0H3;E@*89>-!OBL,1HC3;;4A#O"CFR#"6X2W-\,; DLGJ$0I%BME M=5H.^SX">/MW/AE?9<5-X J!(/KC22/;:=G?05FM>JY4%7^7"YF=IQ5VS)$& MFV --; FN M5N2SEFB%*)$)&>%@3QF.?EMB\4%!9S2GE\_6.L=M= ;=7>R=Q MC],V(P\ZJY]%CCX.CB9->7UNM8:(0A,2TZR33CE:6HQNV1S1"7B378),Q![E09+@J5E%&AMI8=%BFWHD&TWI.VV MEZ?6?61\&E8M>Y2V>A![_&DF$5).%5(V(8IL$ 4;I &C%#K*L1)(&ZQ+1'%, M:\DV5!YI+U^M^X@2/4/'[!F*.6B[@. AR^<>6+W"2[%LP!F)*47<6N<@TQ3R MX$>BC#KJ$*'[S5'K/@2N% &0[18!>"69';]J%<'C.,!C$W;@!CND314#3A$* M18J]*B4M+K&#N]1AD>XWV:W[V+%7]6D#B75?BSIV5U9,<8LI%C'%HDW1LI1' M+276B@E#F'8$80(X\AUZSX0OZ=BWU$^ZZ13M4N8>^KS MVXM,.3G1<2(2@L#F.,UQ0IV1U%%)6.H@=2SDCU#AWZ50O#4;>EE5?U_UFJ,> M:/< ?1.T=Q+!([!%8#L?8,.H*=_(I(5I"KC61DOK;!UY))@@&HN56FYO4'W/ MK41#)X&M5$W_L^QHO/C\2>/FP_<7W\]\GQL!)R]WMX;\KH4.Y]7;\/.?0B/[ M0?^/5;_+Y-?\^WCXW<-$8B;YU6":>+X;# ?3AY-M&=_6D#Z/$C7[-BNF">J5 ME35ZR7V>E$TJ\ZMD,)J.DRR9S)>WDGW]:HVOZS6N/KP?3&^J5U_\IY[VD[]G MPV'^D.AL]%OUQ0^_/K[/D[WZT3\N\?_L0G/:8/G-F3\62U<:@@0! /@("962\QYRL$J MGON-_7Q=S78^V;]FOP]N9[=Z/)F,[_V*F"RT/9\^/,;[2H_%?H< :F#]T8T> M(?YB@9\\[ TY?>QER*<7J_U<$K_ P^6$L2UW(OFA7I6DRI3\,1E/_-[ZS0W; M7?C/PUYG.^_UQJUF3="P-1I0"[P!0I&41!/I1;A M%6SVS5^1>A8/0OK7O)\/O@39*\7A&//(LE\=!PE?QPN??=9TU% YNF#C,(!<+$,;B#R?_/^-,B! MOEC,HDLO%4R_+5?!B.HSQ-OLM+UECDM^%(<]_ M5237D_%M,AW6N_L3._"P_5W?-&PB=/A/M%\M5__?C985[^ MNJUWVGJF#L17:0$85HK']H0S\RK1Y.5I)/=^S/M6$5ASV@&D8\H2R[5,C<# M4J0\U92V4=U4%T 7>FRI0DMTD]T3N_^P9\)=RA)#EB% *4@,X MA- Z:/W7%'GI3P2"LCW-[L!;"1YMY<0 M:#R;%E./48$Q&V9]%@F3;-H9<+DX%@O\4 ;CUQ=WKI0K7E<;/S8K$>B5,LJ+ ML?YX./2VW<0/,^037#X$L1FH8SKP8M3OO9>E00WP,OO."W>6 +%^(%Z M>S3W1F5_.O,VX?P7%\GG)?H:CC.O [R&RNX'I=C.)N5M_:BGO:16#[P!&L8X MMRV]'>JEYZ0T28>SG07))D 2C?VA)2062(4D!-#AE*0,>SE2NA.%E6O:0"S+ M$:^>#(HO=WXR5Y]'?\\F@Z!(_^JG 5_0,8O)])^_AF/S$H/"N[\.1@'1GIR4 M;PM8BU\M#^C1Y;^$Y0Z?MJNT@HO]J*VUC;IGHE@JM(8P9D9R1;V, D@ 32M MB,(@)-6&CHMM$44EYHZ=*.A>B.(B^51#2D#";/3P2 16$#6HRM<&6+RK'//) MK;_/3<# T54)0XW_ZS(;E@E7\XNFC08_O1G/OMW4-^W[@5Z&"[TQ,+@*OPL/ M+Y7_X*#SHTCN\E$V+,V-3WYH5WXK_)1+;Z3&?!*NF\ZO7LJ%RP%RO]'.('>#D\E)BEVAAOCY&HLYQKM[&_E MG.8ZF1G?>KNQ5+GSO#'*C\ "!Q=\'_X7+U ]Q8R"JZTR5[/O7E1_R^>TL# + MNZ64=%!/^K+JI,A_[^=WI8^BLMZ#>E3Q7,FO#X$.2Z[*_Q7T&W]E"X[M#?Q% MESKY!CKG2$ .*!("$0ZM]?Q%H3:6RM=9/X?GJ&?" '_-K_+;*977\/+P,R]6QI.OXTI917Y7)X#KQ"FY%3$6I M26=7WX/VW:&^D"(^&%#UU>*++PFJL4&.I M+\U)]9$K\\K?[HE<6CV&+S^NI,53,;$D%?KE >B3B((5,=*"E.#BR8#+OS>3 M^4WN/,E^O/2Z^F\?R^7X*1O>^P7UC_K/F\GJ;)Y,M^2QKWY:7_)@-/M//B)I MF$R!@T0#S5(H'$S+EB,$: U2'H(_ZEOD5VKZYLO)AC4[,FT @W:&](]POM"? MA:35)+N[FXP]LWAR]4KVGIW2%#:PZL4Y-P!2X;1E2CI.C?:PRI4'6RP@VBK- M]D!'U$M!2>#ERHR8]L :H&L#YU:+7Q3A6,:@2;\X<4F!1R8E%*C))0&1U,)2$9!]:F_,T2=-UQQ+X,HVVW'J$];7VY MQ_/%"!IZX:WG_\J&UW/A]_C;\K!I;G^'KST)5(K__/?-L=2<7B;Y;38HG9;! MOJ^-KSR;# >E$Z'R0SZ5A8O8B"#ZPD7W-X/^3; M%O*U,N(:R5KJR+XI'N,E]MS5ZHVANWQ4^"=]KQVUP\%U/E^?%PY)HS_^+?[XL*>>KHJD M[PEG?)M-O+5Y?3T(+#3X7FW[*,1:A3=]OQ4>Z,.&!C+J>88,(5:>FOVWI:<^ M;,UE-OJM5YVWEW[Z[+)ZTG3<"SOMQS#WUX>CGUXE]A9^)F_6AOE?3O.KD;]W M+_DV\4_TM\N#45R>98=S^*+D)?^)UQ]GD_Y->IPX%MY2%_FAP6J"PLU&0]+ M:R/K* XLD>7G;/.Z-U^U=R9#%$D<^#H98_,XO>1Y\.=[<* )B+EP0 M]65AX4*00S7\?/W.>0C]./=*--?-J63IHZ#)3 9^:_]W=O7MR<\#N4QF=]-^ MY=4"I MQV--,/RJ;?,7W&>30'&# .%_NRL_7(&Y7AU]4<)QB+'P$F88\*P\FYH$?TU MM ;.EYV[XTO/[W4DRMROZUEG5L[KTE/5[:W?ZTKW>^K_#:_SW[VM.@C 6,Z] MC%HOZ@"/<*6WF!;A+&%G7W'2=9%8;R'YSTN9XB7R-'\>XWL-1-=2:'E&KSE7 MZX]GPZMRJJ.^MUR*$O@?9TWLR86 EYK1.&V\IJN-=)("[E)+H5> %$NY3+5Q M&T.WED.TYLY\;Z,OUB(0CZV6[+W5SJZ6I.3MUW&:_U%K0YR!;,<[*;>4ZW-%Y+%:]2@_T&E[I?)=>&53Q9 MT#>+N199B?IBHS*WQSB/-O(O6M@M6@:0K(RE4ZZ)]3IMIYQD@XW/6:&K8*!=CX?# M*NQY6J4@%+-;;U_Y52M-WWY6W%2VX7S>'[T2]K'P,T^*Q:)4EE8I0&^]-CPK M7< A,MG3[?>2;D,,G,>)P;77G,+1R<( ]D^8YM]"2'H0MG4 ^=*%-X-\DGGS M^"'YH?QR/"O\<(H??TI>)ODW$=LV@O$5R_UH%(]2G\$3"@_OEXB5/_'YP-;WQ M+_WZU"FH91CC79'_-'^Q O@?%N5*FG*?X73DN6HFU3,P_<,?YS]Z^AU\_BNQ MU57;?16?=8K/.J?Z.@U#;FJU?= "O+5"W4Q%O'7N8KV>.+>5DA4SZ3SK*[VZ MT_H^MO\-%6;W1A FFTP>@EY3'>N=9[&6LZ>"/P>_>_*WD;>#<^_Z M&6FAIH6_^/>1%LZ2%AJ72B2 LR0 ,W=LE"_2?\T&W[-AY4F+]'"&]/#E9CR9 M?@PER9*_9I/?\LK-TOC]SKE[@RKC3G[:E7+.MH+X"4\\[G[<_;C[YSGQN/MQ M]^/NG^?$X^Z?6@?<8 ;0 Q8#@%NDJ <<):HE$G_ MH:;.X!3(*F+$,BC)2LN9I^$K3X);YFDL(0^N+**RH:+7(A;I26^:14RP)ZH6 MFPSTV)J*G-N7XMX['<8V 1$TN@(:=*FXDN-$2TXAXHAPPRFUM *-%&N>BC>" M1K\_NYV%@F=7Y0E+<\ 2SMIT[CDZ_YK]_JY(LL\F5!%%(HJ<#8HLM1W%0AF# MA9:"(>Z<-9;40=!"69NZME DG-)&%(DH$E'D9%!$-"@"4\542J6RA/"4."F1 MJ T8:[E=*C/+33#=G6R;6?_#.Y]TTIJT/:3!TYVL)+L3(&"6AI MJC1'AAN5G8(O??!K=S:9% M^0/XI(W8II.TDD2J?'P7"*2UXW;.>QRR%D_6GJ6]SI[#GZR'X=PA@RS%SBA. M&&94*XP!8))1A>J*LBDAFK-W"?4_9AS9Y^E\Q)"((5W!$-3TU.-&6^)T*.NM M9"H1@\C4(;I20O<^@?X10R*&1 SI-H:0!D, D12ET.-%FC*ED158U1AB %B- MX=TMS/^8P2$:*A$@S@4@&&N4# Y30P%T2&E#M4VE$'-#!5&VD@?46I!_Q(J( M%1$KNH\5@C;U"[PJD3J3$F4=@P BS.9%3RCG:J7HR38A_L<,"^=E7YQ+0-'+ M?_]V\>4BF4[*[DL/2ZV9=H22(T8,"AKM0@&NC&128*@5=8@88VO$T)R$AFVG M=G+RMR]?:V)HQMU-1.FL+G%.*L,Q\SEJ- -#$$?2@E2YE#E(4\=K-X/_H^Q; M^?Q8CSLB\T?F/Q/F)V3!_$(!DK)424;83C[L?=S_N_GE./.Y^W/VX^^/=[4HR'@ZOD_X#R MOZ.& M9$_TB2$D8L1)Q"1[B%0)HY%! DTR.-_CEI?-A$FA$_.H ?QXP/HHD1 M2!$G!&!)&9>"*(-%.L<'AU+56G3@@0.$3AH?(O]'_M^%_P5H^)\S2Z762F-C M>2J1T#BM#QLAHV8E0/"]8X0B8T?&CHS]'&.C)DS(X5"1A%*.+*2 4)#".HI M2&S,BF#O4)A0Y/'(XY''G^-QTD0*8<*51!H0A"34CG&LY^V&.=2HE;Y>D9V[ MR.8-UYT\?,\N9OVT<.D[.&RV:66X<7TV$LY+ MZ[355+:JU7[.3%IH;Z)I#T"X-Z)CQ,=6\5$TM>HPAN!,0)C!,8(C!T%QJ5X=NRLXT 12RU4/+7,&]T5 M,"J(K%ZIB?_Z(^]H)G?DP/H0>'>35S\$_I>'"DKI0FO7 \[[G.8:]_CTYQKW M^/3G&O?X].<:]_CTYWJ6>]PI!?M@D=X;JX(<,L^[[\W+?+(T%?'6N8<+RG?W M%=5C M:4?(7"> L"2 < M!)<5TLH72T?"D1[.DA[*8["/X1PLJ=JIAE#3Y,M+=?-.K>J@*HI\6NQ:6OP$ MF.'4YQ?W\G3F%_?R=.87]_)TYA?W\G3F=S9[>38E,X+1=R!:?G:INAE*N4.D M9#>"(1'A35:VT41(S#&G(DT-0DJJ>?%.:K2 >ZA:P9=K VTHY!/((1F$X0F&23S*=!BBW7J? L:P &&K Z2CL5TG]\J'(1 MAT.KO4:"1Z2*2!61JC6DHK#))]&0 (JHX$I"G2(K'*@+?Z5 <+M20G%?=1HB M4D6DBD@5D>H)4N$EI*+.:D&I%@!HE*+4R7E%&4Z),SL72(BF782A"$,1AM; M$&T:1DBMB49.4,45M 1"D\XKI6JG[4H"[BZ5"2(B142*B!01:0TB\0:1"$" M"PND9@(;:028M[ 11EJ];17\:)&=8!V ?<25S3T"'_V>?BS\!L<8LY.?7]S+ MTYE?W,O3F5_SEV<2852NP^K=L^95\VE4'/EOWPRE//.Y^ MW/VX^^S_"-/9Y+2J@J$;A M!ZV=W$/6@P2=0H/G<_(*G3*?+\7.0$R,P4X3"S'#R @JZZX>5F$-W\KG[:1% M'#/SGV1G]\CXI\'X'#?-S0@67K1SH@4C&B'_E]>,+Y13]%VR#"+C1\:/C+\' MQI<-XUM@#(44I-JQE"F5FGF&MB52PMV[&IX,1T<]/G)UE[E:0K3@:J:YLDHZ M"$/'4JR MO,8>&(!M7N+@8\,'AD\,OB>&!S#!8,#(*1B3" #D;?,&51JWGY3 M&8)!&R'EQ\S+)ZE^GWWHSLM__W;QY2*9>DO3"ZJ'I'BI=.Q;$*/5Q>P*E-!& M5^"&(JBI@90:#(RD$#I,@6<:1"$7*YU\C]^W_[J!^2."!2:5(EM';, BU,B1G46QW4M.8N[/@Y0;M .U$.J*._10C6BP1(2)"O!DAD&PL%D.YX (Y+8A03@-E M;(D0J5":H!6$..(3D:A-1*R(6/%6K""BP0I*M+0@910(!316$K. %0AHQQE= M\8@>Q^%*U"$.G,[^XEZG M,[^SV)(*D92 3RAIMQUG!=JU'82)9V+2"K:YA4FFNB"\ 4 M=:2(,QW#&;X4^(F(I=0(A67*J4X%EW,5B?$4PPZ'=74.70[SQ=9M,__ZIN$7J[2P]Z78JL?E:Y>A]5D?%CHQ9(VV9B$B M0B-CJ# I0Y+IND-XBBW&8C_'>BV@%\,]B%N-<-VT^^]+T&=<22AB5\2N!78M ME4 WE%BIE.-,2RT YS %-79)Z+7;Z!.\%8L1]I M#B;+8 6%3V/JQ&T(FA%T#HCT"*P 2T$)(-6 M 62=@M( A18A]"E7<"7VZ_4'I&W@4P\($.&I/(S\SVFPZ!>?^S4)BSX8S;)J M4=IXVM+TAH-1_O$F+\$+(O"'1[0/ Z4_78#R_6#DL6SZ$P;^!VT<6_K/\^0^ M_!F-D^DD&Q77^:1(+O/I?9Z/DKH"1IG6-Z^&D=R61^-Y29K)U6SB1YU,;_+D M(<\F2>X'>/48*-\\*IOWRY/VZC88]A)/\6+KV_7*X4\?3;5_DXV^Y44R&)5# M][I!M<_)-._?C ;_FOGO9D5^=='Q#=29'V3BQ^VORYM9C*^7TB_]#+-I-7,_ MW2SQ2D^1W(V+0?AISW^17'DN'(VGR23OC[^-_.W][1Z2<5BRC_[BT<=I?GLW MGF23AV1P>^<5J#+7TZ_A)*RA!YC%_A<5 23=V?NM+PTHNR/-[?)LMO7%%\GV M#WZ=?*-+[@.IF?_02J*@4\#_1-!'5^$T_C1Y[2G^I M*;3X[YG_<.H)^_N2SO[S+%#)Y^O%K^ :*2D>2O>.#5\6R2-*,KDIOL>^XQV -PR;"U(!K/ MBL>\6W+>[=CS=6#2!"+_9C2]*2Z2?^3AHOYP%GBQ9/_ H'[2 ;5*U*O;.@?( MR.=#R.9[\]'?^&/8G644:0;H!S"97GO9/:Y090D=1GZ[IWY[2O*?PXH?2C'P MB9,]03'D;4!Q]3;\_"=/J\-!W]_#C$>EGA0T MH)_'TZ>)\*W- ,G6M('$;XIGC*DGFVN_[ U]!/KQ'$7*C0VL5&X<@7:& MX[ R_N?^JLMI*<&"K"XYY=:S@*>:K-_/[\+5C4R\S:@G@^*WQXI-R359*3.O//WUI_ZNX\LBGWP/'-)+BEF87Y'T/6T.IN4-GB@+ MJSID^7&E%CZE@*7][?OGYY,GZO *A;2PWT'W?S3@\N_-9'Z3N^Q;_O'28_)O M'[-K/Z2?LN%]]E#X1_WGS61U-D^F6TJ-KWY:7_)A7F+EQ]0$3S.65BD*B=,8 MD>J@C0#%M-(?T8-EL.IY_4'GF MRD_N!U?3FY\DO>"A"2.0G# JA/C#W"'0]Z2:W17Y3_,7*ZSZ81$NW,3FDP_/ M1Q-73T3X#W_\L.*\J+Z#+WP%MKLL/BP^;/FR=XUR?Z^4&0AWS)EI-36FQO]F M*N*M",">#_9^]-F]M&LG3AOX)P3$571]_]TIT!'!TZ? V924CC;B-8ZOO;'!HPMVA+%RF_;^R&/D M.*OJ%@G#K)#40&V@$1*D0B-,@6/<":M6&U:&?*NJ\AXP$A$ M)"&6;L3((NGA !!9J]?T6Q50$4N2+*-E(2A_RD(X4=;/,7Q->D8;()C("RY) M!\$=!'<0?%80+*M.J,P@: A#G".L0L]D1*6'8*N ,\82=GP0[(H GP_7BSO: MBK_X@K%&ZW&VDP<[_.WPM\/?"G\%K/!70&V8@0@(Q373B%$B6W4T&GI^8/#AM6[1. 5&2RJ= M)48BRA03N99L4LKL2C'3AIWI[H^\M$:-OW- BEMHVZ,M0R(OI#QD$^C6RF0G M('IU*.!10%8M!S4PDB,B(26260:8$"97 Q73D*X4:&_65[$-")RF.HC0!6*- M^HT[D.E YA5!1D)0BTD1SDI"# *"6,:4P3K7IB#;O\VJO,'*Z#30< '0 < M& !(%?:*J1 MNJ!..(D\ZB@*-(:(Y#&=*5,.;Q0PVHLO+59ASA)GH0^O6-W1!:"- MAGEV$-U!= ?1'403@*M@+F)#8T,A-8)204HMD'G**03*8S4]+$2WV*3P4(2& M](*"#I\[?&XY/I\?!+<%96F%LB$Z#@L.4BR(5MRP5)4ALU)JL=)8=DLO\ZDD MA6Y-'1W8G3?8=<+H\0FCO(HI)D2QT) ;*HRTE@HPRHH25,I*N$/]$W[R]H+F MTT([>;2#Z ZB.X@FH);VX0!TJ560(\(Y=$C95.7V HP$/S1$'X^]8 ]9HR>& MS\_JD7[XKNF'Z+&]?DA__3^]R(E38VT*#4(&>Z51&R E%#:E2H6<")B&GH!_ M[CUG+CL/-7Y<+D0N+@OT>.\Y?#*X6F9LFQL"_^?+2IS3Y]GXZO<;_XQL,G7_ MG@]F/T)(4L6TH:.A'OIKWJQI<,B,HI1B":TFAFH$.4N+/HF6D-#?<@%8(9J3 M*:2EM1HPI[!A-F\?[2QQVCW9"'/C>^";)//\?Q=89>)A[:_)YYO>)"OF]:2\2QK2O*G\62[(^[T)4[MG?M#8=E6]B[27:=3<(/T\!I MR=U\626##AM[P1]X=KOQM>INV88Y4Y%JV*(V(LQ_S"QQ?R',+(_X]_6>"*[X/Q?!H:DX]&7N:[\J_PDE\VN?>WS[*1)_2O M?O<\#^3[%9BAH9=OTB$DY!E#HJ9"6&(1 MPY0@'1!GD9AD)GG3;2LO62PJ_3 MJ3_;[#R,_:,?U;@?#]KI^^P^_C1=UB@*N*P^?YU^F@/^A-?GSV$O^'ZWA-%6O]Y7[\I>@WK49]%\@M MRT8YGY1LLJ)/1!";UE6*7]^G"YT"/*E3R O,T04%&VWONU)7/L@5\+QHEH+^ M8P,)U;S67MTD A!L4JZ)XPIS&D@HA8!P(=!*8%%M3S_V)A\FD1+Z44WTQ!0I M:9E^?CT6^O'Z:#6#;8@(7 ( ]TU BT[PETD2&L20; M7&7E:;P K67CUI9FCHT$QBJ''8:((.W^X1G"Z",-)>M^^3;)O?CF3;Y/Q=.II:7R5 M9?TH^?7N_*<_HK5H^.,@Y$0J)903D@IMC=$I\;I\RCQI!7+BTA@AS:*W1MBQ M=Q^+4:>3\6TXVWK^,/]P72. 7T=7PWD_>B:& ?+RFQ$/P,Q/=A8$J.E--KQ./+T%A2-7<*;EZE[F M!/;>"\@+&HQ/"*"V$,'N,Z^_O )=DAI=]K*W0]=15H)L'10 J%5D@!&P#"3 D\81%L.+ 7<$T@HRX&\@DB6SL;2 MX;,X\SY+?NV)0CQZ9.6Z![M87/C2'E>>9L61]\\L&?A=&$7C MVWR:Q6M&]7/PP7U1I==1>.?'U\ U?S^679U,_++\&T01M#+9W/MP3;Q@YH&YZ ?UG>_*.%14_]W M$J3/*T]5T\&L1%P/P'?#2&Z>8)*O\^E@E$WCE,IW783;ZN]Z@;7QA(V+/%&S MMYY&WC9B8SP94^R2P1V4%O?[+%>>=Q0:-^!UK:"!!P6*L-6<4 V)T (9FIOO MC-+&K-A>MC7?\?_&?K(0O YZ?_90,0KPK69?;K*<$//WEM3H9>%OD]YMPQ8] M(,&%!!M3)A_F=8):$BU7#2K[ M)B]1V?B49$Y(S%*1,D"!H8JHDKP4%"MNK2UL*>=&24CL30T.-KV'QI1)SLD+ M%:>N>SRPIAR6R&I5200#),7" 00-Y*AE!?GIW$(KOI.GVM-.3?2 I=\;Y05 M%<9!P=)^I:>S5Z"9R@)G"1= .Y$B1S4!_@HJ"V!"J>4K(;NJ_[_S0K/],E;] M?M1H>\./O4'_UY')5>Z:4%]BEPGS[ @+7*ZZOIH[_/PDIE[ABT+6]7SHZ2C[ MXZ;GMRO+C7B%E#^[Z/4#8>UR70K!,:C9>2A/ MH-K!]8^E42'6T*BVBG&MHED]F8:=T;UIU@\4[\^7Z#)2DTDHSQ>93?^HKOG8 M^Q$+^=WW)OTG(V&]K,$%A8*F*=9 &I42A"E&0$LOY6I3BX3E6&$ "1"$,2T= M(UIK?RE&"!JLT=.1L!O?LQ()JV95 !2&M0"HFUYNEIM\+X/X2G-9%1,0B/5Z M'@QZ%9#F=)M%[HW&M7(1D[MASQ_+/<\2X^%P?#]]ESP=<;L:1?Y,$KL*8#)9 M3H@)=%\GN?5\T$"0+WK68YZS44_%"J?.'Q6"&@V)<1 :F@),A8$\3:UA[BU8 MCA7>N!3UY1P%V!PNI<5 D.=&Q;C_Y"H;#HM?HZX;/ON-NRH_KV'9+X-;3S_O ML_ODT_BVMY))==N;?!N,\N'UYK-Q^46>F!6_N1_T9S?OI+P$"!/,Z4]E@L25 MIZ;>W31[5_ZQ$CCX9E%P<5'V%(8%>JP>8_XJ*G[Z2WG1P]_@$S^A[6YKX1.? M7ZIR#T5BMZ]8*5YZ>HCU.1,_#T:)'_V?IK]T-8);L/W;Y4,59T'SU/$YNYH' MC[Z'M2_C1&=)+FQ3%G(IKH)R$;6LJ-A^]!L9SO$@DD6!-?F[UYD>Z9W8$6%'A(\0H1?- M@VH0R>RV-Q@%*UN-,-5"<4V]+I#FND!I:U@'>6=3_AH!((O$PN374=B?P?=L M389:5_7@8!-O>19_L AR4:NS HU!1EE+J.,:(8U3Z'5$K_8Y)1UW*U;D3;:+ MQTP7.8\7QH^IFL]NQA,_[OZ&-A:KZ[O1N.?V19/(IRV>>!:3#PP'L_ M\L>L@>^]+IHSSH)OPBW/<.$_.\^_V49IQY7!?P::2PL5 MI5JQ 4,ZUG_] D'/4?".1H^#L#$][M1Q[SB[P44$0Q6",2 X@Q09#!6T *;4 MZ"@E,Z &PU)V9[>.QDG([77\KKI,IK(RD'7'D1 MQ2!I%77$_T_D=4X0MREJ%Z_O42,Z"//#"X8WAKYWS-\Q_QZ9G_*J\Y4@B F8 M&D"8I;'P(,Q5%4C\X;_"_(=650YU(*,F*YZV7_,X=M>2_/#A5JQ> @-XC*U@@H"A2/:,)";.U(H!%CIH7RR*M >@.)5 M#,,=4'1 T1102%!YCQ'%F.O0;<)IIJTC2+K"LT.)3E?JD!U:7>KXM_/=//3= M<*\/]>=7\5Q*XDG2^6Y.S:0C40VC4JN8P@@X:2$UAF+#RZ YS4S+[+G-*3F+ M%-J*W..K&K<6D29[2':22L?L+V5V7#EJ!1!68\,00"F3VH4RO64XFX&T91:- M/6HNA^)^W*BEH^/^COM?ROVUDJ32,@ZUDLJK)2FRS!7Q\0@C9J5=X?Y#JR.' M8DIX03H'SE$Y<*)>4LI\1=+>Q[)#4N>UV5^*WK$3SK,@DE<0*8@TW*M"?NZI M,]!0ZF@>W8)DJH%JEX#4D#:TP-VEYY3\]23Z_C$=O!L-AD5QE,?@=QSG-)J% M.@F/H&[7W?B%$S\DX[9$E!&5:Y91+HWFS"AI5?#'&E[P*8# TC-QP>S N*]N MR]V6?ENK W50=#Y0! &HW,'*6<$9X@ 0J GE"D%>!,4YAM7KYN_L&2(>]BZ2 MC09V'!U&O*H_J$V8<.KSV]BE_IBQ#578QBPW1G+-'0JU%8!&,B^IP!PV"J^V M.6JW/M14 # 6&QL!-DE,K95Y.C8_S?1D"'#E(<8IAX9B*PASQNM=%A;A;AP2 MA,G1ZUI-&94EV]C?I$G2:V:('&LE!9$.:I,R"@QQ)M>(,'"6 MKUA1&]*(&BIU=.%AK6/DJ,K\.=8O7GR_4E]Z]9LFWE^;\.'ZP_WU__0B24\% M-%909@RDE'*LI#08.>QQX_+Y0;E9;)[$??Z M.5WT_8EM#U:.Z>F31=N%E9!(0 /;0RTPT!@4I;Z-0E#6B[9;:P&QQ@+_AW*, ML[)AEG082?)D,>^-[UDIVAZAY6V<27073I\NI+ZY'/ESAK#+#-";%]+64L^" M1HCMS5]#2Z*OXQ !.KY.^H.)'_QX,DVFV6P:^RS,LLGM]"+,,V^F4?24G!3" M5RSB6S:?F8UC@S;W^>/'16O6;Y/0:,L_.R^./[XK'O+I\]_S?I5WE=#V]FO< MO%Z0]:9%S?SPP.^]R6 \G^:/*"Z*=?,OD^21\?>S,/#0M3+OXID7[ R=3/*' M^Z'F(PM#\&?'.)]QZ(LY""US_%KY]>I=/JS6N:[Z?@DV#\%BM1+IA@UO8#L% M?##@^._-I'S(7>^;7^9)UOO];6PA]*XWO._]F :\NYFLSJ8!)D&[,0EN Y/\ M.BK;O!:$&^@D\>O12_X][TW\.@Y_))XN!],DR*G^Z[O8*'*G)G'7GO2W[^/S M(^M-:HW;^Z'AF!]-0?3^_Y))\=6^NF_Z7449@Y7$"!5#E!B1:B>YXHAQO]?4 M2Y#. 0+<2J9$/)F^;M8QOS[4,>,__\A9^5,@E:G7# ,+>N)_\]C9N<'<]$#; MC*JE)X45[3)'FKI0BA8R:>"%ITQ.J_:FGW;NY^1W).S_]6 R#6 W&GCZG(:F MOD4OXYP@(GE$7.\%:?!'DO6N;DK:SFDZ7#Q95#N&J/S58_ET_O5_BU;$X:JL ML,Q-_U1K9IQ_&5OU/%\0/!!SEZGA2T=47 Z_%V^GL]YL[@^5'P]^CROG9U;U M)(I5L8+HD=ST_.-Z\? ,"ST:)[?C26@H[7]KAM]*2? !NZ&J9R3A&'F]C!@H MF4AQ*B&#GMTTX 8YI$5C)ITZN^4-_74$@^##*-OK1UV0^?;GW?__(BTB4W%MCRK?3[.I=?SZY]PK; M-!N]^>LL&^5@^J@XN2UK/@;.02(9)5G9+>'.ORS^[%$[E+>?[1FQ<27!"RM2 MD#H7"O]H(2U' !4M^VC*R7+;T9HA_C_#1*9EOX>/80*_>=SPNUP!\8=1VAM, M\K9FL2GN2Y%YSS3Q!*+7N]INP'0(5C-#&@#U'+NO_0(FMWFC\;S);?%#A*3A MCT'1_''1FJHX#);H[3+Y]3H(++U@UQC<16G]?E0(VQ[Q[T*_JU&4BIO&L$\++6PX3*Z&O>FT:NN] M1*&55!+4S=#+=,T1G>MRN=X9;JJ3\/W O^'53F$L:EW#-362"X^9:I@PX*KVJZ4Q!&*CH47HQHN^FD&\&MUF4D_U_'SHU M7FZ!JWFG]V&1"UW35MU"T=U?^&\NHLKPE-^J=G\RCN9)OY.Y46\XF MX^^#:5S&P6CA-XK+M^0X*KL]3ZHSOOZ.<.JL.+26>YH'E>1K4%,&?@QS?^)_ MGGONO>O]\!\6O_:2Z_DH/Y6+8\$O<-A4OWGW-X-PP_J9^8$].K&H"'W-,J\R M7=T,/ WW=S;"-AF@L,;E_7B#@;83[X=1\E^]T=SC6!Y?A$3L'PX?)=E>W[-Q MUJ\LR.NG_?.2A?F7PNR> @NJG7('^%!?CH?SH+>L@N) M[H58&'W[=9UEV==Q MWUO0 1@]P8["4CSQSJ_9E3^QD\R? M>!'^+@I1.)#RLC,J/P,+*%V\\ C@[UDUNII#/[ ?]*,1_/B%W]PEH$N'\T%_ M\.TV,>/)W7B2P\OCL\XI,V0H(O"7VA7AM_@M_,LO95Q*C";5+L:3_IQ&E&^_S0?9@EEF/Y\]OY._#7*I+UP5 MSM)Z#-6:V<6#>3P:QM/YMM>/RH''@H&?W=SOLY<<9GZRV?<0>.6O6CJU Z8' MR:+\(KF-9+/8CS5"SL_^ENOQ<#B^#X.''?<\XHCT3* M?^CYJ4R^!8%_XM??[^@T!KU=+$(;&3A>O_,ZGN2R@A[VKW]]^OKH9#P-!1JGC;;#1 MYX[*?A:)(JA"MZ7X$.VT"^7MJ6".2.TY7%2B=1YQ6"0-;!6.ZT>;]3T=%!B^ M@O!+YHIR:Y3'LMO\NR\A4/O)Z%P#%+50"TZD$4 )8Y'$E#C$C>:8J5IT+L5, MI(RD3!N(%+96AJ.+.(RPI2E53X;M;7S/2G1N -.<^ (\?L\FO6]>(JCF%C:V M_]261>FP-RU09/KNZ>C>ITCUJ0[Q)6EN#GQ\QA(L#6,I)P0\8)#PN3[.46# MX3)3@3PG)D;K)U?9<%C\^G_?@#?QLY__5?EY#5=]&=QZ3GF?W2>?QEY'>SCI MV][DVV"4#Z_G]<7RBSPA)WYS/^C/;MY)>4D@18 P+C!#E/]49C=<^:WIW4VS M=^4?*R+GFT7F]*)Z$0P1GH\E5N=OI.*GOY07/?P-;O?3EK>=S,M:6M18O/1@ M$&>?PEXQ$MRQ#EBCZ>PKR+K5UJZ16?XG\P*S&X6X#YM=1<$SP?"B;84:.AK? M!XWC5R#Q%^STWH@^B)3=UI_KUO-NZ\]UZ]DY5X3]7%?1WW7EVK;DCA->A+.= M>+?[W>Z?\^YOJ=N!UIYU_WQH&\W^N,MB;,;W\; W&PP'LQ]G+@9NJG-^E.7X MHC]9HBIA!#& $..4.(HHHBGH1(7,=@99*R&C?F30]Q_C/BO>1A<073_6-#< MI][L\92 )X.M\7.#K9FX) W6XEDEWUWHH"G^_JECWE-E7E++]A*I00A"SEU* M-$ R+W'@F=<*J&A+F)9QWS=LQ[4.9E%?-:#!D&Q *5IH1R)'./ M;CAY+9>,MX-Y68/,2_"9GKQ-F]".4:\(06F=7KT=X!USNX/UV5U2TEK9#\6D M!M@P:%/L &,LY*P;(Y%B2J\'PFT*-3T%A%\\>3Z>P;XV^RKDAWM0N^0KV5=% MYOBVP-:^)@0=EYXEET( J]HHA""A4J2)=A1R+2@+%7@#FP)H&'>ORJ9\,YNB MCDT[-CU1-L55NT'H%0AMC0:::<^DBC*2GZ8B!79@W2;=";!CW8YUCYAU9<6Z2B!II8(9,S2H'(O3,RZQAE#$B M!48$6%@PM=.4R38P]3,TE(ZI3]V-\;9T8]3JP=QE16'!\[2F',Z"TM1F_L<. M$SD"7*W%3R');5RUBQ" E5EHC;XVK1:VHO,_#KZ.\[4?) M-"KGF?BC]>"Z .'GZ$/S:>BF'M^ZOH ^>-(6A"_):@7][:&VM6)2!R0=D#0, M)*@6X<4,P<(BJB0A&'"%L=,ED$CZ2,?,5P62%1UL1R!!E[))AU ')!V0G V0 MU-KH$8H1ALXI*:A-D=1.FAQ(*.,H)>T#DA6];V>)!,I3 ))V%G]Y"#5EN4UQ MUTC=U^,L G' 13B.@A =5714T5'%:R]"1Q4KY^F?8U'EQ?J]]25JX9#^F2WZ;65%>?V5FC=)WE AM,.:3Y*;P70VG@123?+Z[7E7UMKE MW\HNFK$KA)=T7@X&4RK MP=4&YH70ZVPPFT_R>R>#T,+NHFHD&V3/[WZH><.CJD=-T?ZH/\CKH3\ZH$=" M^9>&$^[\^^5G?\,DZ_DE^)&'[(26!WG/G-!5-+XZ](5;]+P-32V"R\2/8W[G M'[/\B-%XEA6]YOP*SOV6#D)'M;N[R?B/N*:A(>&_YWD[AMB9,#XU>E[X7Z;5 M2CY@PQ5VBU_GY/J03E?++KYYFHX;(%.!'@PX_GLS*1]RYW6:MU_]*OW^MA?Z M&;[K#>][/Z;^57^^F:S.9G-I>6$E#$J<@]I +3#0&,26,@08A:!\BY\LSK_Q M=K)AS?:@S@P'U]EEX@)1Y(0]#>1[-Y^%ME!ESZ;092%P0<7#D]"%(71ZF?K! M#*X]?WDJ_=]Y_UOLY?'U1S(OF&*YM\-3S7?]Z[SB."X?'7L.^ O\4%9:#GAN MOIH/>V4SOK)71.R5\?GCQ\LD">T80Y^6><$\%>]/0Z\"_[P?R?CJ:CYY0>>/ M\ST,FF:83:=Y(_?5SAXK+8$*K'O0;WD-W83.=_5>=57' MF]#DK#HZUC5P#M1X.Q_.!G$7;ZOZ ONQMVOO6DA. MNW9H>3\>A4::6?_3HDMB+$?[]]#N4!5'^.:&+%Q"2%)-&=-4TM09JPBF)!66 M<$RUJ35DD8PHHP%P+.4Z%5Q(%N+%4\G]!Q/B)I_ _(WO66G(4LYAJ1]?T7_J M8KE;7OXQ-CC,/Y:"R\.F4H/I\SNT;#X&GS.G798$O? 8/ O.R3^&R]\-9OY- M5_DWRX6I*YXH.EY&KMBZG=O#TL[K!,(=A)4&*.T!J2PIP"WLY5.T>P%@M]8\ MXLWC1N?\%9P<04<+P3/B,Q)\K/7_/V$_C3] MY\/8 M>=6KCO4N4T%$IL?F6S@9ITK!FU&"6F',ED1=$%!EP@%%*)%"<,4YI59AJ1"F M%! E80BY;RSJ(N_F_NO(2^7S\.7T@]?.)E]N>J,B'F.AS;XOHN>7].'0,YK^ M-UGTBX[/_/+C+F\877Z[3A'^]/GOSV@9_18_%I__L)@PPX<(T-^.CEX[1.QL M,60KJ&CGWF\3<;9QWX\=,5$MVHB!RU&\CP;IOK[<*$F3/2A:*P%V#-PE"30-/+5T M<( =13"E-H4\5[=,'VB&$\4O 3@&>VIEZL"1.22PZY0T9'9Y8K0[\XR=Z"@BK;(AQ216LEG MIQPA5EA(2$H53T.K%PJ,5)QPC ^'B&E)C4<@(B+8I/7NN;1V_)+BJ:-&9PX\ MO'A':L6'-,"*&(PXA98:#V. !_&.8,>]OMM<'>?G@EG(JCIVV0[R2X'.W!AX M,I& K%/O3]PXN DN:]X3*3TR(IIZW1<2!X@FPA7!?LH8>T#9;W.P'VM#L!^\ M *S)(I'M4W,[+.A,?4=LZA-5#U-#B05:$.LP<1I9HQV,<7G,">IEPB.)RVL. M]W85 ^DE[DQ\QV;BZT+O3C#TCH$*YE2JA?&ZKH*.,I$"!5.0A]XI +4^H']W M8^@=;XGQ3L*3B&WI&+BSM1T:>!"J@$<:QBS$.*5$4T =);P(O?.BEFFNS>L! M0N\:1:8=Y2QZR9O,*&N_-'7LUK8N]*XIZ]H.^]X6URHC%4("@I Q7&I+&+(L M]:"H\] [ZQR1M$6A=VT1S4BC/5@V4MCQ.U3/%CV:L<<5]-!*L7 C];8 #C>A M(:O0D &&!+4:6H(<%$Q9R?+0.\,M0 =,U=@]]*Y-\B*DE[3)?C.OQR3G9)?K M0N_.,_2.B0H1":0$"^&842F5*64(I$7H7:B@"=H5>M<6$1&S1K,SNM"[$T&- MSAQX'!;-O0NU;)=O@2-NES;;\( M=^S&P"="[WBGWI^X<7 37-:\)X1ZB'04ARPTD!J+:-2& 5'&4-BNT#O>CM [ MV*S@USHUM\."SM1WO*8^3N "W#"#5 M@4\8$%8H*HT >>I=*9>$!TS!V"KUK M#O=V% /%)3V(6Z3]XN&12(%=Y-V)1MYQ5J$<4HQ1@51*G2*66 2AR2/OA!8$ M'K#PY\;(.]$2VQV\$.@D4LDZ%NZ,;8>&'E'UW2*$>9BAD$&M)- *"Z6*V#NB M4G? W(;=8^\:Q::=8^]DDSIF^^6I8S>W=;%W9V1>V^1;%: 2SE*M4@@05XI2 MHR@@4,$B]BXDNQXP.GEC[%U;A#/9Q=YUZ-$9Y$[%("<0K'D;A"*$ID99:"A7 M04PL8N^@8A0=4^Q=F^1%>;GG[C^=8:X+O6L[LK=&_*MY(!"'VE&KB&::2*2( M0;((K8.6'!+PGA-:UQ8)$.$FT>QT!+V.ZSMK7M/26$Y%SHE/.MXUHQW=_)/WQ_.LP6X2T M-THHQ]"M48B:75"D1CK,G 764",M=3*/NU.,B$-Z3C;'W8EVQ-T)V*3+=GOR M;&>_Q@Z'.B/A\1H)):B M0TV>OG'PS[.>1^_%]WZZ84<&HWDOGV\3;ZM-;S@896]O(EF\@PC\M*?Y/?7& MARL5D?3P57R/1!\,KY./*U.DYQ! MDMZHOW" )_VYO_1;XKDI^9'U)DGF!]5?2-,YDI^[ MN\GX#T^^LVSX(RF79$OH^8]-V .K*G98 FMUT'I9BC@A0NK0EX>F2J8IU^M+ MI7S=C#U?7XP]ZMNW2?;-+\"OY<)'H,G]%@?0>9>$-+J &O8DU+#+U;"5Q._1 MT/_Q '%>O)D7^Z<#OJ #BQE6V!@ _0$DM+$@.JH\'2B:4I6VEPZ:3AO7I=>_DNN>U-?L]FU>/&\XE?Z]O;<1BL7[+$_Q$N#J\)-_;]T\+#PG>CJ%.' MNW+5MQC+9:*F_LO\)'SL7 SWST>3[&K\;>0GW0\O7="3_S"=3<-\XMAG8S^L MV73FYQB&,"_DUGR:7E0+8_##SB*)^36Z\O3E%RVY&_9&TWCF+NM7>^.KJE>[ M\T>J$51C:&6*K82$$,]7'%@.+;;\(5^YV[OA^$>6?]P\,OV>1V MNB=1K48Z;Z?9U3LO<@=1.^#M0MDKEO:AKO?R$S<\>7K9+LVD=SRO>>CWLW_[KR_WXR\UX/O4XJ$9]%V$P&RVH/!)Y0>// M< " 9UJQ,)<75&Z,"WDYN/F3+*9(3NL"XI)DU?,?2A;^&EGX+I_>91+DN/Y@ M>C4<3W-"#5*6F4\F_G+/^'?CR2R(AZF?5R+>_K_D>C#TUX5OLJ^3>6_R(X$@ MMX!<^*/6/S?[/O!+._0RFA=W(I6$LS>*?KW1C[?W@WZV,IJ:.)>/*PSD_F9P M=9,+?7]D5_/X\_CZVDM.DVGP;0:.F@UNL\3OPCBYZP53W^"N%X73($E-?KG_W2_7XI[RF6%M[V_&N6DG*\2XY4'$1WI* M2^Y[T^6I^ST)]T[B^9K<#V8W23J<#_J#;[?^KLEX_NTF^:_>*%_+N)3R,ODP M2CYG=[/<>5O8F J)^H$0?7L[F'GR+>7ZKV//*>%#?^#%HMDXK%6P17V/0_%+ M>743N'=^GOE5SZ\WO5&OWXL3#MCV M"-DMK>QE\FO^M(=CNT@RC\^#X-):VHFK\7S8][\5TM\T$FM0$/Q#O+83[?Z% M6)B%"?5J&QQ&OGA/F-SU?.AIM5 V)@M *12CP/9!RYK._5>5%N(W R8YR/G! ME[0;@*94I69!#N[@KXN6)KVRP.+9_TCMY@LC>*1%8PC]JMX=9-]&&4K(M>MI$M9IO]-.K6ZLW4FAEK'8&6:0!@%:E2 LDD,8%A2*. .XH], 4 MZM_7+(6N"2%L/X76(DM52@0S#@#F("1I*E54G0*%\A1 TU'HH2GT9I(UC*)\ M+RCJ9]81"JPS/_/1_/!G[\%TD,[0GZVEWYV\@3 M6-!)AZ4_Z\(O?QB]5RNBV\RK&H-^Z3.+L^_=^J?,GER:V4UOYK7/M5)_E/>G M2P*_?XW?F.*YBZ'O&QLJ)P0!F#"2:@>UTX"ECACJL2$U(M4XU7(K;'BYZ:^. M#?$1RX#P862&XZG?BA"=]F'BW^Z?EB#X=12-M*&%O\.K?5/]3R:TI]()%L M\B B;Q\A:P(_&'#\]V92/N3.$^K;KY.L]_O;WK4?TKO>\+[W8^I?]>>;R>IL M'DPW\N,7/ZW/$1#\-V]%)M%0^^#VPA3M%^_]^'MN *6Y_;.X M/@_G6T0SU(EN3RC*6=4,VQA"$+!2 L'+H?X/ *Q*ZSG=;_^?%@*N"OH'^F[9*8B M%.!+T*W"4:^'_L9=QH2R)9)HEWE82[(ML^5P9\QE!WFBE^O@Q8"-JK[%2[?XG[ B#4$2)\ MKK]@%%!SN)2Y!4&>IQ437)*K;#@L?HV'??CL%_2J_+QF=[X,;OW1_#Z[3SZ- M;WLKV7BWO3Y^\@Y*>_E!<]_ T^\1/:[K;M?FK^B?B5QMC2 MNDKBI6>2.'R.:,MR8!=,AMX\/==]=#5\P4ZO(.96>[WF9'F_,'Y&::DX3Y.? M_9S^-#W3:CL+HL!G2A1EE/;;(DP[DH;[(YM8\">6\ MB2.20$$AR2*2/ZF%\B=_&UQGR<]>._R?$ O?P,;JBS/4FBDM.(N%1SHE#)G;, W(S"7!C77RFMC/FNI M(T45:2/J[5BA"('+/?=\: 7U=\C7KHFW"1W6I\$CB$D%#M!Z#' I4"HU!FEF M=!!^).6&4 [7QTYLX\)>:I$0G,*Q5$#6_S(.7[T\!QZNB:Z@A>OOB3QVM"&/ MO3V$="1*>6NXZ9 KU%(/Q]83+>W:75O78^P=L4D6Y+6<&6 4ELH9#9&&S ). MHRR(I756ZN9"Y9X;$,<*R&ZDQQ<_B?Z&':MU#1L.#1&R4A=92F0*G%&ANR#C MAF(1HFFQPY)@BU[>7'#Z(HQX@L0JK6M2Z%DAD(",-14",*02X-@02VWT-%5 M.W0(8?XUYGK86/L[%Q#R!,5ZO'8I(^Q;OZ"KU3/W:#TZ_LYR9\O*C3K76JG: M[.(_:XG.@VJE1(@@H3PW,*E2F& I1(H#-*6I : ]>6X=]%Y2LAJB]I#+D&3 M:L_K$7/G#NLFWDV\.YV._G22U>G$(&>$$\*<85@)C)7D_G12UG_%7?-&^Y7# M*5:\7\XL?N:9M%W,&FRRN6G[SJ+3]!YVK>%AT?PYJ.3ZQV5@IKI+$Z MM.8@ :JPU_ )(Z"Y#J2K/9T/Y&1DH,DV\L^EB^,W!IPZAW=>RX/+2!A7P .) M\8H[%3!TVN-60*0"\!"H'?(R$VA<@U^#/*^LPR-\29O$IM;JZAV4=//K?)>= M[[)1,'HBE9!UUJ4NE?!Q*42@6GAERH!-F36*0NL(2GF92HB502_W(S202LB: M2R6D[""&F2ZAYJ@XOK,G'X&N1&H)STX["I $C*>8*YHR!42>$(B\]L1%>Q(" M69,)@9!=LH.D0G<0U3:(>BWA]*!I?0326F7:P.!"L!11EEIIN#$AK0]Q9 23 MZX.XVYK6QS:E];&J]&N7UG<,:7U'H,\>B=K:9>Z=<.8>H95J:3#TFB:1F"BM M+ CI>SK/W'.(*]QX%8>-F7N\0:<:O,"L2[OIF*T]*M\1@40MO9?0%%/@%3F( MG;&$&0%0D;LG$((O=[_O-7=O!4%V5/#H)8,=B)PGB'3S:ZQS/1O_5Y>[ MUQ;[4EOB^BBJM ^''3!.4N[_"P"$@G-0Y.YA"MUJ"'(3N7M-:AAKVG%WN7L= M*W?>K*/T9E%201,"4C-*E:4BI18J"8$M4ARK4NMR]IM4><@D.DIC<6GWH M;+&JF_BY3;P[G8[A=.+5Z4243!U(30HP!H :+SBG>>X>-HYPV9+I>UWJ7I>ZUX"*+VNQJ\8JJ0$TH3XT4JG4PN:I>\!RYEXI=:]1&\ % MQXV: ;KDO1/A\7 AB<&:D"0L1]AA UV:4LT<5Z9(WK,>C9I7X7=/WFM: MB8?L$G?)>V<*)=W\.N=EY[S<3_(>[\Q+7?+>XU((PY4CP0$!4Z\B$*_Q2"05 MRQT)4##$$>2OD;S'FTK>0Q>PT0C++GGO-#B^,R@?@ZY42S$&SF$($$DUEMAB MA!Q+RVY^0/.7%SK96_(>;S1Y#UR2)H,[VV=:[B"J#1-_K>0])EEEB9484JR- ML9P0Q0R"E!;)>XA"L#[5HZW)>WQS\A[KDO>ZY+TN>:]SOIU4\A['E6J).;&, M*&F59RE/W%!<"-.\#VREU;P4_=E3OV"5HTC/?@<@1@4@WOW:J$<<^U[/Q M?G6I>VVQ+K4EKL^+$0O!@EN.E?6_J31E4AF,B"E2]X3_:/>2NM>D?D$.4G3R M=(+USI:5.U]6&[!I$S2A"IHLP%@!K'!JA!,4(2M-V7;/.?3RFD;[3MUK6NVA MEZAKNW>66-5-_-PFWIU.QW ZT>IT>2LS)U+]5N?0W5PZ?N MK3N3MI*SQ6G'5YRF\[!+W7N*"$\X=4_P&E)12XTAFCIID+:4Z!05J7N2T]2] M3NI>HS8 V6B)BRYQ[T0XO'-:'EY$DA7P0"4,-@RE2$I-6&HAMWGBGA>0.&Q> M@=\]<:]I%1ZR2R [U^5Y0DDWO\YUV;DN]Y.X)SKCTK82+?82;7\\_SK,%B+M MV67V25)UPY&.,T=$ZJ0#2 NIH.1Y9I\03M'&PR^?D]DGFLOLPV)_54U>0DI= MZM]1849GD#X";4NR2MLBA%$I!74@)=8XPR!4>>H?(9B8U2+,KY;Z)YI,_>.7 ME)VT9;I#J#9,_+4R_R07"P[7EFH#4JZ#0=8?IWA-K%:;,__$ILP_ MWK7MZX[Q,SG&:T93#A1(H10:&,BQP$QHZ9E<(\8X,KCQ0HLU;G[2F;SVX-Y* M):$74G;.Y&-R)N<'05-FF%.'W(TJ\HY&E35/; >.80!KSA],H(!& ZPX=<1( MJ$-'2@J]=H*<7)^QMK.PDAM4/EQ_+BPF>W4[PPN &M4]-MI6MB."U]903IWA M.S?SX9&FGCZ/N%/0"FRMUXNL336$'FF82[W8!,1"8KH>]F]W%I=RF'E-@X>\ ME$U6T>]0XXA0HZ56"@P(K^H3L=0@(A20TFAGE!4FUB>RRG*312X1"5[D5O+ADE^S@+ MU;=OD^Q;;Y8=R'R +B \B4;.9Q/&49J/D]DX^>YIIHOG.*IXCK; G*A@S@K" MC1$F=51!070J=$@-90 XR3!I5L9XU/NQ-GJC>2,#IDU&D&Y/.ZW5%,X6!SKG MSA'@%@15&2^NJ%*,&Z4Y5=*E$L:4=BZ4<-A8MD?<>DV3!;WD318![!#J:!#J M'&(T,(15=>:4ZQ0SP[F$C D+% (XI 4CD!KA_S@,T9W79W%> M8U1S+5B1*H,E2+52%EL7,]ATJBD%2J2'T3,.;6'!%X(WJG*T[KR.II<_SWI> M[UE\'_^M#6]$V.K!:-[+MR*./+G*AL-B M4%$""Y_]?5?EYS6O_3*XS:;)^^P^^32^[8W^DJR^?]DB=3_HSV[>(9+S9['= MSS9@>6Y_$_FM/OS(<%_\RGW.AEFDK;>: *2 809C+0!V0KG@PH.8J50H2 +I M%H_PY]OLQ;>3-T]O[8-56,)ID$_]Q1OY,WR8DKVRC4]SCU^\OVP8]V;Z:V#M MR6YK3[=9O 7D)8,2\Y+O ?22WC097Z^:#Y-[_X-?NZOYL!=CE:;)["9+^H/K MZVR2A22RK]GL/LM&\>NKX7CJ-SBY"]I/?$RTTX>W#'O36>+EJ$ 82;_W(UP;7GR1W-\,KF[B^\O]WO)@^H]-)U/=RR8E=2HT M!H%.<>OU21[":YP25DL@UX<)[J3L_?H^?::Z)R[99@_U"C.\?-$:H&U/G!>) M/V7C%I<54@NR\!L0:?]OW/+*P6#'_13^L MIV?![-_SP>R'7]AM:+A._'Q;RC]#>-A9SJOQN_9N_'L__) M/#^6J[J>:_]5O/=?'_WJO/W29)/\,K!ADX4 O"\+RA#;VO)D35-#JDIXG MAUSE37JYSAN@?##N!X["U!PE1+#"Q(K4U%(!%NF68>=AH+ MV"YW=#J;S&,UC ^>]29?;GJCC1E9C]D"'H^0W(ZR'K4?H(UMG%Z\3TEX\M23 MRS*H-@:AM D$S3^&R]\-/)Z/JYNP^_N:"I+-G 9^ MSX?SOF>W02X3Q9GDV)T$&/@>(+OWU3-G,LCEK\&MUT=FI5SUQ,P_3L;?)KU; MOYT?1HF:?YM[:0OAO$>O%[&"_#4?7=T$5O<26?9VYA69IQ^5_!P&4'SXI133 M,K]"@Z \9052%V=*5*@\W&3E4ZZ\,.YY9NF\*@3"XK#ZV97/*O@OOB0+3)F4 MY]ID<<;YWP:S&R]K/!0SO*#KS\:)7R[_V[Z/-E;AEI52":X%$@!!J@#GBGG< MXIH!"X%HOJ7(#N5U\U9QV-,%PD\@TY>;K-CO=4?=+AX,K+V*^,/8G_P#&(<1_[&L+;30.(/V")8%W+)YA<_ M1+^W80Z]9)A-I_ZYEG,Z__F]QZH>7/V2OQ0@]_MS>9OV!'_SP MA]?K_.B">A=>'_GEOYOE:BH""RB+*+"Z MM_OF?%Y%3U#HN+,00IPBH*"$(3Z,>B'7I9AJ1Y^K.^9M7+&?)0*-^?*RY0>R6QQBD=%S#6LZGTRRJ$BM<% @X_G$MI0Q(;00&$%J I2<]S8T64/ 5TC,1XN(YGZ?TY*TG7JP-/4&#J[$Y MSR<_>($ N8!RHW?[Y318H.,:J/HL#I8!C5QB-K4K93;:1)1/BU6(C[O[V$=/GW^^VNA"B47 MDFSL5-(DJ%PD6>_JYB*<+--Y;[10&6;!IE4>=5'VC^13V!Y@DINNDH7M*@EK ME(OOX'SVXF7K/(+5(MEQGK MNDI_T(]ZCE_F^7 6SOM>CJTG$.O]W7/6W,?=ZV;X?#+6C:5"_ MKGKS:197Z[HWF!3>NF(K:HL;_&2]N[O)^(_!;2YQ9/^>^S<4.[AZ[SHYIRZP M^./$BR;%[0MQ)0@WE_G>A EO\L3&KW//^\-=J^U)H)ILLLDIV\ >"?)@P/'? MFTGYD#M_@KS]ZN6TW]]&4>U=;WC?^S$-'OJ;R>IL-CO*A)4P@)R#VD#M17.- M 79(0 *,0E &U\ 33N"-M[,-:[:1$QI8U/'$:T,C3VK/H[&[X;RP8;Z$#P;3 MPA)1?1T/^_ZA7F"()X-' MU&)9\IGL"00AWZ-57B2UV13&Y7BVMAS1\T:,^0$8SR%_3LYNIDF@Z'XP_GFM MK?+7WF>+ VZ_TA*"E;0$"0O=)2EC1J8IM003+RT)(H"3%#U2NFPO3K+EQM9K M)6_XWQLE[QJAY-)>Y.O)^#;YKYX_.2<_DBKF8?PP @F!?"W\ M;4%*Z$4[^N/K?=.;Y2+D_6 X]$/T)![G'V86@R5BR,-X.LA]:[-K_^&ZQJ(1Q)?#:Q]7N:>3V;\^A9%$A@^??AN,!K?SVP?JU;; ,"JR!M<# MPUOT)#*L8L)/.X.")^8]$PJJ#,"82@P%58P+Q@UQ3$%2$(HB%NGC)I3>'VTA M%+3F^-B=5$IU;@'X.9P5\D3;-=^_1WT^59]UHCX;?\[<#:X27L:P>97T^V : M1?\U(%NA=ZG(UF+:PED3_+*>4J:#7(L(>G1TNOKO^A'%:W&&T2Y?O,9C^\,K MD^G->#[TIV+F7W)=.'8*EV--+*D,HQ^^&&,ZHVC,*AN3R:/9MV M$:HB8:V7)JE&:>@L1!VR3J;4(PJ7%G/H4..-&)<%R =FW?BC]T \(01I/O2GQB*(L[91D63B&:** M:*@O(:XHV$KTT./'FS66E]1 FE+H-*8&&T"M"'U$>$T^W?RWG4+.#1B7Y,:'6 MB_1>#K\>#X?C^^F[Y-%XOYWHH3#!U2D"K"6(S3:O9ZS(TCA7LD(>#J(^D5%8 MH>'R5(I,DL:2=QY,VF/VM\$H'UYO/AN77^29D?&;/)L' K_(11V(*[]=O;MI M]J[\8X7YJI2@18,E4:8"K^V5RWF>^S9 MJRV;WX*"T8868?OH#?N"]/4"Y:JYB94\G/7JST\_G3 M]$S;ASZ[9]RI$D0IO[XM!-CH-HI2;!+$V"3(L4D49*-D%ZBFV5)F7Z\S[2@B[3'P'.CB"AG,8@RJIC#/JL.2$(V8U)<9R![S&"E+E17DFU.&< M(0LEYM%&='QC,,HVKI#'2Q'\?]EDW.]-;P)M"0317_9:AZ @NE-I3;='+&T3 M>#131J45>]],C94'^W[L4(EJ3>V8L]!H B'1B'%LJ4H]5,+0KM-2NCY58;]0 M^5*+7U,H^E)S7X>D)]N/Y]/GOY<^E_-4VQJ?7UN@CU30YPA+<8H%I=8)0"WW MR!>@#T)CE "N52$SC3@T=JF2RS8F-1Q#2? S8-UGF^".F8UIE7F2&J_C66L$ MI+$W+U,P1+Y!JC1*"3F@LG=6CLMCX/:SL9H%>662#;- LIV5[)4T_+9@8ZV, M?RHE)TI2Z5+D"! 2 A-%G%1;;&5Z.&S,6YFT2\1Y%06NM:+/*5N[GN^6/$5 MD%4L%TBMPB0U4%OBG.!>8@JQ7)!9Y@S2Y+4 X8B$I?-"C5.T[/C=O,X&G6WG M4&[X0^'@SQN D* J7XH:K1SQ*J+@CBG%#! B "'RV$@8/&!1P;2DQG8)1P]U MPB9;HCZ7R"J&V87*FH*.(8#PU\3@ 2B0_ZCU M >U)!3+,/<\>D7S4&9..W)CT1 A6UT1ROXT CU_9)*PF8T%I#* 200H TJFU M7.1A6,Y2"5L5AK6Y)M!^Q2M*7[<%Y6OKF:T"U:-"D4:#M=H9C[4SD!X!;@I8 MQ60I+W-*"2PEB"OE]520QV1)@ S%+R\<_3HQ64U :LN$SR,$UG6=N!IH#;/Z MMC-HK>(OGV:+.FL'Z)1":O40G5-I2@@RCDN"4LP$#*9[@1V0TNNF;>F4L@.K M;]4K!9Y[KQ0BJS(Q6E$MM-9,8ZVT0ASAX/ 53%'$'#N@R+V77BDOI*TGNJ6@ M8^N6@M=G8;]PG/G'R 9=DH MJ/B1!TYTT!+-,%4"8,9#<)HDG#ILR0'#ZS?&F+*G6"U6MWU8B*%6%;GA\FR" M7 "ZA_)L@8KWO/FP*B?!TE0R I@PD'(-#=8B1"Y*ZBQCT!W0Q[2'S7]0(GD? M9"#X!4/[+=)78-UR@Y5 ):O7/%(=^^>\4')OJ6I'%!%_N0CWW.4= H8_+O+N M1VN+_RWJ_2V:7<:625=77I,(+PR] 7K3LF=?687H\=* A8@:BQ_52@,639/R M:GA5/4 _@4'V/5)8>%!9J+#^P"N_DJ%H<3+-9F5SQ@>R\NWM8#;+%KUS5KN^ M+.KW/;GX-[W^FF+V2QU$]RQT4UCE"%B-C4O]_ZN44"-3EX9N\R*D2B&M$6]? M[:.&87Q'!9Q?PN89.-;?JD3QC26#'RD/O*X*6:G;W62CAVSQ\-(%2WSU(PEU M8^XFXZ]!S?8RX)?'KETT/KK-9E6]LN*M9;'P,,PXQZIZ>#G7WNC'8EHKBNF: MB0Q&A::;=Y*+5=K9+I6CFI% ETLDQ+&5ZFHA6GXL6YJ$ O*M%JG?_+5JJ ?+ M)E0! 2-=Y@56BXKLW[-^U:;OJ0DG/[O/'S_^4M8E[8U&H8+[;99%\@VMO6K/ MODP^^&>&&_+.8M/D[Y>?+_.BLIXP/06-WL9OJHY\X:'1OKG4/>:ICCB+5]R$ M\O+;0_!T\,?6][Z-99?S259LO.CX%6K@%YP=QIZ-8@6^XHR['DP>MI<>!7Z( MU=V3W_QG#..2O?>[E+L\05B)<+I'U>XRJ7I!A7/HL/[MQG_W8S*. MI6?[\ZM96?5P?K?_:J 4U=JR" (9P,8JC(#$3AED8]UXKWP@EC87[UE4YEP8 MG>9?IQ[TXJ'RR2_+[GU]-O?>N!]_N1G/IWX3/WO8]F_+1DM/*#EL;:?>G6J! MKCGCFBH%.I@LGVF!1&\]M89C8<&XMZ$_WR':6U)'K$9 MB1Y^KKH35-4QEU4NGU&3];\<(^'>OZ@!R)"..CCRWI/7I9+.?G#*G&J M]IBOV3<_3?_2#UZA#3)"(>^5$LCT9CR9Q>DLWY?EW8W]C37I(K_U\N@ZY]"V M=1I:@US;\&3^[?Q=OCFKWE#BXUV@)J?-S;)6M32C54:9P6Z3G\I2NLN ML^%F+EV[-9S\M*:Z[L9*M]LL]+,HO8'].M6JO4S JH#35F5[(7[S>+!P_A(" M1#[=M55QZ1._R2=^X^B)'\E9O;"K)GPZ\ZL8"[Y"]=A'0[;V5BLV+>34__&: M6.*BBZ8>@=^V],R.VO=#[>=:*GG+!)-NZT]BZ[''3UKEU:CO8KA. M-EIP" #OTZ].O0KX9^K$(_I#BGA& #A%5& M$*FXS,4_XY27#!M#/]:A7[O0[]2J$;XTN^[LC&(G7'.,BPK1"&0X-5YSU8@* MZ3 DC$1$GT!84Z='L08)7I,;&=%A^P8/5[_BK@G7,>!K,*&4E M7D +4PV<0]ARFRI"6"Y>.&J0__-PRM6!F%%<2-YD><^.&3MFW(49!12U:IQ: M<26!29T_#)T5*=2YI4,AX]!* LO^9/T#,2/$%X**4^#&L_'@/3]U\>Q-.#LT M8MAA$=J":_7F-J<#>-9%736I*(T &5$-HEC MCU)$:\6-CI&?$;9RDHS.JA9,$(*4<$M$BGD*B7:$F%R X4K#U.Y+FS@DH\/- M55H:[ [0 4$'!,<"!*)6O]&?_^%_C5) (BM)WF[6.B@6"O MOHFCPX%3761_C;F)IZ+ >8%)-M4L>[C-QH@01$PN9.Z111I)JS&N<*71-2&[P "!^T.G8KG,0*LP<-+E]C3AI(9-J]%M].@=*68]JQ/)X7N3[&?&\9]>).2I@DY+ MIQE7W%%*F1#&2@$AI$P)8D(]E3_WGC/4.COOK101!)?)@X83C^H@RZSVZR@4 MPOW2^\,.IE?#\70^R4)I&>T9\/,#,E;@C#*)>("XJ)@C:5 F[=5 M@)Q#J7*ITH(B9[!43FN45WL3?FWQTR6$-KX'ODDRS\IW@1\F\RPT#0@S2?Q4 MLFGR:*>(9Q:P>L[K=QD]>O,TU>RCM\X+>6PO0]B*1C]?W63]^3#[<)WOL/4D&?LSBB!LC);06N[WA!6%,/T&$8I)C8Q3 MI#E"*"7,6$40P\3_;T[&+#7$/$D(&]^S0L:AG)WGPVGR-1D/8MD[=\T M'<3V-47QO5@+R\/+PVI83]/_QFU_)'W\^76MGC'OTRQ()>6E 'ZZ B'FUU/0 MG_9=G8J*G_[R9D4*R7^#V_VTY6TG\[*6^@2VJM[0U>>Y.Z-J5$=2A:JC\:X: M35>#JMOZ)K:^JT%UMEM_UC6H2K6WBVU[I8(#[70O[%!3X%">@Y\?=1U0RD'& M915R#QEQ"*8I@-8JGG(+4%KTPJ$:G..UB88HU530:$)Q]A8CV9&$&&X085_WOIOL&H MQHJP@H-HB"'R[*"IF<<#9AUSGP=S\XJYE38&I@ABA@3W0HH46A;,S31W*T76 M&F7NYA4J=B$AZ7B[X^VSY6U9\39UD "G' 780O\?35-=6$N$E.E*5'BCO-V\ M^@')A61-UD<\'>8^&Y_$;O+3@^A\#%Z0/>I\VQ!0^P^5#D!; : GF(%Y]'T9-D$OJ:!7*P09TQYY M.88*440-+:!7,:)DNZ!W#QHYON"RTUV6_#I<[7.YPN3%<9E5!>ZX= M9=:E$!K)#>" I"S'99XBAIIPSC:(R\U;4P2X@)QWN-RP$693*O]!DHIKSS3G/S@)'1=[XGI6%O%80](H+8Y^-4U"3OL33"9+K$*)#B)CE ;-^D9)]M\/9.0FWJ,=+Q M^WGS>RU=$T!(-)%&:":%32E+!2GYG0AE=N?W[3M\G"2_-VWJ:Z\6]'G6FV6= MLK]E1NDQ]NG=J(G46$<4.J"?@ M_35./N:*,AW7G@G7BHIK":964DDY189C)(6RI3/!,&[<[ES;F%I 0:-U:#NV M[=BV56R[@6O]:5JU3S6 00IEFC++0PU'K_ 77,MUJA]U"3R?:YM//D;BD'7< M3L9YT%KI_\MXUALF5SEEA>31Y.&U! M0,DTMAC0,L9)I.EC^/5(EO8^504N.B-&Q[^OR;_'4&0%$E(Q-U;82HT)E#3% MCDO%R][NQDH&5JI?O9BYF],H8'NYNWVU3CK6/TO6W\3YM?I*#AFGD=-.Z%1I M2B77N.!\J/5JW;L7<_X>M!+>J"VPG87#=M95CD0EL=EUYBFJOTWNXBF!U*8T MI1.8ZZG/K]O+TYG?V>QE%SC;R4&Y:RHLRH MA8CIE;C94FQ9"M4YA*UKG]'[K]<<8MLTGHXW3Y4W!5SPIN%&"BZUT$1Q(@P" MM+0\"X?U2E>,'7FSG9ET'6]VO-D2WF2@*I!+,40$:V>AT Q1R* H(UP5PGPE M@FQ'WFQGUEO[>+.+6ST9!:T+IWQZW8U/),B>LYH>@QB$G"J@#4VYHT;#11-C;EFZ MOHGQJ^DOX+#]AEL99]^A58=6YX16O%+M-'$X518ZS1!77$J!5='T& @1FAYO MBU;[4.D0:[1F68=6'5IU:-5VM)*UN@1.:&H%HRY5&$M%&9$%6@GLV$IKA=?4 MM<;WO=^3/VK M_GPS69W-@^E&SOWBI_4Y&V:1W-]2!XST_&H%891+Q#VK_O_LO7ESXT:6+_I5 M$'6GW[,C6.I_)!$"0 M@A:* E64A-MSRR*))9=S?F?)LUB&=5'(P$+Z2$I>A$):/E)#D=Z_'83.]+LD*GS_$B^9S @X;I)+5+>6[X MQ:Q%,,F&?WRX8V5]Y(>::NTRS"/!L!L*5B]-Z"/ZL;%( \&I,",+B$LX\W!$ MJZ GPBN_0>WX-'WX ]. L@X-R2=+Y,//VW.Q,G&&\XB)UXXBZL$5CQ>+!=9 M?N/D,'MGD=EO5RZF/)LZW\WS[$M:F(< SGZ_^9@6< #)J"^%#_4@%SMWA,PY$XZ>(3\MUB\C9=N:"X(R'6=?LWG M]5'-C.R9;(AYC$K-S<*M,TPFD^K7__Z /MC/,-MA_?D.HC]/I["V)\FU\SF; MQBT][SH=+:Y^\/TC@1CR!"$>+(U@?ZEESQ!6.9X7R0_U'S_>EC0?5G[1E0L? MHP_WNTW+-S+QEQ\_M.1D^1M^X">RVVT'^,0#]2COU-2YSS:V="\.*61M;^VZ M_Y7$N:-G!JG#9)A,+Y+@Y->A)_75&93]CI??:H%_W6O]>MY_W6O]>M MOVU?OZ]XW_CKRH #*V]<-CB\9>GU@4S?:.('XL[U&6_.E+' M1R\2V]2FX^?00%<04)+Z7[XUK?=,_HV9G).U-) ]#'"+)1>A'*!124E97EN6$4.&]#).W M#G%[)M\#DQ^HGV[GF=KR-+9!1M4?8^#,DH4Y1:HMF-TS%]\ZKKU>^"((-5D4 ME)D $N;Z@C$BP1J1U3D=E2K402MF=QOXNKOJ45+L9H'0K>V/(]HA:/5!;CUC M/9FQ2*/\*TDQ1UB['G*9"$GD>U73R8AX*-PW8VVA]6_-6.RHRTS?GK%ZQGHR M8ZUUF]8RP%I0@@*B?:*E=.L.39PA05O9\ATSUA::]A,D5I=ADH>?\_?:W?Q5 MK1BK,=?N_E5KN6]M&[\F*'J53H%'.DT1Q!J0XB@* RD"^)]0KD),N57M/AU% MVF^%:V\#4KIZZ.C3O/,#JX^0<^K;XE7'Q7) M@JVU@/-]4R5$,NYCSYER_$K$^V'[81R>BHTUSVUR^2WYJG7EW% ML\O$9'Q\B2=5TD5L\CKBV7"7P**WCF:O&;0P:NP(&888H$JR2(94!('KZY6& M0=EN[OF2EHYG=4$DN$@61;(H_EF3EJPIZ\5,"K]33\CKP:F>3P^73Q]C4](8 M A'!$291Z!KS@(58B:!R]FLM749>GDV[M EHM]QYL+I_SVP'+!1IH\D+'7$9 M:<*E$(@()A"KA"+GVA6MQAC[Y[:]*/44OU.A^'[.$ZHHFSPIDC@?7CGQ; 0D M\R699'.3T.T,@1+[NN%OWHWQ&/:M'RPH+U!*@:+!<.A2S7!05:WBE!&RT^DG M?*DLH16?*T)\N:.$OH9XSZ9OA4UY4W@D0$5 H_TD)0EU(O=#&NJK9'-"1JIPH@]4FEGL$;[$'E[M5][@\!^$^29Z.X MN#*;*P@F/[YIST+/H&^)01]5.;RUO@H*<^Y^2]S]&'.ON?=Y$&C7C5P1D8AB#O_4Q2TBS)FK]\K< MSTH4?E_B]ZTY]D_!',AM+9W>6?%MB[N_L&9!UUS]4LN(AY+ZBB'B1XR[]=EB MA#V.=XK4L80E1_]>%@O;\./E_/S[ZSYW/P6\?LVBY^57S,MKYP2!\@FG- Q< MYG.FM4NH5Y\3!+[>*0UG"U[>TR'!_OK>]KS<\_(!V@1T[8S!]4+/)Z$*"0M# M%Q'7#U%M\'/?;[5][8B5NRP;A+H-QWMDWP_?*GCMQP@K$K-!0'VK@.?0[UW= M0;M=(]@MPN1/(D!>;;-J3MJY3W(/)\$%D[)%$8 8AHR3VF>!0H+!6O0 1SS]U2 M9]H21+JM7-IIJ;(>1'H0Z4'D*2"R=AC#L @U]Z5/ QJX$?$DK6(M=2!5%'0* M(EV:6ZS3(.<>1!KC[J^V6_/J^U8/^2Y,R;4)ODR/]-FLT6>C99#N#!V+O(L'H%U;.I@F8@[8RHG MAFV=:1(7RSPIG,55O+ ^T'0,C#=;3&Z<85DXR\3GU3TMFF;JSB2^+HX<1RXV M.O3:D0R#F9W%4+ MS(DOXW16P-K!D'X].CM:3=O4%K"MX@$#RQH7=OBQK7(Q,&//$[LWL\QV 4FK MX,:9'8&YM&E*#U?%IFK!0)86B2P)H8Z,J#?16I6'XBA2.W\S5/@ M/_.L6'S$OO ,GMM2SM+PRMZ=]F MIX\ =C2!OYSOS)$_03^>R<#^A7_\WCG)CAR,A25*()(Y7%E19=P\ =8TME]G MZ]P!3[34#W."U_ZYC'.8KAF^,=@M5<"&K]8@;KR8]CFWZ'ZM5XREE3SY M)XM2HM=$5?%HR=C3&-@Y7A85-Z>S9LO&>3;=X#X8P'!98'B-_W(F2)KR/+,:"03>.987]@A-F7I*0CBS#Y:L^O4P N MPWVKJ^U&E-?;Q]1\M.+7;+DHTE&Y[;\"6<'K;,'^HI06P[BXJGD1?K(;7A@@ M!2):?UZQO(#'I'&> A(98KI( )#@CA%<7%A5#88"E#,&[':RE7IYY,C9S>JB MP>IYAHVOLLG(0II!TA7 EF"W(EIXSPBX8CF')1@O%X"1,.%YO,C+TP,SSM5< MT\(N3@F )2_#[6LR[0W0:M?J3JF;GRRG\/OP?J_DIGEQ-KQ*1LM)^+ "T9%KQIXVP8VH8%U@G2?%X?Y\S8A),-*PNC MT@-A#1=GF$PFU:___0%]L)]A_L/Z\QU4? Z*2^&<)-?.YPS@[_:DIW%^F<[* MX<7+159_4=I\]IOK=+2X@JMA#2OC#LS$23PODA_J/UJ<_V%UD+9J5>Y_N/^8 MK7P%)W_Y\4/+JJU>O]M/.]ZVSY=]T]C#0_)>O8'YK8B;?WAXKB\:Z]""-_'4 MJ9L;[*?K$I@N0.N )ZQK9(<65=M3]GXHFWX#RGY"2,3>:-WHMY^\Y M/"ALJ^D_],=R._+(&UZ$=SOQ?O=W5/7$P6+>B6E#/J^]ZY.L*)QAG.]_'_WK&1 X_KISY36'F@'B2!$QZ"!.-)4*AK-*]=,@0;262 MM[R.IS6Y_PS4KM:)_59\PW'ITUP+;E@6H_7(AH]-: -],++!%P.?H+ZU0\_\ M/?,_F?D]W-1Y"8346.F *:20J?E"4>76USSRE=LM\_-NF!\/..HR//+-)(H< MKEID*@KG7Y+RF"8>#O,E['EO#=QM#9"7M 8.!936VN2PD*@ :>+BD#,I"151 M5=I&*Q5YWJ.@!'_4W^DRYJ.F/SD;R8KZ]J:<\ 'V7J2KY<$J+3V7OE4N74O0 M(@)QGS"-.:)^B$2HW"JU7$O"T/ZXM!LM@H(%\;:Y],WY5L)DGL/V-6%X\32# M^?S'?O$^;:NMT>@U@PYO$KHT4U(IB0(24*D5TX&N$KIT1$.,-@KMMA!GG8 , MQJR1S]ZT 7= O+X)9<]-!\--OFC*S$6<$!PPK*GD0@:N3^K,)NY+KU-NZD9J MLP'S>]/_59G^)K*]; ?Y[).0WJYXHW8%)[01\:X;*( E+S(UJ[@?H54'.NG[ MLE6RZBZ[HNQC]3)G$=@;>+SO!MGSY5OD2Y03Q!!H4 AJ 54*;_JLJ.90I+MX'%4:T0&-DQ0]MDISJ[B/ D,&:Y? MH++B=@N>#M6(@?#?176\GG'?!^.*)L0H4A[#Q-.>5L*E$<6!']5>.ZW]K52' M/3!N5RX)WW_)(M.'KVV\]KCU\\SD_,,,BN*N5-/>0.H-I!KE!,9-L3E?X<@7 MA#+/]WW$/175CHM N;YZ%.7^9BAN?PH&,4&3;[O1=L^'[Y4/:5.J(&2@50@W M$,+#P#W2C?PZ, %4;/&XF7 ?'W;DER!D@%BGY1T/C@_?6E^<4&SV-]-\1:_TQ$ E>+(/*)&WH*!=SGJT,,%T>MHBXM#%I1G*P);H^* M@3? Z"5]#VWJ/82H_W?:6Z/G7<.[O.%=W^/<"P@--$&"NV MXMV.E GL#PCI])3CS?#N._-7W%D>JK1ST>-%X/*$+F> M(F$8J8A0J42@:B]&2,+'O1@GR?X.25<$$)D5$5E\E#5_)=>; ;E0-X\(U[$=^:]V*C#L]:C/[36QJ M1#CVN. DD$R@P,.,5$<^W->A( \H3&L%LS_EIG+3XN;3))XMY&RD_URF8!TIYD134U9[+5X5I?.2IA[++ M=^3HCARR8N#C3MMNO7Z.?FOVU!W^UC6KZITKXOM(G3V(CH&/HA=M$FM-4JV, M7((B5V'"&.*X3E-7S OO+:NUZABXAF&O1_G8"9&^;9^__LSWO7(K:[B5(M T M(A%JGX6*:"8(K]/@):/!O>[6+;GU0!6+-\*M[^:4UU06OE/GN.F-J%W#&^[H M8KL3XMVWFM^6778I8_K\+K^O7C*(IMR0E &+<*C<("":8D*UKJS04'J!B[:S M0O>GP=$![_8\_#WU>.Z=3SUN]KC9&6YBU. F%I$;">H!F&+JJ4!'JUH1(7'# MAVJXO(@N[0T Y7O<[%@+_ZMM+KGZ_E83S%?:H_7P6AK_ECA)&=!IFH #:5^4 M;;''0,99;KM?CY)%DD]A<%7+JD?.YV287<[2NKGO77U6T\*) MY_,\FYLFP(ES?97,ZA?4M\$[BV3M^FF6)V"M_)&8+L57,-M9MCAR3*12L=96 M_=88[WGW+=IKT9C]NMRSVYO5;OGUX>'-[&"OQ.T&8/;?J[Q^R#R^3#Y>P.3_ M^!B/84@_Q)/K^*: 5_WU*F_/YO&^LDPCY0N/A<+U&/<)!\RM^LJ&# 7*8.0# MG7H?O=U]9,WV@#>C9)Y8#BH;41<)8' \69%[.AM.E@8AG:NT@&]L6W;39'TV M-'WARZ[W5]!*>X=M46X PLT62\8M.-*.J-E;DC*C'=@!O>"N]/4S9#" MC9!R$?88%31 ODL0;$Q Z&"J-V:IX/=X4_:'=/>';Y[.%Z4'[637?>P3[R* M%GK!K7*;D%VA$68$^41X.'"%CC")S%9Y0H1^I/P];)77%2,1\C([Y T,&L^- MJ/D"ND")AD,[3=BW.W%QC0VM)A&G,X#FT3(Q6HZAOKI)/("Y[6Q>@:^M#CY; M48-YO(7[Q2)/+Y:+!.3!D][.VV]?;-P>)2,KE8I%O%B"%+IQC?-LZE#W M+^8&@O\RV) JZ^/?&"D\>7T^YCLSAJ/#TD,/4#6^1[P61J'<-QBP!@P\K;E6 MTG.U! U*JX!IP97V)0_ ),8M,-A']N^VS(^)MT_N-XRX]Y5WUVJP8(655L23 M$2)$NZ#- PKI(A&$7V\>&P'N9M;KSSVC]H'>MVMO*7Z]5;K)8R:'3%SV 3C M@0,&W33.X9GP_<1@E\&X9#K/\AC0S*#G*!W#:B6&H:K,PHU&EQ7LPE.3.!]> MV0\C4-8GF0VYJHI %\YE,C.W):,:ZZS>/"NC?6$46>[3N]&J,4? U(;Y@RR[!-E3+.QR/3:+?X/4*D:I M):>BLL=72V/7R0S7?'G'&O4RYM$AE0Q[LIS"[\/[[9M-H#E;3H&[;D[';8 Q M%G@PR89_?+C#GI=,"2T5]Z@O?.ZZOF)199 K'KCJ8R-U&%%88Q(JR9' 4LI M5K:<3T+&V(.&_Z/OP1^E'Z']SY+GAL;8'>!9CR/!=")(9G"^3D'8G"37SN=L&K?.%P&O@)/+X<5@T]1?E$<5 M]IOK=+2X@JMA#:LSB2%L3SPODA_J/UJ8_&$5KK.*0C-.Q?N">W=+;_VH_N'S&@"6E.[L.(43]@)$!4!=QS58"J\A\2;.B@%?'4 M5F=-]\:ZD6,03^XQH=D_W-^K9_S^\#/.;^:)_)H6#UQ^.F[9\;]8HN^D.IH[ MP/1%.D5^6\YX-TTFU!7H,8D])P=;PU@JK6/E]],/CA*W\9YI%' W\G4(*JOP M".>ZKM,NB2(\>!KSE^L\.L],^763?%=6;K_W).- \> _29Z-XN+*J%6"8/)C MWW[N-9436./V; '7F.[SQA=Q3YY>9]407V6&[F-8X358$?C:XV[(9*")C@(5 M>N(*25XK8E5IR:/9+5%KTVJ&B=JPZP^Y*U&?M22B]M37GO6'$0#1A@ M!IJ#0C((<* \3%WMNY7B0(5@6P2J;&*_&:G"] 1%==H4\?!9^2ZI"5X;! M6]0"*&H8WX]P$/"(HPCL9(VUQDC4\8,A(,2^+ ;^BM0 05%?+O&5.@A>U&0X M9$QX+/N'$GV,W][#7\'011Y/HZ0'VDMM!\25C5@\2-7^UOD4NQF5(A#4R#Z M8XBWZ%OHCR&>BQ5BK=%:(*B,D/ 1E]@8&]C7@KC"C;0;!N&N6/&8K7'04'$[ M3Q(LC$X]$/TIQ($9#.+9N]A509?7%]NU[3*\\A@O%Z_EJLH0^2X7KD>(4O"W M9J+VSX1,\Z[L)_%J["?; 7-_)[5W%80YW%BOOHS+YA"\;H8@[\['&Y0%)$9W M9)DYPSC/;X!NK^-\5-@,F8TTM]36'[5I8/-E/L^*%TET=4FC??' PPAL-/B1 M1]Q'+B6A2;<,D7 #/VQE09W6\_L9IJ?69_<(?*Q*K^GR8*Q-3OQ&^4=JDDS,I_5!'2#*-0^DIY0&^ M,>PQCW(AV$O1ZIE9#]"7?LZ &OYG+;_WB<0G]D%\F*.C=D/ %P(]L4%^)0*N M97P?"OY1OJ(I5WH\)*%V*<,24) 2QBN:XDCJ5LC$DVFJR!_Z[D'BCO27C92?V$H[9;HVNR&V4V@;^DOL?1#88+:N3L<91[ M 9ISFZ:^@0(E37C<"P#&"%.A#$5%7-SG@ RDCH;PZR*]547R<38RL%[#^#2^ ?'@%,N+?R?#A?&T MQ^8#Z!(S4](/K@43=N),TFFZ*-^R5LDINYXE>7&5SNN:3LUEA3//LR_IJ*PI M=E9F>YJC')IUU!L__#%)F!@]6V51;':0S63*TL9UG1DJ6JU6O?6**E7YR(QV.0LFT4^@C';C%"+ M7L"W\TEBJK+$[3G&,+&;(BU651KFEE'+\E8;)0[-Z'Z!L6+?;^B[E8/:<(:I MW9B,MMML\_+PGV=5C9AJX^+AGTM8NK*:A!7R5>G345D8!HBPM;>P&:-D;*]9 MPI;D]80=NY_#JHXCS.0D^U(.G""$ZT&7VU!>8#2,T;*\V1SM+&^9Z'=NR_XK MT[EKQ:@(,^X^H0EWN0P4DJ&LO'TB0F!^U=AO /$)L3;VC=&1U$DNH=8VZABD! M0EY;D=S;YQ??O$BN^[PBN>R1-=NHXM&)]+0?-^L@_ J0G"]B "G@/^=35F+D M[1B3=ZAG/+. TPK3E*60RV0V3)/BP2).;FBRY"1WM:G+Q&B$N*X)QF<*KQ5Q MTA$HABQ"?D@]S151GJYB7W@8DN!APGST/:TB3E;9N+S,DTNCAI0 4]0:QD5Y MLE-7#+_,C4A>SO*R2/A_J@ID%\D,9"EH&!42[5ZG:9OA/V?V?9VF%ZG3=)WD MR6%7:MJ*4OI*3:^Y4M-;BPG_YF5[#C-ZXQF5>0XD,(.AIA&E1"[&$4A\Y!-3 M^YW[V!R-,:8UY: 2W-9)?EV3Q:"0!)4DOKO<3A>9; //>Y'>UJ\M4NQPXTZ/ MJ[KB5JFK%+JJ7*S1W[+R=&UE'"SB/Y)9KF,T+7"W@%Q?<]% MKL"8E0RJ(J8+UKEI>]AT-6F?+:N))AWE&?33V:Y2P^X<877>[)+Y?]M M&=KU^BCR5Z04E [9;?Y]#MO7Y;@[8?RW&'_.W 817$4Q)UR2D(:!AR.%7;H2 MV5IYST($5>[$RV("'GB\?9S?"_FW MA PXD4+X../,Y1A'F MD1\A1B53+G6Q A5_2W!8[=JW5A?P +UH/:L^5_W@L*;K EAO4C]8JXR%<,1U M2"F-F(G] 8RME_;OQ:3O5+=_Q2SJK=6PDAK! MYXBZTF#5OI4'M3X1_MO;AUQF>[H5=OUA\P1[\2M?Q5RNK' M]'5OK7!5@"+&,:&2:^ICX5$6A+5[3Z!VO]4]Z>N=X0 9(/Z2M:6Z[7)_V(K\ M*]77GUM;ZN6RPE]8(5BK+T680L9$=S4*E<3:9[CV\C,O:K?OW%YG?[AQY+9L MS0<4[X&M#S$7^5V(_X-1Z%^E@'^,L=<*2U'N>8I31< 8IY1I#<*_EN\N8B_G MK!>=27C698WIWGA_+ZK^(3/THQK[6ODG@CQ@8LX$9J$D6.@@X+6H]B-$7DAC M[XZ?.ZWB^ ;5[K?F/S^UR L])VM@]4>79 M^2*[YZKTB>^;126JK.MO1@H#0\$F@P?^_Y[3E+G;E$5!FE))B,NX"H(PQ)@Q M224#"QT'RB5Z2SEU?A4O?LN6D]'Q= Z/U>.QR?GY8O+U/@/7/5F,;9MRC([: M0JRKE.,'T,$-0??:_6&"EM\)ZZ+8-Q9\F*S7@0\ M$RBT2EXU RHKKQA<@]MLO8:Z3(.MR&$K<21?8;UF<5W*HC7P(YM-73[)5K\ M!*$;S[SUA'J>]9QL2>DCJ?9#=) M4DF73Y-X]G"F-U,":?B5)-Q[&SNR];>NI3"%@-YSCQN9>+NH_S$2\!R M!POY3(*@NRP-H'HQ-Q5?%^'O_OC>*>(OJ>E5,@?RL25YK+Y0$=?=:%_J M%:!0S)>3YG,"]G-J+//F9E/ER$[) *F9;9Y>+!>K(DWFE8/U D^UP%@KUC1P MEO/Z^DE2%&!6/;_6VKUZK(^Q2#R\UD)=, UPR(FK7!E([/$(55SMZC#B&]5V MPK((D:HG"H\V3*FKA5D'H]4UR2BXJ5GY4Y*;+/CX\H%N)J8:X&=3UJ&L_@>? M?HF_IM/EM%5M!S1:^T6C_1Z?1"OUU]#?0W&D[5)\?WFVW@L;MR*2X=IB.%45 MJFDY$R>VM8B,N,^NRRI=E@1-(:966:ZS)/^2#I/-XE>IJ7UERB7:\E1\!E?21_V(F LRZ\7M) M,Z=C^^,VT4?/H@N,]D$8)8OOS3HM]X60IK\Q#76$&7*%!@58@]KCUEQ-@DB* MK;CZ@4VI6%+:LF_V MBFFLOOK+2U39S8^C:AQP+%[MBG9V]36<9N[VIGE-FP/B>DH2CCCQJ0@]3.HVE,!,7&T'Q=6F%7?MVC\3:R.7 M)X0/[,_:PG\LDN$/HV5N#(@//[GW:E\[KM!'\USG2SDNV/JK9+2< -;5TRBA MS<:-K,VCJ.5E)>%7DKTI5VDK%QZ"H_+]5M39,]JMY;3Z\)4,>>1KK-T0!2Y7 MF$JX0F/*9+"M%#+]UCZOG$>[G)H?@O/M&02WY<(W/E#?D\A3G(6^ .F/F/0P M+1<>] W:I7IW77A'PTPWG[A]UEW_ED>[XS A*5F5_.DF)?>Z,G-OGQ@'9\& MK;Q@(C(I_DQPREWFXLA7R/.4JQFAU/1".3 O&#ER=BQVF%P::^AS,L]RHTJ$ M:3&<9,4R3Q[T?FG.?4^C0 <2K.!0$C_T:@*( I PC?)(BY,F02 M!Y5RY@6AT \Z.QY]3\O[=3PK&LZ4OHTC M[*7Y[[>D[V+I.*@YT0,NY)A%2C?KVHD!Z#[1*V.TB?6 M)#X=EPQB8C,JCMDJ.+ HK]W.5+,6 R#_=9:/BF3VX:=LEG1OJ>4UISO5X$H7 M7=4QHQB X3!;CN%M %Y55@\FP*G#--X @\R)D0V*4MT3])Q G-)DRJTM6S[ M<.2<+G,'C(]D["1?D^'2GD=FXW$ZM';)+#:51XTOL3K3,7:)>4_RQ?:"JWX$ MF1O/S$M-'*Q=)ENAU%3B'AI'Y20=V9B-B[A(BR,G,@&S:[UCC(MH6!X8P<#@ M@<-DXRWE#Y?P\:V&'<-X\\^9(FUP6LXCRV5%S EAJG: ,_M6$U2L?C MQ,;NER\LZDKRL-.34;E& MSNX\@3M$#6&[(:".XD6LCSFQA.WZ5?LZ+&Z">E8B+C8BK+QPN MBT4VK?D8+ISGF2EB7QZ#EO[1XG$'0%GU?+T(NN>DQ48LU$D&.TIK]X):9]!H MQ5RK7C45!\ S@&VG#D;_>^3L6JZZHZ4^@-T^LPAB#CM6VW;G&0M N($ Z\/^ MK_U*3M9T6$V"$Z:TZ[4Z9%5N>)LP8RPG>,9OZ>)* M57/3MB$$P(7I\ G_9T)['C[;N+_347G2?O/[KV>KA@/P2N/\+E'LB;CM@BO//A(96.QOT'[PA1\:M>V,+^RHG5#T M>O"%-^XYX4N!)!&P/8AQ M#C,4,(0>03Q4C+*?U$?#FX'7\.OK2=LIVX*4(QL M[\4^0(!:J_2FF:8D"+7T)%>8T*W#FR<"U,'M^#, BNTC)F0+ M;P/VOR\)MS^;<&/-ISTV_W&7!,2 M>S[&8<0]D&;4%]@SIYV^5@!91+?,M6]@MZN3PQ5;V-UC[^']BRU_+>: ,)_A M,& 2@_$N7"4B'PA!(B[!#O-:^LL^[?:7V/%GB"W<[GUR<'9[&U/V2DD<-1:: MBA@#8TR:VCI*A6X4^%YUB"9]I5JU./9IH1TZ);6=?AU8:,]&C4?,'HZ:$U/M M85>XFDE BS"D&/;>K39;>!%OI6M^ [_,0_[WV8DL3#J_J0<2]AG<^U MVNT1TD9\T.$=_SPC->CN076@$>^4V[-C9% 54WPZUC#FQ-)5"9$JCH?,KBIVD _&&*D/((#Q4(N M/"'],!2!-O5:78'<@( "LQ9BY(,($@'U%2:P4I(*;$JOPZ5^%#**Z(-FQ*/O M:848_98X5_'(F62F\(Z9LA/;.=NXA"J;&IAOGIMC],7-P(99EV>NR9_+U)[5 M#\JDUK$3#X?+Z;(L/S$RPGR86NH8U+[Y)J"^=\6 6J2>S5T)F=U7%?VN= #:B>=ZG3M+Y_%Y? M;=177^'4>B*%VZ1Y1X&D*E*NPEX8^,H/ NE2Z;' I9QJTBR>]-A%C7ML:;'FE>#->L-),)(>AX)":9( MZ\BEBH8P3>\]+, 9O"^>9WER>#;3 M89A%[ZO]30E>:[TR7"THEBQ (B*>]D7H^LB"%Z4J('XK@GIOBM+9WSH!+]YM M+^J#ZWW3\^S[Y%E_K3)3KPO*"5F+XWA:,3GF4# M['7:N.[@>/:M.8U4/(M'\?NTX-Y$,ZU'H(8TF;P"469J.A/*(E^9 -"H@AK% M<<#4BZD'2G:B'F#495N9@]4">D9[%8SF-D5>A0A"RH-(25>'W/4\GT2E$X%% M$0U;H9-[D^D=,9K;J#K7*?;"N)CTW:U?D[= %FG\\5-L:\GUILSA M1+V^*"QA@(O&?QDRC0(>$DF4( IA'Y'2J1#XBK#GXM+C"H7YU9!E196=01/I M5*=XA!@.5K7H.?9M<"QMPJDTD1P31$WI_XBXU'.C*L3!QYZ/G^L&?%R3V!O' M=GI:>*@<^VZ\&.SIM\L&I6CUD]9KUIS%J+ M4J-<#:@%$ M=VT!I++I-%W8LOS 5AJ].R%V@A=Q:9)BDD9M:TH%IGS)<[3;%F4 M%5K@^ZD#N_QQ:)JZ3,H^&JM)3.&:PU:W_"Y>.LNF1HZJ^ MV=4D;NHW@10L^VZ;'VUO&L,XDY+4AY-X"1>5G6G**E=5;>>\^[G-#6-B[W5JV.(N2CQ M2',0P9"46D:N'Q 4<"8(T:88E,3FA340?"55ZI(H]]G#E.VQH.C^ M>IA6"TW7ZO133*3&(37M$;7TB'1Y)I>]0.07\=/4OKQ6X< M/*&+,,:(8(DX++%PD:[U)I\%OMAUL3OK4>H=M7N==+?8NY8*?!$=Y+GU]:*E M:;;W2SHSG>'+#?M4B=LHRU<*6*E_G1M]X4%M7"")E8A"X4:,"$]KJ5"M5RJN M-WIS$NQK7U/EN5C 2#5W_8JJ;,K8@_KKH^]I:>/E1)UI.=.69@$,5?]T2Y[? MK33=5AF94+L?5W/%BZD(GW4+KP,.LD[B-F8?>SWJX*-D6I MT3VJ)X5T3PUFM'1Y;[;"GAG=) M#2?)PGG8.WU0<5+?MF8.V RWVSOU\0@= \2]B_7Z"GH])]3@H"M]E9XU[C5N M3"8YCX0/YJ7P/>'Y/J&R\H%$@?):H5.W_#$;SIM:/PF7B5KFYEAE;\%4[@"+ M+M/>#Y1X^T"J'KC>%7!]]PARK36D#2/DL0@A%PM!N E)B6B)7)'+=+ J\S6> MC*8_U#ISJ3+?B5J?DV&2?C%^JQ.8WOEU,OF2_ *CO"KVAF*,=%J6\+'-;QAX M;^30%?%_WX->#WKO!?0>QCRQUGH0:\8\[7DZ1![Q?$0]%U681X7KB0W,VU)5 M T,R&V_BXXL!(!UXWCM6X]Y:7C1!1J"]:W?46RSM5.$06;,:L8IX1#V-M"^Q M5(0&N+(:M:*8[V@U'L_.KS-SW+$_Q"$#@MNA&J^PC%//5*^#J1ZQ:(3;6#0\ M=*E 2&E.?,$DC;BN0\HT,)B_NT7S HR%.Q7D.YDL!VF5]'QX&'SX"!MZ#1M2 MD^GB0=5BB@F$7.92R6)?![4*CQS(_(L%7X/3/J?),]&<7%E=A<,?/)C MSZ$]A[X]#B5-IQ&L7$%)@#F23/N^B( O*QDJE*_"3K7[7JSV3O([]'O2^Q'> MJ!_!9XT?P=,4"Q1%$6?"#3VE652Y\R+$.6_U--I:6X^R9;Y?5!&DR_9%!ROO M>YYZ%3SE-$2B2)&5I**TJ[ 2JQ/WPJMW>+<48MH;Z[VQ7@$31KBQ MUCV0]X&6-$1ATZ_[-DR9XR\:;N\Y\_WRI]TK9$6 MIMS'KM92NSKPI2(KS<$UK7N?I8]WSZ*]N[OGT/? H:SIF!7Y;L I"H$_:4#= M@'EDY84B2GF=ZO:]4.V=W7>PZ/J_YW!E$H\7R7NO:?(>^_#4^,0;WX/B!#'N M1:Z'_$"(*$*LCFGQ6."UZJ!O"5$-F>WUZ&U_M=$/*$VEY\KWP95^4T864\& M&87K,L4"L,&%9K76(#EGN^OU^V#,O:KU/5?V7/D-N1+C)OY3AA[%("@IXX1K M'_E:U;H\QDSS[G3Y7GSVCOPG+T#?JNY9)+OOMD^O,+-_GSVA7D'J/\9NHY)) M[(;2#P.F?1)2+T"KAE&1%W&QJZ&T/WQ' ^)UZJW9F1H.,_N_A\4>%GM8O!,6 M'TF:!IVX48H]$D:2NH)(AAFERJ5(U[C(7?*,E(N]0:/7;>VZ9Y-#7QBJ!](> M2-\BD#Z&HZ+1+RE3PA>AB+ *$=&A&]&Z&TI(N(>Z/B()#U,#7. MNUJ9CNYN:+HVP&_3>;&+7BNV:3&N8#QP:"=^3(?7IFR M\<-FZD>.K)H&E4OPY,%VW)YG8*:^.428K6G9,Y_GV5?@\D4"4]IOXS%,\%I- M'A_A@$6:2Q7)T/<"S9CII^=CW_?@BU:;YFJ53R^ HRW!V7##9U?4V[81&3[R M]M:([.@9G+(/B#@&QIO.TC$ MYEG9XQ\=Y>D)R]7E&=3VQ_5 2XU_[6HN5C&LX6=@>7,YN5V-M/X M9C7^FX%S!1L#,\RG$_MJ\S1[@[D_3]+IA1V>&?)JTK *9B2FOZSMISH$YOEX M+9 M#?R\,$U?X2&9E0:P#\G$B!4#GO.JTSI\.S;M;NUT35?8=&I>9>Y?7*5Y^9)J M5:L.?6:>9HO@$:/ET.#K.0S,]N MN\ 6R4/;#7.]3&!/[&[!&.:)'=#8$I)Y MD"&FJIUL\C49+NNNL.:+UA6O>>N M#>(N8>LN$IC)G\O4K"I,91K_43>?VV;L#:7-LH4S2:>V&2\\)W;,ZIC;JD$< M.2#E# ^:IVS)%FMD;Y?',:,#1/!O5\>T_U[E M]4/F\270?I[$?WRT9V\_Q)/K^*8P6LQ5WIY-!SVZ'^Y&]^CMCW6CZUX,?/BI M;"=MP&H$=#I<9#5NK6#2LG0RG4^RF\1T7/[-D$O]:_)UF,RMN!BT(*VDYU%B M$>BRPLVQ > 2:I/%8E+B2\D8Q0:J&:A9QXT4!@> 8&'-_%:I+YD%'# \S$"Z MZP_:D1C\+6GF9'729O4NDL5UDLR<4]A%TYD:M"!FU\6"G<78/Y< LJ9!]MC\ MR@V:C))Q8K;; ')AELD<5D\S)TH+L_%GP]0 'NS;P'1(.AHXWY47? \[#110 M 3.DEJ8KI&)P:15DVPSE,'V3QZG$YA>;!37.8P+]K,2S2K-A\MT ?;&,E^L M^G(KL]=V;_\WGL33^#]9-G!^28=7H#/.;@\S+?NR3]>)VKF^R@ S1T"1!KV, MFF\6\BJM*&=I>IS#:M^FS&K5!J 2%E:GGN?IJK=X^3%9&$T"9)]5,BWRPFH; M5!I>F:MNVQECH,EA:N[)5CIO8?:I6KSK*U@;$-QP=T/"MBMVL0"]%)ZQFI9Y M?'F7%1 GV9?59GBKS0!UV_8S-\O2++>1,J.1G3?\7R6:2ZW%,>WKRW$-C$@S MQE!C-$UA78=I-9=R((8?/]:L7I%9R:V)O7D$.W99<7 Z^_=R9EOS&G!(D[$= M^?\L84<,O3;&6BW6X@VFKZ&G%&GUW&^I75:!*&HY?]?M]C7VDY6W(-A7JV6H MZ*-5'"IQ_RQ[;TL#BJRU;A8,81IR^$\8:L]S11U_KEWJNNT^V:O-.EM-5%IL ME-=Q#AM_GED+_I/9X4TSRG0;IO^@9O%_+_+%[\VCE&D'_34M?C?.J]_+I?G% MTE8')A?=8T=SIY185S&HH18]8D-FMON;H;Y16@ C%T"]L*G \#6U6FJ:YPD( M'9"5SG)N=+5F^S?)R%*L7%Z"%=#0[#Q.1[?)[04(AZ[U]_ D5RZ5+F94A#+@ M$:3VW,I((5C66;',3:MH M\ZTYD;AY2>ZG:]66"/"[QS%CQ#A0X$^?U9O(?+?5N/VX'OCGMP]OB[)V MBGH 4=FJL% "R)4'3!!H">C+*&1!6D4VO;0OPQ2(>_@'K'1M-#;0W4&D6EG= "9@-\YNYE?V; MCI=UG6B1#*]FV22[O'&*FV*1&)UJ90S47UG*A0>8KX8P<&,=-PZ84;R( 7M! M 1FEI5^S[$INKK8&O1WCH-+R*T?H DSR6>E.L0QBKS1J4)Z!)( QUZ\V,X$5 MN#!*"2@GUTGE2#7'%_;V @P4ZXM)\[J7?.4BR98+IP##V-H^ !G&][+N4ZI& M'L3F?5GEKHZM2Z'V193+:Q4D8]-,YS );WTU(.V&\'K!2T61I,LLF%JZ<(*U-+)M,B7A:6 S+A+7M8Q M[3:5)C6BH0YD2'R$$*&*>B0"J*5*@\#4;BL<[&?8Q(:%;W0UW=/Q)_@A!:HP M%VQBK?%*^__ TSC'Y/?J.;]O/@>@(+@YL7M_.EY[?(/$GU=,)RU1E)B\>MS9 M\J)(_ES"ENLO\,_YS;Q$\7M^[Q#1VU7S.A7'AC1K@V&378N:ODK/FC'XC,-U M:%FSD=SS#+Z[N2T&GGE2MP_P[<(/1>]SEQL'\X4Q'R_^7?E7:].M]"4TCH\2 M\FIS+4\+L_*/.\BMM]2Z5PQX)P9DYLM%9=U-XNMB:1!L34;?Z2L&PS+)+Y.\ MO"T>_KF$]U=>)MC&9%98G*EM9_/@ 6#YUP$\^7()S\[R&^/0*A9Y>E&Z=>,\ MCROG,SQD92+;D5AY8-Y4&O6EQF#\];!#V:ATPMKERY,O:7)=HN$"V-3"H+7D MRWO*X1K7>F&1NO$6CV'!9M8P!B&: 5$F(*M*"&TNLI+!NJ>-.ZITD1MG_:VM M,?DH-?[&Y<3> M "85K"Y83$$RC)3P7+(0QI\;*QQ5P6!"J7O,2%Y"$!. M[^\--J3L[GI #FL[AU6FNIA?/=K[,8 M5&V@W^\=IQ;DU;K=(HG'I=,VPWO.[,C^3Y;N9H5[W[B/N)7=B/=L>)6,EA/0 M'A\F8YLZ^B M>X$@)-(H0&$D?[H+'F=(V6@TBX.F ,">5%@>L1<[6E MY5 B$D0/[_9C[VG1A\ MBZ$_9^9DM^IOSX@7LK)IY[N-*^D9KS;6=%'9[(!(5M4$Q12&9/0U>\QHMQ0V MV"FN[.7E&=_W/ZPXM:7-[Z+E[Z*1;[69'4#G+>S;"#A&MPP2\WE]__O<'],%^AH4=UI_OV,_SU*A-)Z 3?\ZF<2L\^SH=+:[@ M3UC5*H1S"/L;SXODA_J/'V\';'Y897>N\I4Q_W!_\F?Y#M?]RX_U1;=_P[O] MM.-M_=GV6;U[R$W?/;E7/%6ZB[O5U778?J=%">@W*$KPA(VOHIJZW_HH MS8O%O;KF2XR@4A5[^GN7]'>6@%(RZ@FP)\!O1(#G)C*MI[^>_KZ5 #:QA%<' M2H#OJ]J-<8HGLV729R7O%X*^7:76G?**GY$V_,TS@S'S1<)Y4T&82.2& >4D M4%@PJH)0585G./="THK@_%RRA#G/5=5YIXG 5U66D?Y:1SZ5C,[CKQ_N M3K26@'$^*Y7 MA8L*5[A\7U!#.H(:;^"2'FIZJ.FAYB"A1N &:GP)JDQH6@M1CKGG*\GJSB4X M8KK5G;,KJ*$=08T8^![MH::'FAYJ#A)JUC*9L/(CR2(=,!E$C" $.% W,0MQ MNW)G5U#C=@,UE PHZ7N,OZ:V*R=)F;7Q/AW$G<_O(#'R@*#P_G*=)1:R)FV% M*D_KP ]Q$"BYK!MG\DYD'>U\GIGZ7=GL;)$-_S!% M9Y*\"-/)_Z/&CQX\>/^[##[\I M1T(I(<+#4BBE?/'C]Z_.@< M/_RU%EP,OO0H=_U :.P1BA"O?#E<(,F\_>#'4SPYV^('[]*E\WKPX]W$)]4^ MH";_:&#KJ0ZKRE&6VGJW>^]V?UUN]\>PVET+7-*@YFD,_\_5S'.)E*HZXM-: M1%3=QFH=YZ943_$IR<\,OP2&6^1L]#3/4GWW.D*3%4"C[0 :'=%.6\1TV@'F M(/6^'I9Z6#I@6/+68,E3 :,*<1_3(')=C#BI75C4UVX7L-1V6'4$2VZG'?UZ M6.IAJ8>E;PA+@C857J0?:"D]2=T@P'Z$!.!3;=DBKU6Y8Q=8:OO!NM*67B3J MLH>E'I9Z6-H_+&&$&EPBU%AP@KHR%*Z"_W'BU>J2"'7+X[8++K7]:UWA4KL; MT[O&I6\::'4;AZHR,Z2C.I@OBDD'/->M\W/?V+S?TUS[/7[[<^WW^.W/]5WN M<6>ENP[DB+##FEZ\MR7W4VOD6Y%*7P6LI]B>8E]_W;">9-\CR;[F2F,]Q;Y' MBGT;M28C?X\#/0Z\- ZL-8'U.2928A)IKGQ?>UJC.N"-<.RU MXG"[PH&NJGK1@8^[#'OK<:#'@7># ZS! <00]HF(E!<&6$H:!:RJ_: C#OK! MOG"@JY);[H!W6O2AQX$>!]X-#O FH@M[FB#MJ3#P"<%(^]2K:S@(%JA64_BN M<*"C>EB$ PYTF3SYS7#@W>5"]F[,/E+V;47*$E^L<-7#+D,BH-J5%-& $NE7 M_A8=4D^UZ@QVD9O^-&_+5KGI?$!0GV74@U0/4F\%I"@6:P6\ DR%5E[D8E^Y MU-=U4C8/M'9;1F W(+6' EY^I[[A'J1ZD.I!ZIN"%/57(*5#Q#C@$E=,"N13 M#89J?7*EI!?L!Z0ZKQ+&!K[;EY'H0:H'J3<#4JP!*3?";BBQ'RJA(^** ':^ M BD/,]8Z7N\&I#HO188&+NNS)-]TG-*^2I'UF-R?4W2.L*()8/(8I6$4X"!D M/)0*,%;PVE8-M>P@]?PN]UE'J>?,?Y?U'7O,Z#'CI3'#10UF^)2YVB-":T]3 M&I%($UWW%:,JTEU@QMZJ>[$NR^CTF-%C1H\9]V(&:8I*"U\PK9CQ.BD<*<]3 MN+;D0C= +4MN%\S86^DMMTOCK<>,'C-ZS+@7,]P&,WR"L8Y1&D>4O%VD=(?*QZ>_)*<>4,A7Y MH8(EI%R$=4\[)1".2MZ"_4Q&=_8EB%_,;Q!PX0B>\LKO)L M>7GE1,E%;G\@O/QEX%PG3IX,D_1+,G)F&:!.4CAC\XS*1>YD8[@],5<+YR1; MP,_EBLPNG47F?,DFR]DBSF%,9NT,<#GQ?)YG7P$"%PE\6^_2CJ+BO^X7%1YW M$P_Q1E*$C/LJ"I%4H&>J "%*J128*:1"%+78)$PN%LJ.N8 'GP*LIK-X8KZ5 MTPQFA3=EA>$W_Q\8UA;YO\-*$OY[]:3?S3W'LP+(=@I[*;^FQ>_CR6CZ^_EU M=GZ5+8MX-@()I TI),FL?.U>\WOMVZ]Q?BMNV_]7M[]P"$'6TD\[Y$VD>*HW>7-@?V=P!^W)-Z3"<%) M9TY\>9DGET!1SCQ/9\-T'D^3 MQ&P.W'=L.6Z9)\X('CAR?HGSX97C68X0 ^/:' M>+PO8U>_KU]]^^BWQV!)Z]NM2CCV>1/X(PG2 'SZ^ M-6#[[U5>/V0>7R8?+_(D_N-C/(8A_1!/KN.;PHC2J_S!V3R.A^WA=P#JY'F@ M3G=9Q-C2WPIML6MIRVW1EJ&7BGZ.@*J<&+"X6$X6YNYB"419PVL-K@:H"@O: M5_&7I$1BH#$@O?%R F!;P#(5XQLG6^9K=SC9!1"17<'"N;@!#I\ WN<&PCO% MZD>@&C<94@ 8OL\\I4,2:%=K))$+4.UR&0@N@E9FQ"945R"8C!K,M8 'IX JJBA64OBM9YA^,$2=9XL MTAR(^D75B+7 38DY#@,*>H3PM4O\T.<2:),% 0D%:F?SZZ]&&5JFQ94AHM-Q MHT"\.SH\4/VAI<(>.<[I;%,;!D@UZN\X339@N2;=%/9Q9@D'Z#;YFN3#M$CL M+Q9S\O_G_PB"^8^%TZ"4QR5[O O&.#Z)MN4, MO$]X?EBQ!A+=8)GSJP1H_@+HM0!V ?(Q@)4%C>, H8#5\)_A>?9B3G9_V ,05M_Q6'^TW^_!_'I_K7\I3&__(47^7)W_39\[QB2-/0B<\/I-_ M^ZSU+_KD_,SY[?C\[XY4ZO37DW-IOC@]J3\>G_S-WA =G\@3=2Q_-K>JGT_/ M?OVLM]^MW=V],D_CR;9[M_7[-QR'7C>.PY-LEAP=$@&K@$0^C[3/332P% (I M%B"/^U(1XE.TN_=^S]0J@5Q/3\X_G_Y\9FGOT^=3,'2!X,ZV7]X'?<6XDRTO M/YK+?TA![4R'\ S])9Y4F JH&*;%<)(51A.U]0BR26FF?E!J3\;&)_'YD -E)MZ:@;PU56:C!W]-1DN%RD8GJ?C M<3I,VX737X=7\>PR<>00]FJ:Q+-B\TT9 M7)6O+QFL5VSD-$SN!AX1+YS8^%D3'OA\<;/V2!A\:6+-LWQ15$]9../43"C+G6)Y,4WAA[OGX*1&4QB:2JBC M03EL4Z5C +=-IW$.BSVRTRH?;WXP]%F]ER67"YG0!G5 MHIC%NH_9G%D&4UH BSI7\-;K9#)IMLBR"Y!/;.EJ",P/=WY)1XF3S6!L>1(7 MV <5_L61Z =>YD%_\NL:Q\>[."SBPQU%P>],$J3%)# M5;"4_UZ.+NT%L,<5+E:/@XD4BX\7 (OCU,QT4CJ@K]*Y>?,\*PICQ]PW77/F M8N@H*TDGV1!,KQ)A!X\*G7L$CIF?9=^1)9)!-2_K/35G3(-MU\,:[2MQY0"] ME5QY!VU,DB_)Y GJX#?25QI66G']9PLRAFZ.S9&9.:^KE!?G%(SGM>4MKX11 M'[064TJ58@ZL8_D%L-=)"A-;DP(O&3>@9=1TMJC=@B, '0-0:3W_BAX<$U:W MAFQY/7_G.Z H2TY6_J<;TGP#B8UHKR7[V!YYUC!S)Q4U0%@2VB2-+]))NKBI MF?BNP=2F]QR^BO,5SS>7PN07=FF*XJK.U\@!OMYJ'!3L;,[JPF&IPNYR; M_1+6=PBWPNUQ0UGEYN_XUKM8]38W6H8E/YJO+ZW8J$@!YF^- \P]8 <-F0D\C\1*%P)3*K4VRS&O1O+C* 26G M?5P9]4=M,^C8>UDZ\ R/NFA>+&\"KZ=V&KI&D99#J MIJ5[V_]3JZ/QFD(Z<"Z6"W.Z;R ROB@RDP@P*$T<:P2O]%5+:F;IUNS@2CT8 M;@S2OG>:+(Z/:Y%^4=,''#UZ6I_26I_")I;BUQ8U$G MPWA9)/64TIIV)FNT8W3GR>36Z,L]V;3!5R-8=S;4JWM[3=<_=E84?VY1O?A 5'#FGYW_7GYWCD^CT\R_R_/CT MI"OL[RA=X21;E.[$H4'JG7C,?^JK_0=/'P^(P6AG#.8R'6'B(152RDQ0HR<1 MEMS3%+-(8/Y&&.RAKFO=<=@G^?G<.3X^WNG\OJMQ/7I\[M*($,PCCVK,%,72 MQYYP)8X8H*HOY*$>GV-TY(3'G[4Z/_U\-G#T_Z_5K^?'_]3.:10=*_VY/%-7 MIY\_G7Z6Y]KYV^D_]6<3W/&$>(X7?;UQCFKM19[IU%[*EO\ER2Q1IWQ;:W5-*M.XLS9VJ@Y M #_3JCYMA!5P1H 3M18U3DV(EW.3Q'EE^M46G&.,MYT-M^=9?58]M >760[6 MF/52&&T/)G!ASK/&1O,;/D5BO(@\,[[[BRS.1V9U1VD.JF,&>V*<.?$H*_W. M8(>-K ZK83^&I28,-M!H61L$]?E:><)8>[*2Z7R2W23F)+ ^DZS*BE5O63_E M?."H:7#O.5-SYKYY+%HDLS3+[S@3+8,&3.J)8Q:SB:0KYW>Q+%)K>PZKV9F' M)>6D86_G8)4T)WSI#*PMF$9S4N@8 6=^-L^\3BX*8!?G&NZ^,G=/LO+P%];K M^OKZ:#Q9IJ/TP$M(]"@3_I*8%'@>?S_^!'J( VK(N3P^<0)]HD$I,6&E MY>]6-_E%GLB_V=!4^_&S_AGTE- Y.S]5__OWTY]#,,C %CN'RP^;HAM?S"J, MY?T0=H ( @-)2:DC1A@+0'-6H41$!V'$T3-J1^R9:.G1BCPMY0%P&K(]VZ#% M\\\20%79'P=51'6I.EH='A/N8 M]"OPFKF=>:W/^C?=@!6'%T>[NGK,DJ?,.ZH?$3WF"^PR>^#@B+=DE8^NM5>I$^"\%L!&+U&&>2%DU8G0V\LZDI MQC/[/ J+:(AD$++ BT+&1.A3Q+FKHRA0FGOR>116K\*S",D&LI2G#T9]M2<0 M58S6AFZ[KM26136JM9OGR9WH3M/H4R M6Z?";_ 8F76F$&-/2+ M'\XJ47 _66'OT/>W*GY7"7 J?X^,J5^"? M\N=?K4.K_%Z>A.4?__A5_GP<_>OXY&_5#Z43X>S699^U\208+?QY=42WF<]S MEN.Q.J+/QJQ[@LN> $)K5V_HD;?=].;S^N-FQELRV>1\5%8IMM6"G6$RF52_ MVC++YC,, M)#_4?[3J*WQ8=:6"2\PJ_?>',D;FGJ95Y3M<]R\_UA?=_@WO]M..M_4OV^5E M!]J-3#R5R<6]3/Y>"OHW7,L^/#S9"A*JJ>#Y5\?:6,[_L75R4+?5_UO*Q$Y; M>Y)=LH6$(=BHN;]^4QI45W%^F8S*K5ID MWW0L^NL\F15)SQ#ODB'"Q$1S&H[H">!=$L A*0K:1%8?J';PN'4 &_UXM_$# M;\W]KW9ZP]T)ZEUV8'\7\+'?1:C0R7H*6]!TN)9F3QIO?!'>[<3[W>]W_SWO M_G;JTN8LQ<&J1?61<=4$L*S?9ZJ:&M7Y?1I.G<]O[YOXRKL!W]OJ@_H^3WQ* M5V$(Q.,A"P.N7(EYJ(3DF)=A"*&2$M';K3YD3=@5?=,YJ0B_JAA9R-/B=%DG])BE:SC?57JSP9I8N?LZ)XM&,2 M7370'H :0/(=X\@ M"&\0A#*ME0B0P"I@-(BH#E"%(%)KU&J%MYU"\INIQGPZ'K\Z4 % [1!4VGQX M",3]?8]"/0I]>S7&;T#(BXAT(]^3@#[<)0(17U<@Q%G$2-=6D3A8JP@3[RTH M-?V)G#F1X[WKM7>]]KO?[WZ_^_WN][O_KG>_/W3KSO'PY\Q)CY*[L2Z$] M%+J!+[! VB-($!U4]J4O(]URDS_7OO0.UKYDJ'>:]WC2X\D.>$*:4WQ-?(T( M"[2*$",>YHJ&]2D^]KR6T_R)QV[\D#WDQ.T!I >0'D">?.J&L=L@B!_(4&L7 M $,'D4>$=(/JX#X C<15W1^['32H8,KZ8[<>A@YCHUXY##V&0EX?C?AFHQ'[ M^]KO?K_[_>[WN]_O_KO>_?[_OR!>U+PMG*O@QUY"DW M1&X48>1Y&D5A'==)/!7Y7=N7[&#M2XSH6[ O>SSYO^U]6W/C.)+U\^ZO0+BC M-JHB+(G@G573':%KM[M=+G^6NV?F:0(B(8M;%*D&J;+ULK_] T#*DFSY)DLV M0>:#'1))D4@<('&8F<@$??+6^L0SU^Q5/>SBONE8GJ=Y&',=LMSNUL-.YY[5 M_(5^-[O,)G+3!<<;:!#0(#LXW@R\%@HTZ!JN;K9[IM>V^KUN!QM>KD+ZNC?H M6OMWO)5:J[C@=P,M5!*@%-="3RDA ^(1*QN/**U,+5D Y/9X\/*B)'MISYWR M+Z\O%+2'>C)W"L)LJ)\25ER9$G85QGGSR#Q+E@=RU2Z/0%$6>!@49:D7I8*B M+"]TK50'^JK+![G62Y1K'8JRP+0HR;1H!U"4!8JRP(2 HBPP ,I'%* HRWL' M9$%1%@A(A'!40!_0!_0!?4#_L4ZH5BCZ/PEC),X6$'\.<19EBK.P[56<1=?I M&)KM=?L=SVYWL-[KM(M@+Z?CZI93HOW-R^FTO&!O$1:VYU4AP@(T"6B2M]8D M[BI3@MO1!@/L&:[;ZW;LOJ9[W<%2DW3[#G[70BL'TQWXV')@WPIH#] >.T2= M.]I*?=B=@8W[FF9V>]AQ.AW#-MU"?0S'J[)R0(UB:OOD(_I:N&X;)5<.@/^AUM8Y=A)P[7=?V]AYR_HH2*P=3/JY= M"3(#GC4HK@+V54 ?T ?T 7U '] 'SQJ\3L+KY*%?)UUCE=G)ZNC8[6"],["Z MEJE9'7O0+EXGVQW;WGMFIU?L8#Z@+4O3*_%"";H$=,E;ZQ)KY:7ON5W;ZO6Q MW>WH1K=GZWVKN_2MM?N#WKM64SF@7WZ?J5= =X#NJ(SN>,JSYCHKY>%8KM;1 M.F9?RK@#Z@#^@#^H ^H ^>-7B=A-?) [].ZIIFKZSA7:]OX+[N&1VK MBWLF-KW^TK-F#YPRU4PYI"W+L:OP0@FZ!'3)6^L2?>6EY\IC,'#<;J^G]4P' MZ[C;L9>F*=MQ[Q4[>--Z*8<+\]YK40/0': [*J,[GO"LZ9JY%N*#>X-VMS/0 MK7[/M-UVQ^CA0GEXCH?MLE5*.9@^\0P7_&J@@,H!E.(*Z"G]8T.(825##+<5 M2+E7J&0?3UL3[XT*KLA_^>&[+;B?@//HX"WT[KKOY/\)6]YD1JYH8\0H^=X@ M8]ZDSR2Z)HN4/ZHU884T1,[+U#1MO>=X?<.S!I8UZ+J>.3"[7K?C.OV>T?'$ M;\A&-SPFV[H6PD+G'&BX/07*1L,<\\.],BT'&R8/=LW>6R"_WBGF<-G_FB^% MV&ZBP;>+KPAKC3_0\,^O7]L7_W['QK['/#Y+8MHLA>8HYMK Z&GM3D^LH3F.V1\,1'H9N]V].]>> T^A?DH.(E;!<5%[RQ_.:KF9IMJOK-I?)M5Y7&4IJUT<+ M0V%CI[)%YFX_V_%I>,?J548U"RAMF37]FTDX"I^52/P@+9#WYXPS89*&?9[S M><7$C!)J$M0*2D1;& MMHX]L\7OB+%G8-W"IJ9;NFNV MO&IN<&]$;'S4DVW06<]A6C=,KG,2)Q@,XC M_O-DC+Y2=D49"L2JB'XG\9RP!=)=N5W$1*.%O)A,D_@*#:)Y&(174]0MUE'> M(<>H]]<0#?U0K&/I,>*+;),?(_Q=?WGKX7R4'Y>W&DX(HQ,^]_F9"SIC-.4M MXK?Z0=&0LA\AOPLZ/>VN+'@$)DH9)LJ#->1?++O;^ ,T8!6!A:6MHL#BENZU MQ'I0>79FP! ^S!#>%*Z\A MKCFMBO<69EK$ST^H+L2>H/_CC KZM3)*B)@9?F ;R4)C\6J$^(+!6*(Q=2W<%H]F&8-48C0ZC%!A-SFCTG6U'VZA,9Q&1Z_1!TD+'8^I+ MPP[)+RJX2PZ:!_Q%?34*_$5A\&!E4!B[&O$7 T;IFX[2DKO$;, ;>FF O15^DQ.F?+0(TT=YVQ\$<8T2LJ:PTIJEKIB@J[/&_U@_3P:[G_(?SFL:^B$T_"J?ABM@\C[(\9-@!*J.R M2@4JHRYV0&74Q MI8V-5H;I":^2;7NZX[R*M)S(]#5S1H^+;56W4;MFOJWJ>+FO:D2S:\K9S=;X M&7'!G\UA$W5(_!V=R8,D0NTT3?P02([ZRA8L,STEEF/S4PFA,X MR7F"Y.P<$3P(69JAX7PVB^2F&@#[P'LX+U99>QJQ'L@E 9XSZ%X M3\*FPNGT:Y2,."LY2S**/H:Q'\W%_J@P1D46-<39]R<@*BHK3" JZF('[[[J M8EYTNR0WJT)B..?[&FUU,IO;9(1A6D/[C(-=T\ N_^B86HO?\3^[6V:&O/TBP?"C+JFOA#<) MV9+VN,?@B%)O+ /5 >S $:4R=D;+%D1G6XA_U8C.MDAJ&*1 =%Y%=)8NJ/Z- M/R'Q%7W4"66#$TII90DD15WLP FE+G;[)2GEY2A8 Z-AO9U06,.V=$+1&_[Q MM:1$6%RF<;X[6QA15E6GGK2UA%F*@I!1/TM8GFDO&?/[4)8"A5%9E0X;N-4& M':,H>K! J S>?O,$EYK&@$%03>@N9*P*#9J '\@'\H%\(-_>Y*O:&F_\5$,0 MP59Q:ZO0=,=P-2>W51B[VBIT3?-0_^]YF"U$""MGVZ)*T;(B]O8RUR1%)"^" M!,8(E=^(A@UXFU45.[$ 'BJ@J?GR>6T.M"4-O 4X"FW/(6\QJDB=^R0I1IC& $5165,"15$7.ZG\ 3U5T:L11S&!HM2:HFR$?9B[FU(P?IDI M!;B)RAH28CE41D^H?0!/5?!J%,MA@@$%V,F*G1S,@/(0>0&2HK*F!)*B,GI2 M_0-ZJJ)7)Y;2 992"O#>G[4\5,,9:XV=]_FV1;Q)SEFR1!*6K5MG'C'!B#TT MCP2[B-/BMKV_AFCHAY2?38]E4C=Q4PVH45F&/6PG!NQ@CX/2X.VW_G.Y:5$7 M:%$IP'MW6F0Y6#,]41':L2VOE?%/NHDMSHL:P:O2GTB;CLS-!H:=TH_./1IV MNNCR6^,$M(NB^'T,/GW4/P%\BL+'.^\\?[R^Q;9+\,I3=$9O487R93 MT]4LS79UW>8RN=:'+Z.$\46_P6E,1&8I_;S\\.4N.SJZI=C\$M&3/Q]Y1P\3 M\/R!V/CPY>C>%"[./7S*W.UG.SX-FZ]^VM-O( ?4PP_S6/>E\T7\0'Z[SD?J M*(D"?HOQ[ :E210&2+ZK:-J; MKYK[&HP]FOHLG(F! *C7!G7^%EJ8[&GP'#UTL(:,%CDV%W1,F;#XOVMK!BR9 M(O%"#U,!I@),A;P]+Z K!VL-T)*:SGXYYIPS"Z.[$K*:;H@?#NPS8E=I+ ML7..D8MY1*678I>XC7'"T 5-,Q;ZHFC-,$O\[^C/.,Q0^YJP($6_,A*+,UF" M!F+IFJ!S(N ,>3,S2)>JM)45G!QJXR><' 8X.52%[TDG1Y4H4!^&:1FP*S4% MVGEO\*LIT#=I)06V4[YQ#&P'\%NQ'1/8CJKPU8KM#&"8E@&[4K,=:U>V\^(C,J:%(B,VO@)(F,!D5$5OEH1F5]A@TTIP"LUD[%?6\KO M 0_4>H!7(#^*W(C0WD1E7X:D5N?@-R4PKP2DUNG->2 MFYS1Y!XFX#3J#%;@-(#?BM,XP&E4A:].G,;ZGY]<73?K6($2KR3A\G+ X)YS!I%F;S MC H:=$G]2B6XUJN MY#EXYY"?!Y(P.^@D#N9^SGUD6:V\\(1@-8Q&DL*,1;(@LF1(4&E":17J-OX MM:(H=F)5 /!4!8_K^+ID^L$P3&M*71SLF@9V-RB4;X5?6G*V7%[FYNCXE&H7GSS?XQ8ZQ>85HIJ?Z!=ZF('M$MA\-R6+EC7-L]F MY5B7#J-42>PN:$K9#QHT 3^0#^0#^4"^O +=0/6TKMN[JKB;<0CHV MG%9Q1ZQAHY%F] >=^K,)":-DO*NY96M"P&_C,66H"),1R0/%HV+4;:*O_KEX MWM(2,Z C-B=L@717FF$<\!.I_-Z$-;!8* P>7R< /471,UJU*0F!36 S]60S M19"+;GJNI1NMP+0,U\5YD(OYVK)66YE,?SJ+DL5T&=([Y#R&D=C?MM?I08\1 M)?Y$/"#,4D1OJ#^7VYF2\3CT*8/(&*75+KAHU,5.+B6 GJKHZ45LS#8'1N4H MCP64IZ:41WX4P3&:9EFM<11,&W]CX9SDI.?F[U?%]VXQT\PFPDXS86'*NW$B MSH9Q-KDF84:7-IO?Y]$"85/::VQ@+TKK4*WQ_T"O* L>1)@H"Y[5Z]+0MZ'XYK2+( M&.=LZ?CY4<:/4K%]!AS#U%!FT0"ZIC1X30BU5!8\W/($7]M6^*-RY,D!\E13 M\K0E20[>.3_R7>O27^%W1J;H]^1J:4@BL8C]V2@VZH)!264]"4ENU,5.JGY M3U7TZI3EQ@6&4@&&L@I&WCD-\5V.T6$D$+NRVTWT!Z-7_."=.&-LY-N]P8)2 M]M%W$"TY"",^&OA)>AUF$X 1Y /Y2B6?I"JMC(PB>GM\Z1I;NJ^>=I5MME^L M2XT)E=)A7?NP#P&\NWO#Y?\)6]YD1JYH8\0H^=X@8]ZDSR2Z)HN4/ZHU884T MCS5Q'38L(#F0]^^IOGU&WZU=O3'Z--YJ"4T8BY2X\OOZ[>*$34FT*:F6#SZ) M/_)I%!5G?S[2CN1WWGA_^7V+[)?AE*;HC%ZCBV1*[@W5ZS#()I\]K^EJEF:[ MNFYSF5SKPY=1PCB!:7#R$I%92C\O/WRY2V"/;HDTOT3TY,]'WM'#-#M_(#8^ M?#FZ-X&+\8!M=3#KQKN2^>+^('\=IV/U%$2!<+_ ME_/5Y[CL#]*"ATGWT2]G0%=.5AK@);4;%;V^'3,.T6:VNK@C(#*$!7P1>P>+8$US7"Q M5T1+O**F$-E:0;%]T4<--.1W&XA@TS#U$W26-!%VT.EI]\%"0LO-.D,ZR]9* M"17;=K1C$9Y*B@W/=Z[)RPUA**JHM*=CV,"M-F@F1=&#=45I]%J.",78%@I5 M/?8#2J84X)6%#ADZUFS-;046-AW-*5@1V946#;D@G.+(W"R2%V4)>H0J-;81 MI>-G,:7VC(41DE&HV #NH[3^A7TR*H,'BXK"\%GY1IEMB02KQWTZ,$SK:?K) M=QF;XO:VT1(;;E$JP>Y^G",*T[Y\&:O:HDH#?&X3B;W%*>W3F/N,U; M4)Y;?Q?"%A ?]=4O$!^EP8.T*.J"AUMV?9A/#\9I/9E/[MFR3$VW1%H43^,' M@E=EWAV&-V_#=7K4SZE.7E_) J:CLKZ%:@/J8@?I>E4&3V]A:>.Q:L%T^C!0 MRP#>^S.?W.;CB-N;^EKQ 8>3G[SVP$TJ2CON'M[#?_PV3.@KX<(BW3B&,I/* M:V,P^*@,'O @9<$KHGMJ4672&\ P+0-X[\Z"+ =KIB=8D*-CIY7Q3[KNXO\( M_M/8V034%QWR)LRGJ$&@0X5M]14P6(#4Q0Z8C\+@N36JK^W]"L.T#."]._-9 M+S[I>BT_(FD:^IIM:-C]6Q?\1]^5_IR%;V;W62 CK[\$Q0645L%@]E$:/(CS M418\=VNURDJ2'WU; 048I7L6KHQ<9TOQ(UW;E=Y*8?/:^O)&_).5%^M"!&D.M':?4,59?4Q0Z6'*71JU'5)1V43$V9T=IN=ZRM M[?S"O*$%@Y';WE]7Q2D9HPW61/PP"K-%81:Z5S%[19[.,]I$IUG0S"MG=[KH M)$ZS,)N+7B(1NF3"_36D[$?HTQ1]O/WE)W0:3D-.I"1KRL1EE,JJW2E7$0$_ M=D'Y[_MIQMD6ORGOHTQ:IO([YASL&R=U+%+JHF>T M.)NJR68R'6RAM>92EOAL>"LN)8*JK;]W]J9M95 Y<1)TAG=3P85RVQ/)UNC3 M+=%Z-L7Z[8:@$;MS+=TB[.@D]AO'J_Y[TA, E(8'S* T>R NB@,GEZ8:^JPY4RW@+K4 ME+HXV#4-L<7,MBT97/2?5^157/*4%0?I)/$\1?T;?T+B*V&UR;*U@M1DAVI?T/] M><:?5["8\XC$8$Q161%">+'2X/'W5$!/4?2,EN[6I2J[[D#T2ZV-*FL[MERG MJ$\:A7PRI90LG3?783;9E9F!'FLY'FU1HY^(5MS?:PH/N M,9FG*[&3>$[8 NDN%"557],"RU$4WN:_)=DP3 M&T8KT"U+\[R WGC>[G5)Z8P4&097E$80EXL\P\\MO?F5_.\\17\UT3\3EDUX MSV5/9RN\S93C28)C \%16!-,H"YZ("I:U2.T:T!L#\L@:7B*Y'_>DL2A:4HF&6^-_1^9RW1% =B+91 M75,"15$7.XCW51@\MZ4_NG.IE9%11&^/R__RWXBUUKX_W,9-&<3RTYA0*2'6 MM0_[HO080'+ M'MI<=-_]9C_2M\_HN[6K-T:@QELMH0DY!XCS[^NWBQ,V)=&FI%H^ "7^R*=1 M5)S]^4@[DM]YX_WE]RVR7X93FJ(S>HTNDBFY-Q>OPR";?.:O-ZYF:;:KZS:7 MR;4^?!DEC/.4!N[U.?HEC[S2T1/_GSD'3U,KO,'8N/#EZ-[ M,[@X]_ I<[>?[?@T;+[Z:4^_71Q0#3],4MV7SA?Q _GM.A^IHR0*OHAX:TE3 M-V?0&[;@86Y]],O9?#I:V[@&*^)^Y2OT0W$-GMV@-(G" ,G7&4U[P:*YK\'8 MHZG/PID8"(!Z;5 _B?W";DZ#Y^BA@S5D5%0(NJ!CRD04P[NV9L"2*1*;>V$J MP%2 J9"WYP5TY6"M 5I2LUG9X],Q[Y1!&-V=F-5T08 =JA38O;L+PG*P9GHB MRYJC8[V5\4^Z[N(;77@A=G="#$E$TU6XQ3()5%>J)'R3B?\=1HB+=37E,!0E,4.(BT4 M!L]MZ?7A* 9PE%* ]_Z<997O'EM>:UR0CD8ZB\(L$*$=O!5C&L8[9UZ+@X2E M^?:7H;AIHR?OBD[Y;47IPWG.7&ZM-D!?5-:B4)]':?":D)5-6?!PRZD%?]'! M$%A7"XNMN[JK";:B8\.YK?FL8]Q(YZ.44Q?"%E&89J](1)+?)9=(54@="_C! E %_(R:.(-T \;IN^]H. QW*;[K!L;:=U&.85?"T4WB5)A& M.-=-0 MV_>3>9SQ#D*#D$&50*7?XV0P(.(GJ4@K7)+Y50H803Z0KP3R58NCF,!1WMF8 M\AQ)"MKQ4XKUKFYV3;=G=;'E&8YG#CK=KJNUM;:)<;>]2R^=)]>4R1!9+@Z+ MZ0)]]/DUA'.B (6Q+$6<\LXAV9Q1)+9KHRSA1\-4;B3*.UF\5'\"Y@',HXHP M@GP@7PGDJQ3S,,"*]][,8Y^F$ ._VA0B^F/,>T1&NI[/63HG<2:H!G;1G\UA ML]M$0^J+LP7E,"SM6.SN:0?)+)/FD-5O-JXT-%WP&T%DAH2-2$S3QK>;B#.= MMB]M+[J67]&=A'2,5M4"OXUY@R@#7@.\IHHP@GP@7PGDJQJOT6N(875YC5X9 M7C,(8Q+[(8F UP"OJ3*,(!_(5P+YJL5K]";^OQJ"6%EBHY?88.-I-AAL5!BL M0&Q@803YZB9?U8B-#L2F2L2FQ!8;(#:*#%8@-K P@GQUDZ]2Q$8D'SLY&]80 MQBJ@]Z_.Q:G(CY+)]"B]Q)^+["BYR U)(,+ER: XR3_0%,5)ALAL1@E;!N^> MB/6+,R;!(WHD(TBL0VA$?3)/^6VR%,F'9>0J18111*X0)=$_CS*_26G8?Q] M1%(*S "8055A!/E OA+(5SEFT.L/:@AC%=![B!GTZ#B,0R &)8 :B $L+"!? M+>2K'#$X;7=J"&,5T'N(&)R2$8V "@ 5J"J,(!_(5P+YGD<%1@D+*%O*@&'I?_U]HC@L$;$RI;BW7MPX:,[II LA.P."*522AK6'QNR".K)GDO ME<%;$^$GA+Z2F%SE149%ZFH1[)ZBA/$OTQE?1/*58Q:16!XEC(DRZN+R5,3( M7T]"?X*"D%$_2YB\A-YNO$ORC7=%9#S'.>3](O;US8@ /YR1C-X)A-^]G_1[ M_:3OIY]<73>_('2>,-$5Z7(/8K%E$DW(#[$A@,8HF8:9V,$X6]O!R!\FZ2&Z MXOTF3HX6^0Y&WD?\<:)6FBA#W[_Q\_+TW60Z#5.Y=(\E"/$X%.*(S%,9HR3; MLGF@='WV?PB=Q(CX/A==[K(0JQ4ZR6B1\-S6\,?1IX^&_NEC&'X2'7I!KXH8 MB/R*8>,/V2_#?I>?BZAP?9PES2)UE]%P=<.5%QAFPW0\USZ6&;HB=#&/Z.>U M,2W@P\Z7E-]EQ@'DZ,7YG@YQ<5>,]R1"W[B&6,OPE5_*>TD^87-'*V]K+TS] M*$E%0G<^ 6Z1$YM0SWEW)$'H+Y]V++'VU^^0HO&(M[%*9+[E>_.";FCE]UKQ3&?=3Z=97D2?3$',Z&WL@G)MM8; M1.F,^K*]4;18;Q377=E&NW:84@>=0O\8L=8O]]JT/'RWC??)YM'C,NSE?5&[ MLP#*_Q.VO(NH=M 8<9WUO4'&O$V?271-%BE_5FO""G$("H.?CYY3FF&U:?M% M.N\.&CM+NP6/)U&YU[ #O!/(K]?Y,T9)%/!;#$]^/6M?_GG1'^ZV3-P;TL:> M^G!]9[^8O8S^/>?$(><2]]20(10 MCX&GVYW_:_TPX;6Y:>Q9YC'Q4U%B2^Q MV/*5.47!G$]\N5DOR+4FDYJY4%.B- <_P16%4,$C.B'1>+E"2[V47R#OS.A< MJ"YY0S+/)@GCH@4OT!M[HFR[/' )V=K5&UI,NX.X^+Y^NY@O-23:'"5:3K0E MU^7K0A059W\^TH[D=]Y,?_E]BY27X90#>4:OT44R)?=H^7489!/^DE9LBIDDQN<_GG2._GU*^I^NSC_=M&^//EV]H25 MN518%Y/?VH_V+[5-X.U$O458KP_"+QOA"LWPGGB_$:^;C+\;8?<8Z1KV2F9] MWI>LG<7G'2;O>SC'2F'0+(%G<']^AU;:0L.,SB8T1MT)XP0[X9^9"$O-)MZ^5#RW?-)5'3V03VWY'E.R.\V_;68"N@?-O_^Q?H&\#U+Z\_'9QUO]W MR3P$?YQ]^R=JGYZB\_[%\-O9$'7^C2Y_ZP_[Z/R"_S^['![GSCY*^ OWC+(T M$2$(2;I>93M/X"?,^7Q&" ]ZFH79/"L\[?QL$@J'P^/KJ[SVK_ [(U/T>W)U MC/Y7_$J8_OGQE/*A+UR*,G&Q\"HD3+AL4<;F^2\C1XAD>57PE'<4%][/ MQQ:Y$AZ/X]PKSB^+T&Q91CR=C_+6"N>EN)8/RK5#Q])U.PFGRP>*2\)XO0DQ MF=)C$:_AYRU),TJ"8W&1<+K*Q_,'^D08YX4KY5BX0D3G;7,J'\L?\ N$^S@O M9BYO+ULN[D.7[NLL]UCG/TC$M]M4AS).A,,0Y^Z=_%)QA^(^SPN'.,XC*(17 M7OIA4L)?I!_KW_6>E4=SGTVV$/($B3S&1Q#OT&D^G,0! 2SOI>)&(H/C5>ZF M2L68X%W,A:!I2MBB\" %24SSSN5/&"7S3(HS8Y0WFPLC1!5N9I*%X\4RHD & M=;"I_,J;* ?TD^(<2X!SG/DC0K8:*[)AJV_\TBE9%$.0CU@NJX@DD0DKUQK- MF_4C9!D?L**1R7C'H))W\Q8^TR.X+U_H-BV/Y[ ,\[_"&G]?$0'/LIBAC^C^C^R4]?4*_8.E*2 M;H)A\&+YGHQ^*45&E?+XZ6!8@WP@WSOOT:P="5OY,FH(>456VIQBK38J;J%8 MJY."D[5]/YGG3I,EXRI)[P#ZP+->QK.>4F"ELB?4R78":_7>#29D.A<)_IJH MFT0TBDA)E!HH[1V6;!*R*8F73N1.0EB09Q$H4F:41'; %A;D%QH^GJ>E:K-6 MU4G6>J[+9R$'F*3H:Q-U"./J/*+314GT&^COE^_>!->#X@C6? 5^@3ZJSQKN[5?F9ZFIVBQ5=9*UGLOR M.JP+JN.8*G6Y;=?>I^GBFJS'M5)UGJNO5W"HB1% M?S7Y*KR :"UE]3:LO*HC6/.5%Q01R ?RE5B^Q[(%EJNZ$]Y2[>B__M$:)<'B ME__^1VN23:-?_C]02P$"% ,4 " "-@7).7$/]MBVR !_W '0 M @ $ 8VAA&AI8FET,S$Q M,3!K,C Q."YH=&U02P$"% ,4 " "-@7).A]ME^I\( #3-P %0 M @ '!S 97AH:6)I=#,Q,C$P:S(P,3@N:'1M4$L! A0#% @ MC8%R3EW,A<+[! 2QD !4 ( !D]4 &5X:&EB:70S,C$Q M,&LR,#$X+FAT;5!+ 0(4 Q0 ( (V!&AI8FET,S(R,3!K,C Q."YH=&U02P$"% ,4 " "- M@7).TP$ %0 M@ '@]0 9FQD;2TR,#$X,3(S,5]C86PN>&UL4$L! A0#% @ C8%R3F5, M9-LM<@ ;Z$% !4 ( !&" ! &9L9&TM,C Q.#$R,S%?9&5F M+GAM;%!+ 0(4 Q0 ( (V!&UL4$L! A0#% @ C8%R3KX &5^ZL0, "_(M !, ( ! M14\# &9Y93(P,3AF;W)M,3 M:RYH=&U02P4& T #0!C P , $' end

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